Search by Journal
- HOME
- > Search by Journal
- > Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences
Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences
Volume , Issue suppl.1 / 2012


- Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.
![]() |
Waking - of medical - millennium to stand in the forked road Hiroshi Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 151-151, 2012. |
---|
![]() |
A 24 fee-for-service revision and role of the pharmacist Shinya Koyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 152-152, 2012. |
---|
![]() |
A community medical care planning review and role of the pharmacist Masaki Muto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 153-153, 2012. |
---|
![]() |
Hot expectation to a hospital pharmacist Tatsuya Horiuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 154-154, 2012. |
---|
![]() |
To hand future children an antimicrobial agent as effective medical resources; role - of the pharmacist in -Antimicrobial Stewardship Program (antimicrobial agent control program) Akihiko Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 155-155, 2012. |
---|
![]() |
Inflection policy of future and PMDA of the pharmacist Soichiro Isobe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 156-156, 2012. |
---|
![]() |
Medicine - antithrombotic drug (anticoagulation, antiplatelet drug) and NSAID wanting you to be careful by all means from the situation of the digestive organ physician and helicobacter pylori sanitization - Yuichi Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 157-157, 2012. |
---|
![]() |
For relief, safe medical care study on evaluation of - medical supplies and evasion - of the adverse event Toshiaki Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 161-161, 2012. |
---|
![]() |
Promotion of the individualization medical therapy by the pharmacogenomics analysis 平塚真弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 162-162, 2012. |
---|
![]() |
Study on evaluation and offer of the drug information based on a clearance theory Yoshiyuki Ono Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 163-163, 2012. |
---|
![]() |
Study on adverse event evasion in the use of injection Yoichi Kawasaki, Sendo Toshiaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 164-164, 2012. |
---|
![]() |
Establishment and outcome evaluation of the complete enforcement system of the antimicrobial agent proper use promotion program (Antimicrobial Stewardship) Takashi Niwa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 165-165, 2012. |
---|
![]() |
A construction and clinical application of EGFR using PNA-clamp SmartAmp2 and the KRAS mutation in the gene analytical method Takuya Araki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2012. |
---|
![]() |
The elucidation of the onset of peripheral neuropathy mechanism with the anticancer drug and study on countermeasure Yudai Kawajiri Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 166-166, 2012. |
---|
![]() |
Physiology, the biochemical development of children and development of the new child dose estimate method in consideration of drug elimination course Shinya Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2012. |
---|
![]() |
CYP3A5 and effect of the ABCB1 genetic polymorphism to give to the onset of efficacy, side effect after the change on fentanyl patch Takashina Yoshiaki 1), Takafumi Naito 1), 見野靖晃 1), Yagi Tatsuya 1), Kazunori Onishi 2), Junichi Kawakami 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 167-167, 2012. |
---|
![]() |
Search of the disease developing mechanism, new treatment with peritoneal dialysis method of complications Tomohiro Mizuno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 168-168, 2012. |
---|
![]() |
A search and application of the molecular biologic index in the individualization immunosuppressive therapy promotion after the S1B-1-1 liver transplantation Satoshi Masuda point, Miwa Uesugi, Minoru Hosokawa cord, 新家遥, Shunsaku Nakagawa, Kazuo Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2012. |
---|
![]() |
Trial of the chemosensitive monitoring in the S1B-1-2 renal transplant Takafumi Kuzutani, Jun Takamatsu tree Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 171-171, 2012. |
---|
![]() |
Likelihood of the renal transplant tailor-made treatment by the sensitivity testing of the S1B-1-3 immunosuppressive drug Kentaro Sugiyama 1), Hiroyasu Sasahara 2), Tsukaguchi Maho up 2), Kazuya Isogai 2), Satoshi Toyama 2), Hiroshi Sato 2), Toshihiko Hirano 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2012. |
---|
![]() |
It is prevention, the measure of the side effect the drug interactions of the S1B-1-4 immunosuppressive drug Masato Honma, 幸田幸直 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 172-172, 2012. |
---|
![]() |
For the further spread of S1B-2-1 generic drugs Tsuyoshi Matsuno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2012. |
---|
![]() |
Distrust of the physician that S1B-2-2 grounds are ambiguous Isao Tanabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 173-173, 2012. |
---|
![]() |
It is ... from the situation of present conditions and proposal - medical office pharmacist of the S1B-2-3 generic drug Akiko Kume Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 174-174, 2012. |
---|
![]() |
Trend of the diabetes diagnostic criteria and the HbA1c measurement standardization that S1B-3-1 is new Izumi Takei Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2012. |
---|
![]() |
Show S1B-3-2 diabetes and a testing viewpoint; one, how to use Meguro lap Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 175-175, 2012. |
---|
![]() |
Topic ... of S1B-3-3 glycoalbumin - these days Keiko Yasukawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2012. |
---|
![]() |
The latest treatment of S1B-3-4 diabetes Asako Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 176-176, 2012. |
---|
![]() |
For a fact and the future of the S1C-1-1 pharmacist outpatient department Reiko Matsui, Satoshi Izumi Shiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2012. |
---|
![]() |
The role that a pharmacist outpatient takes in S1C-1-2 tumor physician and a mild care physician absence hospital Imamura pasture employee Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 177-177, 2012. |
---|
![]() |
Action to the present conditions of "the pharmacist outpatient department" in the S1C-1-3 cancer medical treatment and "medicine medicine cooperation" in there Tomoki Nozoe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2012. |
---|
![]() |
When outpatient department is to the area more, to connect it from S1C-1-4 hospitalization Toru Hashida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 178-178, 2012. |
---|
![]() |
Expectation to the present conditions and a pharmacist of the promotion of the pharmaceutical products development from the S1C-2-1 academia 荒川義弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2012. |
---|
![]() |
Relation to a study drug preparation utilized the experience of the S1C-2-2 hospital preparation Ryoji Yanagihara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 179-179, 2012. |
---|
![]() |
Action of PMDA for the pharmaceutical products development from the S1C-2-3 academia 下川昌文 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2012. |
---|
![]() |
Role of the S1C-2-4 institutional review board secretariat and a study drug, the information management charge pharmacist Atsushi Aoki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 180-180, 2012. |
---|
![]() |
From the action of the contribution - Kitasato University east Hospital trial control center to the innovative drug development through the S1C-2-5 early stage, search study - Mika Maeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 181-181, 2012. |
---|
![]() |
What was different from the S1C-3-1 disaster medical care - Chuetsu earthquake that changed in by the Great East Japan Earthquake; -? Naito ten thousand sand sentence Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2012. |
---|
![]() |
About the medical support at the S1C-3-2 disaster from the situation of the Japan Pharmaceutical Association Takashi Kodama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 182-182, 2012. |
---|
![]() |
Role of the pharmacist in the S1C-3-3 disaster acute phase 渡邉暁洋, Keiko Fukuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 183-183, 2012. |
---|
![]() |
Ward drug duties and the evaluation that S1D-1-1 psychiatry pharmacist conducts 谷藤弘淳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2012. |
---|
![]() |
Side effect evaluation ... to work on by trial - team of the S1D-1-2 psychiatric pharmacotherapy adequacy Yoko Hashimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 184-184, 2012. |
---|
![]() |
A prescription rate and change of prescription rate of the high-risk medicine in the S1D-1-3 psychiatry sickbed Hiroko Kito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2012. |
---|
![]() |
The present conditions and formulation study of the change of prescription of inpatients in the S1D-1-4 this hospital Willow Tomoyuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 185-185, 2012. |
---|
![]() |
Pharmacotherapy of the pregnancy-induced hypertension syndrome to read from S1D-2-1 guidelines, and to solve Kayoko Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2012. |
---|
![]() |
S1D-2-2 diabetes and pregnancy Tomoko Yashiro 1), Naoko Arata 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 186-186, 2012. |
---|
![]() |
S1D-2-3 maternal feeding and medicine We cannot look at Tada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2012. |
---|
![]() |
S1D-2-4 pregnancy, fetuses and radiation Kayoko Muraoka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 187-187, 2012. |
---|
![]() |
Treatment with Chinese medicine in the S1D-3-1 cancer practice Yoshihiro Imazu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2012. |
---|
![]() |
Cost effectiveness and Chinese medicine of the pharmacotherapy in the S1D-3-2 psychological care 赤瀬朋秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 188-188, 2012. |
---|
![]() |
The advice of the use of Chinese medicine in S1D-3-3 cancer, the mild medical care Shun Ito is elegant Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 189-189, 2012. |
---|
![]() |
About the role of the pharmacist in the S1E-1-1 team approach in medical care Kenji Fujikawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2012. |
---|
![]() |
S1E-1-2 That you want in a team medical pharmacist : From nurses of position 竹股喜代子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 190-190, 2012. |
---|
![]() |
S1E-1-3 It should be the patient in the medical team, it can only to a patient : The "sickness cooperation" of the medical staff that has undergone the acquisition of appropriate medical care information 濱本満紀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2012. |
---|
![]() |
A role and duties expansion of the hospital pharmacist for S1E-1-4 team approach in medical care promotion Junichi Kawakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 191-191, 2012. |
---|
![]() |
From the viewpoint of the expectation to a pharmacist for the team approach in medical care promotion that S1E-1-5 is smooth and the role opening of an office pharmacist who should carry it Yoshihiro Abe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 192-192, 2012. |
---|
![]() |
About the foundation of the pharmacist system specialized in S1E-2-1 pharmacotherapy Ryozo Oishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2012. |
---|
![]() |
The rule of the pharmacist authorization system specialized in S1E-2-2 pharmacotherapy and authorized schedule Kiyobumi Yamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 193-193, 2012. |
---|
![]() |
From the situation of expectation - physician for the pharmacist specialized in S1E-2-3 pharmacotherapy and the medical education Shintaro Ban Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2012. |
---|
![]() |
It is ... from expectation - pharmacist - nurse to a pharmacist specialized in S1E-2-4 pharmacotherapy, the comparison of the specialist system Funada Chiaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 194-194, 2012. |
---|
![]() |
The expectation to a pharmacist specialized in S1E-2-5 pharmacotherapy from the situation of the cancer specialty pharmacist: Kanako Azuma Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2012. |
---|
![]() |
The future directionality that S1E-2-6 Japan cure society aims at Mayumi Mochizuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 195-195, 2012. |
---|
![]() |
Role of S1E-3-1 CKD and the pharmacist Sumio Hirata, Daisuke Kadowaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2012. |
---|
![]() |
Pharmacist duties - duties manual and introduction of the pioneer action that should be carried out for the S1E-3-2 CKD patients Satoshi Izumi 1), Yoshiyuki Ono 2), Tadashi Kamata Expo 3), Hiroki Takeuchi 4), Akio Tanaka 5), Isao Hasegawa 5), Takeshi Miyake sentence 6), Shigeyuki Miyamura 7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 196-196, 2012. |
---|
![]() |
About mention of the dose depending on S1E-3-3 contraindication, renal failure, renal function Akio Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2012. |
---|
![]() |
Problems of mention of the drug administration design to the S1E-3-4 renal function degeneracy patients and the attached document Yoshiyuki Ono Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 197-197, 2012. |
---|
![]() |
The pharmaceutical cooperation that utilized S1E-3-5 CKD seal 寺田智祐 1), Your Utsu 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2012. |
---|
![]() |
Renal function evaluation by the autoserum creatinine measurement of elderly people in the S1E-3-6 health insurance pharmacy Tamotsu Matsumoto right 1), Hiroki Takeuchi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 198-198, 2012. |
---|
![]() |
Is the present pharmacist image which S1F-1 citizen remembers happy for a pharmacist? Masao Onishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2012. |
---|
![]() |
The center of the S1F-1-2 team approach in medical care is a pharmacist 新井裕充 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 199-199, 2012. |
---|
![]() |
It is ... from this of the S1F-1-3 - pharmacist Hideto Sekino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 200-200, 2012. |
---|
![]() |
It is make evidence ... in practice - smart of the clinical studies using the S1F-2-1 pass Satoshi Shibata intellect 1) 2), Toru Maruyama 2), Harumi Tanoe 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2012. |
---|
![]() |
Make use of the viewpoint of the S1F-2-2 pharmacist; and to the better clinical path Kumi Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 201-201, 2012. |
---|
![]() |
About the pass induction to an antiMRSA medicine TDM system in the S1F-2-3 antimicrobial agent proper use Hitoshi Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2012. |
---|
![]() |
Relation - by pass - cardiovascular procedure center clinical path team which a pharmacist makes practice from S1F-2-4 today Rie Ozeki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 202-202, 2012. |
---|
![]() |
When when we expect it and make a pass, the S1F-2-5 physician uses it Katsuo Shinichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2012. |
---|
![]() |
The effect that the participation in planning of the pharmacist gives to pass availability on S1F-2-6 pass Committee Strong marsh Masami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 203-203, 2012. |
---|
![]() |
Collaboration of S1F-3-1 DPC and the clinical path Shigeyuki Tamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2012. |
---|
![]() |
The choice of S1F-3-2 DPC and the generic drug and appropriate evaluation 飛野幸子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 204-204, 2012. |
---|
![]() |
S1F-3-3 DPC and ward duties Hiroko Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2012. |
---|
![]() |
It is ... the drug duties - of the S1F-3-4 DPC era from now on until now Toshiya Ikeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 205-205, 2012. |
---|
![]() |
The clinical index that utilized S1F-3-5 DPC data Mia Kobayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 206-206, 2012. |
---|
![]() |
About the new action of the S1G-1-1 medical supplies medical equipment reporting homepage Uichiro Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2012. |
---|
![]() |
About S1G-1-2 medical information database base maintenance business 小川倫洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 207-207, 2012. |
---|
![]() |
For the change of intelligence, an analysis, the offer after the S1G-1-3 production sale Kazuhiko Mori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2012. |
---|
![]() |
About S1G-1-4 medical supplies safety measures and medical supplies risk management plan Straw bag tree Tomiko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 208-208, 2012. |
---|
![]() |
Application to administration plan of the antiMRSA medicine using S1G-2-1 new renal function marker cystatin C 田中亮裕, Hiroshi Araki positive Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2012. |
---|
![]() |
Proper use and economic effect of the S1G-2-2 antimicrobial agent Takashi Niwa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 209-209, 2012. |
---|
![]() |
Practice of the proper use of the disinfectant in consideration of S1G-2-3 economy, the academic nature, regional alliances Hiroo Nakagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2012. |
---|
![]() |
Practice of the S1G-2-4 antiMRSA medicine proper use Kenichi Kobayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 210-210, 2012. |
---|
![]() |
Practice of the S1G-2-5 infection control Masayo Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 211-211, 2012. |
---|
![]() |
Suggestion and practice in the opportunity -NST intervention case of "the transfusion power" of the S1G-3-1 pharmacist Katsuji Hayashi, Risa Hideshima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2012. |
---|
![]() |
How to use specialized professional ability of the S1G-3-2 pharmacist 杉田尚寛 1), Town piece Tamami 2), 山口浩輝 3), Hiroto Ishii 3), 室石豊輝 3), Mt. Echigo person 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 212-212, 2012. |
---|
![]() |
Transfusion formulation study (support) by the NST pharmacist in the S1G-3-3 this hospital 山下恒弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2012. |
---|
![]() |
Role of the pharmacist in S1G-3-4 regional alliances NST Mitsue Mukai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 213-213, 2012. |
---|
![]() |
The management of NST by the S1G-3-5 pharmacist Naoto Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2012. |
---|
![]() |
A power of a pharmacist is necessary for S1G-3-6 NST! Akiko Tazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 214-214, 2012. |
---|
![]() |
Commercial from S1H-1-1 hospital preparation is activity ... of ... Japanese Society of Hospital Pharmacists arts and sciences Committee to a preparation Shinko Okuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2012. |
---|
![]() |
The guideline that we saw from S1H-1-2 hospital pharmacy preparation (publication) Katsuyoshi Nakajima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 215-215, 2012. |
---|
![]() |
Relation with the fact and the guideline of the hospital preparation in the S1H-1-3 university hospital Toshiaki Nakamura, Yuichiro Kayano, Mikio Masada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2012. |
---|
![]() |
Relation of the university for the S1H-1-4 hospital preparation 花輪剛久 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 216-216, 2012. |
---|
![]() |
About the process in the - "guideline (Version1.0) establishment about a preparation and the use of the hospital preparation" thinking about S1H-1-5 hospital preparation and contents - Fumito Tsuchiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 217-217, 2012. |
---|
![]() |
Characteristics of the practice in S1I-1-1 first aid, the intensive care region Oda order Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2012. |
---|
![]() |
Practice of the pharmaceutical management in the S1I-1-2 sepsis case Kato Takahiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 218-218, 2012. |
---|
![]() |
Pharmaceutical management in the S1I-1-3 heart and the lungs brain resuscitation Masayuki Chuman, Toru Imai, Toru Kitano, Takako Sakagami, Norikazu Kikuchi, Morio Kaburagi, Zenichi Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2012. |
---|
![]() |
Practice of the pharmaceutical management in the S1I-1-4 acute drug intoxication 山崎晃憲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 219-219, 2012. |
---|
![]() |
Education, research activities (activity in the Nagoya University Hospital) to expand pharmacy, the pharmacist education in the S1I-2-1 healthcare setting Yukihiro Noda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2012. |
---|
![]() |
Trial for the foundation of the S1I-2-2 breast cancer outpatient department clinic pharmacist training program Komoda Masayo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 220-220, 2012. |
---|
![]() |
Role of the pro-clinic in S1I-2-3 Kyoto Pharmaceutical University teacher Akira Takayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2012. |
---|
![]() |
Activity (activity in the hospital operation room) and study instructional activity as the teacher to reclaim the new pharmacist professional ability in the S1I-2-4 healthcare setting Masanori Kobayashi, 山田勇磨, Sato evening period, Takeshi Iseki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 221-221, 2012. |
---|
![]() |
Relation of the pharmacist to ethic examination about the use of S2B-1-1 unlicensed drug and medical supplies out of the adaptation Katsuhiko Matsuura, Yoshinori Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2012. |
---|
![]() |
Role of the pharmacist in the clinical trials using the S2B-1-2 off-label use drug Katsuhiko Nagase Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 222-222, 2012. |
---|
![]() |
Use of the hospital preparation in the hospital attached to the S2B-1-3 Gunma University School of Medicine Tomonori Nakamura, Yasushi Yamamoto Jiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 223-223, 2012. |
---|
![]() |
Hospital drug duties support system by S2C-1-1 SPD Tsuneaki Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2012. |
---|
![]() |
It is ... with the significance of existence of standardization - pharmacist of drug duties to take quality of the S2C-1-2 medical care on Tadanori Sasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 224-224, 2012. |
---|
![]() |
S2C-1-3 pharmacist support system and registration distributor Takashi Naito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2012. |
---|
![]() |
Drugstore pharmacist support system in S2C-1-4 foreign countries Hisayuki Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 225-225, 2012. |
---|
![]() |
Medical economic evaluation of the information system about S2C-1-5 medical supplies Hiroyuki Sakamaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 226-226, 2012. |
---|
![]() |
New times - cooperation of the cooperation pass of S2D-1-1 cancer is way ... of the cancer medical care from Keyword this Funada Chiaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2012. |
---|
![]() |
S2D-1-2 "problem to the cooperation pass establishment of cancer Valley water Masato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 227-227, 2012. |
---|
![]() |
Need - medical care care of way - medicine medicine cooperation of the special hospital pharmacist cannot be over only in a hospital in the times when the cooperation pass of S2D-1-3 cancer is new! Matsuhisa Noriaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2012. |
---|
![]() |
Utility of the local pharmaceutical cooperation pass in the examination for S2D-1-4 urology department outpatient Hiroshi Nagae 1), Former Sunao Hori beauty 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 228-228, 2012. |
---|
![]() |
Because a ward pharmacist shows a role by S2D-1-5 General Hospital pharmacist and clinical path - cancer pharmacotherapy; - Ryoji Takahashi, 梅村佳永, Mayumi Kato, 松本佳剛, Ueda exhibition charges Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2012. |
---|
![]() |
From the situation of the nurse at role - medical office of the medical office in S2D-1-6 cancer practice regional alliances Piece valley end season Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 229-229, 2012. |
---|
![]() |
Significance to announce S2D-2-1 results of research as a treatise Yasushi Yamamoto Jiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2012. |
---|
![]() |
Manners when we make S2D-2-2 science article Nobuyuki Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 230-230, 2012. |
---|
![]() |
We are not accepted by these S2D-2-3 forms Juichi Otani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2012. |
---|
![]() |
S2D-2-4 I write an article in this way Takuya Araki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 231-231, 2012. |
---|
![]() |
S2D-2-5 I wrote an article in this way Takaaki Yamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 232-232, 2012. |
---|
![]() |
From the situation of cooperation - physician with S2E-1-1 HIV infection authorization, specialized pharmacist - expanse and pharmacy service under health insurance drugstore Yoshinari Tanabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2012. |
---|
![]() |
Relation of the HIV patients and the pharmacist in S2E-1-2 Niigata Toru Yamada, Mariko Uchiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 233-233, 2012. |
---|
![]() |
AntiHIV medicine management and problems in the S2E-1-3 large hospital Masayuki Senda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2012. |
---|
![]() |
Cooperation - with S2E-1-4 HIV infection authorization, specialized pharmacist - pharmacy service under health insurance drugstore 吉野宗宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 234-234, 2012. |
---|
![]() |
CYP3A gene expression adjustment of human fetal liver cells by the S2F-1-1 partial pressure of oxygen Eiji Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2012. |
---|
![]() |
Evaluation of prescription checking, the formulations for the parenteral injection prescription of S2F-1-2 premature infant, the neonates treatment room (NICU) and the doubt inquiry 西村健二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 235-235, 2012. |
---|
![]() |
Pediatric warfarin PK/PD study based on S2F-1-3 blood vitamin K concentrations and the genetic polymorphism analysis Keita Hirai 1), Hideki Hayashi 2), Yasushi Ono straight 3), Tatsu Sakamoto Ichiro 1), Kunihiko Ito 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2012. |
---|
![]() |
In S2F-1-4 normal business routine through correspondence to "oneself being able to do it now" -A(H1N1) pandemic 2009 - Middle bath Shinji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 236-236, 2012. |
---|
![]() |
Development of the injection inspection system using S2F-1-5 new bar code Kazunori Shimomura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2012. |
---|
![]() |
Examination about the sterility of the hyperalimentation at use of S2F-1-6 clean bench We run the plum bottom, Kazuhiko Igarashi, Masami Kawahara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 237-237, 2012. |
---|
![]() |
Examination - about safety measures - volatilization quantity of the anticancer drug with the S2F-1-7 volatility Yuichi Koizumi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2012. |
---|
![]() |
Reduction of phlebitis by the change of the S2F-1-8 vincristine sulfate administration method Shinichi Kitamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 238-238, 2012. |
---|
![]() |
A trend and examination policy of the pharmacist authorization specialized in S2G-1-1 cancer Yusuke Tanigawara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2012. |
---|
![]() |
A fact and case summary (gastrointestinal carcinoma) of the S2G-1-2 pharmaceutical intervention Kitada Noriaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 239-239, 2012. |
---|
![]() |
A fact and case summary (breast cancer, outpatient department Japan Society of Chemotherapy) of the S2G-1-3 pharmaceutical intervention Junko Kuroda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2012. |
---|
![]() |
A fact and case summary (hematologic cancer) of the S2G-1-4 pharmaceutical intervention Description of basic truth Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 240-240, 2012. |
---|
![]() |
A fact and case summary (mild medical care) of the S2G-1-5 pharmaceutical intervention Hiroki Iwane 1), Yuka Kobayashi 1), Toshiko Aramiya 1), Hirokazu Nakanishi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 241-241, 2012. |
---|
![]() |
The S2G-2-1 "ward drug duties to learn from a precedent of the past" and "a clinical act in future at-home" (pressure sore in particular) Ryoju Miwa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2012. |
---|
![]() |
Action of the physical assessment education for the pharmacist in the S2G-2-2 Kyushu health welfare university pharmacy school and the pharmacy student Jin Tokunaga 1), Takamura rich person 1), Kenji Ogata 1), Nao Setoguchi 1), Miho Utsumi 2), Kei Sato wound 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 242-242, 2012. |
---|
![]() |
Education and practice of the physical assessment by the pharmacist in the S2G-2-3 Gunma University Hospital Kyoko Obayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2012. |
---|
![]() |
With physical assessment education that S2G-2-4 is at home and is usable, actually Teshima infinity Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 243-243, 2012. |
---|
![]() |
Role of OTC medical supplies in the S2I-1-PL regional medicine Mikio Yamazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2012. |
---|
![]() |
The event that a clinician expects in a drugstore, a drug store in S2I-1-1 medical care cooperation Norio Tada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 244-244, 2012. |
---|
![]() |
Role of the local drugstore, pharmacist in the making of health of the S2I-1-2 nation, the consultation support Hidenori Fujiwara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2012. |
---|
![]() |
S2I-1-3 drugstore, drug store at the starting point of the regional medicine cooperation! Toshiaki Nakamura, Mikio Masada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 245-245, 2012. |
---|
![]() |
A function and role of the community pharmacy in S2I-1-4 foreign countries High middle Koichiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2012. |
---|
![]() |
About the role of a drugstore, the pharmacist in the S2I-1-5 regional medicine Taihei Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 246-246, 2012. |
---|
![]() |
Including a system commentary of tendency and measures - Australia of the pharmacist lifetime education in the S2I-2-1 world - Odaka, Kobayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2012. |
---|
![]() |
Educational program - mental health region for pharmacist intervention in S2I-2-2 Australia for a case - Claire O'Reilly Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 247-247, 2012. |
---|
![]() |
Action of the pharmacist lifetime education business in the S2I-2-3 Ueda Pharmacist Association Yasunori Iijima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2012. |
---|
![]() |
Action to pharmacist lifetime education of the S2I-2-4 Japan Pharmaceutical Association Straight appearance spring Taro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 248-248, 2012. |
---|
![]() |
Role of the pharmacist in the S2I-2-5 area History of Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 249-249, 2012. |
---|
![]() |
CJK-PL Contribution of Pharmacists in Pharmaceutical Healthcare and Sciences Takao Ori1), Hitoshi Sasaki2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 253-253, 2012. |
---|
![]() |
CJK-1 Total Quality Management (TQM) in Seki Chuo Hospital Sako Yuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2012. |
---|
![]() |
CJK-2 Application of PBL (Problem Based Learning) for 6-year Pharmacy education in Korea Jung Tae Kim Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 254-254, 2012. |
---|
![]() |
CJK-3 Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants Zhiping Li1), Yewei Chen1), Qin Li1), Di Cao1), Wenjing Shi2), Yun Cao2), Dan Wu1), Yi Wang3), Chao Chen2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2012. |
---|
![]() |
CJK-4 The assessment of statin-associated severe muscle toxicity in Japancohort study by using claims database with laboratory information Chia-Hsien Chang Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 255-255, 2012. |
---|
![]() |
CJK-5 Pharmaceutical care of clinical pharmacists for critical patients in medical oncology You haisheng Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2012. |
---|
![]() |
CJK-6 A review for the role of pharmacist according to relationship Yun Hee Park Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 256-256, 2012. |
---|
![]() |
The future prospects of the clinical pharmacy Junichi Kawakami 1), Homare Ueyama daylight 2), Depths Naoto 1), Shinko Okuda 4), Kazuo Matsubara 5), Kiyobumi Yamada 6), Yasuhiko Yamada 7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 259-259, 2012. |
---|
![]() |
Correspondence to a side effect to see well on the site 継田雅美 1), 齊藤幹央 2), Koji Muto 3), Tomoyuki Sekiguchi 4), Keiko Kurihara 5), Tomoyasu Furukawa 1), Kazuhiko Nagai 6), Toshihiko Takeno 7), Katsuji Uno 8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 260-260, 2012. |
---|
![]() |
Does the current pharmacist education meet a pharmacist image pursued in the settings? Taeyuki Oshima 1), Rough sea well Masayuki 2), Atsumi Nitta 3), Sakaeda Toshiyuki 4), Shoji Fukushima 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 261-261, 2012. |
---|
![]() |
For Tours of the pharmacist for workshop - patients understanding of the practical quality of life rating system to share by a many types of job care team - Takashi Nakajima 1), Etsuko Arita 2), Naoko Ideguchi 3), Keiko Goto 4), Yoko Nanun 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 262-262, 2012. |
---|
![]() |
... which a pharmacist can intervene in from today if we know point - this of three pharmacotherapy that a pressure sore is cured early Old Masaru Den trans1), Fossa Fumihiro God 2), Kinoshita Tomoyasu 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 263-263, 2012. |
---|
![]() |
Action to the ward drug duties less than 20 hours a week in the P1-001 care mix type hospital Yukio Kondo, 奥野靖隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2012. |
---|
![]() |
The evaluation of the document for the P1-002 renal transplant patient compliance instruction and revision Asami Saito, Satoyo Yasuda, Hiroyuki Watanabe, Pond end Hiroaki, Nobuaki Egashira, Ryozo Oishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2012. |
---|
![]() |
Action of the ward exclusive duty pharmacist of the P1-003 this hospital Yumiko Asai, 唐澤匠太, 新井成俊, Junichiro Fukuhara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2012. |
---|
![]() |
Attitude survey of the ward staff for P1-004 pharmacist ward exclusive duty duties Toshihiko Kojima 1), Yokozawa Daisuke 2), Toshiyuki Kaneko 1), Takashi Hatae 3), Tsutomu Takeda 1), Eriko Aoki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2012. |
---|
![]() |
The effect that a difference of the quantity of clinical duties of the P1-005 hospital pharmacist gives to team approach in medical care Tsuneaki Tanaka 1), Masahisa Saito 2), Kiyotaka Inoue 3), Imagawa grammar 4), Masashi Takeuchi 5), Seiji Uchikawa 6), Yukihisa Imaizumi 7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2012. |
---|
![]() |
About assistance to patient compliance instruction with the DVD for the P1-006 on admission orientation 右川浩 1), Mieko Tanaka 1), Right river one sail 2), Tomoko Minowa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 267-267, 2012. |
---|
![]() |
Examination of the utility of the ward drug duties by the P1-007 blood medical ward permanent residence pharmacist Masahiro Yasuda 1), Osamu Umeda 1), New Akiko 2), Ikumi Saeki 2), Fuseya Yoko 2), Hirose 50 child 2), Hideko Goto 3), 笠原千嗣 3), Takeshi Takahashi 3), Senju Goto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2012. |
---|
![]() |
P1-008 drug duties improvement project "team minimalism is activity and ward permanent residence pharmacist of the medicine edition" and drug SPD introduction 濱名則子, 藤嶋若奈, 梶田祐三子, 山城幸子, 葭ちとせ, 濱田晶子, 古出直子, 柏木佑貴, 真砂聖, 河井順計 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2012. |
---|
![]() |
Analysis of propylene glycol - glucose interaction that used NMR fundamental researches about the incompatibility of the dilute phenytoin injection with P1-009 glucose transfusion Yoshinori Onuki 1), Mayumi Ikegami 2), Shigeko Obata 1), Kozo Takayama 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2012. |
---|
![]() |
Participation in planning to the ward rounds of the pharmacist in the P1-010 circulatory organ ward Yoshio Ueno 1), Mitsugu Saegusa 1), Tomoya Asada 1), 眞鍋伸次 1), Yuichiro Takagi 2), 森由弘 3), Thickness well Bunichi 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2012. |
---|
![]() |
Action to ward drug duties enforcement addition by the P1-011 ward exclusive duty pharmacist two placement Tortoise rank Kohei, 茂木孝裕, Yumiko Furuta, Ayumu Nozaki, Yuka Kobayashi, Toshiko Aramiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2012. |
---|
![]() |
A role and professional ability development of the pharmacist in continuous practice, regional alliances of P1-012 HIV infection and the pharmaceutical management Naomi Tanoe 1), Yumi Hashiguchi 1), Takashi Shinohara 2), Ayumi Kimura 3), Hiroshi Nakata intellect 4), Juichi Miyakawa 4), Shuzo Matsushita 5), Hiroaki Mitsuya 4), Hideyuki Saito 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 268-268, 2012. |
---|
![]() |
Ward drug duties enforcement agonizing reappraisal in the P1-013 this hospital and the future prospects Masako Morimoto, Keisuke Shimizu, Satoshi Kaneko, Tomohiko Mori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2012. |
---|
![]() |
The duties change that fixed its eyes on P1-014 ward drug duties enforcement addition and evaluation History of Satoshi Takahashi, 枝廣茂樹, Chisato, Nakamura, Toshio Matsunami, Hiroko Okawa, Mutsuko Okada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2012. |
---|
![]() |
Support of the safe pharmacotherapy by the side effect development situation in P1-015 inside the hospital and the new ward duties system Naoya Ueno 1), Kamura Motoki 1), Kioroshi Shiori 1), Natsuko Takahashi 1), Hiroshi Yoshimatsu chapter 1), 1 related to Fukushima), Ryoichi Nakai 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2012. |
---|
![]() |
Relation ... with the patients who cannot do it with drug control instruction duties - mutual understanding in the P1-016 artificial breathing ward Okada Chihiro 1), Motoko Funato 1), Keiko Nitta 1), Asao Takamatsu 2), 塗谷栄治 3), Yasushi Matsumoto product 3), Masaaki Mori 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2012. |
---|
![]() |
Efficiency of drug control instruction, the ward drug duties using the P1-017 check sheet Shoichi Hayami 1), Tone Yuriko 1), Emi Yamada 1), Taneda hsiang tsai 1), 坂本和央 1), Sho Okano 1), Toshiji Oe 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2012. |
---|
![]() |
P1-018 A study on the safety of LED irradiation after Verteporfin use 佐藤裕紀1), 矢野育子2), 中西晴香2), 土生康司1), 祝千佳子1), 米澤淳1), 深津祥央1), 松原和夫1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 269-269, 2012. |
---|
![]() |
Duties contents in the ward of the P1-019 pharmacist Manami Ichiki, Futoshi Uemura, Mika Kato, Keiko Matsuki, Toru Hasegawa, Jun Hisada life, Kazuko Kawai, Kazuyuki Ito, Satoshi Isotani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2012. |
---|
![]() |
Action ... which we turned to - efficiency-like ward drug duties about ward resident duties in the P1-020 Himeji medical center (the second report) Sakakura immensity 1), 金川明裕 1), Tomishima Kosuke 1), Katsuaki Kobayashi 1), Hideaki Ito 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2012. |
---|
![]() |
Action in this hospital to P1-021 ward drug duties enforcement addition calculation 上村忠聖, Shinya Suzuki, Masao Sekiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2012. |
---|
![]() |
P1-022 Doxil note (R) treatment 阿曽沼和代1), 高柳和伸1), 山崎尚也2), 上田恭典2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2012. |
---|
![]() |
Action of the ward permanent residence pharmacist in the P1-023 Kure medical center, Chinese cancer center Atsuko Hosokawa, 森貞尚之, Tomomi Kotani, Fumiaki Miyamae, Shizue Kimoto, 国冨留美, History of pail east love, Yoshimichi Ogawa, 市場泰全 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2012. |
---|
![]() |
The suggestion of the procedure to gather fixed quantity with P1-024 injector effectively and inspection by the hospital pharmacist 神谷貞浩, Completion right Kazushi, Mika Ozawa, Hiroko Sada, 小嶋文良 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 270-270, 2012. |
---|
![]() |
Analysis ... by fact-finding - text mining of the consultation contents which patients with type II diabetes mellitus approach you with for the patients at P1-025 patient compliance instruction Katsura Nishida University 1), Mitsuko Onda 1), Hiroshi Okada 2), Masaki Shoji 1), Yuka Tanaka 1), 東浦崇光 1), Satoshi Tamura 1), Arakawa line straight 1), Naoki Sakane 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2012. |
---|
![]() |
Present conditions investigation of the pharmacist intervention to the appointed hour prescribed drug in the P1-026 digestive surgery ward Mari Yokota, Junichi Takano, Upper mound Tomoko, Keiso Masuhara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2012. |
---|
![]() |
Contribution of the pharmacist in the P1-027 transplant ambulatory team approach in medical care Kazufumi Iwata, 合澤啓二, Kentaro Ueda, It is Sachiko in a camp, Eiko Fukunaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2012. |
---|
![]() |
Discussion in an investigation and ward duties of the development of hallucinosis situation at the voriconazole administration to patients with P1-028 hematopoietic tumor Marie Yamawaki, The Tanaka immensity, Takashi Kawada, Yukari Asakura, Masa Hashida, Kaori Shimomoto, Yutaka Takahira, Well west Chika, Norifumi Miyamoto, 服部暁昌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2012. |
---|
![]() |
Discharge drug information management instruction and the medicine medicine cooperation that utilized P1-029 medicine notebook Uchida Kei greens child 1), 西尾益冶 1), Atsushi Yamashita 1), Akihiko Shinagawa 2), Osamu Tomita 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2012. |
---|
![]() |
The making of the patient compliance instruction tool to P1-030 patient with ischemic heart disease and investigation of the efficacy understanding degree Sachiko Oda, Old samurai family Yoshimi, Yutaka Kuboi, Yoshimatsu good luck, Takashi Kishino, Shinya Ito, Hideko Iwasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 271-271, 2012. |
---|
![]() |
Effect by the blood medical ward permanent residence of the P1-031 pharmacist Ritsuko Miyajima, Hideya Kokubun, Rumiko Kondo, Hajime Matsubara, Kazuo Yago Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2012. |
---|
![]() |
About the way of the ward drug duties in the P1-032 medical treatment type ward Hoshizaki Hiroko 1), Shiori Fukuda 1), Seiji Utsumi 1), 新枦義之 1), Toishima study 1), Koji Fujimoto 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2012. |
---|
![]() |
For ward pharmacist duties (2) ... "pharmacist to see in the P1-033 Asahikawa Red Cross Hospital," it will be ... with the present conditions in future Yoshie Kawaguchi, 紙谷章基久, 宮崎祐加, Ken Tamura Taro, Yosuke Inoue, Masaki Suzuki, Tomoyuki Kondo, Makise wisdom, Mitsuo Hashimoto, Goto Yoshinobu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2012. |
---|
![]() |
Setup - economic effect of the drug department HIV team in the scale HIV practice base Hospital out of P1-034 and qualitative improvement - Makiko Osawa 1), 前田真輝 1), 井上亜悠 1), Taima Atsuko 1), Yawata window 1), Kazuaki Okada 1), One river Etsuko 2), Hideji Hanabusa 3), Azusa Nagao 3), Kenichi Kojima 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2012. |
---|
![]() |
Difference between consultation support - physician and nurse - to the medical staff by the P1-035 pharmacist 計良貴之, Yasushi Nagatani, Tsuneaki Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2012. |
---|
![]() |
Relation of the pharmacist at triple-drug therapy induction of P1-036 chronic hepatitis C Ayako Koike 1), Nobuyuki Hanabusa 1), Hideki Mori 1), Inner halls of a palace Chikako 2), Yuriko Makihara 2), Ayako Makihara 3), Hiroshi Nagao 3), Kenji Hashimoto 4), Age Junichi Mori 5), Haruhiko Kobashi 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 272-272, 2012. |
---|
![]() |
Ward drug duties in P1-037 heart internal medicine, the surgical ward Miki Nakamura, Tomoko Katsube, The Aya Yamamoto beauty, Kazuya Hirata, Naoyuki Matsumoto, Shuhei Suzuka, Kazuki Tago, Great Yumiko Tsuyama, Person of moat Yumiko, Naoki before yellow Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2012. |
---|
![]() |
It is the active intervention to an investigation after production sale of the chronic hepatitis C triple-drug therapy by the P1-038 ward pharmacist Takashi Ito kernel 1), Masatoshi Saito 1), Satoko Kamata 2), Tsunematsu law 3), Kiyoka Iguchi 3), We merely obtain a forest 3), Akiko Omori 2), Jun Ujihara 1) 2), Atsuta Koichiro 1) 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2012. |
---|
![]() |
The construction of all ward enforcement systems of P1-039 ward drug duties and the operational effect Yasuro Kumakura, Chizaki Yasushi, Mayumi Torimoto, Yusuke Sakai, Aki Kubota, Noriko Kiriyama, Ayano Kojima, Akane Kurachi, Kazuhiro Ishikawa, Kiyobumi Yamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2012. |
---|
![]() |
About the use of medicine notebook suggestion training which we applied P1-040 benefit suggestion narration in Fumitoshi Sano 1) 2), Tomohiro Okumura 2) 3), Kunihiro Hisada 2) 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2012. |
---|
![]() |
Action to the affiliated 8 hospital pharmacy, duties standardization in the drugstore of P1-041 Showa University Hiroshi Shimamura 1), 石下宏征 2), Hiroshi Tanaka period 2), Joji Sasahara 3), Ko Ikeda 4), Manabu Okada 5), Toshitaka Takenouchi 2), Junichiro Murayama 6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2012. |
---|
![]() |
The action of ward drug duties in the P1-042 this hospital and the future prospects Shinichiro Matsuda, Harumi Teramoto, Sakie Senoo, Yuko Nakagawa, Yu Okabayashi, 前岡翠, Chika Yamamoto, Chika Takagi, Keiko Nakatani, Yukiko Ito, 城尾晃太, Akira Miyazaki, 近谷理恵子, Maze Hisanori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 273-273, 2012. |
---|
![]() |
Mutual inspection between the clinical pharmacists for the whole body control of the P1-043 patients Yukari Hara 1), Kernel tail Yuta 1) 2), Yuri Fujimura incense 1), Masahiro Usuda 1) 2), Masaoki 1 Kim), Jun Kawazoe 1), 北原加奈之 1) 2), Yuka Kashiwabara 1), Junko Minemura 1), Junichiro Murayama 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2012. |
---|
![]() |
The system construction for P1-044 ward drug duties and intervention to pharmacotherapy Terumasa Sata 1), Yumi Uehara 1), Yoshiko Suehiro 1), Junpei Shinkawa 1), Satoshi Yamaji ordinary 1), Pond increase sweetfish beauty 1), Shrine gate Takanori 1), Kazuko Tanaka 1), Uemura eyes 2), 庄幸彦 3), Hiroshi Nishijima male 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2012. |
---|
![]() |
Trial and evaluation of the pharmacist permanent residence in the P1-045 orthopedics ward Saori Narita 1), Yukari Hidaka 1), Toru Arino 1), Shigeru Aoyagi 1), Hiromi Yoshida 1), Masashi Nagata 1), Masakazu Nezu 1), 安原眞人 1), Jun Okawa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2012. |
---|
![]() |
Protocol of the acting injection order input of the drug in the operation region by the P1-046 pharmacist and the muscle relaxant and the evaluation The Goto attendant beauty, Sato male oneself, Hiroki Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2012. |
---|
![]() |
Usage of the medical supplies report by a deliberative committee in P1-047 drug control instruction duties Taku Miyakawa, Hiroyuki Isogai, Kiyoshi Okuyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2012. |
---|
![]() |
About prevention of deep part thromboembolism using the blood clotting inhibitor in patients who underwent P1-048 lower limbs orthopedic surgery History of Kumagai reason 1), 松本千聡 1), Rie Shoji 1), Long Akira Shima 1), Setsuo Tsuchiya 2), Koji Ito 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 274-274, 2012. |
---|
![]() |
Management, unionization and problems of the regimen of the P1-049 cancer chemotherapy Kazumi Miyanaga, Masayoshi Nishino, Hiroyuki Sakuta, 久保勝, 1, Sakae, Ota, 傳吉朗 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2012. |
---|
![]() |
Examination of the P1-050 cancer chemotherapy regimen order system modi operandi 野村浩英, Mayuko Mori, Shrine Makiko, 牧秀美, Takahiro Hirata, Atsuko Matsuda, Ryo Yoshioka, Yukiko Inui, Hisao Ikeda, Katsuyoshi Hatanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2012. |
---|
![]() |
Construction of the chemotherapy medication history regime that utilized P1-051 drug control instruction support system PICS Koichi Tamai, Sanae Watanabe, History of Takeshi Korenaga, Nishihata friend fathom, Takako Ichikawa, 石田佳裕, Satsuki Kubo, Tomohisa Kurata, Takeshi Okutsu, Junko Ono Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2012. |
---|
![]() |
A construction and evaluation of the information sharing system about patients who received foreign chemotherapy in the P1-052 this hospital Yukiko Horiuchi, 政賢悟, 宮本晋治, Yuki Hamanabe, 坂本慎弥, 遠原大地, Koji Iwamura, Tsuyoshi Kojima, Yoshiteru Honda, Hideyuki Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2012. |
---|
![]() |
Effect on cisplatin nephrotoxicity by the standardization of the P1-053 moisture load regimen Ayumi Yoshida, Tomomi Sato, Katsuyuki Suzuki, Keiko Minato, Mizunuma lap city, 諏江裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2012. |
---|
![]() |
Validity - after examination - regimen unification about the method of the moisture load at the P1-054 high dose CDDP administration Miho Yamazaki, Yukiyo Funakoshi, Masataka Fukuzawa, Yuko Kubo, Katsuaki Takeda, Yasushi Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 275-275, 2012. |
---|
![]() |
About the cancer chemotherapy regimen that we reviewed on the occasion of P1-055 electronic chart induction Dragon official Maiko, Natsue Yoshioka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2012. |
---|
![]() |
Regimen examination for the cancer chemotherapy with a little P1-056 histories of treatment Ko Tokuda period 1), Koji Moriya 1), Michiko Nishie 1), Yuriko Ishibe 1), Kiyonori Ueda 2), Kazunobu Takayanagi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2012. |
---|
![]() |
The side effect expression situation in the carboplatin + pemetrexed + bevacizumab combination therapy for the P1-057 non-squamous epithelium non-small cell lung cancer High Kado Take, Makoto Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2012. |
---|
![]() |
One case of recurrent ovarian cancer which desensitization succeeded in for the carboplatin long time for patients with P1-058 multiple drug drug allergy This pine Akiko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2012. |
---|
![]() |
Safety assessment of irinotecan + platinum (IP) therapy for the P1-059 prostate small cell carcinoma 薬師寺信匡, Ko Tokuda period, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2012. |
---|
![]() |
Action of the P1-060 outpatient department chemotherapy clinical path induction Sakiko Kurokawa 1), Kyoko Fujieda 1), Nobuo Suzuki 1), Rina Kimura 2), Osamu Fukuhara 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 276-276, 2012. |
---|
![]() |
Reevaluation of 5 drug regimen regimen for the Ewing's sarcoma in P1-061 adults Hiroaki Matsumoto, Ko Tokuda period, Koji Moriya, Michiko Nishie, Yuriko Ishibe, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2012. |
---|
![]() |
Analysis of the dose setting rule factor in the P1-062 outpatient department breast cancer chemotherapy Four Jo Megumi 1), Inferior branch Sadahiko 1), Ashizaki Masayuki 2), Yoichiro Nagamura 2), 堀治 2), Shin Ota 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2012. |
---|
![]() |
From P1-063 cancer chemotherapy regimen management to medicine notebook pasting, it is built reporting and the safety management system Mayuko Ito 1), Yasuo Nagami 1), Kei Murayama 2), Kazunori Yamamoto 1), 沖田敏宜 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2012. |
---|
![]() |
An action and many types of job cooperation to foreign chemotherapy in the P1-064 this hospital Yoshihiro Watanabe, Imuta A, Ikuo Yoshihara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2012. |
---|
![]() |
The effect that was led by a pharmacist, and was given P1-065 cancer chemotherapy regimen management Taizo Fukui, Junko Kamiya, Toshiyuki Kojima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2012. |
---|
![]() |
The effect that the reinforcement of the advance notice system in the P1-066 cancer chemotherapy gives with drug disposal amounts of money Futoshi Saito 1, Kotobuki), Sakai Naoko 1), Teruko Takano 1), 小林彦登 1), Hiroyuki Miyashita 1), Soichi Shibata 1), Masatoshi Saito 1), Atsuta Koichiro 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 277-277, 2012. |
---|
![]() |
Experience action ... case in the municipal hospital in the cisplatin short hydration method of P1-067 lung cancer; and ... 宅和真由美 1), Yoko Imoto 1), Kenji Murakami 1), Goto sheath or 1), Keiko Sano 1), 平田敦宏 1), Yu Kasamatsu 2), 笠松美宏 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2012. |
---|
![]() |
"The handmade medicine medicine cooperation" that we saw from P1-068 drugstore pharmacist Akiko Miki 1), Hiroki Sato 1), Moat foster child 1) 2), Yasufumi Sawada 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2012. |
---|
![]() |
Action by the many types of job team for the practice of the high quality patients care in the P1-069 outpatient department chemotherapy Yoshimichi Ogawa 1), Satoshi Nagashima 1), Atsuko Hosokawa 1), Keita Kameda 1), 武良卓哉 1), 市場泰全 1), 木場崇剛 2), Hiromi Shintani 3), Yuko Okada 3), Takako Taniguchi 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2012. |
---|
![]() |
Action to the inflection of the cancer chemotherapy regimen function in the P1-070 this hospital and communalization of the regimen information 濱元孝 1), 上島聖秀 1), Ability Makiko Sawa 1), Shintaro Takahashi 1), Reiko Miyajima 2), 炭田恵 2), Katsuhiro Yoshimoto 3), Satoshi Kawasaki 4), Koichiro Takeuchi 4), Ryo Kawai intellect 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2012. |
---|
![]() |
Contribution of the positive pharmacist in the P1-071 outpatient department chemotherapy Asako Nakagawa, Nobuaki Ohata, Tomoyuki Oka, Kaori Tsubone, Yuji Hirano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2012. |
---|
![]() |
Investigation for the safety management of the cancer chemotherapy before and after the P1-072 electronic chart induction Kana Sunohara 1), Yu Nakamura 1), Mitsuhiro Sugawara 1), Yukio Ogawa 1), Hajime Matsubara 1), Kazuo Yago 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 278-278, 2012. |
---|
![]() |
Change of the use actual situation of the collection of cancer chemotherapy regimens for the P1-073 inside the hospital exhibition 宅江良隼, Chinami Ueno, Kengo Doi, Kenichi Sakamoto, Masako Imada, Koji Kashimoto, Yoko Sakai, Masatoshi Taniguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2012. |
---|
![]() |
About short hydration induction of cisplatin in the P1-074 this hospital Nishimura Masaji 1), Toshiki Ishigaki 1), Kiyoshi Kawaguchi 2), Koji Wada 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2012. |
---|
![]() |
Safe examination for elderly people of the Gemcitabine monotherapy in P1-075 pancreas, the biliary tract cancer Naomi Hashimoto 1), 岩下佳敬 1), Horai Mai 1), 中尾承司 1), Kimiyoshi Iwasaki 1), Yukiko Narumi 1), Kanae Nakayama 1), Akihiro Sonoda 1), Mulberry crane hemp charges 1), Kazuhisa Ishida 1), Akihiko Sakamoto 2), Hiroshi Imamura 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2012. |
---|
![]() |
About P1-076 security and regimen use for smooth pharmacotherapy Toshiko Hoshika 1), Takuya Yano 1), 福岡竜逸 1), Takako Fujita 2), Kaori Ito 2), Kato three Eiko 2), 松原常起 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2012. |
---|
![]() |
Action as the health insurance pharmacy to a pilot study aiming at cancer therapy cooperation in the P1-077 Hospital Masahisa Kato 1), Erina Kaneko 1), Kenji Kusaba 1), Tomohiro Inoue 1), Shinsuke Karube 1), Manabu Yoshikawa 1), Hideki Fukuoka 1) 2), Kentaro Ogata 3), Yasushi Takamatsu 4), Takashi Seo 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2012. |
---|
![]() |
About the adverse event report system with regimen management and the anticancer drug in the P1-078 this hospital 平郡薫, Sayuri Sakura, Tatsuhiko Ishida, Seiko Yokota, Rie Ueda, Eiji Fukui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 279-279, 2012. |
---|
![]() |
Effect of the age to give it to an adverse event of the weekly TC therapy in patients with P1-079 gynecologic cancer Hideto Takatori 1) 2), Flat field Masaki 2), Kitada Noriaki 2), Kenji Yamamoto 2), North Masato 3), Mulberry well Yukio 1), Toru Hashida 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2012. |
---|
![]() |
Questionary survey about the intervention of the standard regimen enforcement situation and pharmacist in P1-080 this country Iku Nishimura person 1), Shinya Suzuki 2), Kenji Kawazumi 2), 櫻井洋臣 3), Ichiji Endo 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2012. |
---|
![]() |
Discussion about the postoperative supporting XELOX therapy in the P1-081 this hospital Takuya Shirohata, Kana Suzuki, Miki Ishioka, Tetsuya Katori, Takafumi Izumo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2012. |
---|
![]() |
Induction of the check sheet in the P1-082 cancer chemotherapy regimen examination Momoyo Sonobe, Toyohiko Kurosawa, Masahiro Ogami, Atsumi Yanaka, Nara Keitaro, Masahiko Shimada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2012. |
---|
![]() |
It is ... for the registration of a more appropriate than activity ... of the pharmacist for P1-083 anticancer drug regimen reexamination and safe anticancer drug regimen Prince Sawamura will, Nishibeppu Hiroko, Tomoji Fushimi, Akiko Mizoguchi, Igarashi sentence, Okada seven Tsu child, 望月優佑, Junko Mamiya, Ayumu Sato, Kumiko Yano, Chika Ichida, Tamaki Akimoto, Toru Morita, Shun Igarashi, 高尾良洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2012. |
---|
![]() |
Present conditions report after the clinical path induction for the P1-084 cancer chemotherapy standardization Mayumi Shimizu 1), Masayasu Amano 1), Naoko Takabayashi 2), Sakiko Aoki 2), Yukiko Uryu 2), 村田実希郎 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 280-280, 2012. |
---|
![]() |
Safety assessment of the short hydration in the cisplatin administration with the P1-085 respiratory apparatus internal medicine Takashi Yamazaki, Ayumu Nozaki, Yuka Kobayashi, Toshiko Aramiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2012. |
---|
![]() |
Utility of the standardization of the P1-086 cancer chemotherapy regimen check 龍田涼佑, Sato male oneself, Hiroki Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2012. |
---|
![]() |
About induction and the problems of the P1-087 regimen order ring system 春木一伸, Yayoi Azuma, Hiroko Kinpara, Tadaaki Yamashita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2012. |
---|
![]() |
About the management of the foreign cancer chemotherapy by the pharmacist beginning in the P1-088 consulting room Blue Takaaki, 佐々木暢琢, Keiko Yamakawa, Tomohiko Kondo, Keiko Takeuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2012. |
---|
![]() |
Intervention of the pharmacist to P1-089 cancer chemotherapy Mika Tashiro 1), Hiroko Tai 2), Kazunori Shimomura 1), 大河万顕 1), Shinichi Kawaguchi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2012. |
---|
![]() |
Investigation of the cancellation, change case of the day of the foreign chemotherapy enforcement in the P1-090 Kyoto medical center Court official Kayoko, 北宅良祐, Furrow Yoshiko, Hiroyuki Ueno, Kei Nakamura, Yoshio Kitamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 281-281, 2012. |
---|
![]() |
Trial of the side effect of information sharing management using the P1-091 outpatient department chemotherapy interview sheet Junji Asano 1), Izumi Murata 2), Takaaki Shirakawa 1), Rumi Hiyama 1), Kenta Takahashi 1), History of Kei Abe 1), Shigeto Sakuta 1), History of Mitsuru Nishio 3), Yuichi Sekizawa 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2012. |
---|
![]() |
The enforcement situation of the biliary tract cancer gemcitabine cisplatin combination therapy in the P1-092 this hospital Toshiko Okura, Kunio Takahashi, Shoji Takagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2012. |
---|
![]() |
Patients questionary survey to a pharmacist having a talk before the encounter of the P1-093 physician in advance Takahiro Sakai 1), Sonoko Furubayashi 1), Hayasaka University 2), Yoshimi Fujikura 3), Yoshihiro Aoyagi 1), Offering to a priest wish 4), Shigeo Yamamura 5), Yoshizo Watanabe 6), Satoshi Izumi Shiro 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2012. |
---|
![]() |
About the medicine medicine cooperation that is good on the occasion of the out of the hospital prescription issue of oral P1-094 anticancer drug (questionary survey) Reiko Matsui 1), Body marsh Masami 2), Masataka Otsuka 3), Hiroshi Yamamoto 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2012. |
---|
![]() |
Examination of the calculation method of anticancer drug doses in patients with non-Hodgkin's lymphoma with the P1-095 obesity 岡橋朋世 1), Child 1 too rare Mochinaga), Hideaki Tokushima 1), 中野行孝 1), Shinya Kimura 2), Fujito Expo 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2012. |
---|
![]() |
P1-096 Development introduction of pediatric infusion root in the preparation, administration integrated-closing connection equipment (Chemosafe (R)) 島崎博士1), 石村淳1), 原田大1), 奥津利晃2), 安藤尚美1), 北村正樹1), 加藤潤一郎3), 川久保孝1), 鈴木由香4), 前川要5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 282-282, 2012. |
---|
![]() |
Investigation about the ingredient remaining to the P1-097 injection anticancer drug container surface Yasuaki Otsubo, 廣實清司, Kyoji Koda, Yutaka Uchida, Hiroyuki Furukawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2012. |
---|
![]() |
Questionary survey about the vial surface contamination of the P1-098 anticancer drug (injection) 吉田昭昌 1) 2), Morichika Toshiyuki 1) 2), 西川大亮 1) 3), China Ogura 1) 4), Tagashira still person 1) 5), Shigeru Kuramoto Ichiro 1) 6), Tsuneo Maki 1) 7), Masahiro Abe 1) 8), Matsuhisa Noriaki 1) 9) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2012. |
---|
![]() |
Evaluation of the benefit by the full-scale change to P1-099 5-Fluorouracil vial preparation 津野丈彦, Kanako Tajima, Koji Fujimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2012. |
---|
![]() |
Investigation, examination about the artificial error inducer at the P1-100 anticancer drug preparation Koji Nakao, Takashi Iwase, 新美全剛, Fukuda Yasuaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2012. |
---|
![]() |
Evaluation of the policy (disposable type foot cover) not to take the pollution that P1-101 anticancer drug preparation is in a room outside Satoshi Azuma one, Toshihiro Hama, Kazuo Sugita, Yuichi Minowa, Narumi Ito, Wataru Suzuki, Tsuyoshi Aoyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2012. |
---|
![]() |
Performance investigation of in fuser pump (R) in the P1-102 5-FU continuous medication 牧智恵子 1), Manami Goto 1), Makoto Hosomi 1), Masami Nishihara 1), Masahiro Goto 2), Motoki Yoshida 2), Period Takayuki 2), Buddhist monk feeling 2), Jin Nishitani 2), Toshihiro Katsumata 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 283-283, 2012. |
---|
![]() |
Action of the pharmacist for P1-103 anticancer drug preparation ensuring safety Takuto Miyamoto, Takeshi Sasao, Masumi Mori, Hidekazu Sato, Yoshiharu Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2012. |
---|
![]() |
As a result of microanalysis - companies paclitaxel preparation of the vial surface contamination of the P1-104 anticancer drug - Koichi Matsuo 1), Takashi Egawa 2), Kenichi Shimada 2), Kenichi Mishima 3), Yoriko Wada 1), Minako Higuchi 1), Yoshimi Sasaki 1), Sanae Iwatsubo 1), 五味田裕 2), Michihiro Fujiwara 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2012. |
---|
![]() |
Inspection to shortening and costs reduction of the CPA preparation time using the P1-105 closed system drug mixture system Yohei Ikeno 1), Daisuke Arii 1), Hiroshi Nakajima 1), Kunihiko Murooka 1), Michi Nojima husband 1) 2), Akio Kidokoro 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2012. |
---|
![]() |
Investigation about the work environment pollution of the anticancer drug which assumed P1-106 5-FU an index Takuya Furukawa 1), Kazuhiko Saito 1), 松岡佑弥 2), Kaneda under-secretary 2), Akihiro Tada 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2012. |
---|
![]() |
Investigation of the germfree preparation time when we fixed our eyes on ward drug duties enforcement addition in the P1-107 Tokyo medical center Sanae Miyano, Tatsuya Mori, Hiroshi Kudo, Chiaki Ogawa, Megumi Yatabe, Makoto Kobayashi Sachimi, 赤木祐貴, Miyashita Kyuutoku, Yasuo Ide, Yoshihiko Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2012. |
---|
![]() |
As P1-108 simulation anticancer drug quantitative analytical procedure of the quantity of scattering using the fluorescein Na 勝野晋哉 1) 2), 鷹見繁宏 1), Michiko Tatematsu 3), Norio Kaneta 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 284-284, 2012. |
---|
![]() |
Study of the exposure situation at the anticancer drug administration by the P1-109 nurse 東恩納司 1), Nawa Hideki 1), Yoichi Kawasaki 1), Yukie Matsushima 2), Hitomi Nishimoto 2), Kazuhisa Yao 1), Sendo Toshiaki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2012. |
---|
![]() |
Should the P1-110 safety cabinet operate consecutively for 24 hours? 宮松洋信, Yoichi Osato, Masami Onishi, Iga Chinatsu, Sachiyo Sudo, Early part Hiroko, Komi Yoshiyuki, Maki Natsume, Takao Akashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2012. |
---|
![]() |
P1-111 Anti-cancer agents prepared operational efficiency to the efforts (1): Anti-cancer drugs automatic preparation device "CytoCare (R)" and the negative pressure isolator "ChemoSHIELD (R)" cost reduction effect by the introduction 黒井美晴1), 黒田純子1), 近藤勝弘1), 竹本将士1), 鬼頭典子1), 江崎哲夫1), 木村和哲1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2012. |
---|
![]() |
P1-112 Efforts and study to anti-cancer agents prepared operational efficiency (3): CytoCare (R) and ChemoSHIELD (R) of standby time of anti-cancer preparation person by introducing change and the questionnaire survey 鬼頭典子1), 黒田純子1), 竹本将士1), 黒井美晴1), 山本清司1), 江崎哲夫1), 木村和哲1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2012. |
---|
![]() |
P1-113 Anti-cancer agents prepared operational efficiency to efforts (2): Examination of the need for negative pressure isolator "ChemoSHIELD (R)" at the time of use-closing preparation aids 竹本将士1), 前田康博2), 山本清司1), 鬼頭典子1), 黒井美晴1), 黒田純子1), 近藤勝弘1), 木村和哲1)2)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2012. |
---|
![]() |
Examination of the nurse anticancer drug exposure decrease by the priming of the P1-114 pharmacist Motoi Kurahashi still, Yuko Nakao, 眞継賢一, 上田浩貴, Hayato Kuroiwa, Yasuhiko Tsukamoto, Yoshihiko Hamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 285-285, 2012. |
---|
![]() |
Examination of the procedure to reduce a medicinal solution leakage risk from the rubber stopper at the P1-115 anticancer drug preparation 中山季昭 1), Atsushi Shiotsuki 2), Shuichi Haruyama 2), Kinzo Sudo 2), Yoshinori Tsuji 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2012. |
---|
![]() |
P1-116 about an action of the prevention of antineoplastic exposure in being at home 舛甚路子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2012. |
---|
![]() |
Examination about the effect of the alcohol included in P1-117 one Taxotere (R) Yasuhiko Sakata 1), Yasuo Iwamoto 2), Takafumi Sugawara 1), Keisuke Abe 1), Megumi Akagi 1), Shinichi Miyamori 1), Mitsuru Ito arrow 3), Akira Otani Ichiro 3), Kenji Higaki 3), Open Koichi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2012. |
---|
![]() |
Analysis by the structure equation modeling of the psycho status of patient before the P1-118 breast cancer pharmacotherapy induction Takashi Kawaguchi 1), Tetsu Iwase 2), Body marsh Masami 3), Hiroki Takeuchi 1), Megumi Umeda 4), Tadashi Matsunaga east 4), Yoshinori Nanun 4), 畝崎榮 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2012. |
---|
![]() |
Reporting and action to medicine medicine cooperation using a medicine notebook in the P1-119 outpatient department chemotherapy Upper pond Kazuko, Minoru Matsumoto, 邑岡俊明, Yano light Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2012. |
---|
![]() |
Action of the drug department in the out of the hospital prescription of the P1-120 internal use anticancer drug Needle ヶ valley Yoshihisa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 286-286, 2012. |
---|
![]() |
Examination of exclusive duty pharmacist duties about the medical security in the P1-121 outpatient department chemotherapy room and the patients quality of life improvement Fish well Miyuki 1), Takashi Goto 1), Keita Uchino 2), Chiharu Kawanabe 3), Takashi Miyoshi method 1), Hiroko Yamauchi 1), Kazuaki Ueda 1), Saito giant tree 1), 三角紳博 1), Takashi Nishino 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2012. |
---|
![]() |
Construction ... of fur Matthew tical care - efficiency-like efficacy, safety confirmation system for the patients with whole internal use anticancer drug remedy in the P1-122 outpatient department window Ashizaki Masayuki 1), Ayumi Kato 2), Takuya Sakamoto 3), Heron valley Akiko 4), Taeko Futaki 5), Measure Shigenori 6), Yuri Masuda 7), Yuki Yoshikawa 8), Mio Endo 9), Mikiko Okazawa 10) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2012. |
---|
![]() |
Side effect investigation of the non steroidal anti-inflammatory agent combination at the P1-123 pemetrexed administration Yoshimi Sasaki, Koichi Matsuo, Minako Higuchi, Sanae Iwatsubo, Yoriko Wada, Sachi Fukuhara, Tomori Kawano, Hiroaki Nishino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2012. |
---|
![]() |
The understanding degree of patients with cancer for the P1-124 medication explanation and the contributing factor Kaori Endo 1), Kanako Azuma 1), Sayuri Motegi 1), Yusuke Sekine 1), Aihara Hideaki 1), Takashi Kawaguchi 2), Body marsh Masami 3), Hiroki Takeuchi 2), 畝崎榮 2), Takao Akashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2012. |
---|
![]() |
The effect that the medication explanation of the pharmacist gives the tangle that patients with cancer receiving treatment with P1-125 anticancer drug have Kanako Azuma 1), Takashi Kawaguchi 2), Aihara Hideaki 1), Michiko Eda 1), Masami Onishi 1), 山口拓洋 3), Body marsh Masami 4), Hiroki Takeuchi 2), 畝崎榮 2), Takao Akashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2012. |
---|
![]() |
P1-126 "tangle standard (DCS) of the decision making" Japanese edition making and examination of the reliability and the validity Yoko Sano 1), Hiroshi Soeda 1), Yasuko Hamada 1), Kanako Azuma 1), Takashi Kawaguchi 2), 山口拓洋 3), Kenji Onda 4), Eric sky yeah 5), Hiroki Takeuchi 2), 畝崎榮 2), Takao Akashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 287-287, 2012. |
---|
![]() |
Role of the pharmacist in the chemotherapy containing P1-127 pemetrexed Minako Higuchi, Koichi Matsuo, Yoshimi Sasaki, Sanae Iwatsubo, Yoriko Wada, Sachi Fukuhara, Tomori Kawano, Hiroaki Nishino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2012. |
---|
![]() |
Utility of a medication explanation seat in the P1-128 cancer chemotherapy and the side effect check seat Emi Watanabe 1), Yumiko Ando 2), Ritsu Kamoto 2), Field part Masako 2), Ota Shoichiro 3), Shuji Munakata 4), Katsumasa Ishii 5), Toshihisa Suzuki 6), Masayuki Watanabe 7), Shinko Yasuno 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2012. |
---|
![]() |
Support - side effect measures and nutritional evaluation - to patients with cancer in the P1-129 health insurance pharmacy Toshimi Iizuka 1) 2), Kiyoshi Osanai Kei 1), Small Yuta Nozawa 1), Mio Tanaka 1), Masami Horiguchi 1), Tomoji Yoshiyama 2), Hideo Ishizuka 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2012. |
---|
![]() |
About lenalidomide initial agreement explanation and drug control instruction by the P1-130 pharmacist Tachibana Kengo, 足立真保, Tetsuya Konishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2012. |
---|
![]() |
Side effect investigation of the docetaxel bevacizumab combination therapy in P1-131 patients with nonsmall cell lung cancer Dozu Maiko 1), Yuka Kishimoto 1), 京谷充崇 1), Manabu Sakurai 1), Shuji Murakami 2), Tetsuro Kondo 2), 齋藤春洋 2), 尾下文浩 2), Kozo Yamada 2), Mayumi Nagano 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2012. |
---|
![]() |
Examination about the proper use of the TS-1 monotherapy in the P1-132 this hospital Yoko Iwanaga, Keisuke Kakihara, Tomoyuki Inoue, Shiizaki Masahide, Hirakawa Tomonori, Katsue Kabashima, Crane Keiko, Kunio between the fronts, Hidenori Harada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 288-288, 2012. |
---|
![]() |
The need of the drug control instruction that continued for a long term in the P1-133 outpatient department chemotherapy Yuko Nakajima, 巽香菜, Akira Nozawa, Keiji Nakata, Osamu Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2012. |
---|
![]() |
Reporting to the ethical pharmacy in the P1-134 outpatient department chemotherapy Yukiko Yamahata, Small materials Naoto, Noriko Ito, Shoichi Yamaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2012. |
---|
![]() |
Gemcitabine in the P1-135 progress biliary tract cancer impossible of excision, the adverse event expression situation of the cisplatin combination therapy and the future prospects Yoko Tsutsui 1), Haruna Kameoka 1), Tagashira still person 1), 小暮友毅 1), 鵜池敏令 1), Corner British 1), Asagi Akinori 2), Rough sea field adults 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2012. |
---|
![]() |
Side effect expression situation investigation in the cisplatin pemetrexed bevacizumab combination therapy to P1-136 patients with nonsmall cell lung cancer 京谷充崇 1), Dozu Maiko 1), Tomohiko Harada 1), Yuka Kishimoto 1), Shuji Murakami 2), Tetsuro Kondo 2), 齋藤春洋 2), 尾下文浩 2), Kozo Yamada 2), Mayumi Nagano 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2012. |
---|
![]() |
Action of the oral anticancer drug drug control instruction in the P1-137 outpatient department Ogura Takafumi, Ishizuka beauty Europe, Tomoko Kawasaki, Rieko Nagatani, 島田朋弥, Takeba Kazuyo, Takayoshi Matsumoto, Yusuke Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2012. |
---|
![]() |
Role of the working full time pharmacist in the P1-138 outpatient department chemotherapy room Tomoko Kitaoka 1), Aiko Yamashita 1), Ken Nishi Taro 1), Saori Azuma 2), Boundary Kenji 3), Harumi Tanoe 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 289-289, 2012. |
---|
![]() |
Relation of the pharmacist in the oral P1-139 anticancer drug remedy patients Mountain Seki wisdom, Yasushi Otani Jiro, 市江敏和, Inoue lily, Yoshiko Fukazawa, Yoko Natsume, Mana Muto charges, Eiji Nakayama, Yoji Sugiura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2012. |
---|
![]() |
It is ... from a viewpoint of the number of examination - order changes and the number of about the utility of drug control instruction duties to conduct on all intravenous feeding anticancer drug administration day in the P1-140 outpatient department Japan Society of Chemotherapy course Takeshi Midorikawa, Shiro Kawada, Shin Iizuka solstice, Yoshihiro Honda, Takuya Maeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2012. |
---|
![]() |
Use experience of everolimus for the P1-141 pancreatic neuroendocrine tumor Masato Matsuura, Kazuya Arai, Hitoshi Yoshida, Isono Junichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2012. |
---|
![]() |
Example of the pharmaceutical intervention that seemed to contribute to safe securing of P1-142 cancer chemotherapy Hirotaka Shimota, Tomohito Nakazawa, Toshiaki Sudo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2012. |
---|
![]() |
The patients decision making method using the Analytic Hierarchy Processes (AHP) in the P1-143 cancer chemotherapy Hama Wuqing example, Nobuhiko Nakamura, Yoshitaka Yano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2012. |
---|
![]() |
Making of the manual for patients based on the side effect expression of P1-144 azacitidine situation Naoki Mukoyama 1), Yoshiaki Ikeda 1), Koichi Miyamura 2), Kazuhiro Mori 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 290-290, 2012. |
---|
![]() |
A change and evaluation of the prescription suggestion contents of the pharmacist by the P1-145 cancer pain palliation assessment Ryuichi Hishinuma, Kanae Sakakibara, Kyohei Mita, Masateru Kojima, Tsuneaki Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2012. |
---|
![]() |
Patients questionary survey for the medicine notebook induction in the P1-146 breast cancer chemotherapy Shrine way 1, Futaba), Hideya Kokubun 1), Watanabe Koji 1), Ritsuko Miyajima 1), Rumiko Kondo 1), Hajime Matsubara 1), Norihiko Sengoku 2), Makiko Kato 3), Kazuo Yago 1) 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2012. |
---|
![]() |
The serious drug interactions case that led to discovery by P1-147 ward permanent residence Even Chieko, Takao Orii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2012. |
---|
![]() |
Investigation of the use situation and the side effect expression of azacitidine in the P1-148 this hospital Mio Endo 1), Daisuke Hirate 1), Masami Tenma 1), Hideto Yahagi 1), Hongo education 1), Ando spirit chapter 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2012. |
---|
![]() |
Relation of the pharmacist in the P1-149 outpatient department chemotherapy Toshiaki Watanabe, Misako Endo, Shin Oda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2012. |
---|
![]() |
About the effect on side effect of drug interactions of aprepitant and dexamethasone in the P1-150 MonthlyTC therapy and laboratory values Shinichi Kitamoto, Tomohiro Furuya, Yuko Yanagida, Shizuka Fujii, 長崎信浩 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 291-291, 2012. |
---|
![]() |
Use experience of aprepitant and Foss aprepitant in the P1-151 this hospital 渡部寿康, Toshio Yamaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2012. |
---|
![]() |
Discussion for the vasculitis due to P1-152 Fosaprepitant 齊藤麻衣子1), 服部豊1), 山澤真之1), 鈴木真彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2012. |
---|
![]() |
Investigation about nausea and vomiting in gemcitabine + cisplatin combination therapy for the P1-153 biliary tract cancer Ryoko Udagawa 1), 森實千種 2), 牧野好倫 1), Nobuaki Yokote 1), Hideyuki Hayashi 2), Yasunari Sakamoto 2), Shunsuke Kondo 2), Hideki Ueno 2), 奥坂拓志 2), Hiroshi Yamamoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2012. |
---|
![]() |
Examination that it points out the effect by the antiemetics review in the P1-154 this hospital cancer chemotherapy Tomomi Sato, Ayumi Yoshida, Katsuyuki Suzuki, Mizunuma lap city, 諏江裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2012. |
---|
![]() |
Examination about nausea, the vomiting reduction effect of the antiemetics in patients receiving P1-155 cisplatin Katsunori Sakai, 廣畑秀記, Ryuta Urakawa, Kayo Matsuura, Hidekatsu Fukuda, Katsuei Nanba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2012. |
---|
![]() |
The nutritional status in the stage IV patients with nonsmall cell lung cancer using the P1-156 carboplatin regimen and prognostic relative examination Kazumasa Koshikawa 1), Isobe mildness 2), Akiko Kurosawa 3), Kozono Kouki 1), Takayoshi Kosugi 1), Kiyomi Yamada 3), Kenji Nishizawa 1), Sakae Honma 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 292-292, 2012. |
---|
![]() |
The use situation of emetic risk classification and aprepitant of the P1-157 regimen Masayo Shimomura, 上村宅司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2012. |
---|
![]() |
Fact-finding and evaluation in the dose of the P1-158 hydrochloric acid amrubicin and antiemesis therapy 秋山耕治, 山澤理恵子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2012. |
---|
![]() |
A utility of aprepitant in the P1-159 transplantation of autologous hematopoietic stem cells pre-treatment and safe examination King Suetsugu table 1), Uchida まやこ 1), Pond end Hiroaki 1), Saori Uchida 1), Koji Kato 2), Miyamoto Toshihiro 2), Hiroyuki Watanabe 1), Masanori Sueyasu 1), Nobuaki Egashira 1), Ryozo Oishi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2012. |
---|
![]() |
Comparison of nausea, the vomiting frequency in the P1-160 colorectal cancer cancer chemotherapy regimen Norio Takimoto, Shiho Sugawara, Takashi Sakakibara, Kenji Mori, Yoichi Kondo, Sugawara sheath, Noriko Tsuzuki, Mariko Ando, Hoshizaki Yui, 足立守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2012. |
---|
![]() |
Examination of the efficacy of antiemetics at P1-161 altitude, the moderate emetogenic anticancer drug administration 敦見真由美, Koto Fujiwara, Natsuko Fujimoto, Fujimoto A, Kotaki law of nature Yoriko, Yumi Iwasaki, Takashi Nakatani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2012. |
---|
![]() |
Comparison between granisetron and palonosetron for the intermediate-risk anticancer drug in the P1-162 colorectal cancer first therapy mFOLFOX6 therapy Toshiyuki Hirai, Seki Toshikazu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 293-293, 2012. |
---|
![]() |
P1-163 Comparison of the antiemetic effect of the use of performance and Aprepitant of Proemend in Aichi Cancer Center Hospital 松崎雅英, 前田章光, 則竹香奈, 長瀬智也, 水谷旭良, 加藤恵一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2012. |
---|
![]() |
Efficacy of aprepitant for the digestive symptom with carboplatin in patients with P1-164 lung cancer Kaori Yamashita 1), Masayuki Miyazaki 2), Masako Ito 2), Shoko Tsuchiya 1), Seishi Kondo 3), Yoshinori Hasegawa 3), Kiyobumi Yamada 2), Teruhiro Mori 1), Yukihiro Noda 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2012. |
---|
![]() |
Inspection of the risk factor of nausea, vomiting at the P1-165 cancer chemotherapy Sanae Iwatsubo, Koichi Matsuo, Minako Higuchi, Yoshimi Sasaki, Yoriko Wada, Sachi Fukuhara, Tomori Kawano, Hiroaki Nishino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2012. |
---|
![]() |
Comparison of the antinausea effect of Granisetron 3 mg for nausea, vomiting in the P1-166 first line FOLFIRI therapy of progress, patients with recurrent colorectal cancer impossible of excision and Palonosetron 0.75 mg Yutaka Ishikawa 1), Yuko Kudo 1), Kobayashi village British 1), Jin Kimura 1), Toshiaki Kato 1), Michihiro Shino 1), Machida wish 2), Kentaro Yamazaki 2), Hiroshi Yasui 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2012. |
---|
![]() |
Comparison between P1-167 palonosetron and antinausea effect on oxaliplatin component regimen in granisetron Shiho Sugawara, Norio Takimoto, Takashi Sakakibara, Kenji Mori, Noriko Tsuzuki, Mariko Ando, Yusuke Yamanaka, Furukawa sand sail law of nature, Hoshizaki Yui, 足立守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2012. |
---|
![]() |
Examination (examination of the effect of 2 addition drugs of the additional drug in the P1-168 aprepitant combination antinausea therapy Masahiro Kawai, Shinichiro Suzuki, Akio Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 294-294, 2012. |
---|
![]() |
Action ... irinotecan to antiemetics proper use in the P1-169 cancer chemotherapy, evaluation ... by the colorectal cancer chemotherapy regimen containing oxaliplatin Yoriko Wada, Koichi Matsuo, Minako Higuchi, Yoshimi Sasaki, Sanae Iwatsubo, Sachi Fukuhara, Tomori Kawano, Hiroaki Nishino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2012. |
---|
![]() |
Use fact-finding of the cisplatin short time transfusion regimen in the P1-170 Fukui Prefectural hospital 坂井伸成, Hideaki Kato, Mitsue Uno, 佐澤佳彦, Takashi Hiraga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2012. |
---|
![]() |
Pharmacokinetic examination in the repeated doses in the palonosetron vein for severe P1-171 or moderate emetogenic antitumor agents administration cases Kentaro Ogata 1) 2), Yosuke Igari 3), Original Shuji 2), Akira Ishizu direct 3), Yasushi Takamatsu 3), Kazuo Tamura 3), Kojiro Nikami 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2012. |
---|
![]() |
Quality of life evaluation of aprepitant in patients receiving lung cancer cisplatin using the P1-172 effect level Masayuki Ejiri 1) 2), Hiroki Arakawa 2), 牛膓沙織 2), Sumiyo Ito 2), Yumiko Sato 2), Iku Tsukiyama person 2), Tatsuya Hisada 2), Itakura affinity 2), Hiroko Saito 2), Akio Katsumi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2012. |
---|
![]() |
Intervention - to anticipatory nausea, vomiting of the utility -FEC therapy of continuation support from P1-173 hospitalization chemotherapy to ambulatory treatment Miwa Yonezawa, Chiyoko Yamada, Yukiyo Kinoshita, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2012. |
---|
![]() |
Example that P1-174 Olanzapine was effective for nausea, vomiting with the chemotherapy 松野知寛, Noriko Hanada, Yutaka Ueyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 295-295, 2012. |
---|
![]() |
Evaluation of the change of the antinausea effect by the antinausea therapy standardization of the P1-175 outpatient department chemotherapy regimen Kazumi Yamaguchi 1), Mitsuhisa Azuma 2), Mizushima parent beauty 3), 杵崎正典 1), Yutaka Nishikawa 1), Hiroko Yamakawa 1), 山下加那子 1), Eisaku Tanaka 4), Eitaro Nakatsuka 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2012. |
---|
![]() |
Examination - in the action - moderate degree emetic risk regimen to antiemetics proper use in the P1-176 cancer chemotherapy Yuko Okuyama, Takako Miura, Kubota Masae, Yuko Fujii, Tanaka sunlight, Kazuki Ishikura, South Kazushi, Dove Natsuko, 田村健悦, Origin of Hiraga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2012. |
---|
![]() |
A low dose for P1-177 head and neck cancer or prophylactic antiemetics in the chemoradiotherapy to use division cisplatin together at the same time 吉田幹宜 1), Shinya Suzuki 1), Tomohiro Enota 2), Sonoko Furubayashi 1), Inanimate object Hiroto 2), Ichiji Endo 3), Tahara sincerity 2), Satoshi Izumi Shiro 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2012. |
---|
![]() |
Examination about the utility of the use of palonosetron for the P1-178 breast cancer FEC therapy 森光保武 1), Yoshinori Okuno 1), Yu Takada product 1), 濱岡敬 1), Masahiko Ikeda 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2012. |
---|
![]() |
Fact-finding for nausea, vomiting of antiemetics used at P1-179 this hospital cancer chemotherapy Misaki Matsuo 1), Hidetoshi Miyake 1), Akihiro Sumida 1), Naoko Ishikawa 1), Noriko Mukai 2), Kyoko Koga 1), Kazuyo Hashimoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2012. |
---|
![]() |
Examination of the utility of the antinausea therapy standardization for nausea, vomiting with the P1-180 cancer chemotherapy Sato male oneself, 龍田涼佑, Ryosuke Nakahara, Hiroki Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 296-296, 2012. |
---|
![]() |
The onset situation of nausea, vomiting of the cancer chemotherapy with the P1-181 moderate degree emetic risk injection Tomohiro Kakimoto, 野間口寛, Reiko Kirino, Takeshi Takahashi, Middle Yuka Kihara, Toyosumi Ayako, West Kyoko Tsuji, New top Kanako, Hiramatsu sheath, Morihiko Terashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2012. |
---|
![]() |
The use situation of aprepitant in the P1-182 this hospital Miki Watanabe, Tomoko Yamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2012. |
---|
![]() |
Investigation of the palonosetron antinausea effect in the TC therapy using the P1-183 treatment diary Keiko Kawakami 1), White Hiromi Sawa 1), Sayuri Takeuchi 2), Flat pond Mikako 1), Yoichi Hiraki 1), Kenichi Manabe 1), Takashi Nagai 3), Mika Takagi 3), Hiroshi Nishimura 3), Hiroyuki Mimori 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2012. |
---|
![]() |
Comparison of antiemetics in the combination therapy containing carboplatin of the P1-184 non-small cell lung cancer Hiroko Uchiyama, Tree south Shiro, Kazuhiro Igarashi, Two ノ storehouse Hiroyuki, 石本昌裕 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2012. |
---|
![]() |
Examination of the risk factor of the expression of fact-finding of the antinausea control of the P1-185 outpatient and nausea, vomiting Akiko Kawana, Osamu Amuro, Isesaki Tatsuya, Junko Nagai, Tadanori Sasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2012. |
---|
![]() |
Use investigation of antiemetics for nausea, vomiting of P1-186 azacitidine Masato Matsuura, Small Makiko Aze, Hitoshi Yoshida, Isono Junichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 297-297, 2012. |
---|
![]() |
Examination of the antinausea effect by the aprepitant combination in patients who received P1-187 children chemotherapy Tatsuo Kataoka 1), 櫻下弘志 1), Truth Emiko Shida 1), Satoshi Sato person 1), Nakajima spring Kei 1), Mizuka Miki 2), Hiroshi Kawaguchi 2), Yasuyuki Saeki 1), Yasuhiro Kimura 1), Tree flat Kenji 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2012. |
---|
![]() |
Randomized non-recessive controlled trial of the antinausea effect of azasetron oral medicine and the granisetron injection based on P1-188 5-HT3 receptor occupation theory Maya Yamada 1), Iibaru University Minoru 1), 遠渡純輝 2), North city Kiyoyuki 1), Katsuhiko Matsuura 1), Yasushi Ono 2), Yoshinori Ito 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2012. |
---|
![]() |
One patient who experienced administration for granisetron, aprepitant in P1-189 cisplatin divided doses, dexamethasone five days 錦織昌裕, Ryo Iwamoto, The Arai future, Masahiko Usuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2012. |
---|
![]() |
Comparison of the antinausea effect before and after the use of palonosetron in patients with lung cancer given Cisplatin multidrug therapy of the P1-190 cleavage type Kengo Umehara 1), Ai Watanabe 2), Keisuke Otsu 1), Yoshiko Wada 1), Miyamaru Akina 1), Young book Azusa 1), First mountain Tae 1), Michiya Kobayashi 1), Hideki Sato 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2012. |
---|
![]() |
Evaluation of the depression effect of granisetron for nausea, vomiting with the chemotherapy of the P1-191 malignant lymphoma 篠原義剛 1), Hiroaki Morimoto 2), Junji Iwashige 2), 東丈裕 2), Katsuragi Takefumi 2), Naho Nomura 2), Hidehiro Kamachi 1), Shiho Kikuta 3), Junichi Tsukada 2), Kojiro Takahashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2012. |
---|
![]() |
Examination of the onset risk factor of the tumor lysis syndrome in the P1-192 hematopoietic tumor Naomi Noguchi 1), Mt. Ishii husband 2), Yuichi Kinjo 1), Tsuyoshi Suzuki 2), Namba existence intellect 2), We consider among outsiders husband 2), Seiji Kinjo 1), 宇野司 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 298-298, 2012. |
---|
![]() |
Use of antihypertensive agent fact-finding for patients receiving P1-193 bevacizumab Pebbly riverbed intellect Sae 1), Kana Sugitani 1), Keiko Komori 1), Chie Mochizuki 1), 丁元鎮 1), 桝喜惠 1), Mikio Mukai 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2012. |
---|
![]() |
1 case that responded to pregabalin for peripheral neuropathy with the P1-194 taxane system anticancer drug Satoko Amano, Takashi Imai, Atsushi Tsubochi, Yumiko Saeki, Michiko Kamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2012. |
---|
![]() |
Exanthematous examination to occur after P1-195 pemetrexed administration Takashi Imai 1), 西垣俊太 1), East Keiko Tsutsumi 2), Yumiko Saeki 1), Yutaka Otani 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2012. |
---|
![]() |
Relations of skin reaction and NSAIDs of P1-196 panitumumab Satomi Sugano 1) 2), Yutaka Ishikawa 2), Jin Kimura 2), Yuko Kudo 2), Kenichi Suzuki 2) 3), Toshiaki Kato 2), Megumi Konno 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2012. |
---|
![]() |
The adverse event of the administration method takes measures P1-197 recurrence for every albumin-binding paclitaxel three weeks for metastasis-related breast cancer Chiyoko Yamada, Miwa Yonezawa, Yukiyo Kinoshita, Shigeharu Kiyama, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2012. |
---|
![]() |
The effect that example ... high dose dexamethasone of acute renal dysfunction that occurred during P1-198 multiple myeloma treatment gives patients with diabetes Takashi Masuno 1), Hiroyuki Horiguchi 1), Teruo Obata 1), Bank Noriaki 1), Masayuki Tamura 1), Takahiro Jinbo 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 299-299, 2012. |
---|
![]() |
Action to be given side effect monitoring of the P1-199 cancer chemotherapy effectively 和賀信継, Tamami Takahashi, Eri Sugano clothes, Kazufumi Sato, Miyuki Minamikawa, Kumiko Endo, Toshihiro Kumagai, Shoichi Murakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2012. |
---|
![]() |
Investigation about the frequency of tardive phlebitis with P1-200 bendamustine Tetsuo Kume 1), 望月敬浩 1), Shigeyo Sakata 1), Michihiro Shino 1), Ogura sum outside 2), 池田宇次 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2012. |
---|
![]() |
Examination of the effect that ST mixture prophylaxis gives at R-THP-COP-21 therapy enforcement on P1-201 onset B-cell lymphoma Takashi Goto 1), Kazuki Tanimoto 2), Kazuaki Ueda 1), Fish well Miyuki 1), 三角紳博 1), Takashi Nishino 1), Seiichi Okamura 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2012. |
---|
![]() |
It is the factor analysis of complications after the subcutaneous burying type middle cardiac vein port custody in the P1-202 colorectal cancer chemotherapy Shinki Yoshino 1), Naoya Saito 1), Prince Yasushi Takii 2), Mayumi Kaise 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2012. |
---|
![]() |
Examination about the onset of skin reaction by P1-203 Panitumumab Yuko Kudo 1), Satomi Sugano 1) 2), Kobayashi village British 1), Yutaka Ishikawa 1), Jin Kimura 1), Toshiaki Kato 1), Michihiro Shino 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2012. |
---|
![]() |
Examination about the utility of pregabalin for peripheral neuropathy with P1-204 paclitaxel Takuya Fujimura 1), Yasuo Kubota 2) 3), Mayuko Soma 1), 今田愛也 1) 4), Yoichi Sasaki 1), Kumiko Kasashi 2), Takehiro Yamada 2), Takeshi Iseki 2) 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 300-300, 2012. |
---|
![]() |
Evaluation of the situation and the correspondence of the P1-205 doxorubicin-related flare response 森章哉 1), Tomohiro Takahashi 1), Yuka Maekawa 1), Daisaku Kuki 1), Yoshihiro Nishikawa 1), Yumiko Hasegawa 2), Yoshihide Miyazaki 2), Tadashi Fujita will 1), Satoru Morita 1), Takuya Yamakawa 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2012. |
---|
![]() |
Inflection of the nephropathic evaluation and patients self measurement diary at the cisplatin administration using the P1-206 short hydration method Daisuke Nakanishi 1), Ayako Deguchi 1), Tadashi Naito University 2), 畑地治 2), 柳川泰裕 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2012. |
---|
![]() |
One case that produced tinea corporis by skin reaction measures of P1-207 Panitumumab Yoko Hanaoka 1), Yoshikazu Seino 1), Okazawa incense Tsu child 1), Kenichi Ikeda 1), Yoshiro Fujimori 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2012. |
---|
![]() |
Competitive review about the hiccup before and after the P1-208 aprepitant induction 金井貴充 1), Takuya Furukawa 2), Yutaka Kubota 2), Hirofumi Konjo 2), Salt Noiri length male 1), Kazuhiko Saito 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2012. |
---|
![]() |
Utility of the glycemic control by the pharmacist under the search of the glycemic control method at the steroid administration for patients with hematopoietic tumor who had P1-209 diabetes and the joint medical treatment management 土手賢史 1), Description of Sawai hemp 1), Takeshi Hattori 2), Ayumu Nozaki 1), Yuka Kobayashi 1), Moriguchi Kotobuki virtue 3), Shoichi Doi 3), Hirokazu Nakanishi 4), Toshiko Aramiya 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2012. |
---|
![]() |
We look at the rear for a present conditions investigation and early detection about the adverse event of eyes part through P1-210 paclitaxel and examine a mark Yusuke Noguchi, Rie Nishimura, Tile Hiroko, Kiyotaka Omori, Keiji Matsumoto, Yoko Tokuyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 301-301, 2012. |
---|
![]() |
Investigation about the effect that an adverse event of the P1-211 XELOX therapy receives in glycemic control of diabetes Hiroaki Usui 1), 野村久祥 1), 川上英泰 1), Yuichiro Abiru 1), Yoko Kobayashi 1), Tadashi Yoshida 1), Atsushi Furuse 2), 1, Takao, Shinohara), 永井茂 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2012. |
---|
![]() |
P1-212 Comparison of side effects in Bortezomib subcutaneous administration and intravenous administration to patients with multiple myeloma 兼松哲史1), 高井満1), 吉田均2), 伊藤貴彦2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2012. |
---|
![]() |
One case that was treated effectively with methylene blue for P1-213 Ifomide encephalopathy Mikiko Matsuda 1), Yoshikazu Okuma 2), Junichiro Yuda 3), Main room りこ 4), Suguru Omoto Jiro 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2012. |
---|
![]() |
The analysis of the risk factor of the allergic reaction attributable to P1-214 Oxaliplatin and evaluation of the prophylaxis Retsu Shimada, Haruhiko Aikawa, Tomio Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2012. |
---|
![]() |
P1-215 Taxotere (about onset of vasculitis in preparation changes from R note to one Taxotere (R Miki Katsuragawa, Tokutome chapter, 谷口亮央, Hatsumi Kikuta, Ryu Kobayashi, Hideji Ohara, Muki Ryoichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2012. |
---|
![]() |
We are analyzed with a tendency of the myelosuppression at change from TC therapy in the P1-216 gynecologic cancer case to DC therapy Takahiro Arai 1), Makoto Fujita charges will 1), Taeko Saito 1), Fumi Mukoda 1), Tomoji Ibuki 2), Takashi Hirakawa 2), Kanuma Tatsuya 2), Yaeko Mishima 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 302-302, 2012. |
---|
![]() |
Risk factor of serious neutropenia with the P1-217 adriamycin - cisplatin combination therapy Masami Tada, Shinichi Hikasa, Takeshi Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2012. |
---|
![]() |
Investigation of the onset of cutaneous symptom risk factor to lead to cancellation of the P1-218 panitumumab administration or weight loss 古田祐美子, 土手賢史, 溝手彩, 日置三紀, 野崎歩, 岩根裕紀, 小林由佳, 新宮とし子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2012. |
---|
![]() |
Examination of the kidney protection effect of magnesium in the patients considered that P1-219 cisplatin administration is high-risk Takahiro Murakami, Kazuyuki Nanba, Hiroko Yahata, Yuka Watanabe, Junichi Kubo, Eiji Funaki, Yoshihiro Hashimoto, Shigeki Tanaka, Hitoshi Komori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2012. |
---|
![]() |
Acyclovir prophylaxis for the herpes zoster in P1-220 malignancy blood disorder Yasuyuki Fujita 1), Shinichi Goto 2), Ikeda ability interest 1), Shuhei Harada 1), Sadaji Irie 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2012. |
---|
![]() |
Use fact-finding of the rasburicase in the P1-221 Fukui Prefectural hospital 加藤秀明, 坂井伸成, 宇野美津江, 佐澤佳彦, 平賀貴志 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2012. |
---|
![]() |
Efficacy of the pre-medication for oxaliplatin hypersensitivity in the P1-222 this hospital Maki Takimoto 1), Chie Wakaki 2), Yuko Kitano 2), Virtue comfort Masato 3), Toku Mizukami Expo 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 303-303, 2012. |
---|
![]() |
Effect of the expression situation and the vascular pain measures regimen of the vascular pain in patients who received P1-223 XELOX therapy Hideki Ezaki, Norio Takimoto, Shiho Sugawara, Takashi Sakakibara, Noriko Tsuzuki, Mariko Ando, Furukawa lawn sail village, Hoshizaki Yui, Yusuke Yamanaka, 足立守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2012. |
---|
![]() |
Discussion for the hiccup of the P1-224 NK1 receptor blocker Kumagaya 1 required), Toshio Matsunami 1), 枝廣茂樹 1), Hiroko Okawa 1), Mutsuko Okada 1), Kyomi Kaneta 2), Genichi Nishimura 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2012. |
---|
![]() |
Contribution of the pharmacist with the one Taxotere (R) administration actual situation for patients with P1-225 alcohol irritation Hiroyuki Totsuka, 高橋喜統, 多賀允俊, Shizuyo Imagawa, Koji Nishio Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2012. |
---|
![]() |
About neutropenia every regimen that we considered from the use situation of the P1-226 G-CSF preparation Yoshikuni Kenji, Tsuneo Kuwamura, Takashi Akamatsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2012. |
---|
![]() |
Intervention of the pharmacist to skin care instruction aiming at the skin reaction prevention with P1-227 erlotinib Shigeki Ohata 1) 2), 中條倫成 2), Fumiyoshi Kato 2), Keiko Hirano 2), Akiko Mochizuki 2), Hiroaki Utsuki 2), Nabeta Izumi 2), Midori Kimura 2), Takashi Suzuki charges 2), Eto still 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2012. |
---|
![]() |
Effect of the polaprezinc / alginate sodium on stomatitis to be caused by salvage chemotherapy at the P1-228 hematopoietic stem cell transplantation pre-treatment 船渡三結1)2), 林寛子1), 石原正志1), 北市清幸1), 安田公夫2), 伊藤善規1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 304-304, 2012. |
---|
![]() |
About a utility of the moisture retention in patients receiving capecitabine in P1-229 colorectal cancer Mayumi Takeuchi 1), Etsuko Mishima 1), Manabu Yokota 1), Niimi Masanori 1), Yuka Takeuchi 2), Eiji Hayashi 3), Teruyuki Murakami 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2012. |
---|
![]() |
Effect of pregabalin on peripheral neuropathy with the P1-230 cancer chemotherapy 小川晃宏 1) 2), Chiaki Yoshimi 2), Iibaru University Minoru 2), North city Kiyoyuki 2), Takahashi cocoon 3), Kurahashi small child 3), Takao Takahashi 4), Kazuhiro Yoshida 4), Tadashi Sugiyama 1), Yoshinori Ito 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2012. |
---|
![]() |
One case of patients with head and neck cancer that anticoagulant therapy during cancer chemotherapy was managed appropriately by the intervention of the P1-231 pharmacist Shinji Honma, Miki Akizuki, This Western philosopher, Michiyo Terasawa, Hidekazu Kizaki, 川瀬泰裕, Kenichi Ooe, Yasuhiko Hirota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2012. |
---|
![]() |
Examination about a side effect of P1-232 bendamustine and the measures Will intellect Saori 1), Mihoko Hirai 1), Jiyun Hayashi male 1), Yamase University male 1), Emi Shoji 1), Ikuko Kodaira 1), 籠本基成 1), Masahiro Ishizu 1), 通堂満 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2012. |
---|
![]() |
It is the adverse event expression situation of the patients using azacitidine for treatment of the P1-233 marrow atypia syndrome White Hiromi Sawa 1), Flat pond Mikako 1), 1 related to Osono), Noriko Okubo 1), Shina Sogabe 1), Yoichi Hiraki 1), Kenichi Manabe 1), Hidetoshi Kamimura 2), Yoshiharu Karube 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2012. |
---|
![]() |
Comparison of millimeters plastic Japanese spaniel (MPT) and cisplatin (CDDP) to look at for fever after P1-234 hepatic arterial infusion chemistry embolus treatment (TACE) The Kishimoto truth, Long ヶ Takuma Hara, Ogyou Yukiko, Mari Nishimoto, Kazuyuki Sunada, The Yoshimura truth, 佐久間弘匡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 305-305, 2012. |
---|
![]() |
Examination - that we paid our attention to elucidation - internal cause nitric monoxide synthase inhibitor ADMA of the P1-235 cyclophosphamide-induced cystitis haemorrhagic mechanism of pathogenesis Yuka Hattori 1), Yu Hotta will 1), Yutaka Takahata 1), Yasuhiro Maeda 1), 木村和哲 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2012. |
---|
![]() |
Examination of urinary ADMA as the new diagnosis marker for the P1-236 cisplatin-induced renal failure 久野亜耶奈 1), Masae Ono 1), Yu Hotta will 1), Yasuhiro Maeda 1), Katsuhiro Kondo 2), 木村和哲 1) 2) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2012. |
---|
![]() |
Effect of the rebamipide ointment on cheilitis by the side effect of the P1-237 anticancer drug Yasuko Aizawa 1), Aya Okubo 1), Kazuhiro Fujii 2), Arima success 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2012. |
---|
![]() |
Study on onset with the P1-238 irinotecan hydrochloride of dry skin and prevention Satoshi Yokoyama 1), 伊奈田宏康 2), Masahiko Hayashi 3), Kazuya Ooi 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2012. |
---|
![]() |
The use actual situation of the tetracyclines antimicrobial for the dermatopathy of the cetuximab panitumumab in the P1-239 St. Marianna University School of Medicine Hospital 磯部瞳1), 森田一1), 横田真里1), 湊川紘子1), 伊藤由香1), 友野亜妃子2), 京盛千里2), 津田享志3), 増原慶壮1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2012. |
---|
![]() |
Action of the pharmacist for folic acid, the vitamin B12 combination in the P1-240 pemetrexed therapy Fujiko Yamazaki, Takayuki Miyakawa, Fumiko Sasaki, Masato Hikichi, Matsuhisa Noriaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 306-306, 2012. |
---|
![]() |
Non-small cell lung cancer treatment - eruption mild objective weight loss administration and effect of treatment - using P1-241 erlotinib Naoki Takashima 1), Tomoki Kimura 2), Takahiro Watanabe 2), Takumi Umemura 1), 勝野晋哉 1), Nishiyama law of nature 3), Yasuhiro Kondo 2), Hiroyuki Taniguchi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2012. |
---|
![]() |
P1-242 1 case of cancer chemotherapy in implementation drug-induced thrombocytopenia due Sarpogrelate has improved in the involvement of the pharmacist 大久保節子1), 大久保正2), 田中真理子3), 大久保七枝2), 大久保美穂4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2012. |
---|
![]() |
Examination of the renal failure protective efficacy with the magnesium administration for the P1-243 initial FP therapy Shiho Hirai 1), Tadaaki Ito 1), Shinobu Hasebe 1), Kaida Sachiko 2), Masanori Ueno 2), Seishi Udagawa 2), Masahiro Hayashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2012. |
---|
![]() |
Protective efficacy of phlebitis by vascular exposure time shortening of the P1-244 epirubicin hydrochloride and safe examination Kazuya Isoda 1), Kan Yukio 2), Kazuki Takeda 1), Hiroyuki Furukawa 3), Masashi Iguchi 3), 崔吉道 1), Kenichi Miyamoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2012. |
---|
![]() |
Utility inspection (the first report) of the automatic warmer for the transfusion which we used in a symptom reduction purpose for the vascular pain that resulted from P1-245 Oxaliplatin administration 高橋典哉 1), Fumiko Takahashi 2), 小笠原信敬 1), Akito Nagashima 1), Shinsuke Honjo 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2012. |
---|
![]() |
The expression situation of the circulatory system side effect in the P1-246 5FU+ cisplatin combination chemotherapy and association with laboratory values Mayumi Kaise 1), Shinki Yoshino 2), Haruki Nagai 3), Shunya Sasaki 4), Yuji Okura 4), Yoichi Maruyama 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 307-307, 2012. |
---|
![]() |
Investigation about the onset of adverse event situation in the P1-247 XELOX therapy Toshiaki Kato 1), Shigeyo Sakata 1), Yutaka Ishikawa 1), Jin Kimura 1), Yuko Kudo 1), Kobayashi village British 1), Michihiro Shino 1), Kentaro Yamazaki 2), Hiroshi Yasui 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2012. |
---|
![]() |
It is an investigation about the decollement expression at the docetaxel therapy for every P1-248 three weeks Mami Kobayashi 1), Hiroko Suzuki 2), Kiyoshi Mizusawa 1), Joji Okamoto 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2012. |
---|
![]() |
Onset of Colin symptom situation analysis with P1-249 irinotecan Kaori Matsumoto 1) 2), Midori Kimura 2), Nabeta Izumi 2), Hiroaki Utsuki 2), Takashi Suzuki charges 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2012. |
---|
![]() |
About likelihood of the investigation about sleep disorders of patients with P1-250 cancer and the pharmaceutical intervention Ko Hiraide stone 1) 2), Yoshihiro Miyamoto 1), Chika Ichihara 1), Yoko Kobayashi 2) 3), Italy Tetsuya Saji 2) 3), Fumiko Suzuki 2) 3), 江 ノ sweet sake beauty 2) 3), Takako Imazeki 1), Takeshi Kato 1), Yutaka Ozeki 2) 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2012. |
---|
![]() |
Examination to a cancellation reason of the P1-251 outpatient department chemotherapy (colorectal cancer) and foreign drug duties Akira Takagi Kei 1) 2), Kaoru Kobayashi 1) 2), Koichi Tanabe 1) 2), Yasuhiko Mimura 1), Atsushi Kato 1), Isao Adachi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2012. |
---|
![]() |
The expression situation and measures of the skin reaction with cetuximab in patients who received P1-252 outpatient department cancer chemotherapy Tanaka 1, Mayuu) 2), Iibaru University Minoru 1), North city Kiyoyuki 1), Takahashi cocoon 3), Kurahashi small child 3), Takao Takahashi 4), Kazuhiro Yoshida 4), Kimio Yasuda 2), Yoshinori Ito 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 308-308, 2012. |
---|
![]() |
A side effect and measures of P1-253 myelodysplastic syndrome therapeutic drug azacitidine (AZA) Chizuko Ooka 1), Your Teramura early 1), Sakedani Hiromi 2), Mayumi Sato 2), Mayumi Katsuki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2012. |
---|
![]() |
The effectiveness, safe examination of the rasburicase for the tumor lysis syndrome with the chemotherapy in P1-254 blood tumor 大坪達弥, 大塚充, 上田和正, 鹿浦香織, 神田英一郎, 岡橋孝侍, 西川靖之, 藤田敦夫, 野田能成, 小西偉雄, 三上正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2012. |
---|
![]() |
Efficacy of pregabalin in peripheral neuropathy with the P1-255 breast cancer chemotherapy 西村知恭 1), Megumi Matsumoto 1), Fujiwara University 1), Yoshinobu Saito 1), 天野賀弘 1), Chigusa 2 resigning from the post), Hiroki Ueda 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2012. |
---|
![]() |
Evaluation of the regimen intervention of the pharmacist for renal dysfunction of P1-256 cisplatin Hayato Sugimura, Makoto Hayashi, Kenji Miyazawa, Satoru Onishi picture, Akemasa Yamaya, Hiroshi Funaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2012. |
---|
![]() |
Compare the non-elderly people (74 years old or younger) with safe evaluation ... elderly people (75 years old or older) of the XELOX+Bevacizumab(BV) therapy in the P1-257 this hospital; and ... Shun Kawai 1), Shoichi Hattori 2), Shunsuke Hamasaki 2), Yuji Hashimoto 1), Sue Katsuyuki 1), Sosuke Kogure 1), Yuji Sato 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2012. |
---|
![]() |
Effect on supplementation of P1-258 S1/CDDP therapy, aprepitant and the Mg preparation and renal function by the weight loss of hydration Kiyoko Tanimura 1), 菊井利伸 1), Seiji Onda 1), Fumihiko Kimura 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 309-309, 2012. |
---|
![]() |
Examination of the factor about onset of proteinuria with P1-259 bevacizumab 福本慈, 野村充俊, Sumiko Hiura, 加藤祐芳, Toru Asayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2012. |
---|
![]() |
New trial to hypersensitivity, extravasation correspondence in the P1-260 cancer chemotherapy Maiko Saito 1), Yuka Kobayashi 2), Hidekazu Arai 1), Ikuyo Takahashi 3), Harumi Sudo 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2012. |
---|
![]() |
Infusion Reaction expression situation investigation at the P1-261 rituximab initial administration and comparison of the pre-medication Fujitani Masanori, Satsuka Yuki, Akiko Kitayama, Yuichi Koizumi, Mami Nomura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2012. |
---|
![]() |
Skin reaction measures with the P1-262 EGFR-TKI medicine Shinohara Keisuke 1), Atsushi Miura 1), Kazumi Yoda 1), Kiyomi Kurosawa 2), Yuko Maruyama 2), Hiromi Nakajima 2), Naomi Yoda 2), 大浦也明 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2012. |
---|
![]() |
Medical supplies (study implementation situation - in examination of hepatitis B virus - this hospital with the administration of anticancer drug with the P1-263 immunosuppressive action Kentaro Okita, Shinseki green, Mie Ogata, Kazuhiko Tamura, Ayako Moriyama, Nakajima A Ichiro, Tomohiro Habu, Kazuhiro Kondo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2012. |
---|
![]() |
It is an example with suspected chemical thrombocytopenia during P1-264 colorectal cancer chemotherapy Kenji Miyazawa, Hayato Sugimura, Makoto Hayashi, Akemasa Yamaya, Hiroshi Funaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 310-310, 2012. |
---|
![]() |
For the side effect of cancer chemotherapy data collection that is more correct than P1-265 induction - to revision and the hospitalization of the - side effect check sheet 廣畑秀記, Ryuta Urakawa, Katsunori Sakai, Kayo Matsuura, Katsuei Nanba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2012. |
---|
![]() |
Examination of the factor about hematotoxicity augmentation of P1-266 pemetrexed Hiroshi Hashiguchi, Hitomi Iimura, Masae Kubo, Satoshi Shinoda, Divine power Reiko, Kazuma Yano, Terumi Miyazato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2012. |
---|
![]() |
1 case of liver dysfunction that resulted from the intervention uterine cancer postoperative chemotherapy (AP therapy and TC therapy) of the pharmacist to liver dysfunction at the treatment with P1-267 anticancer drug Kazuyuki Ito 1), 大橋養賢 1), Yasushi Arata 1), Michihiro Shino 1), Takekuma Munetaka 2), Yasuyuki Hirashima 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2012. |
---|
![]() |
A comparison and measures of the adverse event of Cetuximab and Panitumumab in the P1-268 this hospital Kenta Takahashi 1), Takaaki Shirakawa 1), History of Kei Abe 1), Junji Asano 1), Izumi Murata 2), Shigeto Sakuta 1), Yuichi Sekizawa 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2012. |
---|
![]() |
Evaluation of the correspondence after the anaphylactic expression with P1-269 oxaliplatin Mieko Kishi, Liquor mouth Hiromitsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2012. |
---|
![]() |
The side effect of gemcitabine chemoradiotherapy expression situation for the P1-270 liver pancreatic cancer Yoichi Tanaka 1) 2), Kiyoshi Shibuya 1) 2), Tei Takahashi person 3), Takako Komiyama 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 311-311, 2012. |
---|
![]() |
The expression situation of the hand-and-foot syndrome with P1-271 molecules target medicine sorafenib and the measures Satoshi Taira, Noriko Moriwaki, 當真房子, Saori Yamamoto, Terumi Nagahama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2012. |
---|
![]() |
Analysis and drug control instruction (2) of the adverse event of the lenalidomide therapy for the P1-272 multiple myeloma Katsuyuki Nakamura 1), Rev. Noda original 1), Toshiaki Hayashi 2), Tei Ishida husband 2), 篠村恭久 2), Koichi Takada 3), 井山諭 3), Junji Kato 3), Hiroshi Nakata elegant 1), Atsushi Miyamoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2012. |
---|
![]() |
The expression situation and actions to be taken of the vascular pain with P1-273 paclitaxel Noriko Moriwaki, 當真房子, Saori Yamamoto, Satoshi Taira, Terumi Nagahama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2012. |
---|
![]() |
Examination about the reactiveness with various menstruum of the P1-274 platinum Takashi Kato children 1), Yu Yamamoto 1), Michiko Kanamori 1), Mizuho Miyake 1), Mikiko Endo 1), 吉開晶一 1), Takushi Sato 2), Yoshio Ijiri 1), Kazuhiko Tanaka 3), Tetsuya Hayashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2012. |
---|
![]() |
Examination about the effectiveness of the rasburicase for the tumor lysis syndrome prevention in P1-275 blood-forming organ tumor and the safety 大里洋一1), 伊賀千夏1), 鮎原秀明1), 藤本涼子1), 石井文雄1), 宮松洋信1), 横山智央2), 明石貴雄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2012. |
---|
![]() |
Examination of the improvement effect on constipation / diarrhea with the chemotherapy of P1-276 functional foods bifidus bacillus end BB536 徳毛孝至 1), Keiko Hara 1), Toru Kiguchi 2), Hyperplasia Taro 2), Takeshi Kanbara 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 312-312, 2012. |
---|
![]() |
Action to measures and patients correspondence after the onset of allergy-like symptom in patients who received P1-277 TC therapy Aya Sugimoto 1), Noriko Kiriyama 2), 椿井朋 3), Masayuki Miyazaki 2), Masayuki Hiramatsu 1), Teruhiro Mori 4), Kiyobumi Yamada 2), Yukihiro Noda 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2012. |
---|
![]() |
Investigation about the dermatopathy by cetuximab in patients with P1-278 colon cancer and the panitumumab 神山紀子1), 鈴木亜実1), 福田萌美1), 渡邊徹2), 岡崎敬之介2), 村山純一郎2), 佐藤温3), 小西一男4), 山元俊憲1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2012. |
---|
![]() |
2 cases that presented Serious ADR with P1-279 oxaliplatin Kaoru Shirai, The number of Yutaka Hashimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2012. |
---|
![]() |
Use experience of pemetrexed in the P1-280 renal function degeneracy patients Nakagawa spring 1), Mizuho Kamata greens 1), Yutaka Ueda 2), Osamu Konishi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2012. |
---|
![]() |
Example that it showed the protraction of the large blood glucose level increase, hyperglycemia state by use of dexamethasone as the antiemetics for patients with P1-281 diabetes Shiro Kawada 1), Jun Sato person 2), Takeshi Midorikawa 1), Shin Iizuka solstice 1), Yoshihiro Honda 1), Takuya Maeda 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2012. |
---|
![]() |
Examination about measures of hyponatremia during the P1-282 FAP therapy enforcement Hilum pond Kaori, Fukuko Shimokawa, Sachiko Yasumoto, Yohei Hayashi, Shunsuke Kawabata, Kumiko Noguchi, Kayoko Watanabe, Atsushi Matsumoto, Kazunari Taniguchi, Fuminori Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 313-313, 2012. |
---|
![]() |
1 case that GFO(R) was effective for severe diarrhea with the P1-283 TPF therapy Kensuke Hirooka, Hiroyuki Shimizu, Eiko Yoneta, Tanaka pine Ichiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2012. |
---|
![]() |
Start use of the P1-284 Mohs paste Toyomi Murakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2012. |
---|
![]() |
An action to reduction of the vascular pain in the P1-285 XELOX therapy and the evaluation Hikino Mayumi 1), Kenji Sato 2), Akihiko Osaki 3), Hiroshi Nakamura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2012. |
---|
![]() |
Evaluation of the tramadol proper use in the P1-286 inside the hospital psychological care team Ayumi Kato 1) 2) 3), Ise Yuya 1) 3), Yumiko Hayashi 1) 2) 4), Shiro Katayama 1) 2) 3), Kazuhiro Nakanishi 1) 2) 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2012. |
---|
![]() |
To practice cooperation ... substantial mild medical care between the pharmacists using P1-287 "information sharing sheet"; ... Miyatake wish 1) 2), Tokuyama picture straight 1), Hamada rabbitfish 1), Makoto Fukushima 1), Sowa Emi 3), Masato Ikeda 2) 4), Takuya Kitada 2) 5), Toshihiko Ishizaka 1), Junji Mukai 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2012. |
---|
![]() |
One case that used it, and was able to remit appropriate for respiratory depression with the P1-288 oxycodone with naloxone Fumie Koresawa 1), Yuichi Umeda 1), Katsuji Hayashi 1), Takehiko Makino 2), Shinsuke Takemoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 314-314, 2012. |
---|
![]() |
P1-289 One case that can be improved is refused drugs in the intervention of the pharmacist distrust for strong patient to the opioid 原敦子, 山下和海 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2012. |
---|
![]() |
About enlightenment activity about opioids, the sedative adjuvant in the P1-290 this hospital Kusakabe young of sweetfish 1), Bank former Maki 1), Sato Kei sinter 1), Rika Fukui 2), Akeda Katsuyuki 3), Kazuki Kikuchi 1), Toshiji Oe 4), Eri Ezoe 2), Many islands Takahiro 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2012. |
---|
![]() |
Three cases that olanzapine was effective for the P1-291 prochlorperazine nausea control bad patients of invalid opioids Kenichi in the new line Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2012. |
---|
![]() |
One case of the lower chin rhabdomyosarcoma which obtained the local control of tumor by P1-292 Mohs ointment Kamura Motoki 1), Naoya Ueno 1), Hiroshi Yoshimatsu chapter 1), Kioroshi Shiori 1), Natsuko Takahashi 1), 1 related to Fukushima), Mahiro Beppu 2), Tetsuro Ishigami 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2012. |
---|
![]() |
About the side effect expression situation and measures after the P1-293 foreign initial opioid instruction and desensitization satisfaction Masato Suzuki, Mari Teramachi, Yuko Takahara, Tetsushi Maeda, The Amano apricot south, Mika Takeuchi, Look at Imai; Yasuko, Yoshihiro Kawade, Tree Masaji, Tomohiko Aoyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2012. |
---|
![]() |
P1-294 cases paroxetine has responded to phantom limb pain after amputation 岡本明大1)2), 岩本卓也1), 松峰昭彦3), 佐藤佳代子2), 鈴木大2), 中村喜美子2), 奥田真弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 315-315, 2012. |
---|
![]() |
Comparison about preparation properties of the P1-295 fentanyl percutaneous absorption type preparation (usability investigation) Akemi Noguchi, Hisashi Tsuru Seiko, Hiroko Fukue, Tomoko Ishikawa, Kazutaka Tsutsumi, Mieko Tsuruta Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2012. |
---|
![]() |
One case that efficacy of the Juzen-taiho-to was suggested in myelosuppression with the chemotherapy of the P1-296 small-cell lung cancer Ai Kuriyama 1), Keisuke Azuma 2), 伊與田友和 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2012. |
---|
![]() |
The efficacy of the midazolam intravenous dosage for the purpose of the securing of night sleep in the P1-297 cancer terminally ill patients and safe examination Yuri Okuno, Kato Daisuke, 長谷川久巳, Tadaaki Ito, Winnow music Mayumi, Yoshiko Yamaura, Kazuma Kishi, Masahiro Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2012. |
---|
![]() |
Effect on stability of the octreotide acetate by the mixture with the P1-298 morphine hydrochloride injection preparation Atsushi Wada child 1), Koichi Tanabe 2), Atsumi Nitta 1), Jun Okubo 2), Tomoaki Ikezaki 2), Mai Tanaka 2), Murakami wish 3), Hidenori Kitazawa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2012. |
---|
![]() |
The preparation of the P1-299 gabapentin suppository and evaluation of the bioavailability Reed mouth sub-Rina, Isamu Murata, Yutaka Inoue, Masayuki Kimura, Ikuo Kanemoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2012. |
---|
![]() |
Use experience of the Juzen-taiho-to to myelosuppression with the chemoradiotherapy for P1-300 head and neck cancer Chika Aruga 1), Tsutomu Koitabashi 2), Hisashi Takeda Hitomi 2), 伊與田友和 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 316-316, 2012. |
---|
![]() |
Blood transition of metronidazole which we applied for the purpose of P1-301 cancer-related bad smell palliation Junichi Iida 1) 2), Toshiyuki Kudo 1), Satoshi Hasegawa 3), Pond Hideyuki 3), Toru Sato 2), Hajime Kagaya 2), Kiyomi Ito 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2012. |
---|
![]() |
Retrospective study on onset of chemical delirium in patients with P1-302 malignant tumor Masatoshi Saito 1), Hitomi Nakamura 2), 椎崇 1), Kensuke Usui 1) 2), Kazue Soda 1), Satoshi Takeshita 3), Atsuta Koichiro 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2012. |
---|
![]() |
Examination about the pregabalin remedy using the P1-303 simple suspension method Kaori Masuda, Umetsubo Shota, Tomohisa Onishi, Hitoshi Amada child, 河邊秀幸, Mayumi Murata, Tetsu Sato, Michihiro Shino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2012. |
---|
![]() |
Fact-finding of the opioid initiation time in patients with P1-304 cancer Kaori Yamamoto 1), Shinya Suzuki 1), Ikuyo Ueda 1), Yasuhiko Ichida 1), Ichiji Endo 2), Satoshi Izumi Shiro 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2012. |
---|
![]() |
The case that chronically administered Chinese medicine suppository two drugs to P1-305 oral administration patients who received difficult ovarian cancer chemotherapy Takahiro Hirata, Hisao Ikeda, Mayuko Mori, Ryo Yoshioka, 野村浩英, Katsuyoshi Hatanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2012. |
---|
![]() |
Drug adoption situation investigation of the neighborhood institution in consideration of P1-306 regional alliances Osamu Kitamura, Kazuo Katsumata, Hiroshi Kawaguchi fruit, Yoshinori Kobayashi, Yutaka Kobayashi, Mariko Ijiri, Naoto Uchida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 317-317, 2012. |
---|
![]() |
Fact-finding and evaluation of the opioid rotation based on the P1-307 WHO method cancer pain therapy Mayu Osaka true 1), Etsuko Shinohara 1), Rei Kimura sand 2), 佐々木英久 1), 松尾和廣 1), Tomoko Watanabe 1), 加藤裕芳 2), Toru Asayama 2), Takashi Yoshio 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2012. |
---|
![]() |
Example that opioids became needless for the pain control of patients with cancer by the intervention of the P1-308 psychological care team Mari Kawano child 1), Mayumi Seino 1), Maki Sakamaki 1), Makoto Hasegawa 1), Shintaro Nomura 1), Nishioka Taro Gen 1), Fuminori Shibuya 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2012. |
---|
![]() |
An intracerebral delivery of morphine decreases at the P1-309 neuropathic pain Mitsumasa Kaneta 1), Marina Nagae 1), Risa Yanagida 1), Ayumi Mineo 1), 増川太輝 2), Igarashi sincerity intellect 1), Ochiai sum 1), Narita two a year), Tsutomu Suzuki 2), Kiyoshi Sugiyama 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2012. |
---|
![]() |
An example of head and neck cancer which was able to contribute to cancerous bad smell reduction by joining P1-310 treatment Hadame proton, Hiromi Suzuki, Kiyo Kawazumi, Iku Tsukiyama person, Yukio Toyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2012. |
---|
![]() |
One case of progress lung cancer that an opioid rotation succeeded from P1-311 high dose morphine constant infusion, and was able to leave the hospital Takako Murayama, Hiroko Amano, Emi Nanun, Hidenori Kawakami, Mt. end Expo man Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2012. |
---|
![]() |
The present conditions and problems of the medical narcotic dispensing of the P1-312 Suwa local health insurance ethical pharmacy Kazuma Amino 1), Aiko Fujimori 1), Junko Taniguchi 1), 登内盛治 1), Osamu Atobe 1), Tomomi Sasaki 2), Mutsumi Hashizume 3), Kotaro Gomi 4), Hiroshi Kawanishi High School 5), Kazuyoshi Fujimori 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 318-318, 2012. |
---|
![]() |
About effect of dexamethasone which gives it to the glycemic control of patients with P1-313 diabetes merger cancer Tomokazu Fujii 1) 2), Hiroshi Suzuki 1), 澤柳直樹 1), Haruhiko Nakamura 1), Hisashi Tsukamoto 1), Kotaro Shibata 1), Tetsuo Adachi 2), Hisashi Kamiya line 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2012. |
---|
![]() |
One case of colon cancer who had the chronic renal failure that P1-314 FOLFIRI repeated dose was effective 北出紘規 1), Takeo Shimazaki 2), 北国憲剛 1), Mitsue Mori 1), Kimiko Shintaku 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2012. |
---|
![]() |
Examination of the toxic epidermal necrolysis (TEN) case by P1-315 Bendamustine Koji Okada 1), Masayuki Omura 1), Jun Oikawa 2), Kyoko Sakurada 3), Wano Masaharu 4), Katsuhiko Sato 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2012. |
---|
![]() |
Development of the remote inspection system supporting the anticancer agent preparation at the P1-316 satellite drugstore 佐藤淳也1)2), 森恵1), 佐々木拓弥1), 二瓶哲1), 於本崇志1), 山内敏司1), 祝偉裕3), 雉鼻一郎3), 工藤賢三1)2), 高橋勝雄1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2012. |
---|
![]() |
Investigation with the actual situation and the regimen of the cancellation reason in the P1-317 outpatient department cancer chemotherapy room Hiroshi Suzuki, Authority of Takashi Uchida, Yoko Sasaki, Katsuhiko Inomata, Yoshio Fujikake Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2012. |
---|
![]() |
Effect on blood phenytoin levels of P1-318 fluorouracil hepatic arterial infusion and the mFOLFOX6 therapy 前島光廣, Mitsuru Koizumi, Masako Oshima, Masaru Nakajima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 319-319, 2012. |
---|
![]() |
Relations of a survival period and the medication of patients with P1-319 progress recurrence colorectal cancer 續木康夫, Field road Akihiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2012. |
---|
![]() |
Conference before treatment by pharmacist leadership in the P1-320 outpatient department cancer chemotherapy room and the evaluation Hiroaki Hatakeyama 1), Kurasawa Hiroki 1), Aki Ichikawa 2), Izumi Morii Sayuri 2), Yoko Yui 2), Noriko Terao 2), Kaori Tanaka 2), Toru Ooi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2012. |
---|
![]() |
Examination - methotrexate high dose therapy ... about the injection preparing compound in consideration of P1-321 medical care security 梅原玲緒奈, Naoki Hayakawa, Ayako Ono, Interval Mari, Katsuya Makihara, 1, Kawabata success, 廣畑和弘, 山内一恭, Katsuya Komori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2012. |
---|
![]() |
Effect on everyday life of patients with breast cancer receiving P1-322 chemotherapy Sekiya wisdom, Kanako Takahashi, Ryoko Maruyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2012. |
---|
![]() |
Can (PFS) become the substitute index of (OS) for a survival period for the progression-free survival period of the P1-323 molecular target drug; analysis - by -Bayes Regression model? Tadao Inoue 1) 2), Hisashi Shimizu example 3), Wataru Yamamoto 2), Upper mound Yoshiro 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2012. |
---|
![]() |
About the patients side factor that a dose change is required after start of therapy 25 mg of P1-324 lenalidomide hydrate Corner proton 1), Kitazawa sentence 1), Fumitaka Ise 1), Kumi Ueda 1), Chihiro Shimazaki 2), History of Hisashi Takara 3), 杉井彦文 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 320-320, 2012. |
---|
![]() |
It is an evaluation of the cancer pharmacotherapy by the clinical judgment analytical procedure scientific choice and evaluation of the P1-325 COX in progress, patients with recurrent colorectal cancer impossible of excision and SOX therapy Tadao Inoue 1) 2), 永瀬怜司 3), Hiroshi Sugano 3), 赤瀬朋秀 4), Ichiro Arakawa 1), Upper mound Yoshiro 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2012. |
---|
![]() |
Examination of the NST intervention patients in the P1-326 cancer special hospital Tagashira still person 1), 鵜池敏令 1), Yukie Asano 2), Michiyo Tanaka 3), Feather wisteria Shinji 4), Corner British 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2012. |
---|
![]() |
Activity of an intervention example and the pharmacist about the renal function evaluation at the P1-327 chemotherapy induction Hiroshi Hashimoto season, 村上通康, Junya Miyaoka, Kyohei Yamaguchi, Shozo Senba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2012. |
---|
![]() |
Effect on hypersensitivity, anaphylaxis inspection of the pre-medication due to P1-328 oxaliplatin Tomoji Fushimi, Prince Sawamura will, Nishibeppu Hiroko, 高尾良洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2012. |
---|
![]() |
Attitude survey for the cancer chemotherapy of the P1-329 healthy subject Kanako Takahashi, Sekiya wisdom, Ryoko Maruyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2012. |
---|
![]() |
The treatment situation for recurrent refractory multiple myeloma that we experienced in P1-330 this hospital Ken Hasuo product 1), 村本慎悟 1), 眞田功 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 321-321, 2012. |
---|
![]() |
1 case that secured safety by the intervention of induction - pharmacist of the mFOLFOX6 therapy to P1-331 chronic heart failure patients Mariko Matsubayashi 1), Maho Miyazawa 1), Yukihisa Imaizumi 1), Eisaku Sasaki 2), Yoshiharu Maeda 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2012. |
---|
![]() |
To get rid of a difference of the cancer therapy between the P1-332 area pharmacist; trial (the first report) ... of the ... Fukushima Hospital Pharmacist Association Kooriyama Branch Tomohiro Suzuki 1), 岩上泰崇 1), Masahiro Kusano 2), Keita Watanabe 2), Yuko Ishida 3), Mikiya Takanashi 4), 5, Kishi, Aitsu), Mamiko Saito 4), Chika Aruga 6), 伊與田友和 6) 7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2012. |
---|
![]() |
We look at P1-333 Cetuximab and the rear about the change of the serum electrolyte level in Panitumumab treated patients and examine a mark Morimoto ability kernel 1), 野村久祥 1), Tadashi Yoshida 1), 川上英泰 1), Hiroaki Usui 1), Yuichiro Abiru 1), 1, Takao, Shinohara), 永井茂 1), Atsushi Furuse 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2012. |
---|
![]() |
The usability investigation after the portable chronofuser adoption change in the P1-334 colorectal cancer chemotherapy and examination of the time of administration 浦瀬剛嗣, Yuka Miyazaki, Tadayuki Harada, Yosuke Nakaji, Yoshiki Matsuoka, Ichiro Mori, Shigenori Koba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2012. |
---|
![]() |
Onset after the postoperative adjuvant chemotherapy enforcement in patients with P1-335 colorectal cancer of neutropenia and prognostic relations Tomiko Sunaga 1), Shuji Suzuki 2), Yagi Akihiro 1), History of Kaji law of nature 2), 小池伸定 2), Mari Kogo 3), Tatsuya Kurihara 4), Harada sincerity ratio old 2), Mamoru Suzuki 2), Yuji Kiuchi 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2012. |
---|
![]() |
Propriety distinction of the simple suspension method in the P1-336 internal use anticancer drug Manabu Amano 1), West comfort Takeshi 1), Cheap Tomomi 1), Ratio intellect shop Hiroyuki 1), History of Tadashi Kiyohara 1), Takanori Nakamura 1), Kurata we see it 2), Mamoru Seto 3), Sachiko Kamiyama 4), Ichio Tanaka 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 322-322, 2012. |
---|
![]() |
On making a notebook for exclusive use of the P1-337 cancer chemotherapy; about the patients during cancer chemotherapy enforcement, the attitude survey for the chemotherapy notebook of each medical staff Kenichi Matsui 1) 2), 齋田正和 2), Book Yumi 2), Chie Okamoto 2), Koichi Hirose 2), Hideyuki Kanemoto 3), Toshiya Ikeda 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2012. |
---|
![]() |
Side effect investigation of Bendamustine in the P1-338 Kurashiki center Hospital Sayo Kano child 1), Yuka Nagao 1), Cedar Rie 1), Junko Takahashi 1), Shinsuke Akagi 1), Lake Aso Kazuyo 1), Kazunobu Takayanagi 1), Kiyonori Ueda 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2012. |
---|
![]() |
Treatment outcome of the P1-339 progress, IRIS therapy in the third treatment for recurrent colorectal cancer impossible of excision Toshihisa Hiraiwa, Hiroyuki Okada, It is still a thought Sawada, Ryo Koike and, Takashi Nakayama Miya, 仙田典保 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2012. |
---|
![]() |
Questionary survey for the medicine medicine cooperation construction of the treatment with anticancer drug in the P1-340 Yamaguchi Red Cross Hospital Hideki Kinoshita, The Amagasaki path of righteousness, 俣賀隆 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2012. |
---|
![]() |
Analysis of the pharmaceutical intervention example by the P1-341 outpatient department chemotherapy exclusive duty pharmacist 日置三紀 1), Yuka Kobayashi 1), Yumiko Furuta 1), 土手賢史 1), Ayumu Nozaki 1), Hiroki Iwane 1), Toshiko Aramiya 1), Hirokazu Nakanishi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2012. |
---|
![]() |
Safety assessment of the TS-1 alternate-day administration in the P1-342 digestive cancer patients Yusuke Ikeda 1), Shinnichi Sado 1), Tadashi Iwamura arrow 1), Akiko Mizoguchi 1), Yasuhiro Tsuji 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 323-323, 2012. |
---|
![]() |
Does aprepitant attenuate efficacy of the warfarin in the patients during P1-343 chemotherapy? Toshimitsu Kurokawa 1), Kenichi Suzuki 1) 2), Michihiro Shino 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2012. |
---|
![]() |
Safety assessment of the multi-tyrosine kinase inhibitor for P1-344 progress, recurrent renal cell carcinoma Michio Kimura, 宇佐美英績, Daisuke Ito, Mina Iwai, Okada sum intellect, Toshiya Nakao, 吉村知哲, Tadashi Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2012. |
---|
![]() |
Examination of the factor which gives it to RDI decrease in the P1-345 Bendamustine alone 宇佐美英績, Michio Kimura, Akihiro Moriya, Shoya Takenaka, Okada sum intellect, Toshiya Nakao, 吉村知哲, Tadashi Yasuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2012. |
---|
![]() |
Examination about the side effect of NSAIDs combination expression at the P1-346 pemetrexed administration Kondo good luck, Color river Masanori, Toshihiro Otani, History of Shigeru Inose, 比氣明子, Takahashi dynasty tree, Kenichi Horikoshi, Tokiwa English sentence Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2012. |
---|
![]() |
The analysis of laboratory values confirmation contents in the P1-347 outpatient department chemotherapy and outcome investigation of the doubt inquiry criteria pertinence case Akira Masuda, Koji Okada, Masayuki Omura, Miho Osawa, Sae Takahashi child, Katsuhiko Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2012. |
---|
![]() |
NET EXCEPTION Err: Could not connect to host 永村陽一郎1), 芦崎雅之1), 下枝貞彦2), 堀治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 324-324, 2012. |
---|
![]() |
Discussion about the blood level after the methotrexate administration for the purpose of the graft-versus-host disease prevention after the P1-349 hematopoietic stem cell transplantation Yumiko Uchida 1), Naoyuki Uchida 2), Masanori Tsuji 2), Kazuya Ishiwata 2), Hiroyuki Fujii 1), Hiromi Tamura 1), Tadaaki Ito 1), Shuichi Taniguchi 2), Masahiro Hayashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2012. |
---|
![]() |
Analysis of the case that resulted in hypophosphatemia due to the P1-350 Tumor genesis syndrome Yoko Inukai 1), Naoyuki Uchida 2), Yumiko Uchida 1), Tadaaki Ito 1), Hiroyuki Fujii 1), Hiromi Tamura 1), Shuichi Taniguchi 2), Masahiro Hayashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2012. |
---|
![]() |
Two patients who presented with hepatic encephalopathy due to hyperammonemia with the P1-351 colorectal cancer chemotherapy mFOLFOX6 therapy Kazuhito Abe 1), Tetsuya Kajimoto 2), Kyohei Abe 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2012. |
---|
![]() |
Examination about the safety of the P1-352 cisplatin generic drug preparation Liujiang Masatsugu 1), Camellia Masahiro 2), Mariko Nakao 1), Fujiwara season Yoshiko 1), Hajime Asano 1), Tetsuya Morita 1), Morihiro Nomura 1), Yuzuru Yamazoe 1), Nishida measure three 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2012. |
---|
![]() |
Case study of the malignant lymphoma given P1-353 immunity thermochemicaltherapy (ITC) 林田諭 1), Shigeru Hayashida 2), 内藤壽則 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2012. |
---|
![]() |
It is ... about use situation investigation - efficacy and problems of the P1-354 Mohs paste Keisuke Seto, Shinya Tamaki, Yoshihiro Naito, Masahiko Takasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 325-325, 2012. |
---|
![]() |
P1-355 Cases of the crizotinib (Xalkori (R)) capsule swallowing difficult lung cancer patients who had oral with desalted capsule: About examination of the oral method 浅野知沙1), 前田章光1), 千葉眞人2), 波戸岡俊三2), 塩田亜由美3), 田内里香3), 山田美佐子3), 水野靖也1), 加藤恵一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2012. |
---|
![]() |
Comparison of the renal function degeneracy in Pemetrexed+Carboplatin combination therapy and the Paclitaxel+Carboplatin combination therapy for the P1-356 non-small cell lung cancer Takashi Sakakibara 1), Hideki Ezaki 1), Naoya Takeda 2), Norio Takimoto 1), Yoichi Kondo 1), Sugawara sheath or 1), Shiho Sugawara 1), Kenji Mori 1), Mitsuru Sugiura 1), 足立守 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2012. |
---|
![]() |
Examination about the safety of the pemetrexed monotherapy for patients with P1-357 renal failure Mari Takagi, Yukie Okada, Kana Yamaji, Yuko Inamoto, Naoteru Fujie, Naomi Tachikawa, Mika Matoba, Hisafumi Yoshida, Court Security Office Mika, 脇條康哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2012. |
---|
![]() |
Styptic treatment of the inflammatory carcinoma of the breast using P1-358 epinephrine dilute solution and the sodium alginate solution Tatsuya Ishikawa 1), Keiko Morimoto 1), Hiroko Kida 2), Mina Kawazoe beauty 2), 舛重奈苗 1), Gold bare cheap 1), 閔貴善 1), Chie Okazaki 1), Fujisawa Minoru 3), Kazuyo Shimojima 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2012. |
---|
![]() |
Association of hypertensive history and ARB for the onset of proteinuria time of patients receiving P1-359 bevacizumab Akira Maeda light 1), 宇良敬 2), Masahide Matsuzaki 1), Seiya Mizuno 1), Keiichi Kato 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2012. |
---|
![]() |
Check list making and evaluation to standardize knowledge and a procedure about the P1-360 anticancer drug handling Satoko Meguro 1), Kayo Sanada 1), Shinichiro Komai 1), Misaki Kurosawa 1), Tomomi Saito 1), Hiroyuki Hasegawa 1), 岡田樹彦 1), Yasukazu Yamauchi 1), Tsuyoshi Aoyama 2), Wataru Suzuki 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 326-326, 2012. |
---|
![]() |
Examination about a side effect and the treatment continuity of P1-361 progress, recurrent breast cancer therapeutic drug eribulin 伊藤大輔1), 浅野裕紀2), 安達志乃2), 松岡知子2), 岡田和智2), 宇佐美英績2), 木村美智男2), 中尾俊也2), 吉村知哲2), 安田忠司2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2012. |
---|
![]() |
Use experience of the Mohs ointment for the local advanced breast carcinoma which was exposed to the P1-362 skin surface 芦埜和幸 1), Bank cotton 2), Yoshihiro Saito 3), Takeshi Shibazaki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2012. |
---|
![]() |
The holding of P1-363 "on koro Gee expert course workshop" two years and the evaluation Koto Fujiwara 1), Kazuyoshi Sakamoto 2), Tanihata Hirohiko 3), Makimoto Shinichiro 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2012. |
---|
![]() |
Examination of the risk factor of the allergic reaction with the P1-364 FOLFOX therapy 細田敦規 1), Furrow Yoshiko 2), 辻琢己 1), Shunsuke Okazaki 3), Hisashi Yasui daylight 3), Takeyuki Kawano 1), Yoshio Kitamura 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2012. |
---|
![]() |
Investigation about the change of the treatment adaptation based on the change of P1-365 breast cancer practice guidelines Hironori Matsui, Toshikazu Takatori, Imamura pasture employee, Chie Takemoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2012. |
---|
![]() |
P1-366 Construction of the anticancer agent preparation duties support system in consideration of Residual liquid amount 長谷川晃司, 和田淳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 327-327, 2012. |
---|
![]() |
Effective and safe examination at the P1-367 rasburicase readministration 山浦佳子1), 伊豆津宏二2), 内田ゆみ子1), 伊藤忠明1), 藤井博之1), 田村宏美1), 谷口修一2), 林昌洋1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2012. |
---|
![]() |
P1-368 linear fuser DIB(C)(R) (TERUMO CORPORATION) usability questionary survey Satoru Tamura 1), Kazuhiro Karasawa 2), Shinichi Fujita 2), Yoshiaki Natsume 2), Hajime Nakai 3), Kazunari Nakamura 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2012. |
---|
![]() |
The inspection of the pre-Abo id contents in P1-369 outpatient department chemotherapy duties and future problem Hideo Sasaki, Keiko Nakahira, Oishi collar, Yoshio Miyake, Kiyoshi Haneda, Atsushi Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2012. |
---|
![]() |
Construction of the operational system of administration in P1-370 anticancer drug mixed preparation duties Tsurusaki University, 深滝利也, Ryo Saegusa is it lower, Shori Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2012. |
---|
![]() |
The examination of the prognostic factor for patients with esophageal cancer after the P1-371 chemoradiotherapy enforcement and construction of the predictive model Ayako Suzuki 1), Mari Kogo 2), Tomiko Sunaga 3), Kazuhiro Kaneko 4), Keiichiro Yoneyama 5), Yuji Kiuchi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2012. |
---|
![]() |
An action and evaluation for the proper use of the oral P1-372 anticancer drug Saito order, Keiichiro Matsuda, Nobukawa Masao, Koichi Arai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 328-328, 2012. |
---|
![]() |
Fact-finding of the chemical interstitial pneumonia in the P1-373 cancer pharmacotherapy Takumi Sakurada 1), Soichiro Tajima 1) 2), Satoshi Kakiuchi 3), Taku Uematsu 4), Tsuyoshi Mori 1), Horinouchi Hironari 1), Kazuyoshi Kawazoe 1) 4), Yasuhiko Nishioka 3), 楊河宏章 2), Kazuo Mizuguchi 1) 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2012. |
---|
![]() |
Examination about the proper use of the treatment with P1-374 zoledronic acid Takuya Fukazawa, 永瀬怜司, Megumi Ota, Jun Takimoto, Hiroshi Sugano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2012. |
---|
![]() |
Example that DOC+TS-1 therapy succeeded for the unresectable progressive gastric cancer with P1-375 peritoneal metastases, and ascitic fluid disappeared Takenori Ichimura 1), Masayuki Obayashi 1), Yagi Satoshi 1) 2), Kazushi Shimamoto 2), Hiroshi Nemoto 3), 小林靖奈 1), Kenji Hibi 3), 山元俊憲 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2012. |
---|
![]() |
About an investigation about the anaphylactic expression situation in the P1-376 outpatient department chemotherapy and the correspondence, evaluation Atsushi Suzuki term 1), Daigo Suzuki 1), Toshiaki Sawada 1), Goji Maeda 1), Hiroshi Sakata 1), Hiroyuki Matsubara 1), Hamaguchi 2, Katsura), Miho Furuta 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2012. |
---|
![]() |
Risk management for the safe administration of P1-377 anticancer drug Hiroko Tai 1), Kazunori Shimomura 2), Mika Tashiro 2), 大河万顕 2), Shinichi Kawaguchi 2), 上田真愉未 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2012. |
---|
![]() |
P1-378 Effects of phytochemicals on breast cancer stem cells 山本明日香, 峯垣哲也, 都築知代, 角田隆紀, 宇野順騎, 高梨仁美, 福島沙織, 森岡千尋, 辻本雅之, 西口工司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 329-329, 2012. |
---|
![]() |
It is examined the monitoring method of the patients receiving the hCG preparation after P1-379 suprasellar region germinoma treatment Oak shallows 1 to bear), Yasuo Aihara 2), 三木伸泰 3), 高橋賢成 1), Yoshikazu Okada 2), Toshimi Kimura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2012. |
---|
![]() |
Generic medicine induction and choice of gemcitabine in the P1-380 this hospital Yutaka Hattori, Maiko Saito, Mountain Masayuki Sawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2012. |
---|
![]() |
Fact-finding about peripheral neuropathy of P1-381 oxaliplatin and examination of the patients background Hiromi Fujimori 1), Megumi Maeda 2), Sono Kaji truth 2), Satoko Fujiwara 2), Matsunaga still 3), Yukihiro Kawakami 2), Sendo Toshiaki 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2012. |
---|
![]() |
Examination of the anaphylactic recurrence after the change to nedaplatin of patients with P1-382 carboplatin hypersensitivity 額田淳, Nawa Hideki, Yoichi Kawasaki, Kazuhisa Yao, Sendo Toshiaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2012. |
---|
![]() |
About tolerability of the pemetrexed monotherapy for elderly people with the P1-383 renal function degeneracy Kuni Imazu intellect, Chiaki Nishikawa, West Yuji, Eri Kuwata, Yutaka Shigemura, Masaru Sugawara, Kyoko Nakata, Masanori Takaoka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2012. |
---|
![]() |
One patient who gave bevacizumab combination mFOLFOX6 therapy in patients with colorectal cancer during P1-384 maintenance haemodialysis 1 related to Osono), White Hiromi Sawa 1), Flat pond Mikako 1), Nagano 1, Makyuu), Noriko Okubo 1), Yoichi Hiraki 1), Kenichi Manabe 1), 尾上公浩 2), Hidetoshi Kamimura 3), Yoshiharu Karube 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 330-330, 2012. |
---|
![]() |
Examination of the oxaliplatin optimal dose in patients with P1-385 chronic renal failure Tsuyoshi Yamashita Shiro 1), Koichi Hirose 1), Noriko Kaneta 1), Kayoko Iwamoto 1), Mizuho Kitamura 1), Hiroshi Ota 1), 金浩敏 2), Junichi Hasegawa 2), 前田頼伸 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2012. |
---|
![]() |
A use case investigation of P1-386 antineoplastic bendamustine and examination about the adverse event Takashi Kimura, Yukio Kadokawa, Kozo Takahashi, Tree Narumi Sawa, Inside many protons, 桝喜惠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2012. |
---|
![]() |
Utility - of the workshop of action - discussion pattern of the medicine medicine cooperation in the P1-387 outpatient department chemotherapy Hanada sum size, Kazufumi Terui, Nao Odagiri, Junichi Nakagawa, Yuji Okamura, Shiori Takahashi, Shiro Itagaki, Early hunting truth Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2012. |
---|
![]() |
Experience two cases that caused anaphylaxis with premedication ranitidine of P1-388 breast cancer chemotherapy PTX+HER Kayo Kimura, 眞下惠次, Akihiro Noda, Hiroko Hatai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2012. |
---|
![]() |
Interaction at combination judging from P1-389 INR of aprepitant and warfarin 野田能成, Eiichiro Kanda, 鹿浦香織, Tadashi Mikami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2012. |
---|
![]() |
Attitude survey - of grasp - new establishment floor nurse of the nursing needs at the P1-390 hospitalization cancer chemotherapy enforcement West Kazuya 1), Akihiko Furuta 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 331-331, 2012. |
---|
![]() |
Comparison of the eGFR estimation type in the carboplatin doses setting of the P1-391 urology department region Naoki Shibata 1), Eiji Niwa 1), Yukiko Omura 1), Hiroko Ogino 1), 酒井繁彰 1), Nobuyuki Sekita 2), Kazuo Mikami 2), Suguru Kasahara Castle 1), Jun Hamada 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2012. |
---|
![]() |
Effect of various culture conditions to give it to a growth rate of the cancer cell line derived from P1-392 human Komiya hills and rivers intellect 1), Kenji Ikeda 2), Yu Kokubo rare 1), Yoshiko Terao 1), 浦嶋庸子 1), Masashi Ogawa 2), 廣谷芳彦 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2012. |
---|
![]() |
Pharmacist permanent residence to the P1-393 outpatient department chemotherapy center estimates the utility as becoming it Furrow Yoshiko 1), Masako Baba 1), Hiroyuki Ueno 1), Kei Nakamura 1), Hisashi Yasui daylight 2), Yoshio Kitamura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2012. |
---|
![]() |
Relation (the third report) as the pharmacist to the chemotherapy in the P1-394 children region Yuka Tanaka 1), Mika Tokuda 2), Shiho Yasue 2), Yokoyama skillful writing 2), Mari Mori 2), Emi Kadoi 2), Great Xisha cord law of nature 2), Kuni Shinoda University 2), Takao light 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2012. |
---|
![]() |
Examination about the PT-INR change with P1-395 warfarin potassium and the FU agent Hidekazu Arai 1), Yuka Kobayashi 2), Maiko Saito 1), Ikuyo Takahashi 3), Harumi Sudo 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2012. |
---|
![]() |
Investigation of the allergic expression of P1-396 oxaliplatin (L-OHP) situation in the first time or the reintroduction 宮崎晃臣, Ebina truth existence, Masahiro Abe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 332-332, 2012. |
---|
![]() |
Anticancer drug in a cancer cell and nerve cells derived from a lot of P1-397 tissue-sensitive difference Yu Kokubo rare 1), Kenji Ikeda 2), Komiya hills and rivers intellect 1), Yoshiko Terao 1), 浦嶋庸子 1), Masashi Ogawa 2), 廣谷芳彦 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2012. |
---|
![]() |
Investigation of the thesis about the support of the cancer chemotherapy-related duties with the computing system in P1-398 this country Makoto Nakajima 1), Yoshie Nomura 1), Takuya Goto 1), Rie Mori 1), Yuka Aizawa 1), Nobuyuki Mishima 1), Tadashi Sugiyama 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2012. |
---|
![]() |
Investigation about chemical hypersensitivity of the P1-399 antitumor agents Kentaro Katayama, Imamura pasture employee, 武本千惠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2012. |
---|
![]() |
Resident placement - first report of the pharmacist in the outpatient department of the P1-400 tumor chemotherapy part shortening - in waiting time: Yusuke Aizawa 1), 南真進 1), Yukihiro Shimizu 1), 守岩美紀 2), 須口由希 2), 高橋威洋 3), Ichikawa degree 3), Sone Wataru Hara 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2012. |
---|
![]() |
Analysis of the bevacizumab-induced high blood pressure in patients with P1-401 colon, rectal cancer 岩井美奈, 木村美智男, 吉村知哲, 安田忠司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2012. |
---|
![]() |
Examination of the injection method for the oral P1-402 tretinoin difficulty patients Hiroe Takeuchi 1), Kobe Kaori 1), Kazue Yamane 1), 牧問美和子 1), Yoshimura table 1), Takuya Otsubo 1), Takayuki Tanaka 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 333-333, 2012. |
---|
![]() |
Elucidation of the docetaxel resistance-gaining mechanism of P1-403 non-small cell lung cancer A549 cells Jun Taniguchi 1), Ryuji Ikeda 2) 3), Nishizawa reason Norihiko 3), Akira Higashijima person 4), Yasuo Takeda 2) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2012. |
---|
![]() |
Try the medical supplies safety management person in charge training by the P1-404 e- learning Masako Tahara 1), Yasuko Shinozaki 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2012. |
---|
![]() |
Action to recurrent prevention for the purpose of an analysis and the consciousness improvement of the P1-405 incident development factor Takashi Shiraishi Kotobuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2012. |
---|
![]() |
Association of P1-406 fall, a fall risk and the internal use situation of the sleep inducer 三角紳博 1), Toshihiro Matsumoto 1), Kazuhiro Yamawaki 1), Yui Inoue 1), Takashi Nishino 1), Adachi るい 1), Yagawa Yuko 1), Hideki Sato 1), 小籔真紀子 1), Mitsuko Inoue 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2012. |
---|
![]() |
Examination of the use in inside the hospital of the P1-407 fentanyl patch once a day preparation Tamura wise person, Tomoichi Kaneko, Makoto Kaneko, Young sea eight states male, Takayuki Matsui, Hideaki Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2012. |
---|
![]() |
Result of the mini-lecture to the nurse in the P1-408 ward The Ishikawa immensity, 後藤志央, Shrine Akihiro Ichiro, 末安由拓, Tatsuya Sasaki, Kaifu Masayo, Akihiro Kai, Prince Taniguchi chapter, Takahiro Rikitake Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 334-334, 2012. |
---|
![]() |
Comparison ... of the internal medicine in observance situation and our well-known degree investigation ... House of Japanese diabetes society Recommendation in the P1-409 sitagliptin and other clinical departments 小林理栄, 新井亘, 大島聡子, 紙屋めぐみ, 笹山祐布子, 坂下舞, 難波由里子, 増田裕一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2012. |
---|
![]() |
Construction of the cancer chemotherapy plan making system which linked P1-410 electronic chart Tree Masaji 1), Tatsuya Suzuki 2), 松浦美聡 3), Yuko Takahara 1), Amano apricot south 1), Hiroki Yoshida 1), Mari Teramachi 1), Yoshihiro Kawade 1), Toshiki Uchida 2), Michinori Ogura 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2012. |
---|
![]() |
Examination about the safety of the order input by the P1-411 pharmacist Star Hiroshi Noji, Akira Nakamoto University, 豊島佳那子, Keisuke Oshima, Aiko Hirano, Yumiko Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2012. |
---|
![]() |
About P1-412 cold water re-hat example decrease measures Tomoko Yamazaki, Yasunori Nagano, Naoyuki Watanabe, Koji Kamiya, Mitsuru Kaneta Expo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2012. |
---|
![]() |
The effect that difference between color difference and size of the multiple sites of the P1-413 PTP sheet gives to a subjective appearance similarity ratio Tamaki Hirofumi 1), Hiroki Sato 2), Moat foster child 2) 3), Yasufumi Sawada 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2012. |
---|
![]() |
Action to risk management by the child dose check system induction in the P1-414 Kitasato University Hospital God one dream 1), Toshiko Sasaki 1), Megumi Seki 1), Tomoko Suzuki 1), Jun Kainuma 1), Rumiko Kondo 1), Hajime Matsubara 1), Kazuo Yago 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 335-335, 2012. |
---|
![]() |
A construction and evaluation of the injection cancellation confirmation system which linked P1-415 electronic chart 行本拓史 1), Kaori Kimura 1), Matsuo Kimiko 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2012. |
---|
![]() |
A characteristic and measures of the incident in the P1-416 business training Rumiko Amano 1), 新井成俊 2), Junichiro Fukuhara 2), Yutaka Inoue 1), Isamu Murata 1), Masayuki Kimura 1), Ikuo Kanemoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2012. |
---|
![]() |
Action of the pharmacist in the medical safety education for the nurse P1-417 new face Ayako Tsuda 1), Keizo Kato 1), Hiromi Fujimori 1), Kazuko Yamamoto 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2012. |
---|
![]() |
Evaluation of the utility of the injection automatic return device in the disposal of injection work returned by the P1-418 ward Satoshi Shimizu way, Ryoji Yanagihara, Toshihide Abe, Katsuyoshi Nakajima, Hiroshi Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2012. |
---|
![]() |
Distribution of medicine cart set duties by the P1-419 pharmacy 森光恵, 北出紘規, 木戸裕美, 北国憲剛, 中川貴史, 栂谷内良枝, 中村紗季, 塚本佳奈子, 新田千恵, 新宅君子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2012. |
---|
![]() |
Adequacy of the IV line at the P1-420 cancer chemotherapy Keisuke Abe 1), Yasuhiko Sakata 1), Takafumi Sugawara 1), Shinichi Miyamori 1), Misako Sasaki 2), Open Koichi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 336-336, 2012. |
---|
![]() |
A tendency and remedy of the incident of the physician in the P1-421 outpatient department prescription Shinya Watanabe, Takami indigo plant, Yuta Komai, 櫻間和紗, Rie Tsuchimoto, Ryota Nakamura, Yukiko Kita, Hirotsugu Kita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2012. |
---|
![]() |
P1-422 Medical safety improvement of using the bar code of ethical drug : Part 2 Application to injection drug inspection 宇都宮暁, 小泉盛, 伊藤護之, 眞壁秀樹, 杉本修, 北澤貴樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2012. |
---|
![]() |
Need - two levels bag transfusion preparation ... of the assessment of the P1-423 medical supplies body indication 廣實清司 1), Hiroyuki Furukawa 1), Chizuru Hanada beauty 2), Yuko Tokunaga 3), Kazuo Ukita 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2012. |
---|
![]() |
The environmental maintenance enlightenment document of being accelerated will be easy to be understood use of P1-424 generic medicine; is the examination about the difference of - producer Miyoko Fujimori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2012. |
---|
![]() |
New construction of an evaluation, the reporting of medical supplies by the P1-425 clinical trials Profile induction Mariko Kawana 1), Yutaka Kobori ankle 1), Makoto Nakazaki person 1), Junko Nagai 1), 陳惠一 2), Tadanori Sasaki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2012. |
---|
![]() |
About ward resident duties in the P1-426 Himeji medical center (the fifth report) action - for - drug information offer Tsubosaka Naoko, Yuka Takahara, Yoriyuki Kawato, Hiroshi Hashimoto, Katsuaki Kobayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 337-337, 2012. |
---|
![]() |
Analysis of the thyroid function abnormality event using the P1-427 adverse event spontaneous report database Koichi Hosomi, Aya Fukuda, Mitsutaka Takada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2012. |
---|
![]() |
Action to prevention of the incompatibility in the P1-428 simple suspension method Muko Yuko 1), Miwa Ishihara 1), Tomoko Sasaki 1), Kayoko Baba 1), Mayumi Mochizuki 2), Muko Yoshio 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2012. |
---|
![]() |
About ward resident duties in the P1-429 Himeji medical center (the fourth report) about communalization of the drug information in - Himeji medical center - Yoriyuki Kawato, 金川明裕, Tsubosaka Naoko, Yuka Takahara, Tomishima Kosuke, Hiroshi Hashimoto, Katsuaki Kobayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2012. |
---|
![]() |
An action and follow-up results to P1-430 safety reporting 延藤勇, 豊浜隆, Koji Takai, Yoshinobu Kitao Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2012. |
---|
![]() |
Action - in database compilation of P1-431 drug information and nurse duties using a database and the cottage-hospital in upbringing support - area 和田匡央, Atsuko Takada, Satoshi Hirota University, Hiromi Fujimoto, Nakata is quiet Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2012. |
---|
![]() |
It is making ... of a ... incompatibility list, shading bag attachment criteria for safe use of the P1-432 injection Kazuki Tago, Naoki before yellow, Fujita Aoi, The Aya Yamamoto beauty, Kazuya Hirata, Naoyuki Matsumoto, Shuhei Suzuka, Miki Nakamura, Great Yumiko Tsuyama, Person of moat Yumiko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 338-338, 2012. |
---|
![]() |
Competitive review of the drug information book for public patients in P1-433 Japan, the United States and Europe Aya Furukawa 1) 2), Hiroki Sugimori 3), Michiko Yamamoto 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2012. |
---|
![]() |
- made with a review and the system of the drug information administrative work for paradigm shift - ward drug duties of the P1-434 drug information administrative work The Tanaka immensity, Step pine Masahiro, Takashi Kawada, Marie Yamawaki, Naoko Matsumoto, So Yamamoto one, 服部暁昌 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2012. |
---|
![]() |
Construction of the safe information database about the treatment with Chinese medicine of P1-435 pregnant woman, the nursing mother Iwade Ayumi 1), Nao Yoshida 1), Kumiko Sakamoto 2), Yoichi Sato 1), Aiko Yamauchi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2012. |
---|
![]() |
Demand for information in the P1-436 drug information management room and analysis of the offer Junichi Masuda, The Takahashi fish to eat beauty, 中村真依, Atsushi Kubota, Koichi Mizuno, Jiro Mikami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2012. |
---|
![]() |
General evaluation of ARB as the antihypertensive drug on the basis of the discussion about physicochemical characteristics of P1-437 ARB from literatures Shiro Itagaki, Hideki Noro, Descent from a mountain Ritsuko, Sachiko Fujita, Early hunting truth Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2012. |
---|
![]() |
Residual medicine investigation in outpatients taking P1-438 antiHIV medicine 森下和美1), 野毛一郎1), 吉田康秀2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 339-339, 2012. |
---|
![]() |
Action to use of contraindicated medicine evasion in patients with P1-439 prostatic hyperplasia Tomohiro Takahashi, 森章哉, Tadashi Fujita will, Satoru Morita, Takuya Yamakawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2012. |
---|
![]() |
Attitude survey for the handling of the medical equipment to P1-440 health insurance pharmacy pharmacist and the sale 曽賀千智 1) 2), Kiyoto Edo 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2012. |
---|
![]() |
Action for the present conditions of the simple suspension method in the P1-441 this hospital and the in-hospital unionization Yoshimi Imada, Kanako Tsujimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2012. |
---|
![]() |
The use situation of the P1-442 bringing medicine drug and future problem Akira Nagayama, Masako Kondo, Tomiko Inoue, Kazumi Morishita, Masaya Sato, Yagi Makiko, Yumi Kanetani, Noge Ichiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2012. |
---|
![]() |
The actual situation of the use of attached document information at prescription in the P1-443 specialist Kayoko Maezawa 1), Asako Terashima 1), 木村一幾 1), Yuri Ohashi 1), 秋田博伸 2), Moat Seiji 3), Junko Kitsu 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2012. |
---|
![]() |
Analysis of the factor in the management insufficiency case of the anticoagulant therapy for P1-444 patients with atrial fibrillation Hiroki Nakano 1), Motoaki Nakao 2), Hiroyuki Ueno 2), Kei Nakamura 2), Yoshio Kitamura 2), 辻琢己 1), Takeyuki Kawano 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 340-340, 2012. |
---|
![]() |
Investigation about pharmacist awareness and the patients satisfaction for the drugstore service of the P1-445 ethical pharmacy 岡遼太郎, Castle self denial, Daiya Sakurada, Eriko Kobayashi, Noboru Sato example Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2012. |
---|
![]() |
Use situation investigation of pioglitazone in the P1-446 eight City municipal hospital Dove Natsuko, 田村健悦, South Kazushi, Yuko Okuyama, Teru Saito still, Yuko Fujii, Tanaka sunlight, Isao Miura Taro, Kazuki Ishikura, Origin of Hiraga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2012. |
---|
![]() |
Examination to a use of P1-447 dabigatran situation investigation and proper use 竹内仁, 小林千恵, 白澤吉哲 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2012. |
---|
![]() |
Use situation investigation of the peramivir in the P1-448 Kurashiki center Hospital 赤木晋介, 加納沙代子, 高橋順子, 長尾由佳, 高柳和伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2012. |
---|
![]() |
A use of P1-449 dabigatran situation investigation and construction of the management method 水野由紀子1), 柴田大地2), 杉浦充2), 足立守2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2012. |
---|
![]() |
Examination about economic effect in the P1-450 ARB/CCB compounding agent induction and the role of the pharmacist Yoichi Hiraoka 1), Tatsuo Nakagawa 2), Kazumi Kito 1), Akito Nagai 1), Takanobu Hashimoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 341-341, 2012. |
---|
![]() |
It is ... from the attitude survey of ... nurse for the future action of the P1-451 psychological care team Your Tsuyoshi Ito 1) 2), Aimi Matsukura 1), Chiaki Matsumoto 1), Mai Iida 1) 2), Junko Kurata 2) 3), Shigeyoshi Uchida 2) 4), Kumiko Umeda 2) 5), Miyoko Tanaka 2) 5), Kazuko Matsunaga 1), Shigeo Isaka 2) 6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2012. |
---|
![]() |
A prescription investigation and examination of the antipsychotics in the P1-452 this hospital Mieko Morita, 岩瀬利康, Yoshio Ito, Junko Miyakawa, Koichi Hoshino, Miyuki Suehiro, 双樹恵, Tomoko Koyama, Tomoaki Toyama, Yuki Tsukada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2012. |
---|
![]() |
We look at the rear of the factors associated with efficacy, the side effect of the P1-453 new antiMRSA medicine daptomycin and investigate a mark 小曳恵里子1), 安藤基純2), 北田徳昭1)3), 中浴伸二1), 柏木裕子1), 山本健児1), 西岡弘晶4), 橋田亨1)3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2012. |
---|
![]() |
The combination situation with the medicine for dyslipidemia judging from the prescription fact-finding of P1-454 antihypertensive medications Young Susumu Hayashi 1), 1, Takao, Shinohara), 永井茂 1), Nobukazu Tanaka 2), Junichi Hayashi 2), Minoru Yamamoto 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2012. |
---|
![]() |
About proper use of the P1-455 hypertonic albumin preparation 滝浪由季乃, Aiko Iguchi, Junko Totsuka, Yoshiyuki Shibayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2012. |
---|
![]() |
About the reason why a combination (an angiotensin II receptor antagonist and diuretic) was deleted by P1-456 this hospital adoption medical supplies Keiji Totsuka, Kazuya Matsushita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 342-342, 2012. |
---|
![]() |
P1-457 Consciousness change of pharmacists such as through the use of service tools in drug stores: Preliminary investigation with the aim of customer service capacity building 森達哉1), 鶴見健2), 恩田光子1), 金岡世晃1), 田方裕梨1), 森川祥彦1), 岡本昌樹1), 荒川行生1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2012. |
---|
![]() |
Analysis of the sales promotion factor in the P1-458 drugstore Ken Kamata 1), Yuko Itakura 2), 植沢芳広 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2012. |
---|
![]() |
Prognosis investigation after the OTC medical supplies purchase in the dweller of the P1-459 cold-like symptom 田方裕梨 1), Takeshi Tsurumi 2), Mitsuko Onda 1), Tatsuya Mori 1), Kaneoka world daylight 1), 1, Sawa, Tokai), Masaki Okamoto 1), Yoshihiko Morikawa 1), Arakawa line straight 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2012. |
---|
![]() |
Gap analysis between patients - pharmacists for the pharmaceutical management instruction of the high-risk medicine in the P1-460 health insurance pharmacy Yoshi Hashimoto tree 1), Mitsuko Onda 1), Inner book Hideki 1), Iwasaki future 1), Yuka Tanaka 1), Arakawa line straight 1), Miho Murakami 2), 早瀬幸俊 2), Hidehiko Sakurai 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2012. |
---|
![]() |
Use situation investigation about the tuberculosis prophylaxis administration of isoniazid in the P1-461 neonates department Tadashi Kitagawa 1), Chika Teraoka 1), Masako Muroi 1), 望月成隆 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2012. |
---|
![]() |
Present conditions of examination - combination contraindication medicine about the combination contraindication in the P1-462 this hospital and future action ... Koji Okanishi, Seiji Kominami, Rikio Tsuji, Yukiko Morita, North Keiji, Masayuki Uno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 343-343, 2012. |
---|
![]() |
About the effect of the bucolome on P1-463 warfarin potassium doses and test value 飛澤国広, Shunsuke Fuchigami, Takayuki Mita, The Azuchi greens beauty, Suyama Akina, Takashi Yasushi Inoue, Takato Imai, Hiroaki Watanabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2012. |
---|
![]() |
It is a case with suspected onset of the serotonin syndrome by combination of P1-464 tramadol mirtazapine fluvoxamine Noriko Kaneta, Hirohira Fukami, Tsuyoshi Yamashita Shiro, 藤田將嗣, Koichi Hirose, Satoshi Yamamoto, Tsuyoshi Oda, Tsuyoshi Oda, 前田直就, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2012. |
---|
![]() |
Combination of P1-465 warfarin potassium and interaction case - after real - atrial fibrillation catheter ablation in the amiodarone combination Takada Australia, Toshihiro Otani, Kenichi Horikoshi, Tokiwa English sentence Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2012. |
---|
![]() |
Effect of the baicalin combination in the de-conjugation response of hydrochloric acid irinotecan metabolite (SN38G) through P1-466 beta-glucuronidase Old Takaaki Tawara, Takashi Azuma, Yutaka Negoro, Watanabe Toru is flat, Ryoichi Yano, Toshiaki Nakamura, Mikio Masada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2012. |
---|
![]() |
Investigation about the expression time of the INR increase in P1-467 Warfarin and the S-1 combination patients Kei Yamaguchi Taro, Naoya Uto, 北森靖隆, Ichimura line celebration, Hideaki Tamaoki, Hideaki Ishida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2012. |
---|
![]() |
Effect on flavor at decomposition, the suspension with luxury goods of P1-468 Mukoda in (R)DS50% and stability of the L-carbocysteine Akira Takagi period, Manabu Okumura, Tomomi Iwakiri, Rie Ono, Ai Minoda, Kazuya Yasuda, Yuko Matsumoto, North field Tomomi, Kenji Nakanishi, Kazuhiko Arimori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 344-344, 2012. |
---|
![]() |
1 case that anticoagulant action of the warfarin was prolonged by the miconazole gel which P1-469 preceded Miyako Kawamura 1), Daisuke Matsubara 1), Akira Takada 1), Kazuki Tanaka 2), Yasuda Yorimasa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2012. |
---|
![]() |
The case that measurement of 6-TGN was useful in a diagnosis of the myelosuppression with the P1-470 azathioprine Hiroshi Watanabe plan, Kuni Isobe finally, Miyoshi straight celebration, Katsuhiro Yamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2012. |
---|
![]() |
Pharmacokinetic model for interaction evasion with P1-471 phenytoin and TS-1 Takumi Shinpo 1), Hiroki Sato 1), Akiko Miki 1), Moat foster child 1) 2), Toshiaki Nakamura 3), Mikio Masada 3), Yasufumi Sawada 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2012. |
---|
![]() |
1 case that interaction with P1-472 Warfarin and Vincristine was strongly suspected of Tetsuro Koide 1) 2), Takuya Iwamoto 2) 3), Megumi Fukazawa children 4), Kaoru Kuroki line 4), Masatoshi Muramatsu 4), Shinko Okuda 2) 3), Keiko Watanabe 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2012. |
---|
![]() |
Examination of the appropriate warfarin dose at the P1-473 bath comb supply cancellation Koji Endo, Toshihiro Otani, Kenichi Horikoshi, Tokiwa English sentence Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2012. |
---|
![]() |
The resolution of the beta-lactam antibiotic with the P1-474 L-cysteine Yukiko Katagiri 1), Chie Kudo 1), Fumio Itagaki 1), 忍足鉄太 2), 高橋秀依 3), 夏苅英昭 2), Hideaki Niwata 1), Machiko Watanabe 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 345-345, 2012. |
---|
![]() |
Examination of the discussion of the factor of the Serious ADR case in specialists in citizen of P1-475 Osaka and future measures Miyuki Matsumoto 1), Yoshiko Yamauchi 2), 吉原由治 3), Yumiko Teranishi 4), Kamiura Mana true 5), Small appendix Tetsuya 6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2012. |
---|
![]() |
The P1-476 atrioventricular block complete patients are cases with suspected induction of torsades de pointes by sulpiride internal use Atsushi Miura 1), Masayuki Ogiwara 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2012. |
---|
![]() |
The polymerization initiator of the mixture out of the injection induces apoptosis for P1-477 human peripheral-blood mononuclear cells Minoru Mori Miwa 1), Yoichi Kawasaki 2), Chiaki Tsuboi 1), Sendo Toshiaki 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2012. |
---|
![]() |
Examination about the hypophosphatemia to occur after P1-478 linezolid administration 八木仁史1)2), 氏家秀太2), 宮本渚2), 渡邊徹1), 齋藤勲1), 竹ノ内敏孝2), 村山純一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2012. |
---|
![]() |
One patient who had a diagnosis of Reiter syndrome with the infusion in the BCG bladder by P1-479 pharmacist intervention 久保嘉靖 1), Masahiro Okuno 1), 金丸聰淳 2), Satoshi Ito 2), Yoshiharu Umetani 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2012. |
---|
![]() |
Search of the hemorrhagic side effect expression of P1-480 new anticoagulant dabigatran factor 木村嘉彦, 尾上雅英, 川田将義, 橋本恵美奈, 小形瑛, 津田真弘, 吉野秀紀, 佐澤瑞穂, 森田洋亮, 増田智先, 矢野育子, 松原和夫 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 346-346, 2012. |
---|
![]() |
The onset of Colin symptom situation with the P1-481 irinotecan hydrochloride Naoya Suzuki, 吉嶋抄苗, Yuko Watanabe, Yoshiko Sasaki, Maiko Tokumura, Shohei Kawahara, Landowner Takafumi, Makoto Takahashi, Tadahiro Aota Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2012. |
---|
![]() |
Present conditions investigation of the expression situation and symptom measures of the skin reaction in the P1-482 chronic hepatitis C triple-drug therapy Akiko Nishimura, Koji Akiyama, Tomoko Matsumoto, Mountain Rieko Sawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2012. |
---|
![]() |
Construction of the uniform management system of P1-483 adverse drug reaction, the allergic information Kanae Sakakibara, Hanako Kohata, Tsuneaki Tanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2012. |
---|
![]() |
Preventive measures of the P1-484 dabigatran against side effects and the effect 鈴木美奈1), 冨田道夫1), 坂本拓也1), 須田智栄子1), 松田俊之1), 酒井英行2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2012. |
---|
![]() |
Age difference examination of acetaminophen hypersensitivity by P1-485 LMT Kenichi Shimizu 1), Tomoyasu Furukawa 1), Manabu Abe 2), 斎藤幹央 2), Yagi Motohiro 3), Koike reason Expo 4), 継田雅美 1), Katsuji Uno 5), Susumu Ozaki 6), Takashi Toyoshima thickness 7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2012. |
---|
![]() |
One case of liver dysfunction with P1-486 mosapride citrate (Gasmotin (R)) Megumi Mizuno, Kazuyuki Ito, Keita Urasaki, Kazuko Kawai, Satoshi Isotani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 347-347, 2012. |
---|
![]() |
Examination of NSAIDs hypersensitivity by P1-487 LMT-chamber Tomoyasu Furukawa 1), Manabu Abe 2), 齋藤幹央 2), Yagi Motohiro 3), Koike reason Expo 4), 継田雅美 1), Katsuji Uno 5), Katsumi Enomoto 6), Susumu Ozaki 7), Takashi Toyoshima thickness 8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2012. |
---|
![]() |
One patient whom hepatic dysfunction developed in by P1-488 edoxaban 森英樹1), 金井美緒1), 熊岸奈緒1), 小池彩子1), 大道淳二1), 諏訪耕三1), 中山集1), 歳森淳一2), 小橋春彦2), 東原信七郎3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2012. |
---|
![]() |
Fact-finding of the onset of liver dysfunction with the P1-489 acetaminophen dosage regimen change 澤柳直樹, Tomokazu Fujii, Kato Yue Loong, Haruhiko Nakamura, Hisashi Tsukamoto, Hisashi Kamiya line Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2012. |
---|
![]() |
Analysis of DLST positive rate and the effect factor in the P1-490 drug hepatopathy Itsumi Sasaki, Toshiaki Nakamura, Mikio Masada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2012. |
---|
![]() |
Retrospective investigation about the effect of the renin angiotensin system effects drug in the blood pressure fluctuation at the P1-491 general anesthesia induction Chihiro Ito 1) 2), Takeshi Hashimoto Shiro 1), Kensuke Usui 1) 2), Masanori Kashiwagi 3), Atsuta Koichiro 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2012. |
---|
![]() |
Examination - in comparison between en bloc administration and side effect - ovarian cancer weekly TC(paclitaxel+carboplatin) of P1-492 Carboplatin in divided doses Tomoki Yoshioka 1), Mariko Kinoshita 1), Ayumi Ozeki 1), Masanobu Ogawa 1), 森善洋 1), Takayoshi Tsuruta 1), Mayumi Yamashita 1), Kohei Kodera 2), Quantity lower Hiroko 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 348-348, 2012. |
---|
![]() |
The cancellation of the P1-493 Kress Thor lock and side effect investigation for weight loss cases 櫻間和紗, Rie Tsuchimoto, Tomoko Kitamura, Hiroko Okano, Yusuke Komatsu, Shiohira Saki, 田中紋乃, Cherry blossom viewing Yuko, Yuriko Hitomi, Yuka Murase, Hirotsugu Kita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2012. |
---|
![]() |
Fact-finding of the acute adverse event in the P1-494 outpatient department chemotherapy room Takeru Kawai, Shunichiro Saito, Shuji Azuma, Juria Kaneko, Yukiko Honda, Yu Goto, 小原郁司, Ryuji Kodera, Descent from a mountain Koichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2012. |
---|
![]() |
Investigation of the side effect expression of P1-495 terra pre-building situation aiming at proper use Hirohira Fukami, Koichi Hirose, Noi Asami, Tasuku Fujiwara season, 藤田將嗣, Tsuyoshi Yamashita Shiro, Satoshi Yamamoto, Mizuho Kitamura, Tasuku Kawai levator, Takashi Inoue solstice, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2012. |
---|
![]() |
Experience of the drug-related diarrhea improved by the change of prescription of the P1-496 proton pump inhibitor (PPI) Nobukazu Ryu 1) 2), Norimasa Takahashi 1), Kazuhisa Naoi 1), Yasuhiko Mimura 1), Atsushi Kato 1), Isao Adachi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2012. |
---|
![]() |
P1-497 One case that has brought severe thrombocytopenia by garenoxacin (Geninax (R)) taking 中村豪志, 藤澤浩美, 中村綾奈, 大北直美, 木村健 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2012. |
---|
![]() |
P1-498 Recognition survey of sitagliptin side effects and patients and doctors 寺西由美子1), 松本ミユキ2), 山内美子3), 吉原由治4), 神浦茉奈実5), 小垂徹也6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 349-349, 2012. |
---|
![]() |
Elucidation of the cytotoxic augmentation mechanism of statin drugs with the indoxyl sulfate in P1-499 human striated muscle model cells Tomoko Oda 1), Masayuki Tsujimoto 1), Jin Ogino non-1), New book only 1), Takuya Yoshida 2), Old Taku Kubo 2), Satoshi Izumi 2), Tomoyuki Yamakawa 3), 峯垣哲也 1), 西口工司 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2012. |
---|
![]() |
1 case that prevented progression of lithium intoxication by the intervention of the P1-500 psychological care team pharmacist Masaki Kumai 1), Mami Kiyokawa 1), Kumiko Kasashi 1), Takehiro Yamada 1), Takeshi Iseki 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2012. |
---|
![]() |
Trial of the economic evaluation of the P1-501 ADE(Adverse Drug Events) evasion Tomohiko Igawa 1), Hisae Murata 2), Yukiko Enomoto 2), Chiho Komai 2), Nakano Chihiro 2), Wild moat early period 2), Yoko Okayama 2), Mai Fujinami 2), Okamoto law of nature tree 1), Mitsuko Onda 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2012. |
---|
![]() |
Investigation about an opinion and the experience for the reporters in the side effect report from the P1-502 patients Michiko Yamamoto 1), Kiyoshi Kubota 2), Mitsuhiro Okazaki 3), Akira Dobashi 4), Masayuki Hashiguchi 5), Suka Machi 6), Masahiko Hayashi 1), Hideaki Takasu 1), Mayumi Mochizuki 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2012. |
---|
![]() |
Utility of the nitroprusside note for the reperfusion injury of the P1-503 acute myocardial infarction patients Shunichi Aida 1), Hiroaki Abe 2), Naotake Takase 1), Keisuke Yonezawa 1), Branch 1 early on Nakata day), Ikuko Miki 1), 千崎昭輝 1), Gutter book Mayuko 1), Takashi Fujii 2), Nobuyuki Muroi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2012. |
---|
![]() |
Pharmaceutical treatment with P1-504 blood L-DOPA and L-DOPA metabolite monitoring management of patients with advanced Parkinson's disease that used MAO-B inhibitor together Yumi Tsuruoka 1), Kuzuu Ami 1), Member of Satoshi Doi 2), Masaka Wataru 2), Takatsugu Sakakibara 3), Mitsutoshi Sato 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 350-350, 2012. |
---|
![]() |
Study on allergic onset with the additive derived from the food included in the P1-505 ethical drug Mitsuhiro Okazaki 1), Mikami window or 1), Koji Itagaki 2), Tetsuko Teshima 2), Reiko Teshima 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2012. |
---|
![]() |
The correspondence to the elderly people with dementia case that drank P1-506 S-1 by mistake in large quantities and the course Miki Kobayashi 1), 六波羅孝 1), Masayuki Kitahara 1), 唐澤頼勝 1), Shinichiro Ohashi 2), 3 in Nakayama) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2012. |
---|
![]() |
An evaluation and problem of the bringing medicine management in the P1-507 Fujinomiya Municipal Hospital Yoshinori Kobayashi, Mariko Ijiri, Yutaka Kobayashi, Hiroshi Kawaguchi fruit, Kazuo Katsumata, Osamu Kitamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2012. |
---|
![]() |
The bringing medicine operational investigation which assumed medical security after the electronic chart system transition in the P1-508 this hospital an index 栗崎貴啓 1), Chiharu Nakahara 2), Yoshiharu Wada 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2012. |
---|
![]() |
Utility of the bringing medicine copying system in the P1-509 cancer base Hospital Hayasaka state life, Hidenori Kitayama, Kimiyoshi Takeuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2012. |
---|
![]() |
Examination about the quick differentiation of the bringing medicine using the P1-510 portable Raman spectrometer Kazuo Tomono 1), 深水啓朗 1), Yoshihisa Yamamoto 1) 2), Hiroshi Hisada 3), Tatsuo Koide 4), Noriko Katori 4), Suzuki Toyoshi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 351-351, 2012. |
---|
![]() |
Investigation about the information tool which is effective for confirmation of the patients medication situation judging from P1-511 bringing medicine investigation Noriko Ito, Shoichi Yamaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2012. |
---|
![]() |
Bringing medicine management using an electronic chart system in the P1-512 this hospital River Chinese mustard cord, Matting Toshika Fuchi, Adachi texture to praise, Junko Tsujimoto, Takashi Nishio, Hitoshi Okugawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2012. |
---|
![]() |
The comparison of the duties in the bringing medicine control center before and after the P1-513 electronic chart system induction and the evaluation Yutaka Hatakeyama child 1), Kenichi Horiuchi 1), Kazumi Yoda 1), 納誠人 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2012. |
---|
![]() |
It is ... through relation ... pre-Abo id example of bringing medicine management and the pharmacist in the P1-514 cancer special hospital Koki Yamashita 1), Maki Abe 1), Shinki Yoshino 1), Naoya Saito 1), Mayumi Kaise 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2012. |
---|
![]() |
An evaluation and problem of the bringing medicine management using P1-515 hospital information system 小暮友毅 1) 2), Corner British 1), Valley water Masato 2) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2012. |
---|
![]() |
Action to safe medical treatment mainly on the patients bringing medicine confirmation in the P1-516 hospitalization and release, medical cooperation center Shoji Izumo, Manami Kanda, 四方公亮, Misa Sugano tree, Kaori Sato, Yuki Inoue, Miyako Shoda Noriko, Toru Hirashima, Hideo Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 352-352, 2012. |
---|
![]() |
Investigation of the adverse event in the patients who changed the P1-517 anticancer drug from the starting medical supplies to the generic medicine Megumi Kadoi Yoshiko, The Yoshimura spring beauty, Junya Ogawa, Koji Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2012. |
---|
![]() |
What you should think about at the reshuffling to P1-518 transfusion generic drug (with Fischer liquid for a case) Keiji Kuramoto 1), Takako Suzuki 2), Takashi Hatae 3), Toru Shoji 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2012. |
---|
![]() |
Desensitization of the forerunner, the generic medicine of the ST mixture in patients with P1-519 HIV infection and product comparison 矢倉裕輝 1), 吉野宗宏 1), Hiroyuki Kushida 1), 廣畑和弘 1), 山内一恭 1), Asako Kamihira 2), Katsuya Komori 1), Takuma Shirasaka 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2012. |
---|
![]() |
Competitive review of P1-520 gemcitabine Ryoko Maruyama, Sekiya wisdom, Kanako Takahashi, Masae Hirasawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2012. |
---|
![]() |
Differentiation of the white petrolatum basis used for a lot of P1-521 clobetasone butyric acid ester ointment Yoshihisa Yamamoto 1) 2), 深水啓朗 2), Eyes bird Koichi 2), Yoshinori Onuki 3), Tatsuo Koide 4), Noriko Katori 4), Suzuki Toyoshi 2), Kazuo Tomono 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2012. |
---|
![]() |
It is ... for a case with nondestructive evaluation - amlodipine preparation using the near-infrared light of the P1-522 Generic drug 大鳥徹, Yoshi Hashimoto good luck, Kenji Matsuyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 353-353, 2012. |
---|
![]() |
Efficacy, safe and medical economical examination for hypercholesterolemia when we changed it to atorvastatin tablets "EE" from P1-523 Lipitor tablets Jun Okubo, Tomoaki Ikezaki, Mai Tanaka, Satoko Takeuchi, Koichi Tanabe, Hidenori Kitazawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2012. |
---|
![]() |
Side effect investigation of the P1-524 iopamidol injection generic drug 小茂池潤太 1), Yasuaki Hashimoto 1), Shinji Taniguchi 2), Kojiro Awano 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2012. |
---|
![]() |
Comparison about the preparation evaluation of the P1-525 rebamipide component lock Every field Chieko 1), Koji Muto 2), Tetsuya Miyakawa 3), Yuka Tanaka 1), Hideyuki Sumita 1), Akemi Machino 1), Interest village Keiko 1), Etsuko Miyamoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2012. |
---|
![]() |
Taste bitter evaluation of a generic drug, the donepezil hydrochloride orally disintegrating tablet using the P1-526 taste sensor Midori Sota 1), Takashi Nagata 1), 内藤悦伸 2), Hidekazu Ikezaki 2), Keiko Yamamura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2012. |
---|
![]() |
Examination of stability of the P1-527 hospital preparation 0.5% ganciclovir instillation and the efficacy Kanda Kosuke 1), 坂元利彰 1), 兒玉幸修 1), Hiroo Nakagawa 1), Kentaro Yamaguchi 1), Fujikawa sub-month tea 2), Norihide Higuchi 1), Tadahiro Nakamura 1), Takashi Kitahara 1), Hitoshi Sasaki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2012. |
---|
![]() |
Stability of the P1-528 nimustine hydrochloride lotion Yasushi Sekiya, Manabu Okumura, Yohei Kawano, Akira Takagi period, Tomomi Iwakiri, Kazuhiko Arimori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 354-354, 2012. |
---|
![]() |
About the change of rheology properties with the mixture with P1-529 white petrolatum and an additive or the cream Megumi Fujiwara, Yuta out of the offing, Yudani Reiko, Reiko Teraoka, Shuji Kitagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2012. |
---|
![]() |
Change of the rheological nature with the mixture with P1-530 ointment and the cream Yuta 1 out of the offing), Megumi Fujiwara 1), Yudani Reiko 1), Reiko Teraoka 1), Shunichi Aida 2), Nobuyuki Muroi 2), Shuji Kitagawa 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2012. |
---|
![]() |
Lability test of the P1-531 hospital preparation vitamin K1 ointment 原茉梨絵, Reiko Makihara, Takako Yanai, 橋本浩伸, 牧野好倫, Nobuaki Yokote, Hiroshi Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2012. |
---|
![]() |
Examination about the adsorption to an injector of P1-532 Bevacizumab Hiroshi Kudo 1), Tatsuya Mori 1), Nobue Sato 1), 足立茂 2), Sanae Miyano 1), Chiaki Ogawa 1), Megumi Yatabe 1), Makoto Kobayashi Sachimi 1), Miyashita 1, Kyuutoku), Yasuo Ide 1), Yoshihiko Suzuki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2012. |
---|
![]() |
1 case that the repeated doses of the desiccated thyroid gland suppository in patients with P1-533 hypothyroidism were effective Sugimoto lapis lazuli, Toshiyuki Hirai, Seki Toshikazu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2012. |
---|
![]() |
Approach from characteristics of the physical pharmacy for the in-hospital formulation of the P1-534 mianserin suppository Takanori Nakajima 1), Masanori Iwata 2), Shuichi Nawata 3), Your Nakamura existence 1), Hiroshi Saito 1), 小林靖奈 3), 山元俊憲 3), Yoshikazu Matsuda 1), Masayuki Kimura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 355-355, 2012. |
---|
![]() |
Examination about the method of dispensing of the P1-535 7% lidocaine gel Your Shun Nakamura 1), Hiroyuki Miyashita 1), Soichi Shibata 1), Kensuke Usui 2), Takahiko Kagaya 1), Atsuta Koichiro 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2012. |
---|
![]() |
Utility - of the single use therapy at clinical evaluations - remission maintenance therapy of the hospital preparation mesalazine suppository in the P1-536 proctitis type ulcerative colitis Michihiro Yamaguchi 1), Hiroshi Muramatsu 1), Masaya Yamaguchi 1), Shunichi Kawamura 1), Asako Terashima 2), Kayoko Maezawa 2), Junko Kitsu 2), Matsuoka Katsuyoshi 3), Toshifumi Hibi 3), Shinichiro Okamoto 1) 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2012. |
---|
![]() |
P1-537 Stomatitis after chemotherapy will heal and licking candy : Development of Polaprezinc candy (P candy) formulation 日比徹, 矢吹真弓, 中野遥, 日笠淳一, 渡辺正教, 菊地丈, 河治智美, 吉羽真由美, 中沢修司, 大木崇弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2012. |
---|
![]() |
Nondestructiveness, non-contact assay by the far-red spectroscopy of the active ingredient out of the crude drug component ointment as the P1-538 hospital preparation Makoto Otsuka 1), Peerapattana Jomjai2), Kuniko Otsuka 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2012. |
---|
![]() |
1 case that responded to a tramadol combination lock for a pain control of the umbilical hernia to repeat P1-539 exacerbation, reduction Masahiro Okada 1), Description of Hiroshi Sugihara 1), Precincts of a shrine Erina 1), Yoshinari Kawai 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2012. |
---|
![]() |
Utility of the electrocardiogram evaluation by the P1-540 pharmacist Hiroshi Onoe 1), Kazue Nakata 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 356-356, 2012. |
---|
![]() |
Application of the inhalational pattern measuring assembly for the proper use of the P1-541 inhalant Flat 1, Taiki) 2), Okuda resourceful general 2), Shinya Morita 1), 寺田智祐 1), Koichi Okamoto 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2012. |
---|
![]() |
2 cases that we introduced a fentanyl MT patch into from a tramadol hydrochloride / acetaminophen combination lock for P1-542 intractable nature neuropathic pain Noriko Nagahara, Nao Sakoda, Chika Sakaguchi, Yoshiko Okuda, Shoichi Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2012. |
---|
![]() |
Examination ... from action ... incident report to in-hospital staff knowledge improvement of the P1-543 inhalational instruction Takaaki Nakajima, Hiroaki Tabata, Takami Sato, Nami Sugimura, Maeda Miyuki, 猿谷淳, 向一美, Ground field Mikiko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2012. |
---|
![]() |
Examination about the efficacy of P1-544 pregabalin 佐藤裕資, Miho Michishita, 門脇督, Flat land tax, Tanaya Mitsugu, Yutaka Kanetani, Chinami Suzuki, Hirokazu Tabata, 柴波明男 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2012. |
---|
![]() |
Galanthamine in the P1-545 this hospital, effect of treatment and side effect of memantine Akari Tanikawa 1), Satoshi Suda 1), Yukiko Kaieda 1), Shintaro Mochizuki 1), Ueda bare reason 1), Takeshi Murai 1), Yoshiko Onuki 1), Keiko Hagiwara 2), Yoshinobu Akiyama 2), Tsutomu Shimada 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2012. |
---|
![]() |
Development and examination of Japanese edition MISS-21modified evaluating patients satisfaction in the correspondence of the OTC medicine of the P1-546 pharmacist Mayu Sakurai, 半谷眞七子, Yukari Yoshioka, Hiroyuki Kamei, Takuji Kawamura, Megumi Ogawa Rina Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 357-357, 2012. |
---|
![]() |
Evaluation (the third report) of the folic acid combination situation to patients with articular rheumatism during P1-547 methotrexate administration Toru Miyazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2012. |
---|
![]() |
Examination about exercise tolerability and the dose in the P1-548 carvedilol internal use patients Azusa Yamamoto 1), Yukiko Yokota 1), Junko Hirai 1), Mami Ishibashi 1), Osamu Ichikawa 2), Tamaki Ono 3), Masaki Kataoka 4), Hironori Saito 3), Hideki Mori 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2012. |
---|
![]() |
Examination of safety, the effectiveness in the P1-549 tolvaptan long-term use 阿部正樹, 村井彩紗, 木原理絵, 中蔵伊知郎, 服部雄司, 関本裕美, 廣畑和弘, 山内一恭, 小森勝也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2012. |
---|
![]() |
Use fact-finding of the infliximab increase in quantity for the P1-550 articular rheumatism 森澤貴啓, Taniguchi male person, Tsuyoshi Fujita is flat, Ooi greens Yoshiko, Tadashi Tsuda University, Hideaki Izumi, Yoshihiro Hashimoto, Shigeki Tanaka, Hitoshi Komori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2012. |
---|
![]() |
Examination about the utility of delirium treatment using the Chinese medicine to patients with P1-551 femoral neck fracture 内川晶裕, Yoko Akamatsu, Hiromi Azuma, Kazumi Kuwahara, Keiko Yamamoto, Ayaka Amano, Akihiro Maruo, Field road Akemi, Tsutomu Hamanaka, Ichio Tanaka, Norio Yamada, Sachimi Moriyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2012. |
---|
![]() |
Examination about adalimumab therapy and the immunomodulator combination for Crohn's disease in the P1-552 Sapporo welfare hospital Sudo University male, Yuka Uemura, Drunk Mariko, Tokutome chapter, Muranaka one size, Rie Kawamoto, Hatsumi Kikuta, Ryu Kobayashi, Hideji Ohara, Muki Ryoji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 358-358, 2012. |
---|
![]() |
NET EXCEPTION Err: Could not connect to host 出口綾子1), 中西大介1), 畑地治2), 柳川泰裕1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2012. |
---|
![]() |
Effect to give to P1-554 probucol, blood pressure plethysmography (CAVI) of the cilostazol Keiichi Hara 1), Hideki Kobayashi 1), Hidetoshi Kawana 2), Endo Valley 2), Koji Shirai 3), Ichiro Tatsuno 2), Masaka Wataru 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2012. |
---|
![]() |
Examination of the terra pre-building weight loss factor in the triple-drug therapy for P1-555 chronic hepatitis C Shigeru Sato 1), Tetsuya Hirose 1), Mihoko Sasaki 1), Hatsumi Kikuta 1), Miki Katsuragawa 1), Hideji Ohara 1), Ryu Kobayashi 1), Muki Ryoji 1), Ozeki solstice 2), Yoshiyasu Kano 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2012. |
---|
![]() |
The cerebral infarction onset situation by the cancellation of P1-556 antiplatelet drug, the anticoagulant Yoriko Kasamatsu, Kojiro Takashima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2012. |
---|
![]() |
About the effect that patient compliance instruction before the medication initiation of the P1-557 antiHIV medicine gives to regimen choice, adherence Chikako Shimokawa, Akiko Yasuda, Table Shiho, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2012. |
---|
![]() |
Problems in an international comparison for the proper use of the P1-558 emergency contraceptive and the do-it-yourself importing Kuniko Otsuka 1) 2), Hajime Yasuhara 2), Naoki Uchida 2), Shinichi Kobayashi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 359-359, 2012. |
---|
![]() |
Aldose reductase antagonism of the P1-559 All-trans- retinoic acid 石川稚佳子 1), Midori Ito 2), 小野田稔久 2), Kaiden Mariko 3), Masaka Wataru 2), Masahiko Obayashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2012. |
---|
![]() |
Present conditions investigation of the orthopedics postoperative pain control in the P1-560 this hospital Kazutoshi Terayama 1), Taeko Ogata 1), Daisuke Sato 1), Kengo Kuroda 1), Kikuo Kato 1), Kunihisa Miura 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2012. |
---|
![]() |
It is ... using approach - short play in heart of patients with P1-561 Niigata pharmacist diabetes network actograph (1) diabetes Ayumu Maruyama 1), Tatsushi Saito 2), Kazuhiko Nagai 3), Eiko Hara 4), Toru Yamada 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2012. |
---|
![]() |
Want to know P1-562 Niigata pharmacist diabetes network actograph (2) here; is ... from exercise therapy - theory of diabetes to practice Kazuhiko Nagai 1), Tatsushi Saito 2), Eiko Hara 3), Ayumu Maruyama 4), Toru Yamada 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2012. |
---|
![]() |
Are P1-563 Niigata pharmacist diabetes network actograph (3) you all right; "diabetes at first a diet ...?" Tatsushi Saito 1), Kazuhiko Nagai 2), Eiko Hara 3), Ayumu Maruyama 4), Toru Yamada 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2012. |
---|
![]() |
... that ... I regard P1-564 Niigata pharmacist diabetes network actograph (4) as "the test value that a physician pays attention" to in this way Toru Yamada 1), Tatsushi Saito 2), Kazuhiko Nagai 3), Eiko Hara 4), Ayumu Maruyama 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 360-360, 2012. |
---|
![]() |
Diabetes education ... to learn by P1-565 Niigata pharmacist diabetes network actograph (5) "toss queen crab Ann" - game Eiko Hara 1), Tatsushi Saito 2), Kazuhiko Nagai 3), Ayumu Maruyama 4), Toru Yamada 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2012. |
---|
![]() |
Transtime change by the blood mixture to P1-566 insulin preparation Takeshi Sekino, Yukiko Tanaka, Naohiro Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2012. |
---|
![]() |
The effect that the fruit juice which attached to P1-567 finger gives to the blood glucose level with the simple blood glucose measuring instrument Satomi Harima 1), Aya Saito 1), Chisato Matsumoto 1), 小金井要治 1), Saori Takemoto 1), Ai Oshima 1), Aiba Koichi 1), 上野彩恵 1), Kazumasa Hasegawa 1), Masayuki Arakawa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2012. |
---|
![]() |
Combined effect of the sitagliptin for patients with diabetes during P1-568 insulin therapy 野口景子, 葛葉守, 久嶋真紀子, 中野玲子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2012. |
---|
![]() |
The effect that cilnidipine administration gives to vascular elastic CAVI on patients with type II diabetes mellitus during P1-569 ARB remedy Minoru Morimoto 1), 佐々木英久 1), 松尾和廣 1), Tomoko Watanabe 1), Etsuko Shinohara 1), 齋木厚人 2), Ichiro Tatsuno 2), Koji Shirai 2), Masaka Wataru 3), Takashi Yoshio 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2012. |
---|
![]() |
The effect that combination of valsartan and hydrochlorothiazide gives to arteriosclerosis on patients with P1-570 type II diabetes mellitus Tomoko Tsuzuki 1), 佐々木英久 1), 松尾和廣 1), Tomoko Watanabe 1), Etsuko Shinohara 1), 齋木厚人 2), Ichiro Tatsuno 2), Masaka Wataru 3), Takashi Yoshio 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 361-361, 2012. |
---|
![]() |
Examination about change cases from P1-571 pioglitazone to sitagliptin 堅石法子, 中村雅敏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2012. |
---|
![]() |
Study on effect that a dosage regimen of the P1-572 oral hypoglycemics gives in the adherence of patients with type II diabetes mellitus Taketo Okubo 1), Mitsuko Onda 1), Hiroshi Okada 2), Masaki Shoji 1), Yuka Tanaka 1), Tomoharu Oda 1), Saki Kato 1), Arakawa line straight 1), Naoki Sakane 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2012. |
---|
![]() |
Improvement ... of the hypoglycemia instruction by the active intervention of hypoglycemia instruction - ward pharmacist who P1-573 pharmacist collaborates with a nurse, and is carried out Shin Aoyama is flat, Yu Tomita product, Nakajima Mizuki, Yoshitsugu Sano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2012. |
---|
![]() |
About the attitude survey health food of patients with P1-574 diabetes Katsura Harada product 1), Yoshiko Miyano 1), Yoshiko Sakamoto 1), Keiko Nagai 1), Sen Oe spring 2) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2012. |
---|
![]() |
Analysis of the factor affecting the blood glucose level improvement by the glucose supplementation jelly intake at P1-575 hypoglycemia Yu Tanaka season 1), Kaoru Makita 1), Descent from a mountain Asako 1), Yuka Nakamura 1), Plains sum 2), Takeru Kawai 1), Bridge Ryosuke 1), Maiko Suda 2), Hiroko Kaido 2), Descent from a mountain Koichi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2012. |
---|
![]() |
Examination about the effect of alogliptin 25 mg in patients with P1-576 type 2 diabetes 井上稚枝子, 小川大介, 武本千惠 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 362-362, 2012. |
---|
![]() |
Examination of the HbA1c improvement effect at the new introduction, supplementation, change administration of the sitagliptin in patients with P1-577 type 2 diabetes 岩本英子, 奥野知美, 江口貴俊, 永田梨紗, 水町信一郎, 馬場亮一, 杉本悠花, 岡田昌之, 松浦まなみ, 成末まさみ Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2012. |
---|
![]() |
It is examined HbA1c at supplementation in sitagliptin by P1-578 glimepiride 石橋真実1), 大村祐加1), 砂場亜希1), 森英樹1), 宮下雄博2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2012. |
---|
![]() |
Factor about effect of treatment of the DPP-4 inhibitor sitagliptin in patients with P1-579 diabetes 早苗富士子1), 笹谷知美1), 喜多香菜1), 赤松紗奈江1), 日下部千晶1), 辻昌江2), 岡田守弘2), 西上潤2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2012. |
---|
![]() |
The use of insulin fact-finding of patients with P1-580 elderly people diabetes and examination about effectively utilizing it of the aid Ono Hiroshige 1), Yoko Moriyasu 2), Naoki Matsumura 1), Shoko Okazaki 1), Aki Kawakami 1), Kenichi Shimada 3), Takashi Egawa 3), Takashi Shibata 3), Masashi Takahashi 2), 五味田裕 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2012. |
---|
![]() |
Induction and evaluation of the sponge for the P1-581 insulin injection instruction Takashi Kamata will, Naoko Ooi, Kusajima Kohei, Takuya Sato, Daisuke Ishikawa, Daisuke Tanaka, Kazuto Abe, 佐藤導 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2012. |
---|
![]() |
Examination about the utility of the new insulin induction in the P1-582 outpatient department Shigeo Akiyama 1), Small Makiko Aze 1), Hitoshi Yoshida 1), Akie Kobayashi 1), Isono Junichi 1), Tomoyuki Aoki 2), Takayuki Ogiwara 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 363-363, 2012. |
---|
![]() |
Comparison II of patients with poisoning in the critical care center of P1-583 two Eiichi Maruta 1), 上山進 2), Nishimoto incense king village 2), Second place Chihiro 3), 辰見明俊 3), 韓秀妃 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2012. |
---|
![]() |
Questionary survey about P1-584 emergency care and the pharmacy education Shiro Hatakeyama, Yagi Tomomi, Takeshi Katsuyama, Yukio Kishikawa, Jin Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2012. |
---|
![]() |
About a case with suspected participation of the common use medicine in new inpatients in P1-585 lifesaving emergency ward and ICU 寺西正充, 森山史就, Kenichi Anjiki, Tomohiro Sonoyama, Katsuki Yokote, Ei Hirano product, Sumiko Goto, Yuki Imaoka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2012. |
---|
![]() |
Relation of the pharmacist at the P1-586 cardiopulmonary resuscitation The Ogasawara history, Kazuko Tateishi, Kazue Nakamura, Yuka Masuyama, Yukiko Okura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2012. |
---|
![]() |
Present conditions investigation about the disposal of injection in the P1-587 ICU Harada University 1), Nami Suda 1), Tamayo Takahashi 1), Dr. Shimazaki 1), Masaki Kitamura 1), Shigehiko Uchino 2), Masaru Takinami celebration 2), Takashi Kawakubo 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2012. |
---|
![]() |
Specific example of the pharmacist intervention in the P1-588 neonatal intensive care unit Tsujimura Imperial attendance, 安間保恵, Katsuya Hirose, Taku Yamauchi, Kazumi Kawamura, Mitsuru Shiokawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 364-364, 2012. |
---|
![]() |
Examination ... which was made from ... questions and answers with the information that P1-589 operating room staff required Sakai Naoko 1), Teruko Takano 1), 小林彦登 1), Futoshi Saito 1, Kotobuki), Soichi Shibata 1), Atsuta Koichiro 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2012. |
---|
![]() |
Practice of the precedence-like pharmaceutical management in P1-590 first aid, the intensive care region Mitsuru Otsuka 1), Shinji Sawada 1), Kazumasa Ueda 1) 2), Tatsuya Otsubo 1), Eiichiro Kanda 1), Horiuchi tomorrow incense 1), Komori Tamao 1), Yasuyuki Nishikawa 1), 小西偉雄 1), Tadashi Mikami 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2012. |
---|
![]() |
Job analysis by the thyme study of the clinical pharmacy duties in P1-591 Kochi medical center, the critical care center Satoshi Tanaka 1), Tadashi Kadoguchi kernel 1), Takashi Kawada 1), Norifumi Miyamoto 1), So Yamamoto one 1), Kazuhiko Sugimoto 2), Murata thickness husband 2), 服部暁昌 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2012. |
---|
![]() |
About the mixed preparation use of the action - cardiovascular surgery preoperative preparations drug to a specialist in P1-592 anesthesia medical department support task - Koji Moriya, Existence Reiko Sawa, Ko Tokuda period, Shinsuke Akagi, Toshikatsu Okuda, Kazunobu Takayanagi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2012. |
---|
![]() |
Than the investigation of present conditions investigation - 2011 Ministry of Health, Labour and Welfare team approach in medical care proof business 202 institutions about the pharmacist duties in the P1-593 operating room of the whole country - Yuka Shibata 1), Furrow well Hiroko 1), Masashi Kawamoto 2), Tree flat Kenji 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2012. |
---|
![]() |
Pharmacist duties in the P1-594 operating room Tokumitsu Horii, Daisuke Masuda, 杉山一覚, Tomio Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 365-365, 2012. |
---|
![]() |
For medicine medicine cooperation promotion in the P1-595 cancer chemotherapy Masahide Sugiyama, Atsushi Miura, Kazumi Yoda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2012. |
---|
![]() |
Research about the utility of the present conditions of the medication assistance in patients with P1-596 dementia and patch agent Ise Yuya 1), Shiro Katayama 1), Hiroshi Nakano 2), Kenzo Ohba 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2012. |
---|
![]() |
It is ... from the questionary survey to ... physician, a dentist investigating a problem and measures for the P1-597 medicine notebook spread Katsura Maeda I, Tsuchiya 1,000 Masako, Takaaki Ishii, Mayumi Sakaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2012. |
---|
![]() |
Making of medicine medicine cooperation - format by the medicine notebook utilization for patients who received P1-598 outpatient department cancer chemotherapy and use investigation - for the health insurance pharmacy Hiroki Miyata 1) 2), Yuri Ito 3), Ono A rare child 4), Chigusa Kaneko 5), Chihiro Kawakami 6), Yasushi Kondo etiquette 7), Tsurusaki University 8), Mari Hosaka 9), Shuhei Moriyama 10), Hisashi Shimizu example 2) 11), Toshihiro Hama 2), Takao Akashi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2012. |
---|
![]() |
Questionary survey for the problems improvement of the medicine medicine cooperation through the medicine notebook for patients with P1-599 cancer Hiroki Mase 1), Kazuko Koyama 1), Tatsuya Kobayashi 2), Satoyo Horisawa 1), Sachiko Kubo 1), Yumi Konishi 1), Keiko Kondo 1), Masako Watanabe 1), Takahiro Yajima 1), Naoya Inukai 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2012. |
---|
![]() |
Example that the physical evaluation of the P1-600 pharmacist led to visit practice Yamaguchi High School 1), 金児潔 2), Mayumi Maruyama 1), Mao Nakamura 1), Hiroki Nagashima 1), Shinsuke Higuchi 1), Wife Valley Tami charges 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 366-366, 2012. |
---|
![]() |
Mediation ... with action ... hospital and the local health insurance ethical pharmacy of the hospital pharmacist for P1-601 treatment at home cooperation promotion Kinoshita Tomoyasu 1), 上地小与里 2), Takanobu Ichino 1), Kazuhiro Ito 1), Old Masaru Den trans1) 3), Hisayuki Miura 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2012. |
---|
![]() |
1 case report which was connected by the drug control instruction duties to patients with P1-602 tongue cancer from pain care to treatment at home Takeshi Tanaka group, 枝重満希, 森田祐加, 古味章乃, Masaaki Kimura, Kazue Takeichi, 田處香澄 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2012. |
---|
![]() |
Consciousness of the citizen for the treatment at home that P1-603 pharmacist participates in Tomomi Horino 1), Yamato trunk and branch 1), Forest ten Hisako 2), Kamoike Shinji 3), Kazuhiko Saeki 4), Mitsuru Kishida straight 5), Naoko Takahashi 1), Kitakoji study 1), Sumio Matsuno 1), Mitsutaka Takada 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2012. |
---|
![]() |
Development and utility evaluation of new one Dors package (GTpack) with the P1-604 medication support jelly Eriko Kimura, 于琳, 孟媛, 張玉, 楊偉燕, Mayumi Joko, Mikako Nishiyama, Masao Nozaki, Yutaka Sakuma, 盛本修司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2012. |
---|
![]() |
Unification ... of the patients with medicine medicine cooperation information sharing paper to use in action ... 2 institution in the oral P1-605 anticancer drug Naoko Tsuji 1), Masaki Manda 1), 野際俊希 1), Shigeo Asai 1), Katsufumi Okamoto 2), 澤本成史 2), Makoto Kimura 2), Hideo Maruyama 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2012. |
---|
![]() |
About an action of "oral managed care cooperation model business" (medicine, teeth, medicine cooperation) around the P1-606 Aichi cancer center center Hospital Noritake Kana 1), Ayako Hasegawa 1), Michiko Tatematsu 1) 2), Keiichi Kato 1), Chiharu Ito 3), Yasuhisa Hasegawa 4) 5), Hiroshi Nishikawa 6), Tamamizu truth 6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 367-367, 2012. |
---|
![]() |
Examination for effective inhalational instruction promotion by the illness medicine cooperation using the P1-607 inhalation procedure evaluation vote Imai wealth Noriko 1), 東敬一朗 1), 宇夛裕基 1), Kazuhiko Igarashi 1), We run the plum bottom 1), 藺上圭子 1), Masahide Yasui 2), 中積泰人 2), Masami Kawahara 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2012. |
---|
![]() |
Role of the health insurance pharmacy pharmacist in the patient on dialysis entering P1-608 pay old man institution 山村彩 1) 2), Toru Maeda 1), Atsuko Inagaki 2), Hiroko Suzuki 2), Yukihisa Kurono 2) 3), 黒野加直子 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2012. |
---|
![]() |
Questionary survey about the impression for the pharmacist of patients who received P1-609 at-home fluid therapy, the caregiver Nakayama etiquette field 1), 中野宜範 2), Yuka Taguchi 2), Tetsu Inoue Tarou 2), Hidemi Kawano 2), Ueno Hiromi Sana 2), 行川淳 2), 植沢芳広 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2012. |
---|
![]() |
Investigation about the use situation of the emergency communication card taking P1-610 disease medicine cooperation Goji Maeda, Atsushi Suzuki term, Daigo Suzuki, Akira Ogawa intellect, Hiroshi Sakata, Hiroyuki Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2012. |
---|
![]() |
Association between enforcement presence or absence of at-home duties and drugstore attribute in the P1-611 health insurance pharmacy Masako Tanaka 1), Mitsuko Onda 1), Shinya Hirata 1), Makoto Takamatsu 1), Hidekazu Tanaka 1), Yuta Kataoka 1), Seven Kaiyo child 2), Yuka Tanaka 1), Yukio Arakawa 1), Hirohisa Imai 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2012. |
---|
![]() |
1 case - that we supported home care transition in cooperation with the relation II- drugstore pharmacist of the hospital pharmacist in the P1-612 medicine medicine cooperation 高柳論也 1), Motoyuki Watanabe 1), Takeshi Sugai people 1), Mitsunori Akimoto 2) 3), Megumi Akiyoshi storehouse 3), Yoshio Kosaka 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 368-368, 2012. |
---|
![]() |
Cooperation ... with the wide area Hospital through evaluation and examination - inhalation instruction request book of the inhalational instruction by the P1-613 insurance pharmacist Saori Mizusawa 1), Koji Okubo 1) 2), Manabu Fujiki 1) 2), Shigeru Yamada 1), Masatomo Murohashi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2012. |
---|
![]() |
Trial of medicine, the medicine cooperation in the P1-614 inhalational instruction 1, Shizu, Asano), Junko Hirai 1), 河村茉衣 1), Azusa Yamamoto 1), Megumi Mukai 1), Hideki Mori 1), Yamaguchi sum truth 2), Masaru Inoue 2), Koji Narahara 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2012. |
---|
![]() |
Effect - that construction - second report inhalation instruction study session of the inhalational instruction cooperation in P1-615 Suita-shi gives to consciousness and the behavior of the pharmacist Akira Kodama person 1), Mitsuyo Takemura 1), Azusa Miki 1), Iwatate Chizuko 1), Fusa Honna beauty 1), Shinsuke Mori 1), Fumio Tsuji 2), 岡橋義弘 3), Suma Kazuo 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2012. |
---|
![]() |
Hold present conditions and problem - physical assessment workshop for the duties development of the physical assessment by the P1-616 pharmacist; and ... Akiko Emoto 1) 2), Kenji Sakamoto 3), Pine snow trunk one 3), Koji Takeuchi 1) 2), West Kazuya 1) 2), Yukiko Takemori 1) 2), Tsuyoshi Miyahara 2) 4), 湯川潤輝 1) 2), Naosuke Yoshitomi 5), Fujito Expo 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2012. |
---|
![]() |
The medicine medicine cooperation that began with P1-617 at-home transfusion Megumi Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2012. |
---|
![]() |
The case that led to visit drug control instruction by the suggestion from P1-618 pharmacist Yoshihiro Okada 1), Oshiyama Takamitsu 1), Megumi Takahashi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 369-369, 2012. |
---|
![]() |
Association to affect the at-home visit by the P1-619 drugstore pharmacist between quantity of duties and outcome Yuta Kataoka 1), Mitsuko Onda 1), Shinya Hirata 1), Makoto Takamatsu 1), Hidekazu Tanaka 1), Masako Tanaka 1), Seven Kaiyo child 2), Yuka Tanaka 1), Arakawa straight husband 1), Hirohisa Imai 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2012. |
---|
![]() |
From the viewpoint of present conditions and problem - medical supplies offer of the P1-620 treatment at home - Kazuki Kushida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2012. |
---|
![]() |
Construction of the business training visit support system by the use of P1-621 i-Pad Makoto Ishibashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2012. |
---|
![]() |
Induction of the communication educational program using the character analysis for the P1-622 business trainee Kozoe kernel 1), 末丸克矢 2), Mamoru Tanaka 1), Hiroshi Araki positive 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2012. |
---|
![]() |
The presentation of the results of the study of the business trainee in the P1-623 this hospital and evaluation of the business training schedule obtained from the questionnaire Nobuko Takayanagi 1), Masahiro Okuno 2), Yuko Ogawa 1), Takayuki Yamazaki 1), Manabu Nakata 2), Yoshiharu Umetani 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2012. |
---|
![]() |
It is ... (2) from the situation of the student who finished the hospital training of drug instruction (through a case of the malignant pleural mesothelioma) - 11 weeks for patients with P1-624 cancer Chiaki Kataoka 1), Masahiro Okuno 2), Nobuko Takayanagi 3), Manabu Nakata 2), Yoshiharu Umetani 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 370-370, 2012. |
---|
![]() |
It is ... (1) from the situation of the student who finished the hospital training of need (through 3 cases of the terminal) - 11 weeks of the drug instruction in the medical care for P1-625 terminal phase Taku Kurata light 1), Nobuko Takayanagi 2), Masahiro Okuno 3), Manabu Nakata 3), Yoshiharu Umetani 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2012. |
---|
![]() |
An evaluation and improvement of the business training in the P1-626 Tokushima Red Cross Hospital Matsushima flourishing endlessly, Group bridge Yuki, Rie Aisaka, Atsuko Horimoto, Otani eyes, Tomoko Suzue Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2012. |
---|
![]() |
Step of the business training result briefing session where we invited university teachers in the P1-627 group training to for 2 years Hirokazu Someya 1) 2), Shin Oda 2) 3), 岡田樹彦 2) 4), Kenjiro Kimura 2) 5), 奈良部修弘 2) 6), Akiko Sakai 2) 7), Tomoko Hirose 2) 8), Akiko Nagaki 2) 4), Haruyuki Sakuma 2) 4), Yasukazu Yamauchi 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2012. |
---|
![]() |
Action for self-assessment type anticancer drug preparation training systems construction in the P1-628 pharmacy school business training Hiroyuki Fujii, Rock texture Reiko, Keiko Ogasawara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2012. |
---|
![]() |
It is analyzed the cause about the arrival degree insufficient training item in P1-629 drugstore training Ayako Terada, Miki Nakamura, Kazuhiro Watanabe, Akito Takano, 廣原正宜, Shibuya Fuminori, Kyoji Taguchi, Tomoyuki Hamamoto, Yoshie Horiguchi, Jun Toda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2012. |
---|
![]() |
About contents about the fact finding - on the university side and the hospital side to hope for for business training for P1-630 long term particularly anticancer drug treatment - Tsuyoshi Suzuki 1), Mt. Ishii husband 1), Namba existence intellect 1), Isagawa Sayaka 1), Yukako Shimabukuro 2), Shinichiro Maeda 2), 比嘉義太 2), Yuri Aragaki 2), We consider among outsiders husband 1), 宇野司 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 371-371, 2012. |
---|
![]() |
About the business training instruction pharmacist upbringing lecture in the P1-631 Keio University pharmacy school Kazuko Fujimoto, Juichi Otani, Junko Kitsu, Yutaka Hattori, Masahiko Masuno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2012. |
---|
![]() |
It is analyzed the cause about the arrival degree insufficient training item in P1-632 Hospital training Miki Nakamura, Ayako Terada, Kazuhiro Watanabe, Akito Takano, 廣原正宜, Shibuya Fuminori, Kyoji Taguchi, Tomoyuki Hamamoto, Yoshie Horiguchi, Jun Toda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2012. |
---|
![]() |
Induction of the critical foresight training for the P1-633 pharmacy trainee Yamase University male, Takashi Doi still, Ryoko Nakanishi, Hama Tsu Yoriko, The autumn Yamahana world, 籠本基成, Masahiro Ishizu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2012. |
---|
![]() |
Construction of action - training system to long-term business training in the P1-634 this hospital and improvement - Chiaki Yokota 1), Kazuhito Hirota 2), Masato Tateishi 2), Takahiko Nakao 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2012. |
---|
![]() |
Questionary survey about the long-term business training in the P1-635 Himeji Dokkyo University pharmacy school Cheap Tomomi 1), Manabu Amano 1), Hiroaki Kachi 1), Jun Kinoshita 1), Ratio intellect shop Hiroyuki 1), History of Tadashi Kiyohara 1), Fusa Komada husband 1), Aki Amano 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2012. |
---|
![]() |
Trial of the clinical judgment skill evaluation using the patients image sheet in the P1-636 long-term business training Hiroki Inoue 1), Yuzuru Saito one 2), Jun Hirano 2), Yamaguchi cloth sand 1), Satoru Yoshida reason 1), Sanji Sato 1), Shunsuke Kurono 3), Yoichi Hasegawa 3), Akira Takahashi 2), Toshiharu Nomura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 372-372, 2012. |
---|
![]() |
The action for "TDM duties" in the P1-637 Hospital long-term business training and the evaluation Yodoshi Masahiro 1), Hiroyuki Morishima 2), Morihiro Nomura 1), Yuzuru Yamazoe 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2012. |
---|
![]() |
Action of the business training instruction in a first aid, the intensive care region by the P1-638 pharmacy school teacher Shinji Abe 1), Natsuko Ise 2), Kenji Ikuta 2), Naoto Okada 2), Satoyoshi Yoshiko 1), Hirofumi Shibata 1), Kazuyoshi Kawazoe 2), East beauty 1), Kazuo Mizuguchi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2012. |
---|
![]() |
Action of the pharmacy business training third year aiming at the cooperation reinforcement with the P1-639 University of Shizuoka businessman teacher Midori Kimura, Nabeta Izumi, 嘉屋道裕, Hiroaki Utsuki, Satoru Minami, Takeshi Sakurai, Keiko Hirano, 角入寿彦, Takashi Suzuki charges Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2012. |
---|
![]() |
It is change in the annual of the operational evaluation of "a business training teachers' textbook" aiming at homogenization of the P1-640 business training and efficiency and "the training book" Hideo Nakata 1), Matsuoka sentence 1), Soichiro Tsuda 1), Takeshi Kaneko 1), Hiroshi Shiina good luck 1), Yamakichi Yasuko 1), Osamu Ikeya 1), Kyoko Nashimoto 1), Shunichi Kawamura 1), Shinichiro Okamoto 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2012. |
---|
![]() |
The consciousness of the student facing the P1-641 business training and the change The east beauty, Satoyoshi Yoshiko, Shinji Abe, Hirofumi Shibata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2012. |
---|
![]() |
Than problems - questionary survey of the communicative competence in the business training that saw from P1-642 student and Small group discussion using the KJ method - Noriko Kobayashi 1), Aono Izumi 1), Yoshiko Kadota 1), Sayo Suzuki 1), Naoko Otsuka 1), Shuku Tezuka person 1), Juichi Otani 1), Junko Kitsu 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 373-373, 2012. |
---|
![]() |
Satisfaction and the understanding degree of program evaluation - learner of the business training in the P1-643 drugstore and the contribution factor Hiroshi Onishi High School 1), Miho Utsumi 2), Sachi Hirano 2), Yuki Fujii 2), Hiroshi Yamamoto 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2012. |
---|
![]() |
Education about the medical security in the learning before P1-644 business true taking lessons Keiko Morita, Taiko Masao, Junji Iwashita, Katsumi Kido, Megumi Iimori Yoshiko, Shinichiro Ando, 前田共秀 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2012. |
---|
![]() |
The construction of the advanced PBL class with the unification type curriculum in the P1-645 sixth grader and the evaluation Teramachi eyes 1), Tomoya Tate 1), Tadashi Horiuchi 2), 保住功 3), Tadashi Sugiyama 4), Teruo Tsuchiya 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2012. |
---|
![]() |
Attitude survey for patients with mental disorder of the pharmacy student by the P1-646 new education curriculum induction Ono sand lily 1), Hiroshi Tanaka 1), Cates Marshall2), 半谷眞七子 1), Hiroyuki Kamei 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2012. |
---|
![]() |
A scholastic ability investigation and inspection of the biology (high school course) for the P1-647 this school new student Katsuya Koike, Strong marsh Masami, Hitoshi Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2012. |
---|
![]() |
Making and evaluation of the training manual for the P1-648 new face pharmacist Aya Ishihara, Megumi Mizuno, Eiko Hishida, Keita Urasaki, 金正煥, Kazuko Kawai, Kazuyuki Ito, Satoshi Isotani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 374-374, 2012. |
---|
![]() |
Effect of the simulated patient to give in the consensual manner of the P1-649 pharmacy student 毎熊隆誉 1) 2), Kenichi Shimada 1), Ono Hiroshige 1), Takashi Egawa 1), Takashi Shibata 1), Tamiko Nishimura 1), Sumiko Shiota 1), Junko Maeda 2), 五味田裕 1), Daisuke Teshima 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2012. |
---|
![]() |
Result of the practice using the simulator to develop ability for P1-650 clinical judgment Shunsuke Kurono, Aki Ito male, Fumiko Otsu, Shigeyuki Yamada, Yoichi Hasegawa, Tadashi Nagamatsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2012. |
---|
![]() |
Development of the international exchange in the P1-651 pharmacy six years system education Miyoshi Kawakami, Arumi Hideto, Tomoji Yoshiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2012. |
---|
![]() |
Training - with the scenario based on enforcement of the physical assessment training for the P1-652 6 annual student and the case of evaluation (the second report) - healthcare setting 廣原正宜 1), Tomoyuki Hamamoto 1), Kazuo Takayama 2), Ayako Terada 1), Miki Nakamura 1), Yoshiko Chiba 1), Shibuya Fuminori 1), Kyoji Taguchi 1), Jun Toda 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2012. |
---|
![]() |
What is the ability that a pharmacy student is demanded from for medical person training in the P1-653 University? Takeshi Kotake 1), Masaru Matsumoto Rika 1), Satoyo Noguchi 1), Tomomi Inoue 1), Mitsutaka Takada 1), Kakehi Kazuaki 1), Morihiro Nomura 2), Yuzuru Yamazoe 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2012. |
---|
![]() |
Construction of the physical assessment, CBL unification type training in the P1-654 business training post-education and evaluation - tertiary report Hisakuni Hashimoto 1), Takanori Nakajima 1), Hiroshi Saito 1), Your Nakamura existence 1), Itsumi Yoshimura 2), Tetsuya Hayashi 1), Yoshikazu Matsuda 1), Masayuki Kimura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 375-375, 2012. |
---|
![]() |
Medical system integrated education - for students by informed consent - student plan as the P1-655 medical care system department joint class Yagi Ryuta Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2012. |
---|
![]() |
About a social pharmacy class of 2 annual in the P1-656 pharmacy education six years system 久岡清子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2012. |
---|
![]() |
Examination of the utility in the drug preparation by the water-soluble formulation of the P1-657 time of use decomposition anticancer drug Ogre Toshihide Kubo 1) 2), Kumi Nakamura 1) 2), Akira Shinohara ability 3), Hiroaki Takagi 3), 白澤吉哲 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2012. |
---|
![]() |
Examination about the germfree preparation duties efficiency of the P1-658 hyperalimentation Makiko Ota, 3, Hiji, Matsuda, Osamu Asai line, 寺部保成, Fukuura Kumiko, Shigeru Yamada tree Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2012. |
---|
![]() |
Cross sectional study for hypertension of patients with P1-659 Japanese HIV infection Shinichi Hikasa 1), Megumi Yasuda 1), 秀田恭子 1), Satoshi Hikasa 2), 澤田暁宏 2), Tazuko Tokugawa 2), Takeshi Kimura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2012. |
---|
![]() |
Evaluation of the understanding degree for the medicine before and after the P1-660 heart failure classroom participation Asako Nozawa 1), Noriko Yamashita 1), Mina Yanai 1), Junko Nishida 2), Tooru Masuyama 3), Takeshi Kimura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 376-376, 2012. |
---|
![]() |
About the association with the P1-661 inside the hospital adoption medicine number of articles and the institution attribute Takuya Maeda 1), Body marsh Masami 1) 2), Hisashi Fujiwara up 1) 3), Junichi Iida 1), Tetsuro Yumoto 1) 4), Hajime Matsubara 1), Masahisa Saito 1), Hajime Kagaya 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2012. |
---|
![]() |
Fact-finding about the hospital information disclosure in the hospital homepage judging from P1-662 patients viewpoint Hiromi Yoshino, Fumiko Otsu, Nobuyuki Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2012. |
---|
![]() |
Competitive review of the contents in the P1-663 Japan and the United States Hospital Pharmacist Association magazine article 3, Tajima lawn child 1), Shinya Suzuki 1), Naoki Kondo 2), Cho Soo Min3), 山口拓洋 4), Satoshi Izumi Shiro 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2012. |
---|
![]() |
Examination of the utility about the reporting using the P1-664 multifunctional cell-phone Ryota Tsukioka 1), Jinguji Hideyuki 1), Koji Omae 2), Sakon Yasutaka 2), Doi reason Yuko 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2012. |
---|
![]() |
About the guidelines on pneumocystis pneumonia preventive medicine observance in the medication in P1-665 HIV-positive patients Megumi Yasuda, Shinichi Hikasa, 秀田恭子, Takeshi Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2012. |
---|
![]() |
Estimate of the condition to forward required for the substitution of the bypass infusion drug in the P1-666 intravenous feeding route Nozawa (Ishii) Reiko 1), Satoko Ando 2), Makoto Hiraide 2), 植沢芳広 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 377-377, 2012. |
---|
![]() |
The inspection that is useful as a workshop for the authorized pharmacist acquisition specialized P1-667 Shizuoka Hospital Pharmacist Association workshop Emi Takeda 1) 2), Manabu Watanabe 2) 3), Michihiro Shino 2) 4), Yoshihiro Yamada 1), Junichi Kawakami 2) 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2012. |
---|
![]() |
P1-668 Usefulness of lithium to Tauopathy 島田侯陛 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2012. |
---|
![]() |
New pharmacological effect of the P1-670 nucleus transitivity inhibitor of angiotensin converting enzyme Early hunting truth, Sachiko Kanazawa, Descent from a mountain Ritsuko, Sachiko Fujita, Shiro Itagaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2012. |
---|
![]() |
Through P2-001 1 case, we think about the medication adherence of elderly people 守内匡, Satomi Asano, Osamu Tanaka, Hiromi Matsui, Yoshimi Matsuda, 高田加壽代 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2012. |
---|
![]() |
P2-002 Influence the operation of the Spiriva Respimat is on COPD control 坂野昌志, 佐野元基, 青田真理子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 378-378, 2012. |
---|
![]() |
Many types of job evaluation of a physician, the nurse by the induction of the P2-003 ward drug duties enforcement addition Masami Murakami 1), Noriko Takahara 1), Shinnichi Sado 1), Akiko Mizoguchi 1), Yasuhiro Tsuji 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2012. |
---|
![]() |
About the systems construction of P2-004 pharmacist ward placement duties Yuko Shimamoto, Kaori Yamanishi, Narumi Matsumura, Hiromi Hashizume, Akemi Horibe, Kyoichi Wada, Oida chapter, Takeshi Kuwahara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2012. |
---|
![]() |
The present conditions and problem of the use of P2-005 dabigatran capsule situation 成田千香子, 八代佳子, 一関美江子, 金美紀, 吹谷真紀子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2012. |
---|
![]() |
Triple-drug therapy ... including the proper use management - terra pre-building by the P2-006 pharmacist Tokuyama picture straight 1), Miyatake wish 1), Hiroki Sakaguchi 2), Takuya Kitada 2), Makoto Fukushima 1), Toshihiko Ishizaka 1), Junji Mukai 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2012. |
---|
![]() |
About the oral medicine management in the ward by the P2-007 pharmacist 礒口 Yuki, Aya Suzuki, Reiko Yasuda, Hideki Koyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2012. |
---|
![]() |
The present conditions and problem of the ward drug duties enforcement in the P2-008 Kyoto medical center Motoaki Nakao, Noriko Takahata, Hiroyuki Ueno, Kei Nakamura, Yoshio Kitamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 379-379, 2012. |
---|
![]() |
Of the drug control instruction in the triple-drug therapy including the terra pre-building for P2-009 chronic hepatitis C, actually Yurina Shimada 1), Miyaze Shiho 2), Fukunaga still world 1), Hiroko Miyamoto 1), Shigetoshi Fujiyama 2), Junko Morioka 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2012. |
---|
![]() |
Utilization - of style improvement and the DI question record vote of examination - ward drug log book of the intelligence means for an analysis, an evaluation to present P2-010 ward drug duties Teruo Tanaka, Aya Takasaki, It is Hashimoto dirt, Yusuke Nakagawa, Miwa Tadokoro, Rie Yoshioka, Makiko Ichiyoshi, Yagi Akiko, Megumi Komatsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2012. |
---|
![]() |
For the new oral medicine induction of the P2-011 multiple sclerosis therapeutic drug Kazuko Kawai 1), Kazuyuki Ito 1), Satoshi Isotani 1), Kenichiro Fujishiro 2), Land Shigeo 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2012. |
---|
![]() |
It is ... through action ... physician, a nurse midwife of the pharmacist permanent residence to P2-012 maternity ward, the questionnaire results for the pharmacist from a nurse Kyoji Terasawa, Haruko Yui, Ai Sakamoto, Tomoaki Katayama, Tomomi Kimura, Tomoko Yamashita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2012. |
---|
![]() |
Can change the recognition of action ... parent of the pharmacist for the P2-013 childhood immunization spread; or ... Yuki Mikami, 日置三紀, Takashi Yamazaki, Ayumu Nozaki, Yuka Kobayashi, Toshiko Aramiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2012. |
---|
![]() |
For improvement of the quality of P2-014 ward drug duties Yuki Nishitani, 久岡清子, Aida sheath, Aya Furushima charges, Kenji Sasaki, Naomi Kawakami, North residence Miki, Interval Chiharu, Takashi Kameoka, Kanuma Nao, Mai Rikitake, Tadashi Adachi, Tray child Hara is free, Hisayuki Haji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 380-380, 2012. |
---|
![]() |
Induction of the conference in the duties time for the purpose of the information sharing of the P2-015 pharmacist Ai Sakamoto, Kyoji Terasawa, Tomoaki Katayama, Haruko Yui, Tomomi Kimura, Uchiyama eyes, Tomoko Yamashita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2012. |
---|
![]() |
Trial ... of the DIC treatment flow chart making by action ... pharmacist of the pharmacotherapy by the many types of job cooperation in the cottage-hospital out of P2-016 Noriko Shimizu, Katsuaki Arai, 前原梨恵, Person of truth Yusuke, Maki Kikuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2012. |
---|
![]() |
1 case that experienced an allergic symptom during P2-017 furosemide administration Yukiko Matsuda 1), Keiko Nitta 1), Motoko Funato 1), Satoshi Konya 2), Masaaki Mori 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2012. |
---|
![]() |
Electrocardiogram monitor management by the P2-018 pharmacist Kazuyuki Ito 1), Keita Urasaki 1), Kazuko Kawai 1), Satoshi Isotani 1), Hiroshi Murakami 2), Naoya Tsuboi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2012. |
---|
![]() |
Rheumatic patients satisfaction investigation in the drug control instruction using the P2-019 touch panel type information terminal Junichi Mizumachi, Yoshihiro Nakagawa, Sayuri Takeuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2012. |
---|
![]() |
About the relation of the pharmacist of the terra pre-building induction in the P2-020 this hospital Well Keisuke Hata, Tanbara Toshio Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 381-381, 2012. |
---|
![]() |
Contribution of the P2-021 ward permanent residence type pharmacist to a smooth discharge adjustment Toru Hasegawa, Keita Urasaki, Tomoko Asai, Sachiko Tsujimoto, Yasuo Ukai, Jun Hisada life, Kazuko Kawai, Kazuyuki Ito, Satoshi Isotani Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2012. |
---|
![]() |
Utility of the on admission patients interview by the P2-022 ward charge pharmacist Hiromi Atsumi, Keiko Mitsui, Kumiko Shimada, Miho Takano, Atsushi Yamashita, Yoshihiro Kakiuchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2012. |
---|
![]() |
Activity report of the pharmacist in the P2-023 collagenosis rheumatism center Yasuo Ukai 1), Keiko Matsuki 1), Keita Urasaki 1), 金正煌 1), Kazuko Kawai 1), Kazuyuki Ito 1), Satoshi Isotani 1), Masaya Kodera 2), Aoyama success 3), Hideki Yasuma 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2012. |
---|
![]() |
Relation of the pharmacist to chronic hepatitis C treatment using the P2-024 terra pre-building Misako Yamaguchi 1), Akiko Emoto 1), Kazuhiro Hirano 1), 中野行孝 1), Eguchi existence Ichiro 2), Fujito Expo 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2012. |
---|
![]() |
Change after drug control instruction duties and the exclusive duty pharmacist placement in the P2-025 CCU Fumiko Kato, Yuki Meishin, Yuka Tsutsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2012. |
---|
![]() |
The enforcement situation and evaluation of P2-026 ward drug duties Masaki Manda, Yasuko Takinami, Miyuki Miyake, Keiko Noguchi, Kaori Ozaki, 野際俊希, Takami Fujii, Naoko Tsuji, Shigeo Asai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 382-382, 2012. |
---|
![]() |
Good use of action - assessment sheet - for P2-027 efficiency-like ward drug duties Kawai wish, Tomoko Kitamoto, Katsuya Nakano, Yuka Tsutsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2012. |
---|
![]() |
The enforcement situation and problems of ward drug duties in the P2-028 Kitasato Inst. Hospital Reiko Fujino 1), Masayoshi Nishi beauty 1), Takashi Ito kernel 1), Shinya Abe 1), Takamitsu Fujioka 1), Yoshikazu Kobayashi 1), Soichi Shibata 1), Masatoshi Saito 1), Atsuta Koichiro 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2012. |
---|
![]() |
Action ... to efficiency of construction - log book making, the management of the P2-029 ward drug log book system Yoshikazu Kobayashi 1), Masayoshi Nishi beauty 1), Takashi Ito kernel 1), Shinya Abe 1), Takamitsu Fujioka 1), Reiko Fujino 1), Soichi Shibata 1), Masatoshi Saito 1), Atsuta Koichiro 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2012. |
---|
![]() |
Examination of the utility of the P2-030 ward pharmacist conference Aiko Koyanagi, Takahiro Goto, Kozue Kurihara, Kusaka Toyoshi, Yusuke Taki, Hirokazu Yamashiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2012. |
---|
![]() |
The ward drug duties in the P2-031 medical treatment ward contribute to team approach in medical care and the duties burden reduction of the physician Tomoko Otani, Tomoko Aoyama, Yukari Mihara, Yayoi Kamioka, Akiko Kumano, Shoko Omori, Mami Higuchi, 賀勢泰子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2012. |
---|
![]() |
It is ... with the needs of other types of job to the action Vol.1 - ward exclusive duty pharmacist of the drug section in the small and medium size hospital with the new establishment of the P2-032 ward drug duties enforcement addition Kenjiro Inaba 1), Body marsh Masami 2), Motomu Kobayashi 1), Tetsuro Yumoto 1) 3), 赤瀬朋秀 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 383-383, 2012. |
---|
![]() |
Judging from ward pharmacist duties (1) - prescription suggestion example in the P2-033 Asahikawa Red Cross Hospital, it is ... Many ground Takanori, Yuki Nakaoka, Keiko Saito, Minoshima arch non-child, Eiichi Nishimura, Downhill path Kazufumi, Takayuki Itokawa, White prefecture Toshihiro, Goto Yoshinobu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2012. |
---|
![]() |
It is discussion about the satisfaction of the patients after consciousness and the instruction of the P2-034 pharmacist Yuriko Watanabe 1), Wataru Arai 2), Kazumasa Hasegawa 3), 矢吹直寛 4), Miki Yajima 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2012. |
---|
![]() |
Intervention ... to the medical security by the role (15) - ward permanent residence pharmacist of the pharmacist in the P2-035 team approach in medical care Senaha Hiromasa 1), 名徳倫明 2), Akiko Nakanishi 1), Chiaki Iwamoto 1), Field river Miyuki 1), Fumiko Konishi 1), Erina Konishi 1), Field Akiko 1), Yumi Tomita 1), Shinichi Kawaguchi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2012. |
---|
![]() |
Reexamination of nausea, the vomiting prevention after the neurosurgery by the P2-036 pharmacist Kana Yamazaki 1), Hidetomo Yasujima 1), Ayumu Nakamura rare 2), Hiroyuki Hayashi 3), Yoshio Taguchi 2), Akio Saito 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2012. |
---|
![]() |
The present conditions and problems of ward exclusive duty pharmacist duties in the P2-037 this hospital 倉繁正勝, Toshi Tanaka, Hiromi Ito, Shinsuke Sato, 齊木敦子, Masuo Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2012. |
---|
![]() |
For the enforcement of P2-038 ward drug duties examination - about the oral medicine management in - mixture ward Ayumu Hirata, Miki Kubo, Kayo Shiraishi, Saburo Yoshioka, Michihiko Miyamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 384-384, 2012. |
---|
![]() |
Trial of the periodical prescription collaboration input by P2-039 pharmacist and the physician Ko Yamaguchi tree 1), Tsuyoshi Miura 1), Akira Ishii 1), Keiichi Ishida 2), 仲佐啓詳 1), Hiroshi Nakamura justice 1), Goro Matsumiya 2), Amount of Ariyoshi example 1), Koichi Kitada 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2012. |
---|
![]() |
Action of this hospital for the P2-040 ward drug duties enforcement addition calculation 殿塚早百合, Nozomi Iida Rika, 加藤七奈, Tsurukawa lily, Hiroshi Tomiyama field, Hiroko Nakamura, 吉田羽奈, Watanabe friend levator, Hiroki Miyata, Shiro Katayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2012. |
---|
![]() |
Standard model construction of the drug duties in the P2-041 ward Hisako Yoshimoto, Kyoji Koda, Masanori Watanabe, Yuko Nagasawa, Tomohiro Nishikawa Kei, 廣實清司, Hiroyuki Furukawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2012. |
---|
![]() |
Duties contents in the P2-042 ward drug duties enforcement addition calculation and future problem Prince Taniguchi chapter, 後藤志央, Shrine Akihiro Ichiro, 末安由拓, Tatsuya Sasaki, Kaifu Masayo, Akihiro Kai, The Ishikawa immensity, Takahiro Rikitake Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2012. |
---|
![]() |
Examination second report of the problem to the pharmacist whom P2-043 "ward drug duties enforcement addition" brings 矢吹直寛, Katsura Orimoto, Naohisa Koseki, Nihiko Sekine, Satomi Yoshida, Tomokazu Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2012. |
---|
![]() |
About the present conditions of ward drug duties in the P2-044 this hospital Parent pine Takahiro, 川嵜英二 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 385-385, 2012. |
---|
![]() |
Examination - from the case that we experienced through examination - ward drug duties for the participation in planning to the medical treatment in the P2-045 orthopedics ward Toshiko Ogawa, Takenori Kurata, Rina Osato, Samura A, 1, Kotobuki, Sekine Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2012. |
---|
![]() |
Construction of the ward drug duties by the additional post with P2-046 center duties Charcoal Masaki, Sudo Seicho, Koji Uenishi, Nobuo Hoshino, Shinya Morita, 寺田智祐 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2012. |
---|
![]() |
Examination of the effect by the acting pharmacist input in the P2-047 constant placement medicine management 隅岡瞳, Yasuyuki Saeki, Furrow well Hiroko, Yasuhiro Kimura, Tree flat Kenji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2012. |
---|
![]() |
Action of ward drug duties in the P2-048 Toku Matsubara bank meeting Hospital Kishii Akito, Shinichi Nakamura, Yoshihiko Kida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2012. |
---|
![]() |
It is considered 3 cases that led to cancellation after a change from P2-049 VCM, TEIC to DAP Hiroaki Arakawa, Yukie Suzuki, Akiko Komori, Kayo Murai, Yasuhiro Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2012. |
---|
![]() |
Effective intervention to make use of P2-050 pharmacist bundle (one for all, all for one) antimicrobial agent Toshihiko Ishizaka, U.S. Hara non-origin, Mika Kimoto, Hamada rabbitfish, Morita connection, Miyatake wish, Tokuyama picture life, Naoki Ogawa, Junji Mukai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 386-386, 2012. |
---|
![]() |
Contribution of the pharmacist in the P2-051 antimicrobial agent doses adequacy Takeshi Kimura 1) 2), Worth Chongwen 1) 2), Saikai life 1), Former river Rie 1), Masako Yamamoto 1), Kimura Shuya 1), Hidemi Sasaki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2012. |
---|
![]() |
The adequacy of the transurethral endoscopy clinical path antimicrobial agent by the P2-052 pharmacist leadership and the evaluation Sachiko Sahara, Kenji Mori, Daichi Shibata, Mitsuru Sugiura, 足立守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2012. |
---|
![]() |
Multicenter investigation about the TDM enforcement situation and the clinical response of the P2-053 infection with MRSA therapeutic drug Hiroshi Takane 1) 2), Yukiko Miyoshi 1), 堀井俊伸 2) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2012. |
---|
![]() |
Examination about a dose, the number of dose of the P2-054 carbapenem system antimicrobial agent (meropenem) Aspect shrine Koji 1), Kenji Miyazawa 2), Makoto Hayashi 2), Akemasa Yamaya 2), Hiroshi Funaki 2), North Toshiyuki 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2012. |
---|
![]() |
Activity and outcome to TDM perfection enforcement at the P2-055 antiMRSA medicine administration Junpei Yamamoto, Masaki Kubo, Takeshi Yoshimoto Saburo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2012. |
---|
![]() |
Problems for the antimicrobial agent proper use judging from a drug resistance ratio of P2-056 Pseudomonas aeruginosa Yukiyo Funakoshi 1), Kunihiko Kohama 2), Shinji Fukuhara 1), Shizuko Ono 1), Katsuaki Takeda 1), Yasushi Nakamura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 387-387, 2012. |
---|
![]() |
Examination ... of action ... use situation investigation and the registration system for the proper use of the P2-057 carbapenem system antimicrobial agent Kenji Goto 1), Shinya Aoyama 1), Makoto Ishikawa flat 1), 酒井欣嗣 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2012. |
---|
![]() |
P2-058 Dosage determination of antibacterial agents in empiric treatment of bacterial meningitis and drug selection at the time of De-escalation, the case About the pharmacist it was intervention 鈴木峻輔1), 上田恵子1), 松山明日香1), 酒井裕介1), 松橋明子1), 小久保由美子1), 新井亘2), 町田充1), 矢嶋美樹3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2012. |
---|
![]() |
It is investigation ... of ... use situation for proper use of the P2-059 antiMRSA medicine Yoshiko Yamaguchi 1) 2), Horiuchi Kotobuki will 2) 3), Yasukochi still up 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2012. |
---|
![]() |
1 case that responded to arbekacin for pneumonia by P2-060 metallo- β - lactamase-producing Pseudomonas putida 榎屋友幸1)2), 村木優一1)2), 中村明子2), 山田絵梨2), 岩下義明3), 今井寛3), 岩本卓也1), 奥田真弘1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2012. |
---|
![]() |
Examination of the clinical risk factor associated with the Escherichia coli of P2-061 levofloxacin-sensitive rate Hajime Nakai 1), Kasumi Kudo 1), Yoshida Yasunori 2), Sato good luck cord 3), Akira Takahashi 1), Kazunari Nakamura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2012. |
---|
![]() |
Utility of the in-hospital information paper issue for the proper use of P2-062 levofloxacin Kasumi Kudo 1), Hajime Nakai 1), Yoshida Yasunori 2), Sato good luck cord 3), Akira Takahashi 1), Kazunari Nakamura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 388-388, 2012. |
---|
![]() |
P2-063 Changes in antibiotic usage and bacterial susceptibility by promoting appropriate empiric treatment 後藤拓也1)2), 森理惠1), 中島誠1), 野村美枝1), 相澤佑佳1), 若林公夫1)2), 熊谷隆浩1), 三島信行1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2012. |
---|
![]() |
Fact-finding about the P2-064 cephalexin prescription patients Kunio Naruse 1), 伊藤匡伸 1), Jun Naito 2), Yoshio Miyake 1), Kiyoshi Haneda 1), Atsushi Yoshida 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2012. |
---|
![]() |
Evaluation of the P2-065 wide area spectrum antimicrobial agent registration system induction Saori Nagatsuka, Satoru Kaneko reason, Hiroyuki Kageyama, Katsumata Harumi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2012. |
---|
![]() |
Examination of sulfamethoxazole trimethoprim doses for the P2-066 pneumocystis pneumonia Hiroyuki Iwata, Keiko Fujita, Rie Ueda, Satoshi Hasegawa, Gilt bronze Yoko, Kazuko Shimura, Nobuhisa Fukushima, Tomonari Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2012. |
---|
![]() |
MEPM proper use investigation in the P2-067 Hirosaki stroke, rehabilitation center 倉内寿孝, 蝦名範嗣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2012. |
---|
![]() |
Proper use of the daptomycin to learn from a P2-068 adverse event case and role of the pharmacist 内田裕之1), 三木智子2), 前野努2), 前田正3), 岡秀昭2), 石井嘉之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 389-389, 2012. |
---|
![]() |
Clinical benefit of the starting medical supplies and generic medicine of the Cefepim for the P2-069 febrile neutropenia Imai and your 1), Akira Kodama person 1), Azusa Miki 1), Iwatate Chizuko 1), Takako Morita 2), Yoneta Italy product 3), Takeshi Kotake 4), Shinsuke Mori 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2012. |
---|
![]() |
Comparison ... with the fact-finding - carbapenem system antimicrobial agent for the proper use of the P2-070 tazobactam / piperacillin 近藤匡慶, Field stake Naoya, 菅谷量俊, Kazuya Murata Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2012. |
---|
![]() |
Examination about the effectiveness of the P2-071 antiMRSA medicine linezolid and the safety 小川美希1), 松尾和廣1), 木村伊都紀2), 平山忍2), 佐々木英久1), 渡辺朋子1), 篠原悦子1), 小杉隆祥2), 西澤健司2), 吉尾隆1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2012. |
---|
![]() |
Cholangitis in the P2-072 this hospital, the use situation of the antimicrobial agent for the cholecystitis 白石史遠, Tetsuya Sugihara, Tsuneo Kuwamura, Takashi Akamatsu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2012. |
---|
![]() |
Examination about candidemia treatment in the cottage-hospital out of P2-073 Mariko Aota, Masashi Sakano, 寺井文廣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2012. |
---|
![]() |
Examination of the initial dose for the P2-074 Clostridiumu difficile-related diarrhea Emi Takeuchi, Iga Masanori, Katsuhiko Inomata, Yoshio Fujikake Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 390-390, 2012. |
---|
![]() |
P2-075 Evaluation of the efficacy and safety of doripenem high-dose administration 槙田芳, 吉田直哉, 中村友香, 鈴木悠加, 田中悠季, 亀井浩二郎, 小原郁司, 小寺隆二, 下山光一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2012. |
---|
![]() |
Examination of the factor affecting thrombocytopenia with the P2-076 linezolid administration 石田茂伸, 前田佳代, 西尾千尋, 中井由佳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2012. |
---|
![]() |
Effect to give to resistant bacteria expression of the antimicrobial agent choice based on P2-077 anti bio gram 冨山育朗 1), Susumu Kudo 1), Kentaro Tanaka 2), 丹代恭太 1), 蒲澤一行 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2012. |
---|
![]() |
Examination about use fact-finding of the P2-078 meropenem and the individual administration plan Aya Omuro 1) 2), Mt. Kobayashi 1) 2), Kazuhiro Hayakawa 1) 2), Yuichi Yano 1), Mitsuo Sakamoto 2) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2012. |
---|
![]() |
Result of the antibiotic proper use by the P2-079 ICT round Ryota Nakamura 1) 2) 3), Yukiko Kita 1) 2) 3), Hirotsugu Kita 1) 2) 4), Yuji Niisato 1) 3) 5), Koichi Ikehara 1) 3) 5), 与古田美智代 1) 4) 6) 7), 伊波敬 1) 3) 8), Groundwork wing 1) 3) 8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2012. |
---|
![]() |
Making, evaluation (the second report) of the pocket edition "ICT recommendation antimicrobial agent doses table" for P2-080 proper use Megumi Yoshida 1), Mariko Negishi 1), 中村造 2) 3), Yuko Sagara 2), Haruko Kazama 4), Chisato Sugiyama 5), Hiroshi Matsuzawa 1), Funatsu Kumi 6), Akira Fukuda 7), Keiko Kotake 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 391-391, 2012. |
---|
![]() |
Discussion of the philology about the efficacy of the adjuvant to use for antiMRSA medicine for P2-081 sepsis, pneumonia 入口慎史 1), Toru Imai 2), Takao Orii 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2012. |
---|
![]() |
Examination of the case that an antimicrobial agent was continuously used at P2-082 Clostridium difficile(toxinA/B) positive Hiroshi Kawasaki 1), Hiromi Suzuki 2), Mukozaka Motohide 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2012. |
---|
![]() |
About the pre-medication of patients receiving P2-083 vancomycin hydrochloride powder Kazuhiro Nakamura, Nobuhiro Tsutsui Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2012. |
---|
![]() |
Investigation of the efficacy by the change of hydrochloric acid banco machine powder doses in the P2-084 Clostridium difficile-related diarrhea Hiromi Tsuchiya, 庄司知摩, 佐藤導 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2012. |
---|
![]() |
P2-085 Clinical study of the combination drug and drug change of antiretroviral therapy (ART) to the key drag the anti-HIV drugs raltegravir 沖中美奈子1)2), 大澤麻貴子1), 前田真輝1), 當麻厚子1), 井上亜悠1), 川端佑美1), 花房秀次3), 小島賢一3), 長尾梓3), 越前宏俊2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2012. |
---|
![]() |
Efficacy and safety of the amikacin once a day administration method in P2-086 elderly people Yoshihiko Matsuki, Toshiaki Onuki, Yumi Matsumoto, Asami Yasuda, Keiko Fujioka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 392-392, 2012. |
---|
![]() |
The enforcement of the hand-washing classroom in the P2-087 nursery school and the evaluation Koji Okubo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2012. |
---|
![]() |
The use of antimicrobial agent situation of the cancer terminally ill patients in the P2-088 Ichinomiya City municipal hospital and the analysis Mountains Noriaki, Masako Yoshida, Mountain village gain oneself, Aoyama Kei daylight Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2012. |
---|
![]() |
Action for the proper use by the induction of the use of P2-089 antimicrobial agent registration system Michiya Tanuma 1), 上野将臣 2), Toshiki Saito 1), Naoko Furuya 1), Yoshizo Watanabe 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2012. |
---|
![]() |
Factor of the decrease of the initial number of onset and rate of recurrence of Clostridium difficle association diarrhea / enterocolitis (CDAD) treated patients in the P2-090 Nagaoka Red Cross Hospital Kenichi Kobayashi 1), Akemi Kawakami 2), Star Shuichiro 3), Takeaki Nishibori 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2012. |
---|
![]() |
Relations from P2-091 core ICT to an antimicrobial agent to send Saori Kawajiri 1) 2), Yuki Nishimura 1), Shogo Kanda 1), Wakigawa Fumiko 2) 3), Miyako Kanazawa 2) 4), Koji Hashiguchi 2) 5), Tsuyoshi Machida 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2012. |
---|
![]() |
Examination about the risk factor of ESBL-producing Escherichia coli detected in P2-092 urine Takafumi Sugawara 1), Nobue Uetake 1), Toshiharu Matsumoto 1), Shinichi Miyamori 1), 木村公重 2), Open Koichi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 393-393, 2012. |
---|
![]() |
Questionary survey about "the operation limit rule at infection affection" in the hospital in P2-093 Kyushu Yamaguchi District Yuichi Umeda 1), Takahiro Muro 2), Mamoru Uchida next 1), Kosuke Miyoshi 1), Shinsuke Takemoto 1), Nakamura right one 3), Hidetoshi Kamimura 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2012. |
---|
![]() |
Risk factor of the P2-094 substrate specificity expansion type beta lactamase (ESBL)-producing Escherichia coli infection Yoshiaki Ikeda 1) 2), Hideki Nishiyama 1) 3), Kumiko Kosaka 1) 4), Koichi Miyamura 1) 5), Kazuhiro Mori 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2012. |
---|
![]() |
About the effect of the use of P2-095 wide area antimicrobial agent registration system and a change of the antimicrobial agent consumption Yoko Kitano, Minako Yoshii, 田中三広 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2012. |
---|
![]() |
Antimicrobial Useand Resistance(AUR) surveillance in the P2-096 Nagano throughout the prefecture 7 institution Takeshi Kubota 1), Kenji Kiyohara 1), Nobuhiro Yasuoka 2), Maruyama fine weather straight 3), Kazuno Shohei 4), Kenji Tanaka 5), Kei Matsuoka tree 6), Sachiko Otsuka 7), Masaru Hori good luck 8) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2012. |
---|
![]() |
Improvement ... by the enlightenment activity of action ... ICT to two sets of examination of blood cultures sampling promotion aiming at P2-097 antimicrobial agent proper use Hidechika Ueda 1), Takayuki Inagaki 1), Yasuyo Goto 2), Capital bamboo Chikako 2), 橋渡彦典 3), Atsushi Hosoe celebration 4), Masaru Nishio 4), Shiro Yoshioka 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2012. |
---|
![]() |
The antimicrobial agent consumption for the P2-098 whole country 203 institution and Pseudomonas aeruginosa-resistant surveillance 2011 Japanese Society of Hospital Pharmacists arts and sciences fifth subcommittee report Yuichi Muraki 1), Masaki Kitamura 2), 前田頼伸 3), Takashi Kitahara 4), Ken Mori 5), Ikegami English sentence 6), 継田雅美 7), Mere field Koji 8), Takashi Akamatsu 9), Katsutoshi Takada 10), Takehiro Yamada 11), Tadashi Shiraishi 12), Shinko Okuda 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 394-394, 2012. |
---|
![]() |
Utility ... of the testing order enforcement by participation in P2-099 antiMRSA medicine proper use - pharmacist Akira Fujii, Naoki Hayashi, Masahiro Yasunaga, Kazunari Uchida, Castle former Naoko, Naoko Fujiwara, 小礒克己, Emiko Harada, Akira Ogata, Takeshi Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2012. |
---|
![]() |
1 case that intervened in treatment of the septic bursitis with P2-100 Peptostreptococcus Kazutaka Nakata, 中島満尭, Misa Matsumiya, Makoto Morizumi, Chiyoko Sakamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2012. |
---|
![]() |
Examination of the use of antimicrobial agent case in the P2-101 convalescent rehabilitation ward Naoki Soma 1), Absence Katsuyuki 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2012. |
---|
![]() |
Relation - of the ward pharmacist for the severe infection with one - myelodysplastic syndrome that suffered from medical treatment of the prosthetic valve endocarditis that P2-102 surgery had difficulty with Samura A 1), 腰岡桜 1), Koibuchi Hiroyuki 1), Toshiko Ogawa 1), Naoko Yamaguchi 1), 1, Kotobuki, Sekine 1), Tsurumi Yukio 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2012. |
---|
![]() |
Bacteria detection pulse-taking from opening of a Diet session in the P2-103 Hirosaki stroke, rehabilitation center 蝦名範嗣, Kumeda Kazuyoshi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2012. |
---|
![]() |
Making and the susceptibility situation of the anti-biogram for the P2-104 antimicrobial agent proper use Kumeda Kazuyoshi, 蝦名範嗣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 395-395, 2012. |
---|
![]() |
Intranasal resident flora investigation of the staff engaged in P2-105 treatment at home Shunji Horikawa 1), Yozo Takeyama 2), 中南秀将 2), 野口雅久 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2012. |
---|
![]() |
Investigation, analysis of the cause to give it to annual usage increase of P2-106 vancomycin 坂元利彰 1), Takashi Kitahara 1), Hiroo Nakagawa 1), Noriko Matsunaga 1), Katsunori Yanagihara 2), Masanobu Imamura 1), Takahiro Muro 1), Tadahiro Nakamura 1), Norihide Higuchi 1), Hitoshi Sasaki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2012. |
---|
![]() |
MRSA infection measures - using the PCR for infection control - elective surgery patients that P2-107 pharmacist is carried out Yoshiko Takahashi 1), Yoshio Takesue 2), Kaoru Ichiki 2), Sumiyo Tatsumi 1), Shingo Takubo 1), Takashi Ueda 2), Takeshi Kimura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2012. |
---|
![]() |
The situation of the long-term use of the antimicrobial agent targeted for a report in the P2-108 Nissei Hospital and the intervention situation of the ICT Hisao Ikeda 1) 2), Takahiro Hirata 1), Hiroshi Nomura British 1), Nao Takigawa 1), Akihiko Asano 2), Noriko Ono 2), Yukiko Arai 2), Ikuko Fujita 2), 角田道久 2), Katsuyoshi Hatanaka 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2012. |
---|
![]() |
Effect ... of the intervention to use of chemosensitive change - identification antimicrobial agent with P2-109 regional alliances Yukako Hatanaka 1) 2), Kazuya Fujita 1) 2), Keiko Adachi 1) 2), Naoyuki Kitamura 2), Zamami Yoshito 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2012. |
---|
![]() |
Antimicrobial agent consumption in approximately the antimicrobial agent registration system induction using P2-110 AUD and chemosensitive examination Kengo Yamazaki 1), Yuichi Hirashima 1), Takeshi Nakaya 1), Your history of Terahara 1), Hoshina walnut 1), Kimito Sato 1), Hiroshi Tamura 1), Field Yuri 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 396-396, 2012. |
---|
![]() |
The construction of the use of P2-111 identification antimicrobial agent report system and antimicrobial agent consumption change after the induction Takehiro Yamada 1) 2), Nobuhisa Ishiguro 2), Tsuyoshi Miyamoto celebration 1) 2), Kumiko Kasashi 1), Toshitaka Fukai 1), Takeshi Iseki 1) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2012. |
---|
![]() |
Action effect by the ICT for the dosage interval adequacy at the daily multiple administration in the P2-112 identification antimicrobial agent Yui Yoichi Sono 1) 2), 入江徳俊 1) 2), Ai Sumita 1) 2), Kenji Suenaga 2), Takeshi Shimomura 2), Daisuke Yoshimura 2), Yoji Nagasaki 2), 槇林智子 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2012. |
---|
![]() |
Report of the simultaneous inoculation of 23 values pneumococcus vaccine and the influenza vaccine by the P2-113 pharmacy leadership 眞継賢一, Hayato Kuroiwa, 上田浩貴, Yoshihiko Hamaguchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2012. |
---|
![]() |
P2-114 Thermal Stability Evaluation of tenofovir disoproxil fumarate for the application of simple suspension method: In the case of two agents simultaneous application 大野靖子1), 矢倉裕輝2), 大歳菜美子1), 湯谷玲子1), 寺岡麗子1), 北河修治1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2012. |
---|
![]() |
Effect on antiseptic effect of the alcohol-based hand rub at use of P2-115 hand cream Risa Kanie, Mariko Aota, Masashi Sakano, 寺井文廣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2012. |
---|
![]() |
For preventive measures against P2-116 infection addition 1 calculation action - of the pharmacist in the scale institution out of - Emi Momiyama, Chie Shinohara, Aiko Saito, Kazumi Kimura, Keiko Sunakawa, Yumiko Iijima, Thin wave Tomoko, Hiromi Nagai, Kanako Sakashita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 397-397, 2012. |
---|
![]() |
Action of our House for the proper use of the antiMRSA medicine daptomycin that P2-117 is new 染谷雅弘, 篠崎陽一, 行川洋平, 北村好申, 北村正樹, 川久保孝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2012. |
---|
![]() |
Examination of the dialysis extraction ratio for the proper use of vancomycin in the P2-118 hemodialysis patient Yuichi Kumaki 1), Wild Hideki Oka 2), Masahiro Igarashi 1), Tadaaki Ito 1), Hiroyuki Fujii 1), Yumiko Uchida 1), Hiromi Tamura 1), Akiko Yoneyama 2), Masahiro Hayashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2012. |
---|
![]() |
Example that helped P2-119 ward drug duties and infection treatment of the MDRP patients by the cooperation of the ICT Sachiko Saito 1), Ayako Sakamoto 2), 澤畠孝幸 1), Slightly dried fish Yuka 1), Masashi Onozaki 1), Yoshifumi Aoyama 1), Yoshibumi Akatsu 3), Hideyuki Mishima 4), Tsunehiko Maruyama 4), Kazumitsu Ueda 4), Yasunori Watanabe 4), Shinji Hirai 4), Okumura Minoru 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2012. |
---|
![]() |
About a sterile effect in the clean bench caused by P2-120 peracetic acid system antiseptic Ryo Sugawa, Ayumu Nakamura, Miki Takenaka, 小門諒平, Suzuki hsiang tsai charges, Manabu Takegami, Masako Oishi, Yoshihiro Miwa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2012. |
---|
![]() |
Use trend of P2-121 antimicrobial agent ten years Mayumi Kato, 小畑伯子, Wariden Masako, Chikako Aoki, Kazuko Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2012. |
---|
![]() |
Action of the antimicrobial agent proper use promotion group activity in the P2-122 Kitasato University east Hospital ICT (infection control team) Mariko Arai 1), Yoko Matsuoka 1), Yukihiro Hamada 1), Yoshie Ohara 1), Takeshi Hirayama 1) 2), Masaichi Kuroyama 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 398-398, 2012. |
---|
![]() |
Examination of the carriage risk factor in the P2-123 VRE outbreak Goto will celebration, Mikiya Hayashi, Yamane A is rare, Midori Ito, 乗安久晴, Junko Akasaki, Castle former Keiji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2012. |
---|
![]() |
It is ... using the use of antimicrobial agent situation and resistant bacteria development turn of eventss - anti bio gram and the ATC/DDD system by the action to report of use of P2-124 antimicrobial agent revision Taku Kitamura Maro 1), Aya Saito 1), Naoki Azuma 2), Yuko Kikuchi 2), Aiba Koichi 1), Day Takaaki Nozawa 1), 上野彩恵 1), 神谷力嗣 1), Tatsuya Shimamura 1), Kazumasa Hasegawa 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2012. |
---|
![]() |
Examination of the prophylactic antimicrobial agent in the P2-125 transrectal prostate biopsy Cheap place Toshiyuki 1), Hiroyuki Fujiwara 1), Nanun Noriaki 1), Akihiko Abe 2), Togashi Kotobuki sentence 2), Shunya Ishida 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2012. |
---|
![]() |
Development of the P2-126 anti bio gram making web application -Chans- server-free version 初田泰敏, Sono Kawanishi charges, Kenji Ikeda, 名徳倫明, 西井諭司, Masashi Ogawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2012. |
---|
![]() |
The use situation of antibiotics in P2-127 pneumococcal infection Makoto Tanaka, High Kado Take Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2012. |
---|
![]() |
Retrospective research about the risk factor of the P2-128 Clostridium difficile-related diarrhea onset Takashi Uno, Ayako Sato, Kyoko Fujieda, Gutter ground Megumi, Eiji Tsutsumi, Nobuo Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 399-399, 2012. |
---|
![]() |
Infection consultation duties effect of the pharmacist in the P2-129 this hospital Hiroshi Hara person, Toru Nagai, Makoto Usuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2012. |
---|
![]() |
Establishment of the inspection procedure in the measurement compounding of medicines of the injection which put the P2-130 weight inspection method and the direct surveillance method together Hisashi Ono, Ikuyo Kanzaki, Tomomi Tanikawa, History of Takashi Yamada, Katsuhisa Tahara, 木村周古, Hemp lower Tomoka, Twig Masayoshi, Toshio Awaya, Yoshikazu Tazaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2012. |
---|
![]() |
Incident decrease with the PDA which we introduced into P2-131 compounding of medicines system newly Hoshino Yugo, Yoko Kamiya, Kiyotaka Kawazumi, Yoshiharu Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2012. |
---|
![]() |
Improvement of the remaining of the active principle in the simple suspension method of the P2-132 soft capsule Ai Yoshino 1), Masato Takahashi 1), Kurata we see it 2), Akihiro Nakamura 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2012. |
---|
![]() |
Compounding of medicines duties using all P2-133 automatic seat withdrawal device (robo-pick) and drug system (MONET) Hiroyuki Kawahara, Masako Ido, Junpei Mizuta, Country original Junichi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2012. |
---|
![]() |
Action for the simple suspension method induction in the P2-134 Kyushu medical center Nakagawa Takehiro 1), Toshihiro Matsumoto 1), Hama place Akiko 2), 三角紳博 1), Makoto Ishibashi 3), Takashi Nishino 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 400-400, 2012. |
---|
![]() |
Action of the simple suspension method induction in the P2-135 Morioka friendship hospital Shintaro Abe, Shiori Sasaki, Shino village five child, Toshinari Nakajima, Hideki Omori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2012. |
---|
![]() |
Retrospective observational study about the medication history management method of the P2-136 tea S one Makoto Maeda, Yoshimasa Saito, Haruhiko Sakamoto, 牧野好倫, Nobuaki Yokote, Hiroshi Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2012. |
---|
![]() |
The construction of the P2-137 child dose inspection system and evaluation of the utility Setsuko Ihara, Keita Hirai, Hiroyasu Hasegawa, 高橋成隆, Tatsu Sakamoto Ichiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2012. |
---|
![]() |
Evaluation of the prescription checking in consideration of renal function for P2-138 levofloxacin tablets proper use 舘知也1), 浅野祥子1), 田中和秀2), 福田聖啓2), 大澤友裕2), 青山智2), 水井貴詞2), 後藤千寿2), 寺町ひとみ1), 土屋照雄1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2012. |
---|
![]() |
Basic study on medication method of the P2-139 internal use mixture Asoh cool air, Maki Inoue, Masahiro Sugino, Oshima Shinji, Osamu Hosoya, 從二和彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2012. |
---|
![]() |
Report of problems and the end run of the P2-140 electronic chart bringing medicine order system Tadahiro Tanaka, Harumi Tanoe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 401-401, 2012. |
---|
![]() |
About an action of pharmacy from P2-141 order ring system and electronic chart system induction to after operational initiation Yukie Yamamoto, Mina Kamei, 行本拓史 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2012. |
---|
![]() |
From construction - compounding of medicines of the medication system by the simple suspension method in the P2-142 artificial breathing special hospital to irrigation - Kazuhiko Takeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2012. |
---|
![]() |
Analysis - second report - of the doubt inquiry for the injection prescription with the P2-143 order ring system Midori Ito, The Hogari volost beauty, Satoshi Sato, Aya Komine, Kiyoshi Sakuma, Hideki Kobayashi, Masaka Wataru Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2012. |
---|
![]() |
Electrostatic charge-related effect of the drug to give quantity of Residual medicine in the P2-144 divided powder plane 櫨川舞, 大砂瑞穂, 原口珠実, 吉田都, 内田享弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2012. |
---|
![]() |
Taste bitter prediction of the ambroxol tablets 10 preparation using the P2-145 taste sensor Takahiro Uchida, Haji River dance, Tamami Haraguchi, Miyako Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2012. |
---|
![]() |
Precision criteria to weigh of the syrup which added P2-146 dry syrup Piece bridge beauty princess 1), Yasuko Ono 2), Yudani Reiko 2), Reiko Teraoka 2), Shuji Kitagawa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 402-402, 2012. |
---|
![]() |
About an action about the proper use of the high-risk medicine in the P2-147 this hospital Jun Matsunami 1), Masae Fujino 1), Makoto Kurabayashi 1), Yuka Igarashi village 1), Junko Takagi 1), 池井良貴 1), Hidetoshi Yamada 1), Shimamori beauty light 2), 早瀬幸俊 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2012. |
---|
![]() |
Change of the P2-148 automatic PTP sheet safety and compounding of medicines efficiency that we pay it, and a device brings Hironari Honma 1), Oshiyama Takamitsu 1), Yoshihiro Okada 1), Yoichi Kumaki 1), Mai Nakazawa 1), Masaki Terasawa 2), Takuya Ohira 2), Hideaki Nagasawa 1), Megumi Takahashi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2012. |
---|
![]() |
Examination of alerting it in inside the hospital with the attached document revision of the P2-149 aliskiren fumarate Igarashi sentence, Toru Morita, Shun Igarashi, 高尾良洋 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2012. |
---|
![]() |
Action to the safe medication to the eating dysphagia user in the P2-150 seriously disabled child institution Atsuo Kuramoto, Kazushi Abe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2012. |
---|
![]() |
Relation of the pharmacist to fall, a fall accident of the P2-151 this hospital 高田加壽代, Satomi Asano, Osamu Tanaka, Hiromi Matsui, Yoshimi Matsuda, 守内匡 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2012. |
---|
![]() |
Examination - of the indication design which is effective for what about P2-152 injection label indication in - safety management an eye is attracted, and where you confirm Hiroyuki Furukawa 1), Fumito Tsuchiya 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 403-403, 2012. |
---|
![]() |
It is the making of the Anjo rebirth hospital version withdrawal agreement an action to standardization with an examination for P2-153, treatment, the surgery for withdrawal Negi Tawa original 1), Yoji Sugiura 2), Watarai Masato 3), Akio Katsumi 1), Yoshitaka Ono 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2012. |
---|
![]() |
We contribute to risk management in the P2-154 drug master maintenance 六波羅孝, Junichi Hara, Miki Kobayashi, Koichiro Takano, 唐澤頼勝 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2012. |
---|
![]() |
Systems construction of compounding of medicines misinvestigation collection of, the analysis tool in P2-155 risk management measures Person of box Yuko 1), Tsutsui Mizuki 1), Yutaka Ito root 1), Takemoto Chihiro 2), Koto Fujiwara 2), Yoshiaki Fujimura 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2012. |
---|
![]() |
Evaluation of the incompatibility of ozagrel sodium injection and calcium which assumed P2-156 solubility product an index Mio Tange, Umeki friend Rie, Rie Tanaka, Kana Matsuda, Miyako Yoshida, Haji River dance, Tamami Haraguchi, Takahiro Uchida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2012. |
---|
![]() |
Construction of the present conditions and the administration management of the tolvaptan administration to patients with P2-157 heart failure 柴田大地, 水野由紀子, 杉浦充, 足立守 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2012. |
---|
![]() |
We promote ward drug duties from P2-158 pre-Abo id report Now Yoshiko Takada, Shinichi Tamiya, Tomohiko Aoyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 404-404, 2012. |
---|
![]() |
Fall risk in P2-159 sleeping drug, anxiolytics and the hospital Long Tawa person 1), Saori Miyamoto 1), 藤井宏亮 1), Satoshi Nishimura Kei 1), Masato Takamori 1), 瀧澤好廣 2), Akizuki chapter 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2012. |
---|
![]() |
Usefulness evaluation of the anticancer agent coinfusion inspection system using the P2-160 point checker 新井雄一朗1), 鈴木紀誉昭1), 桜井純蘭1), 沖畠里恵1), 深山智子1), 渡部真由美1), 水野善郎2), 原澤秀樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2012. |
---|
![]() |
Action for the proper use of the tolvaptan lock in the eastern part of P2-161 Saiseikai Yokohama-shi Hospital 江口裕三1), 新倉白朗1), 渥美景子1), 竹之内正記1), 山谷武司1), 滝村英幸2), 中野雅嗣2), 伊藤良明2), 村松俊哉2), 菅野浩1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2012. |
---|
![]() |
Analysis of the ascertainment behavior in the powder compounding of medicines using the P2-162 viewpoint measurement machine Hiroki Nakamura 1) 2), Iida A Taro 2), Inooka Kyoko 2), Yuriko Murai 2) 3), 眞野成康 2) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2012. |
---|
![]() |
Epicritic evaluation (the seventh report) of the P2-163 tablet, capsules body Keiko Nakano, 徳良嘉将, Masahiro Iwasa, Double cross Shintaro, Masayuki Watanabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2012. |
---|
![]() |
Action to an inquiry and risk aversion between the team approach in medical care in the P2-164 operating room 藤田將嗣, Tsuyoshi Oda, Satoshi Yamamoto, Mutsumi Kobayashi, Chizuru Shirokami, Shiho Hirahara, Norifumi Nakajima, Takashi Inoue solstice, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 405-405, 2012. |
---|
![]() |
Examination of the risk of the insoluble particulate matter in the P2-165 injection intravenous administration Takuya Sugawara 1), Keiichiro Matsuda 1), Keiji Kuramoto 2), Koichi Arai 1), Tadashi Shiraishi 3), Toru Shoji 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2012. |
---|
![]() |
Nosocomial action and effect for the evasion of the surgery cancellation with the P2-166 drug Yuika Naito 1), Akira Kawakami three 1), Jun Kawazoe 1), Akiko Fukunaga 1), Mayumi Ishibashi 2), Fukuchi book Harumi 2), Takashi Nagai 3), Junko Minemura 1), Junichiro Murayama 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2012. |
---|
![]() |
Analysis of the associated incident of the medical supplies in P2-167 children 見野靖晃, Takafumi Naito, Kazuka Kasahara, Kimiyoshi Hirano, Nobuhiko Takai, Aono Hironao, Hiroko Terasaka, Junichi Kawakami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2012. |
---|
![]() |
Effect to give to the intravenous feeding speed of the type transfusion pump that a study on proper use administration set of the P2-168 medical care device flow controls Masayuki Umemura 1), Hiroyuki Ono 1) 2), Ikenoo Yuya 1), 市江純治 1), 伊藤彰洋 1), Shoko Kazaki 1), Akito Yada 1), 山田迅 1), Tetsuya Yoshioka 1), Katsuo Shigeno 1) 3), Side shop Yoshibumi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2012. |
---|
![]() |
The surface decrease in the administration set intravenous feeding pipe at P2-169 May Ron (R) IV hydration and the measures 泉伯枝, Kenji Aihara, Hideki Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2012. |
---|
![]() |
P2-170 [Proper use of warfarin : It was towards risk avoidance by contraindication food initiatives] 森田智恵子1), 川井美和1), 久保道也2), 篠田健一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 406-406, 2012. |
---|
![]() |
About the fall risk with the side effect of P2-171 psychotropic drug case sleeping drug Hosokawa law of nature Expo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2012. |
---|
![]() |
Comparison - in the preparation product of evaluation - muscle relaxant and the antitumor agents of the risk of the high-risk medicine which assumed quantity of component / mouse LD50 of the P2-172 preparation product an index Kazuki Nagashima 1), Fumio Itagaki 2), History of Shigeru Kishimoto 3), Ryosuke Iijima 4), Machiko Watanabe 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2012. |
---|
![]() |
Examination about the dissolution of the disintegration film preparation in the P2-173 oral cavity Mai Tanida, Masashi Hamada, Kayo Fukatsu, Makoto Shigematsu, Osamu Takeshita example, Masako Ono, Satoko Katsuragi, Masahiro Moriyama, Hilum Muneo Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2012. |
---|
![]() |
A prediction of the depression time of the glass piece using the Stokes' formula to P2-174 marketing injection and the risk The Okayama future, Nozomu Matsumoto, Corner Midori Mori, Kazuhiro Nakajima, Masanori Sueyasu, Nobuaki Egashira, Ryozo Oishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2012. |
---|
![]() |
Examination about the preparation docimasy reflecting a feeling of taking P2-175 amlodipine orally disintegrating tablet Hiroyuki Yamazaki, Yui Aoki, Middle bear Ayaka, Kenichi Fukumitsu, Mizuyo Kubo, Quantity of Seo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2012. |
---|
![]() |
Comparison of the vial surface contamination of the cisplatin preparation circulating in P2-176 Japan Takashi Osawa 1), Takafumi Naito 1), Naoya Suzuki 1) 2), Toshiya Goto 3), Akira Takada 3), Hidenori Nakamichi 4), Yoshiko Onuki 4), Kimie Imai 2), Kunio Nakanishi 2), Junichi Kawakami 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 407-407, 2012. |
---|
![]() |
Examination about the stability (storage temperature) of the TSW suppository used for nausea, vomiting at the P2-177 opioids administration Kenji Ogata 1), Masahiko Usuda 2), Hiroyuki Ueyama 1), Jin Tokunaga 1), Nao Setoguchi 1), Toyotaka Nishio 3), Takamura rich person 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2012. |
---|
![]() |
Examination about the elution behavior of the drug in the P2-178 simple suspension method Shigeto Arai 1), Field basket Mihoko 2), Hidekazu Kishida 1), Akihiko Ito 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2012. |
---|
![]() |
About the stability in the open system of the P2-179 art celebrity (R) cerebrospinal surgical irrigation perfusate Shigeto Sekimoto, Sagi River Naohiko, 張間香, Nago Yuka, Kenji Aihara, Hideki Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2012. |
---|
![]() |
Examination of the utility of the clause of "the administration to elderly people" of P2-180 ethical drug attachment document Mei Kuribayashi, 山下槙子, Daiya Sakurada, Eriko Kobayashi, Noboru Sato example Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2012. |
---|
![]() |
Study on warning way in the P2-181 ethical drug attachment document Atsushi Kawasaki, Chikako Kurosawa, Daiya Sakurada, Eriko Kobayashi, Noboru Sato example Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2012. |
---|
![]() |
Construction of the drug control instruction guidance database for the P2-182 high risk medicine Itsuko Ono, Junko Abe, Rieko Shibata, 宮村信輝, Sugidaira Naoko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 408-408, 2012. |
---|
![]() |
Information sharing in the P2-183 drug information management room Yumi Niinuma, Yoko Kamo, Sato preference, We see it with Yano, Junko Kurimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2012. |
---|
![]() |
Construction of the contraindicated name of disease database in the proper use of the P2-184 medicine Teruko Kurihara 1), 奥覚子 1), Satoko Suzuki 1), Kenzo Kudo 2), Noboru Sato example 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2012. |
---|
![]() |
A construction and use of the simple suspension advisability information database of the oral medicine corresponding to the P2-185 incompatibility information Masahiro Watanabe, Norimatsu truth size, Shigeko Tsuji, Sumio Kimura, Kenta Sumiyoshi, 藤本高成, Hiromi Ichinose, Hot water wisteria Yuko village, Shinji Kosaka, 福岡憲泰, 芳地一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2012. |
---|
![]() |
Construction of the injection incompatibility intelligence system in P2-186 ward duties Toshinari Uematsu, Kyoji Koda, Hisako Yoshimoto, Aya Inoue, Miho Yamada, Yutaka Uchida, Hiroyuki Furukawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2012. |
---|
![]() |
Construction of the initial symptoms database for P2-187 Serious ADR discovery 奥覚子 1), Teruko Kurihara 1), Satoko Suzuki 1), Kenzo Kudo 2), Noboru Sato example 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2012. |
---|
![]() |
Development and evaluation of the contraindicated database with P2-188 medical supplies and laboratory values Hashimoto Anri, Takeshi Yokoyama Ichiro, Masato Okubo, Toru Matsushima, Kaori Yamazaki, Ko Yamaguchi tree, 仲佐啓詳, Hiroshi Nakamura justice, The amount of Ariyoshi example, Koichi Kitada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 409-409, 2012. |
---|
![]() |
Research about the main literature of P2-189 ethical drug attached document mention Hyodo fort, Isamu Murata, Yutaka Inoue, Ikuo Kanemoto, Masayuki Kimura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2012. |
---|
![]() |
Likelihood of the information on adverse drug reactions acquisition of the injectable antimicrobial agent by the retrospective analysis of P2-190 multicenter medical business accounts data Sunlight intellect love 1), Ryo Matsushita 2) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2012. |
---|
![]() |
A drug information offer and problems about the medical treatment depending on P2-191 patients background Katsuhiro Ogawa, Makiko Adachi, Tatsuya Kaneta, Yoshikazu Shiiki, Hiroshi Takane, Kenji Otsubo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2012. |
---|
![]() |
The registration of the P2-192 questions and answers database "pharmacist notebook" and analysis of the access situation Takayuki Arakawa 1) 2), 豊見敦 2), Toyomi Masafumi 2), Barrel valley Yoshihisa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2012. |
---|
![]() |
Factor - of the analysis - number of questions and answers examples increase in the P2-193 DI room Maruoka eyes 1), Motomu Sumitani Yoshiko 1), Yasuko Yanase 2), Yuji Okada 1), Tetsuo Funamoto 1), Misae Takase 1), 飴谷太 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2012. |
---|
![]() |
Use fact-finding about P2-194 ARB/ diuretics and the ARB/Ca antagonist Tatsuya Takahashi 1), Teramachi eyes 1), Tomoya Tate 1), Hiroyuki Nagasawa 1), Takashi Mizui term 2), Senju Goto 2), Teruo Tsuchiya 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 410-410, 2012. |
---|
![]() |
Cut medicine finely, and the P2-195 patients of how much keep it; is a storage situation investigation of the medicine and an evaluation of the accidental ingestion measures PTP Matsumoto Masaakira 1), Noriko Tamai 2), Hideko Ozaki 2), 廣島真一 3), 山之内崇紘 3), Masaki Takeda 4), 大矢善亨 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2012. |
---|
![]() |
Investigation about the tolvaptan introduction situation and the proper use in our P2-196 House 藤井浩毅1), 山下まゆ子1), 上淵未来1), 濱田政司1), 市川康子1), 藤井裕史1), 上村孝史2), 小出俊一2), 藤井憲一郎1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2012. |
---|
![]() |
Study on reporting to the children for the feeling of remedy change between P2-197 drug, the food and drink Moe Hosaka 1), Megumi Tanaka non-1), Kumi Yabe 1), Eriko Kobayashi 1), Daiya Sakurada 1), Noboru Sato example 1), Hisashi Iijima 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2012. |
---|
![]() |
It is ... through an attitude survey for the examination - et al. post training about the reinforcement of the mutual understanding between the types of job for the P2-198 team approach in medical care promotion Tide Mikiko, Tsuyoshi Matsumaru, Takekawa seven rebirths, Takuya Maeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2012. |
---|
![]() |
Attitude survey for "the medicine" for public primary schoolchildren under P2-199 Iwate Makoto Matsuura 1), Tezuka A 2), Atsushi Sanbe 2), Hideo Nishigoori 2), Satsuka Yasuyuki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2012. |
---|
![]() |
Prescription suggestion using the inhalational device evaluation questionnaire and findings for the P2-200 inhalant-free patients Yoko Sone 1), Mitsugu Saegusa 1), Tomoya Asada 1), 眞鍋伸次 1), 森由弘 2), Thickness well Bunichi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 411-411, 2012. |
---|
![]() |
With the establishment of the use confirmation method of the P2-201 fixed-quantity aerosol-type inhalant, actually Mika Ozawa, Mayumi Yamamoto, 神谷貞浩, Hiroko Sada, 小嶋文良 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2012. |
---|
![]() |
An action and use situation investigation to safe use of the P2-202 new oral anticoagulant drug dabigatran 小財弘己, 八巻美和, 岩堀文香, 信太寛和, 松井七奈, 久保悠, 多田知弘, 今田深雪 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2012. |
---|
![]() |
Utilization ... of the testing leak count results by the action ... side effect automatic monitoring system of the omission of testing improvement using a public information magazine for P2-203 inside the hospital Azusa Matsushima, Toshiaki Igarashi, Aya Konno, Saiki Akiko, Miyuki Uno, Yosuke Morita, Toshiaki Nakamura, Mikio Masada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2012. |
---|
![]() |
The simple suspension method of the P2-204 soft capsule (the second report) Mariko Kato 1), Ai Yoshino 1), Masato Takahashi 1), Kurata we see it 2), Akihiro Nakamura 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2012. |
---|
![]() |
It is ... from factor - pharmacy student affecting the quantity of the medicine feeling that there is much P2-205, the questionary survey for non-medical care system students Megumi Saito 1), Noriko Tanabe 1), Igarashi hemp intellect 1), Yutaka Ishii 1), Hiroshige Inazumi 2), Reveal well Naoko 3), Etsuko Arita 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2012. |
---|
![]() |
Questionary survey about management, the storage of the patients for the P2-206 drug 植沢芳広 1), Mai Nishitani 1), Matashige Shuichi 2), Akane Koyama 2), Naoko Mizuta 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 412-412, 2012. |
---|
![]() |
Attitude survey of the pharmacist about the application to clinical studies information and pharmacotherapy of the P2-207 aromatherapy Shiho Inoue 1), Sincerity field Akemi 1), Minae Izawa 1), 登美斉俊 1), Takuya Sasaki 2), Emi Nakajima 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2012. |
---|
![]() |
Fact-finding of the MR activity of the P2-208 this hospital Takashi Fukazawa 1), Fumiko Yamaguchi 1), Yuko Watanabe 1), Yasuyuki Matsumura 1), Toshio Kawaguchi 2), Toru Sato 1), Hajime Kagaya 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2012. |
---|
![]() |
About sleep disorders and the quality of life in the asthmatic patients who had the P2-209 allergic rhinitis Yuko Nakatake 1), Reiko Utsunomiya 1), Ken Hirota authority 2), Ono Hirofumi 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2012. |
---|
![]() |
Use fact-finding of the antiplatelet drug to P2-210 patients with Kawasaki disease Moat Akiko 1), Yuji Suzuki 1), Ichiro Takakura 2), Yuichiro Tomita 3), 王廉雅 3), Yasuhiko Yamada 4), Haruko Yokoyama 4), Masayuki Watanabe 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2012. |
---|
![]() |
A cognitive degree investigation for the vitamin K component food of the P2-211 warfarin remedy patients and the analysis Hidesuke Yoshikawa 1), Tadashi Suzuki 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2012. |
---|
![]() |
Examination for the use actual situation and the proper use in this hospital of P2-212 Dabigatran (Prazaxa (R)) Kashiwano Yuko 1), Mami Usami 1), Keiko Hasebe 1), Kenji Shibasaki 1), Atsushi Honma 2), Inner liman Masanobu 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 413-413, 2012. |
---|
![]() |
About problems with the P2-213 generic name prescription publication Kazuhiro Hirano, Masaaki Ogata, Akihiro Hayashi, 中野行孝, Fujito Expo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2012. |
---|
![]() |
Investigation about the use situation and the side effect expression of P2-214 new anticoagulant dabigatran 永野真久1), 白澤宏美1), 大窪典子1), 橋本崇広1), 大園ゆかり1), 平木洋一1), 真鍋健一1), 神村英利2), 加留部善晴3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2012. |
---|
![]() |
Comparison between P2-215 Terumi sultan and lipid-related test value by the dose of the irbesartan 野澤彰1), 野澤(石井)玲子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2012. |
---|
![]() |
For the full-scale induction of the simple suspension method in the P2-216 this hospital Asami Fujita, Sanae Kawamura, Tei Wagatsuma, 渡部寿康, Toshio Yamaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2012. |
---|
![]() |
It is the examination in a medication counseling present conditions investigation and health drink clinical trials the study on P2-217 clinical response and psychic control structure Shimizu, Shimizu, Eri Miyashita, Sincerity field Akemi, Minae Izawa, 登美斉俊, Emi Nakajima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2012. |
---|
![]() |
Neutropenia after the S-1 therapy enforcement in patients with P2-218 progress pancreatic cancer and prognostic relative examination Tatsuya Kurihara 1), Yuna Miki 1), Mari Kogo 1), Kazuo Konishi 2), City storehouse Daisuke 1), Chikako Miyamoto 3), Masahiro Usuda 1), Shunichi Shimizu 1), Keiichiro Yoneyama 4), Yuji Kiuchi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 414-414, 2012. |
---|
![]() |
Relations of neutropenia and the vital prognosis after the platinum administration for patients with P2-219 progress lung cancer Hiroshi Kitashima branch 1), Mari Kogo 2), Tatsuya Kurihara 1), Shibuya green 2), Megumi Sugano 1), Yusuke 3 between the deer), Keiichiro Yoneyama 4), Yuji Kiuchi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2012. |
---|
![]() |
It is the daily drug cost of 1mmHg glaucoma eye drops to make it drop by P2-220 ocular tension 櫻下弘志 1), Hiroaki Ikeda 1), Yasuyuki Saeki 1), Takashi Tomita 1), Hidetoshi Tsukamoto 2), Tree flat Kenji 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2012. |
---|
![]() |
Simplifying it and drug costs reduction of the medication management by the pharmacist intervention of the internal use prescription of the P2-221 medical treatment ward Harumi Sakakida, Nobuko Shiratori, 川奈部英洋, Naoko Hiraoka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2012. |
---|
![]() |
Reactive examination - to examination - neuropathic pain of the factor to contribute to opioid reactivity to P2-222 cancer pain Yasuha Ogawa 1), Megumi Omura 1), Tatsuya Kurihara 1), Mari Kogo 1), Mami Saito 2), Higuchi ratio up true 3), Masakazu Ishii 1), Shunichi Shimizu 1), Keiichiro Yoneyama 4), Yuji Kiuchi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2012. |
---|
![]() |
Impact ... of medical supplies joint purchase produce in P2-223 Oshu-shi and effect - increased income 100 million yen Takeshi Onodera 1) 2) 3), Kenji Minamikawa 1), Chika Sato 4), Yuichiro Mikami 5), Toshihiro Miura 6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2012. |
---|
![]() |
Relative examination of neutropenia and the vital prognosis after the CRT enforcement in patients with P2-224 esophageal cancer Mari Kogo 1), Takahito Imagawa 1), Tatsuya Kurihara 1), Tomiko Sunaga 2), Ayako Suzuki 3), Kazuo Konishi 4), Masakazu Ishii 1), Shunichi Shimizu 1), Keiichiro Yoneyama 5), Yuji Kiuchi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 415-415, 2012. |
---|
![]() |
Analysis of the side effect-related hospitalization in the acute phase medical institution using the P2-225 DPC survey data Shino Imai ぶ 1), Kiyohide Fushimi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2012. |
---|
![]() |
Exploratory study on drug costs reduction of the P2-226 anticancer drug Ryo Seto religion 1), Yu Nakamura 1), Mitsuhiro Sugawara 1), Yukio Ogawa 1), Hajime Matsubara 1), Kazuo Yago 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2012. |
---|
![]() |
Statistical examination about the effectiveness and the safety of linezolid and vancomycin in patients with P2-227 MRSA pneumonia 栗林歩, 岸川幸生, 八木朋美, 勝山壮, 中村仁 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2012. |
---|
![]() |
Strategic study on optimization of the injection sale standard that pointed to P2-228 medical cost suppression Takeshi Yokoyama Ichiro, Takako Nakamura, 仲佐啓詳, Hiroshi Nakamura justice, The amount of Ariyoshi example, Koichi Kitada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2012. |
---|
![]() |
Investigation about the disposal of P2-229 inpatients drug Keiko Yamaguchi, 島田侯陛, Chie Suzuki, Akito Ito, Tadanori Suzuki, Mayumi Inoue Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2012. |
---|
![]() |
One discussion of anticancer drug mixed duties in consideration of P2-230 drug costs reduction Tomohiko Harada, 甲斐維子, Manabu Sakurai, 齋木一郎, Mayumi Nagano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 416-416, 2012. |
---|
![]() |
The catharsis effects are not increased even if they use P2-231 osmotic pressure-related laxative and large intestine irritative diarrhea together Igarashi sincerity intellect, Now Risako, Ayako Mimura, Iizasa Tomohiko, Arrowhead crest green, Chika Nagoya, Takashi Ishii, Yudai Toda, The Ochiai sum, Kiyoshi Sugiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2012. |
---|
![]() |
Examination about drug interactions of salazosulfapyridine and methotrexate in patients with P2-232 articular rheumatism Morihiro Okada 1), Kan Yukio 2), Masae Tsuji 1), Yu Kanetani 1), Kimi Sakata 1), Hisae Miyata 1), Hiroaki Mizuno 1), Taketa former 1), In the west moisture 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2012. |
---|
![]() |
The effect that P2-233 gastric-acid secretion depressant drug gives to efficacy and safety of erlotinib Kazuki Ishikura, 田村健悦, Yuko Okuyama, Teru Saito still, Yuko Fujii, South Kazushi, Isao Miura Taro, Tanaka sunlight, Dove Natsuko, Origin of Hiraga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2012. |
---|
![]() |
Adsorptive examination of the combination drug for P2-234 polystyrene sulfonate drugs Tsuyoshi Kuramochi 1), 柳浦麻未 1), Naoki Uemura 1) 2), Yukie Kanazawa 3), Kunio Sugiura 4), Takafumi Ota 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2012. |
---|
![]() |
It is one patient using the dabigatran for pulmonary embolism due to the P2-235 DVT 植村太志1), 伊藤和幸1), 浦崎圭太1), 河井和子1), 磯谷聡1), 加田賢治2), 坪井直哉2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2012. |
---|
![]() |
P2-236 Interaction at the time of the simple suspension method enforcement of Proton pump inhibitor "Nexium (R) cupsules" 新井克明1), 石田志朗2), 山下あずさ2), 神崎姫奈2), 越野優希2), 岡野善郎2), 清水範子1), 前原梨恵1), 真家佑介1), 菊地麻希1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 417-417, 2012. |
---|
![]() |
Adsorption to a dietary fiber of the P2-237 pravastatin sodium 上間渉, Ayano Iwasaki, Kimie Imai, Kunio Nakanishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2012. |
---|
![]() |
Effect of the magnesium oxide which gives it to gastrointestinal absorption of the gabapentin in patients with P2-238 cancer pain Yagi Tatsuya 1), Takafumi Naito 1), 見野靖晃 1), Kazuo Umemura 2), Junichi Kawakami 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2012. |
---|
![]() |
Effect of the levofloxacin combination to give to anticoagulant ability of the P2-239 warfarin Riding ground Asato, Kayoko Sato, Hiroo Nakagawa, 兒玉幸修, Tadahiro Nakamura, Norihide Higuchi, Takashi Kitahara, Hitoshi Sasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2012. |
---|
![]() |
Problems and proposal of the mention method of the drug interaction information in the P2-240 attachment document Riyo Yamaguchi 1), Yoshiyuki Ono 1), Gutter slope Akihiro 2), Hiroshi Suzuki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2012. |
---|
![]() |
Internal change change of the linezolid at the P2-241 rifampicin combination 崔吉道1), 本田恭子1)2), 藤田浩平1)2), 宮地佑佳1), 伊藤さつき1), 澤本一樹1), 宮本謙一1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2012. |
---|
![]() |
Examination about the interaction of P2-242 bosentan and the warfarin Junichi Terashima 1), Tetsuya Yamada 1), 勝野晋哉 1), 鷹見繁宏 1), Masazumi Ajioka 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 418-418, 2012. |
---|
![]() |
One case that showed PT-INR increase after P2-243 warfarin withdrawal Jun Hirano 1), Yuzuru Saito one 1), Akira Takahashi 1), Mariko Hasegawa 2), Taku Nakagawa 2), Kenji Ogawa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2012. |
---|
![]() |
The present conditions and problem of P2-244 warfarin potassium and the pyrimidine system anticancer drug combination fluoride Katsuyuki Takahashi 1) 2), Hisami Shimizu charges 1), Description of Yasushi Suda 1), Hiroshi Kawaguchi 1), Yasutaka Nakamura 1), Noriko Kawakami 1), Light river Yasuko 1), Takeshi Nishikawa 1), Katsuya Nagayama 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2012. |
---|
![]() |
Examination about the effect of the renal function in the serum Na change by the P2-245 tolvaptan 六車龍介1), 丸山貴生2), 永江隆二1), 岡本勇二1), 桝本知佳1), 太田友里恵1), 高橋亜麻奈1), 佐田竜尚1), 内山幸子1), 江崎圭吾1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2012. |
---|
![]() |
The impurities detected in medical supplies container made of P2-246 plastic bring about cytotoxicity Chiaki Tsuboi 1), Yoichi Kawasaki 2), Minoru Mori Miwa 1), Sendo Toshiaki 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2012. |
---|
![]() |
Adverse event investigation of thienopyridine drugs in the P2-247 Hiroshima City Hiroshima Municipal Hospital circulatory organ internal medicine Toshiharu Matsumoto 1), Mari Sasaki 2), Kayo Yoshida 1), Sho Ishida 1), Shinichi Miyamori 1), Open Koichi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2012. |
---|
![]() |
Investigation of the factor involved in the excessive PT-INR increase of the P2-248 warfarin administration patient on dialysis Takuya Yoshida 1), Old Taku Kubo 1), Chiharu Matsunaga 1), Mizuho Miyake 1), Satoshi Izumi 1), Kenjiro Yamakawa 2), Shigeru Shoji city 2), Tomoyuki Yamakawa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 419-419, 2012. |
---|
![]() |
The development of Cefepim-induced mental neurologic symptoms situation in the P2-249 this hospital Kato good chapter 1) 2), Mitsutaka Iguchi 2) 3), Masato Yamamoto 1) 2), Tetsuya Yagi 2) 3) 4), Kiyobumi Yamada 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2012. |
---|
![]() |
Examination of the onset of cholinergic crisis factor by the P2-250 distigmine Shinichiro Suzuki, Kishi, Matsuzaki, Hidetomo Yasujima, Akio Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2012. |
---|
![]() |
Investigation about satisfaction of the expression situation of hyperprolactinemia induced by the antipsychotics for P2-251 schizophrenia patients and the antipsychotics Asai village Hidemi 1), 佐藤慎祐 1), Hiroyuki Baba 2), 青木治亮 2), 半谷眞七子 1), Hiroyuki Kamei 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2012. |
---|
![]() |
Investigation of the use of amiodarone situation and the thyroid function aberrant expression frequency in the P2-252 LVAS wearing patients Kazuya Nakano 1) 2), Hiroyuki Ochi 1) 2), Kyoichi Wada 1) 2), Oida chapter 1) 2), Takeshi Kuwahara 1) 2), 宍戸稔聡 1) 3), Seguchi law of nature 1) 4), 村田欣洋 1) 4), Masanobu Yanase 1) 4), Takeshi Nakatani 1) 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2012. |
---|
![]() |
Examination about the onset of side effect of P2-253 vancomycin note (VCM) chronic administration Yukino Urata, It is Sachiko in a camp, Eiko Fukunaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2012. |
---|
![]() |
1 adult case that presented low carnitine blood disease by P2-254 cefditoren pivoxil Kuni Isobe finally, Miyoshi straight celebration, Katsuhiro Yamada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 420-420, 2012. |
---|
![]() |
Investigation of the side effect of allergy to P2-255 information registration system report situation Mamoru Uchida next, Yuichi Umeda, 進健司, Yasushi Kanazawa example, Shinsuke Takemoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2012. |
---|
![]() |
Search of the factor influencing fact-finding and the treatment continuance rate of the P2-256 topiramate long-term use patients 矢澤嶺 1), Yoshiaki Yamamoto 2), Kazuyuki Inoue 1), Katsumi Imai 2), Tomoki Tsuji 1), Hideki Hayashi 1), Yukitoshi Takahashi 2), Kunihiko Ito 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2012. |
---|
![]() |
Effect on renal function by the P2-257 pregabalin remedy 晴山知拓, Hiroyasu Sato, Harumi Ishida, Maki Tanaka, Yusuke Kanetaka, Yuichi Nakamura, Takeshi Nishimaki, Gold house Asako, Shigeki Tanaka, Hitoshi Komori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2012. |
---|
![]() |
P2-258 comes out and is examined nausea measures in meat phosphorus smoking cessation-treated patients Ryota Torii 1), Mariko Domae 1), Kayoko Okuyama 1), 黒井扶美恵 1), Yasuyuki Tsukioka 1), Yuzuru Yamazoe 2), Saori Kawakami 3), Warabino eyes 3), Makoto Shimada Jiro 4), Junkichi Hama 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2012. |
---|
![]() |
Examination of the cancellation case due to the infection in patients with use of P2-259 biological preparation rheumatism Tomoko Ido 1) 2), Shinsaku Kishimoto 1), Koichi Takahashi 2), Kazuko Shiozawa 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2012. |
---|
![]() |
One case that presented a hallucination by P2-260 valacyclovir hydrochloride Yasushi Tsurusaki, Makiko Hatada, Hanada sacred book, Yoshihiro Nakagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 421-421, 2012. |
---|
![]() |
Contribution of the pharmacist in the TD onset evasion of elderly people with the P2-261 sulpiride Hiroshi Tani child Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2012. |
---|
![]() |
Action of the use of side effect of P2-262 medicine medicine cooperation signal detection system promotion Kyoji Koda, Yuko Nagasawa, Naomi Uematsu, Chieko Hino, Hisako Yoshimoto, Hiroyuki Furukawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2012. |
---|
![]() |
3 cases of the atypical shaft of femur fracture that occurred during P2-263 Bisphosphonate drugs remedy Hanada sacred book 1), Yasushi Tsurusaki 1), Yoshihiro Nakagawa 1), Takeshi Yamashita 2), Shallows form Takeki 2), Kensuke Yonemura 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2012. |
---|
![]() |
Side effect expression of P2-264 lipid microsphere investigation about the dosing rate Tsuyoshi Oda, 前田直就, Hirofumi Takada, 馬島務, Ayaka Nakai, Noi Asami, Tasuku Fujiwara season, 前田頼伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2012. |
---|
![]() |
Side effect onset of P2-265 chronic hepatitis C investigation in the treatment (triple-drug therapy) Yukiyo Fujisaki, Chiyoko Yamada, Miwa Yonezawa, Shino Taga, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2012. |
---|
![]() |
2 cases that heart failure was exacerbated by taking P2-266 non-steroid-related antiinflammatory analgesic Misako Kimura 1), Teruhiko Hoshino 1) 2), Yuji Mizuno 3), Eisaku Harada 3), Kazunori Shiozu 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 422-422, 2012. |
---|
![]() |
The making of the treatment diary for the patients of the P2-267 terra pre-building +PEG-IFNα2b+ ribavirin combination therapy and investigation of the side effect expression situation 平池美香子1), 白澤宏美1), 川上恵子1), 平木洋一1), 真鍋健一1), 牧野公治2), 尾上公浩3), 中田成紀3), 杉和洋3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2012. |
---|
![]() |
Of renal dysfunction in the triple-drug therapy of P2-268 chronic hepatitis C, actually Mihoko Sasaki 1), Tetsuya Hirose 1), Shigeru Sato 1), Hatsumi Kikuta 1), Miki Katsuragawa 1), Ryu Kobayashi 1), Hideji Ohara 1), Muki Ryoji 1), Ozeki solstice 2), Yoshiyasu Kano 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2012. |
---|
![]() |
A factor and the measures to influence side effect expression of P2-269 dabigatran 山西香織1), 増田瑠美子1), 田中佑佳1), 生駒佳織1), 和田恭一1), 老田章1), 桑原健1), 清水渉2), 鎌倉史郎3), 長束一行4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2012. |
---|
![]() |
Examination about the food in patients with P2-270 drug hypersensitivity and drug allergy history rate 齊藤幹央 1), Manabu Abe 1), Tomoyasu Furukawa 2), Yagi Motohiro 3), Koike reason Expo 4), Katsumi Enomoto 5), Yutaka Wakasugi 5), Katsuji Uno 6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2012. |
---|
![]() |
It is examined the risk factor about the ... adverse event expression to use P2-271 dabigatran more safely and appropriately 上村裕美, 鷲見佳子, 芦川直也 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2012. |
---|
![]() |
Clinical evaluations in change cases from the spironolactone for P2-272 heart failure patients to eplerenone Keiji Nakajima 1), 宇佐美英績 1), Eri Abe 1), Tadashi Yasuda 1), Hideyuki Tsuboi 2), Takahito Sone 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 423-423, 2012. |
---|
![]() |
Fact-finding of the ACE inhibitor in the P2-273 aliskiren fumarate remedy patients or the ARB combination and examination of the side effect expression situation Shino Taga, Shigeharu Kiyama, 柏原宏暢 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2012. |
---|
![]() |
Taste bitter evaluation of P2-274 zopiclone tablets (Amo van tablets (R)) and S zopiclone tablets (Rene studio lock (R)) Atsushi Uda 1), Tamami Haraguchi 2), Miyako Yoshida 2), Satoshi Mukai 1), Kazuhiro Yamamoto 1), Manabu Kume 1), Makimoto Hiroo 1), Tsuyoshi Hirano 1) 3), Takahiro Uchida 2), Hirai green 1) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2012. |
---|
![]() |
It is an action of this hospital for the proper use of the antiarrhythmic drug the electrocardiogram monitoring by the P2-275 pharmacist Hirofumi Kajiwara 1), 波津久崇幸 2), 菅野公浩 2), Tetsuji Sugata 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2012. |
---|
![]() |
We look at the expression situation of the side effect of P2-276 tocolytic agent ritodrine hydrochloride injection administration and the rear about the affector and research a mark Naoki Shibatani 1) 2), Shiho Sato 2), Kitada Noriaki 1) 3), North Masato 4), Kenji Yamamoto 1), Shuichi Kishimoto 2), Shoji Fukushima 2), Toru Hashida 1) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2012. |
---|
![]() |
Intervention effect of the outpatient clinic support by the pharmacist in the P2-277 terra pre-building induction patients 舟越亮寛 1), Daisuke Negishi 1), Miyara Ayako 1), Shogo Iwabuchi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2012. |
---|
![]() |
Medication inspection duties of the anticoagulant by the intervention of the pharmacist for P2-278 surgery adaptation planned outpatients 永野俊玲, 佐藤雄介, 西明子, 朝倉俊治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 424-424, 2012. |
---|
![]() |
About the utility of the bringing medicine differentiation system "medicine model" in the P2-279 children special hospital Kyoko Saito, Sachi Sugai, Masumi Nakamura, Ryohei Takahashi, Fumio Iwasaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2012. |
---|
![]() |
Action to drug proper use about Lyrica (R) which assumed P2-280 renal function an index and Prazaxa (R) Ogata Miyuki 1), Kaori Izumi 1), Michiyo Makino 1), Tomomi Kakimoto 1), 服部文忠 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2012. |
---|
![]() |
The need of testing, the preoperative oral medicine management for the patients taking P2-281 anticoagulant, an antiplatelet drug 早舩美保子, Mikio Shirota, Yoshiko Mori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2012. |
---|
![]() |
About an action of the withdrawal differentiation instruction in the orthopedics outpatient department of the P2-282 this hospital Maiko Matsuda, 登内盛治, Osamu Atobe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2012. |
---|
![]() |
Contribution to a drug economic merit of the P2-283 bringing medicine management and medical security Hiroki Ito, Junko Nakajima, Ko Hiraide stone, Takako Imazeki, Takeshi Kato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2012. |
---|
![]() |
Risk management by the bringing medicine check in the cottage-hospital out of P2-284 Great posterior Yukiko, 小野朗弘, Hiroshi Wagatsuma positive, Mieko Yoshimura, Saori Takahashi, Kunio Kuwahara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 425-425, 2012. |
---|
![]() |
It is ... from contribution - bringing medicine confirmation to the medical security and economic effect through P2-285 ward pharmacist duties to discharge teachers' textbook making Shuhei Suzuka, Tomoko Katsube, Fujita Aoi, Kazuya Hirata, Naoyuki Matsumoto, Kazuki Tago, Miki Nakamura, Great Yumiko Tsuyama, Person of moat Yumiko, Naoki before yellow Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2012. |
---|
![]() |
Induction of the bringing medicine management using a P2-286 electronic chart "bringing medicine management capability" system and future problem 宮里弥篤, The Hiroshi Kawakami shallows, Onaga Shinichiro, Tamotsu Hika Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2012. |
---|
![]() |
The present conditions of the inpatients bringing medicine management in the P2-287 IHI Harima Hospital Tatsuya Ono 1) 2), Noriko Ishida 1) 2), Hideyuki Nishida 1), Tokuyama still I 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2012. |
---|
![]() |
An action and evaluation of bringing medicine confirmation duties to conduct in P2-288 ward Hiroko Sugimoto, Corner Rieko, Noriko Sasaki, Miki Ishibashi, Seko mouth Noriko, Hiroaki Matsuda, Takuya Iwamoto, Shinko Okuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2012. |
---|
![]() |
Action about the oral medicine management of perioperative (preoperative) in the P2-289 Tsuyama center Hospital Akiko Sakuma 1), Tetsu Sugiyama University 1), 杉山浩江 1), Yukihiro Kawakami 2), Sachiyo Kondo 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2012. |
---|
![]() |
Analysis of the intellectual property rights dispute example to affect P2-290 generic medicine Kazuno Shohei Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 426-426, 2012. |
---|
![]() |
Investigation - by effect - self entry method questionnaire that the difference in technique of the preparation about the taste of the P2-291 donepezil hydrochloride orally disintegrating tablet gives in the palatability of the patients 柏宗伸 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2012. |
---|
![]() |
Examination about the blood level of the patients who started treatment with P2-292 amiodarone generic drug Daisuke Yamashita 1), Rei Ikeda 1), Kaori Ikoma 1), Akemi Horibe 1), Kyoichi Wada 1), Oida chapter 1), Takeshi Kuwahara 1), Wataru Shimizu 2), Kamakura Shiro 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2012. |
---|
![]() |
Fact-finding of the substitute compounding of medicines to generic medicine before and after the P2-293 generic name prescription induction Shiori Morishita, Reina Nishimoto, 北村友乃, 菊池紗恵, Yukiko Kiyama, Masaki Hirakawa, Goro Ikushima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2012. |
---|
![]() |
Examination of the equivalency with an agent Kremezin infinitesimal grain and the generic medicine for the P2-294 chronic renal failure Junko Miyakawa, 岩瀬利康, Yoshio Ito, Koichi Hoshino, Miyuki Suehiro, 双樹恵, Tomoko Koyama, Tomoaki Toyama, Osamu Suzuki ear, Yuki Tsukada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2012. |
---|
![]() |
Action of the generic name prescription in the P2-295 Kitasato University Kitasato Inst. Hospital Koji Masubuchi 1), Ito Funato charges 1), Soichi Shibata 1), Atsuta Koichiro 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2012. |
---|
![]() |
Properties of matter evaluation of the starting medical supplies and generic medicine in the P2-296 triamcinolone acetonide ointment preparation Maeda Rikimaru, Kayoko Furuya, Yutaka Inoue, Isamu Murata, Tanaka Toru, Masayuki Kimura, Ikuo Kanemoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 427-427, 2012. |
---|
![]() |
Investigation about the substitute compounding of medicines to the generic medicine in the out of the hospital prescription of the P2-297 this hospital publication Yuka Iwaki, Hiromi Ieda, 星野真輝, Miki Aoki, 仙田典保 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2012. |
---|
![]() |
Comparison - of pharmaceutic evaluation - forerunner medical supplies and six items of generic medicine of the P2-298 fluticasone propionate ester nasal drop Chinatsu Kawashima, Minami Sanpei, Shoko Tsukahara, Shuji Shimada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2012. |
---|
![]() |
For contribution to action - hospital management about the reduction of the P2-299 stock amount of money and the adoption promotion of the generic medicine - Yuko Ichiki 1) 2), Kazuya Koreki 2), Ichiro Yoshimizu 2), Daisuke Kobayashi 1), Toshio Kubota 1), Takao Shimazoe 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2012. |
---|
![]() |
Stability after the conservation of P2-300 steroid ointment and the mixed ointment of the moisturizer and release-related evaluation Tsuneyoshi Suzuki 1) 2), Satoshi Uchino sincerity 1), 宮嵜靖則 1), Yoshiyuki Kagawa 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2012. |
---|
![]() |
Comparison between the product of the disintegration of the P2-301 donepezil hydrochloride component orally disintegrating tablet Eriko Sano, Yu Sato pear, 村山信浩, Is Kurata; see it, Akihiro Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2012. |
---|
![]() |
It is disintegration at remedy with the water of the P2-302 donepezil hydrochloride component orally disintegrating tablet Hironori Kobayashi, Mariko Kobayashi, Nakamura is constipated, Osamu Genda period, 村山信浩, Is Kurata; see it, Akihiro Nakamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 428-428, 2012. |
---|
![]() |
Development 3 of the set medicine inspection system of the operating room in the cottage-hospital out of P2-303 齋藤進 1), Yuka Watanabe 1), Yuka Saito 1), Shuichi Shimura 1), Yasuko Sato 2), Shigeo Katsumi 3), Takashi Matsukawa 4), Noriaki Fujii 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2012. |
---|
![]() |
Construction second report of the product system of administration derived from the specific organism which linked P2-304 electronic chart Toshiyuki Ozaki, Kenichi Anjiki, Yorimitsu runs, Emiko Fukuda, 卜蔵俊仁, Kazuo Takeshita, Ei Hirano product, Sumiko Goto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2012. |
---|
![]() |
Establishment of the operation region medicine administrative work which we introduced the storage of P2-305 fingerprint attestation ceremony medicine storage into and the evaluation Field Takefu, Cutting the ears of rice Reiko, Kazuko Yamana, Ichiei Ooi, Noriko Suzuki, Kaoru Suzuki, Masami Nishihara, 勝間田敬弘 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2012. |
---|
![]() |
Difference (2)-PTP, medical supplies body - with the indication that a fact and a pharmacist of the indication of P2-306 medical supplies hope for Mayumi Suzuki 1), 芦野優佑 1), Many Nei Shigeharu 2), Shuji Yamashita 3), Shiho Miyahara 1), Nami Mizukami 1), Kawashima A season 1), Tadashi Sugiyama 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2012. |
---|
![]() |
Difference (1)- outer box - with the indication that a fact and a pharmacist of the indication of P2-307 medical supplies hope for 芦野優佑 1), Mayumi Suzuki 1), Many Nei Shigeharu 2), Shuji Yamashita 3), Kawashima A season 1), Nami Mizukami 1), Shiho Miyahara 1), Tadashi Sugiyama 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2012. |
---|
![]() |
The actual situation and problems of the Residual medicine which we extracted from P2-308 literature 大澄朋香1)2), 飯嶋久志1), 渡邉文之2), 亀井美和子2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 429-429, 2012. |
---|
![]() |
Evaluation of the action of the resident pharmacist for the risk management of SPD induction effect and the medical supplies management in the P2-309 operating room Azusa Nakajima 1), Tomohisa Hayakawa 1), Aki Nakahara 1), Taste Yumi Sawa 1), Yamakichi Yasuko 1), Osamu Ikeya 1), Hiroshi Shiina good luck 1), Door Emi Nako 1), Shunichi Kawamura 1), Shinichiro Okamoto 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2012. |
---|
![]() |
It is induction ... of the injection individual set about inventory control of the injection in the P2-310 this hospital for ... 24 hours Kaori Sato, Asako Higuchi, Keiko Arimura, Yuki Arai, Yuzuru Watanabe, Shoji Izumo, Yuki Inoue, Miyako Shoda Noriko, Toru Hirashima, Hideo Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2012. |
---|
![]() |
Construction of the drug regime that P2-311 is new Yasushi Miyamoto 1), Ueno English sentence 1), Kurashima 2, Kyuutoku), Koichi Onishi 3), Three soil Chieko 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2012. |
---|
![]() |
Induction of the inventory control system using P2-312 PDA terminal Ryota Yamamura, 西村文宏, Makibara Yoko, Yosuke Katayama, Kanako Fujisaki, Wild Owa reason, Hiroki Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2012. |
---|
![]() |
Action of the operation region permanent residence pharmacist who contributed to improvement of P2-313 medicine management and the hospital management Masashi Matsuda 1), Hiromi Teraoka 1), Miyuki Miyaguchi 1), Michiyo Matsuo 1), Yoshihiro Horie 1), Okamoto positive incense 1), Chiaki Hasegawa 1), Yumi Kitawaki 2), Shuichi Nosaka 3), 寺田智祐 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2012. |
---|
![]() |
The expiration date for use management situation of Epinephrine autoinjector injection (R) after the P2-314 drug grant 戸田康裕1), 土本大輔1), 福井愛子1), 水谷貴樹1), 宮川佐和子1), 宇都宮純平1), 出口裕子1), 平野茂樹1), 小川裕2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 430-430, 2012. |
---|
![]() |
About the action of PCA pump drug preparation duties by the P2-315 this hospital operating room pharmacist Sachiko Hiraki 1), Junko Oketani 1), Small Reiko Ikeda 1), Akiko Soga 1), Yusuke Tanimura 1), Rika Sasaki 1), 成徳理代 1), Takashi Okada 1), Hideaki Tsuchida 2), Koji Nishio 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2012. |
---|
![]() |
Examination of the method of dispensing in the P2-316 hydroquinone cream Hiroyuki Miyashita 1), Kensuke Usui 2), Teruko Takano 1), Futoshi Saito 1, Kotobuki), Takahiko Kagaya 1), Atsuta Koichiro 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2012. |
---|
![]() |
A comparison and examination of the old and new MET synthesizers in our P2-317 institution Yasushi Yokoyama 1), 福山誠介 2), Takeshi Kato 3), Kentaro Hatano 4), Toshitaka Nabeshima 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2012. |
---|
![]() |
Effect of the indomethacin spray on stomatitis pain at the P2-318 cancer chemotherapy Ikumi Sugiyama, 遠藤智宇, Kenzo Kudo, Satsuka Yasuyuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2012. |
---|
![]() |
About a study of the pharmaceutics of the study on P2-319 Mohs' paste (the third report) -Mohs' paste - Yuko Inagaki 1), Mari Kobayashi 2), Maho Taguchi 3), Kenji Onodera 1), 山本浩充 2), Masato Shigeyama 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2012. |
---|
![]() |
It is examined the - second report - girls power improvement effect towards the health insurance pharmacy that can contribute to regional medicine through P2-320 Chinese medicine preparations manufactured by pharmacy 高島英滋 1), 坂京彙子 2), Tomomi Sugiyama 3), Emiko Asakura 2), Tetsuya Ohashi 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 431-431, 2012. |
---|
![]() |
Development of the P2-321 meloxicam percutaneous absorption type preparation Shigeko Obata, Sureewan Duangjit, Satoshi Sano, Shingo Kikuchi, Yoshinori Onuki, Kozo Takayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2012. |
---|
![]() |
The actual situation of the use of the urinastatin pessary in the P2-322 this hospital Ai Tsukada 1), Rumi Ishida 1), Junko Momiyama 1), Rock appendix Kazuko 1), Kan book Rie 1), Yoshito Tobaru 2), Shiro Abe 2), Funatsu Kumi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2012. |
---|
![]() |
Effect on rheological property that a storage temperature gives it to of the P2-323 methyl cellulose liquid drug and drug delivery Descent from a mountain Tetsuya, Miyagi reason Riko, 浦木睦, Aya Takahashi, Kunihiko Ito, Michiya Kobayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2012. |
---|
![]() |
About a change of color change by the combination with P2-324 acetaminophen preparation and the magnesium oxide Osamu Suzuki ear, 岩瀬利康, Yoshio Ito, Mieko Morita, Koichi Hoshino, Miyuki Suehiro, 双樹恵, Tomoko Koyama, Tomoaki Toyama, Yuki Tsukada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2012. |
---|
![]() |
Examination of the gelation hospital preparation of acetaminophen for the purpose of the P2-325 intubation administration Risa Takahashi, Hiromi Okada, Yutaka Inoue, Isamu Murata, Ikuo Kanemoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2012. |
---|
![]() |
A preparation and evaluation of the intraoral attachment film for stomatitis treatment using the P2-326 xyloglucan Manami Ono Rina 1), 笹津備尚 1), Yayoi Kawano 1) 2), Kaori Hirose 1) 3), Toshimi Kimura 2), Satoshi Onishi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 432-432, 2012. |
---|
![]() |
Action to the improvement of the preparation duties that intended P2-327 medical care security Makoto Seo 1), Yurika Kimura 2), Yoshiko Mori 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2012. |
---|
![]() |
A preparation of the P2-328 flurbiprofen enclosure vesicle and the characterization Matsumoto ゆいこ, Satoshi Uchino sincerity, 宮嵜靖則, Yoshiyuki Kagawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2012. |
---|
![]() |
Investigation of three MRSA pneumonia treatment with the antiMRSA medicine given P2-329 TDM Kazushige Sakano, Yasuhiro Miki, Yu Yamauchi levator, Shunsuke Nakanishi, Motomi Okumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2012. |
---|
![]() |
Inspection (comparison, evaluation with antimicrobial agent TDM guidelines) of antimicrobial agent TDM duties in the P2-330 this hospital Toshiya Takemura 1), 下雅意彩 1), Kimi Ikuta 1), Kyoko Okuno 1), Hirose wealth period 2), Kitsunezuka good tree 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2012. |
---|
![]() |
Examination about the increase in quantity method using the proportion calculation of vancomycin for P2-331 children Junichi Suwa, Haruka Sasaki, Risa Aoki, Miyako Sekizuka Yoshiko, It is still understood Kudo, Makiko Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 433-433, 2012. |
---|
![]() |
Blood level of the linezolid may not increase in the patients with P2-332 altitude obesity 辻泰弘1), 平木洋一2), 松元加奈3), 溝口晶子4), 佐道紳一4), 森田邦彦3), 湯川栄二5), 神村英利6), 加留部善晴6), 藤秀人1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2012. |
---|
![]() |
Examination of the vancomycin administration regimen for the P2-333 continuous hemodialysis embodiment Takashi Ueda 1), Yoshio Takesue 1), Kazuhiko Nakajima 1), Kaoru Ichiki 1), Miyuki Komatsu 1), Yasushi Wada direct 1), Toshie Tsuchida 1), Yoshiko Takahashi 2), Mika Ishihara 2), Takeshi Kimura 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2012. |
---|
![]() |
Methotrexate serum concentration by P2-334 Dimension and clinical evaluation Teiko Toyoguchi, Takeshi Kobayashi, Noboru Konno, Toshihiro Shida, 丘龍祥, Kato Yuta, Kanako Takano, Aya Tominaga, Shinseki Masahiro, Tadashi Shiraishi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2012. |
---|
![]() |
Examination of a trough level and the clinical response in the P2-335 teicoplanin initial administration plan Takayuki Seko 1), Yanase non-season 1), 山田一聡 1), 村井邦充 1), Mai Shirakawa 1), Minako Yasuda 1), Hiroshi Hotta 1), Yoshihiro Ito 1), Michiyo Okada 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2012. |
---|
![]() |
Pharmacokinetics of the vancomycin hydrochloride in cytopenia period of the P2-336 hematopoietic stem cell transplantation Eiji Fukada 1), Small Ido Keiichi 1), Daisuke Watanabe 1), Yoshimasa Saito 1), 冲中敬二 2) 3), 牧野好倫 1), Nobuaki Yokote 1), Takuya Yamashita 2), Takahiro Fukuda 2), Hiroshi Yamamoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2012. |
---|
![]() |
Development of the teicoplanin simple administration method using the P2-337 Monte Carlo simulation Takaaki Yamada 1), Takahisa Yano 1), Yudai Kawajiri 1), Toshio Kubota 1) 2), Nobuaki Egashira 1), Toshiharu Nonaka 3), Ryozo Oishi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-434, 2012. |
---|
![]() |
Result analysis - second report - of Vancomycin Therapeutic Drug Monitoring by the pharmacist in the gate Hospital of the P2-338 tiger Yoshiji Kei ear village 1), Tadaaki Ito 1), Yuichi Kumaki 1), Masahiro Igarashi 1), Hiromi Tamura 1), Shinobu Hasebe 1), 木村宗芳 2), Wild Hideki Oka 2), Akiko Yoneyama 2), Masahiro Hayashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 434-435, 2012. |
---|
![]() |
Intervention of the pharmacist for the P2-339 TDM enforcement reinforcement Masako Ieda, Morihiro Nomura, Yodoshi Masahiro, Hajime Asano, 角野雄亮, Takeshi Ito, Zhongcheng Misako, Sowa Tomoko, Yuzuru Yamazoe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2012. |
---|
![]() |
Utility of the patients pool specimen in the blood P2-340 tacrolimus levels measurement accuracy management Takahisa Yano 1), Takaaki Yamada 1), Yudai Kawajiri 1), Nobuaki Egashira 1), Toshiharu Nonaka 2), Ryozo Oishi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2012. |
---|
![]() |
Effect on valproic acid serum concentration with P2-341 cyclosporin A 守作美咲 1), Junko Ishizaki 1) 2), East summer evening 1), Shiho Kawabe 1), Kan Yukio 1) 2), Arai country three 1) 2), 崔吉道 1) 3), Kenichi Miyamoto 1) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2012. |
---|
![]() |
A stomach discharge function evaluation and blood L-DOPA levels evaluation (the second report) of patients with Parkinson's disease using the P2-342 13C breath test Member of Satoshi Doi 1), 1, Seiwa, Hirai), Masaka Wataru 1), Kuzuu Ami 2), Yumi Tsuruoka 2), Mitsutoshi Sato 2), Ishii Toshihiro 2), Takatsugu Sakakibara 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2012. |
---|
![]() |
A construction of the TDM modi operandi in consideration of the duties burden on P2-343 nurse and the evaluation 霍間尚樹 1), 細川浩輝 2), Hiroshi Nakamura 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2012. |
---|
![]() |
Comparison of the vancomycin TDM prediction precision of the P2-344 perioperative patients and the non-perioperative patients Chiharu Murakami, Mariko Takayama, 茂木孝裕, Ayumu Nozaki, Yuka Kobayashi, Toshiko Aramiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 435-435, 2012. |
---|
![]() |
For P2-345 neonates Staphylococcal scalded skin syndrome (SSSS), it is one patient using vancomycin hydrochloride Tatsuo Kai, Manami Kurita, Shun Iwamatsu period Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2012. |
---|
![]() |
It is efficacy and a safe evaluation 1 case receiving the sunitinib to P2-346 patient on dialysis Tetsushi Noda 1), Shigeru Kubota 2, Kotobuki), Current Teruhiko 2), Tetsuya Yoshida 2), 影山進 2), Kei Okamoto straight 2), Yusaku Okada 2), Shinya Morita 1), 寺田智祐 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2012. |
---|
![]() |
Pharmacokinetic examination at the itraconazole internal use liquid administration to patients with P2-347 hematopoietic stem cell transplantation and acute leukemia Mariko Sugita 1), Hiroshi Okumura sum 2), Kana Matsumoto 3), Kunihiko Morita 3), Liquor mouth Hiromitsu 1), Takashi Yoshida 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2012. |
---|
![]() |
One patient who experienced acute tubulointerstitial nephritis by the vancomycin hydrochloride and thrombocytopenia by the linezolid during P2-348 purulent spondylitis treatment 黄前尚樹, 堀家有美子, 勝部智子, 藤田葵, 平田和也, 松本直之, 鈴鹿修平, 多胡和樹, 中村美樹, 大津山裕美子 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2012. |
---|
![]() |
TDM duties of the Arbekacin in the P2-349 this hospital Sato Kei sinter 1), Bank former Maki 1), Kusakabe young of sweetfish 1), Akeda Katsuyuki 2), Yoshinobu 3 in the willow), Kazuki Kikuchi 1), Toshiji Oe 4), Eri Ezoe 3), Many islands Takahiro 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2012. |
---|
![]() |
Examination of the factor affecting the initial trough level of vancomycin in patients with P2-350 MRSA pneumonia Akira Ogawa straight 1), Forest eight Keiko 1), Naohiko Fuchigami 1), Masanori Endo 1), House Masaru Den 1), Masayuki Tsujimoto 2), 西口工司 2), Toshiaki Ono 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 436-436, 2012. |
---|
![]() |
Inspection of P2-351 VCM and the TEIC nomogram Kuniaki Sano, Takashi Okuda, Shin Suzuki will, Tomio Matsumoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2012. |
---|
![]() |
Blood level prediction precision of vancomycin using P2-352 TDM analysis software EasyTDM(R) 山口佳津騎 1), Mari Kawano 1), Hiromi Ichinose 1), Sumio Kimura 1), Naoki Shinohara 1), Takeshi Abe reason 2), Toshi Takeuchi oneself 3), Shinji Kosaka 1), 福岡憲泰 1), 芳地一 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2012. |
---|
![]() |
About the TDM rate of use of the antiMRSA medicine by the P2-353 operational change Middle Yuka Kihara, 野間口寛, Reiko Kirino, Tomohiro Kakimoto, Takeshi Takahashi, Toyosumi Ayako, West Kyoko Tsuji, New top Kanako, Hiramatsu sheath, Morihiko Terashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2012. |
---|
![]() |
Investigation about patients background at the P2-354 vancomycin administration and the TDM enforcement Origin of Harada, Shigeharu Oie, Hiroyuki Furukawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2012. |
---|
![]() |
PK/PD analysis about the antiplatelet action of the P2-355 nonsteroidal antiinflammatory drug Midori Arai 1), Hitoshi Shimomura 1), Shuji Shimada 1), Your Yu Akagi 2), Yasushi Yamamoto Jiro 3), Takao Aoyama 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2012. |
---|
![]() |
Active intervention of the pharmacist in the P2-356 TDM enforcement drug Nobue Yoshinari, Masayo Tanaka, Tetsuya Kudo, Hitomi Aruga, Ota あや incense, Takao Orii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 437-437, 2012. |
---|
![]() |
P2-357 Study of biliary excretion behavior of tazobactam-piperacillin hydrate and aspoxicillin 内村綾菜, 小田雅子, 青木志織, 伊藤舞, 寺嶋望, 百瀬祥人, 市村祐一, 齊藤浩司 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2012. |
---|
![]() |
Analysis of TDM of Vancomycin in the P2-358 this hospital and the associated renal failure development situation Masashi Katagiri, Kayo Noguchi, 篠永浩, Tsutomu Kachi, Eiji Mukai Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2012. |
---|
![]() |
Examination of the initial loading dose of vancomycin aiming at P2-359 high trough value Kazutaka Oda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2012. |
---|
![]() |
Evaluation of urinary excretion dynamics of the fentanyl in the P2-360 postoperative patient and the metabolite Noriaki Tanaka 1), Takafumi Naito 1), Yagi Tatsuya 1), Kimiyoshi Hirano 1), Matsuyuki Doi 2), Shigehito Sato 3), Junichi Kawakami 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2012. |
---|
![]() |
Examination for the practical use of the TDM by the P2-361 very small amount blood collection method Jun Nakano is rare, Kaori Fujimaki, Akiko Yasunaga, Nobuo Mochizuki, Kunihiro Matsumoto, Keiko Ono, Satoshi Kishino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2012. |
---|
![]() |
Urinary indomethacin densitometry in the use patients of the P2-362 indomethacin mist preparation 100 Kenji, Masato Honma, Tree Yoshiyuki Sawa, Long Okahiro incense, Yasuyuki Kanbayashi, 幸田幸直 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 438-438, 2012. |
---|
![]() |
About a teicoplanin loading dose and a trough value in the P2-363 Toho University medical center Sakura Hospital Kazuaki Sugio, Kazuki Fukawa, Ikuno Watanabe, Hideki Kobayashi, Masaka Wataru Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2012. |
---|
![]() |
The effect that the high fat diet intake of the P2-364 gestation period gives for the expression of each Cytochrome P450 molecular specie of the pup 田島正教1)2), 岡庭健洋1), 今堀由賀里1), 猿田かな子1), 今理紗子1), 楠欣己1), 戸田雄大1), 石井敬1), 五十嵐信智1), 落合和1), 山田治美2), 杉山清1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2012. |
---|
![]() |
The serum creatinine level is ... about the factor that became clear from examination - laboratory study data of the case that rose after the vancomycin hydrochloride administration for the P2-365 injection Daisuke Negishi, Suguru Kimura daylight, Naoko Kawajiri Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2012. |
---|
![]() |
It is examined the dialysis extraction ratio of 2 cases receiving arbekacin aulfate and the administration design by P2-366 hemodialysis patient Kiyomi Ueyama 1), Naomi Iwasaki 2), Etsuko Nishio 1), Kuto chapter wide 1), Hiroyuki Morishima 3), Morihiro Nomura 2), Tetsuya Morita 2), Rui Tamura 4), Naohiko Moriguchi 5), Yuzuru Yamazoe 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2012. |
---|
![]() |
Examination of the injection method of the teicoplanin in the P2-367 hemodialysis patient Mariko Kobayashi, 樋山芙裕子, Kana Matsuzaki, Harumi Sudo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2012. |
---|
![]() |
Participation in planning to the treatment of the pharmacist mainly on the blood cyclosporine levels monitoring in the P2-368 hematopoietic stem cell transplantation Tomonori Hayashi 1), Aiko Fukui 1), People long A 1), Masaru Matsumoto Kyoko 1), Saori Nishiura 1), Yutaka Matsuoka 1), Keigo Sano 2), Fujita jasmin child 2), Takashi Iizuka 2), Yoshiko Yamazaki 2), Jin Hanamoto 2), Yagi Hideo 2), 椿和央 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 439-439, 2012. |
---|
![]() |
The effect that P2-369 cerebrospinal fluid drainage gives to a pharmacokinetic parameter of vancomycin 市江敏和 1) 2) 3), Kimihiko Urano 2), Daisuke Suzuki 1), Yoji Sugiura 1), Takeshi Okada 4), Nozomu Kobayashi 4), Takashi Katano University 2), Tadashi Sugiyama 3), Keiko Yamamura 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2012. |
---|
![]() |
Elution behavior control of the enteric beclomethasone capsule for the purpose of the P2-370 graft host disease (GVHD) treatment Satsuka Yasuyuki 1), Ikumi Sugiyama 1), Junya Sato 2), Kenzo Kudo 1) 2), Katsuo Takahashi 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2012. |
---|
![]() |
Effect of the anoxia exposure to give to the oxidation, conjugation metabolism to P2-371 carvedilol The Tadashi Taguchi up, Miki Fukao, Shizuka Yamaura, Kazuya Ishida, Seiya Hashimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2012. |
---|
![]() |
Evaluation of the Warfarin administration nomogram for the deep vein thrombosis after P2-372 cosmetic surgery procedures Horiuchi wish, 茂木孝裕, Ayumu Nozaki, Yuka Kobayashi, Toshiko Aramiya Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2012. |
---|
![]() |
Basic examination of the L-cysteine which has an influence on the free form level of P2-373 cisplatin Ryu Sugimoto star 1), Jin Tokunaga 1), Ai Okazaki 1), Tokuko Matsuo 1), Kenji Ogata 1), Nao Setoguchi 1), Toyotaka Nishio 2), Takamura rich person 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2012. |
---|
![]() |
Effect of the inhibitor under the long time coexistence on uptake to colorectal cancer cells of the DNA methylation inhibitor through the P2-374 nucleic acid transporter Kumiko Ueda, Kanae Fujitani, Mika Ikehata, Seigo Iwakawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 440-440, 2012. |
---|
![]() |
Examination of the vancomycin trough value in patients with P2-375 cancer Akinori Mori, Tomomi Fujii, Masaki Sato, 坂部米治, Motoaki Ishikawa, Takahiro Ishida, Masumi Nakagami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2012. |
---|
![]() |
About renal function estimation type (eGFR) and patients background to influence blood level prediction precision of P2-376 vancomycin Emi Tanaka 1), Akihiro Kai 1), Kuroki Noriaki 1), Yasuyuki Koorogi 1), Eri Ogawa 1), Sho Iwase branch 1), Kenji Ogata 2), Nao Setoguchi 2), Takamura rich person 2), Chiyo Susumu Tanda 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2012. |
---|
![]() |
The analysis of the digoxin pharmacokinetics parameter in the Japanese of the P2-377 majority and examination of the initial administration nomogram Kyoko Fukumoto 1), Soil lower Yoshimasa 2), Yasuo Fujimura 2), Naruyuki Kojima 3), Kazuyuki Ueno 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2012. |
---|
![]() |
Development of blood level guess support application "tinyPK" for the P2-378 mobile terminal Yasuyuki Koorogi 1), Kenji Ogata 2), Akihiro Kai 1), Kuroki Noriaki 1), Eri Ogawa 1), Emi Tanaka 1), Sho Iwase branch 1), Jin Tokunaga 2), Takamura rich person 2), Chiyo Susumu Tanda 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2012. |
---|
![]() |
Contribution - to utility - serious liver damage evasion and treatment continuation of the TDM for fungal infection treatment with P2-379 voriconazole Carefully pine Kazuko 1), Kazuaki Matsumoto 1), 茂見茜里 1), Naoko Kanazawa 1), Eri Watanabe incense 1), Yuta Yokoyama 1), 猪川和朗 2), Norifumi Morikawa 2), Yasuo Takeda 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2012. |
---|
![]() |
Action of the TDM duties induction promotion in the cottage-hospital in P2-380 Kanagawa Toishima study 1) 2), Yukiko Nakamura 3), Yuko Komura 3), Jun Inoue Expo 3), Koji Fujimoto 3), Hajime Kagaya 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 441-441, 2012. |
---|
![]() |
Comparison of the teicoplanin surface coverage due to the ultrafilter of the P2-381 persistent hemocatharsis method Toshiyuki Irie 1), 道越淳一 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2012. |
---|
![]() |
Examination of the simultaneous assay of the plasma concentration of sildenafil, bosentan, tadalafil in the P2-382 pulmonary artery-related patient with pulmonary arterial hypertension and ambrisentan 田中紫茉子 1), Shinya Uchida 1), Yukiko Miyakawa 2), Naoteru Inui 2), Kazuhiko Takeuchi 2), Yuji Watanabe 2), Tokuyuki Namiki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2012. |
---|
![]() |
To use the information of the P2-383 renal excretion contribution ratio for the administration plan of patients with renal failure effectively Maiko Yamada 1), Yoshiyuki Ono 1), Gutter slope Akihiro 2), Hiroshi Suzuki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2012. |
---|
![]() |
P2-384 About blood drug concentration analysis of molecular targeted therapy (Imatinib, Nilotinib, Dasatinib) in chronic myeloid leukemia (CML) patients 中原良介, 津田浩和, 緒方正男, 伊東弘樹 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2012. |
---|
![]() |
Association ... with clinical response of tazobactam/piperacillin in patients with P2-385 medical care, care-related pneumonia and side effect - pharmacokinetics Nobuhiro Nishimura 1), Fumi Kano 1), Noriyuki Ishihara 1), 猪川和朗 2), Takeshi Isobe 3), Norifumi Morikawa 2), 直良浩司 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2012. |
---|
![]() |
Examination of the 14C-oxaliplatin serum concentration assay using P2-386 accelerator mass spectrometry (AMS) Takeshi Kobayashi 1), Teiko Toyoguchi 1), Kazuhiro Kato 2), Hilum Kano Fuyuki 2), Tadashi Shiraishi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 442-442, 2012. |
---|
![]() |
TDM of the new antiMRSA medicine daptomycin by the P2-387 gradient HPLC-UV analytical procedure 安井友佳子1), 山本圭城1), 八野芳巳1), 藤本卓司2), 今村博司3), 安井裕之4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2012. |
---|
![]() |
Establishment of the quick assay of P2-388 human plasma and urinary daptomycin levels 山田尚広, 内藤隆文, 八木達也, 石田卓矢, 川上純一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2012. |
---|
![]() |
Examination of the factor affecting the pharmacokinetics of P2-389 clobazam and N-desmethyl clobazam Yoshiaki Yamamoto 1) 2), Hiroshi Miyakawa 1), Yukitoshi Takahashi 1), Katsumi Imai 1), Kazumi Matsuda 1), Yushi Inoue 1), Yoshiyuki Kagawa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2012. |
---|
![]() |
Effect of the UGT1A1 genetic polymorphism heterozygote which gives it to P2-390 irinotecan doses adjustment Naoya Ishibashi, Masahide Onoe, Tadehara Masami, Yuka Kageyama, Makoto Terao, Satoshi Masuda point, Ikemi Yasuaki, Kazuo Matsubara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2012. |
---|
![]() |
Development of the simple quick genetic polymorphism diagnostic method of the P2-391 humans IgG type Fcγ receptor 渋谷彩1), 松本准2), 有吉範高1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2012. |
---|
![]() |
Effect of the CYP3A5 genetic polymorphism which gives it to the bioavailability of the P2-392 tacrolimus once a day oral administration preparation 加賀谷英彰 1), 三浦昌朋 1), New Takenori Oka 1), Mitsuru Saito 2), Kazuyuki Numakura 2), Tomonori Habuchi 2), Shigeru Sato 2) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 443-443, 2012. |
---|
![]() |
Individual difference of the methotrexate-related genetic expression level in P2-393 human peripheral-blood mononuclear cells Kanako Takashima, Naotaka Tsumura, Satoshi Muto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2012. |
---|
![]() |
Comparison between P2-394 monocytes and expression level of the methotrexate-related drug transporter in lymphocytes Katsuto Mochizuki, We congratulate Hachiya reason, 堀口瑛司, Satoshi Muto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2012. |
---|
![]() |
Comparison of the effect of treatment with hydroquinone and the kojic acid to P2-395 chloasma Akiko Kume 1), Hitomi Kato 2), Seiko Soeda 3), Fuminori Shibuya 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2012. |
---|
![]() |
Meta-analysis about cancer inhibition by the P2-396 NSAIDs remedy and the effect of the COX genetic polymorphism 長尾麻以, Yoichi Sato, Aiko Yamauchi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2012. |
---|
![]() |
Dose change, side effect expression of irinotecan situation investigation - second report ... in the P2-397 UGT1A1 genetic polymorphism analysis patients Keinosuke Okazaki 1) 2), Ayumu Kawashima 1) 2), Kosuke Suzuki 1) 2), Toru Watanabe 1), Junichiro Murayama 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2012. |
---|
![]() |
Efficacy of the Xa inhibitor to use for prevention of P2-398 venous thromboembolism and safe examination 出石恭久 1), 中村孝佑 1), Hitoshi Taniguchi 1), Kuwata gain rare 1), Takuma honest 1), Tadashi Shiota 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 444-444, 2012. |
---|
![]() |
Coefficient of viscosity change by the water addition of the P2-399 half solidification nutrient preparation 秦毅司, Ancient ceremony Tomomi, Yuriko Nimura, Nakayama first arrow child, Masayo Hashizume, 川合甲祐, Hitoshi Kakumu, Nakano truth line Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2012. |
---|
![]() |
Action of the preoperative oral rehydration therapy in the P2-400 this hospital orthopedics ward Kanako Miyake 1), Noriko Matsui 1), Mukai light Ichiro 1), 櫻間啓基 1), Kazutaka Sakamoto 1), Teruyo Ikegami 2), Mizue Oga 2), Toshiko Mizumoto 2), Kazuko Murakami 1), Koichi Matsuo 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2012. |
---|
![]() |
Action of the hyperalimentation preparation mixed injection in the P2-401 pharmacy Junko Sugawara 1), Tomoko Komatsu 1), Miho Horie 1), Reiko Yasuda 1), Hideki Koyama 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2012. |
---|
![]() |
About a test value change with the P2-402 lipid microsphere Naoko Katayama 1), Tomozawa Akinori 2), Yellow former Naoki 3), Country relation Kayoko 2), Akiko Kuwahara 4), Mountain Hiroshi Morimoto 4), Kadoyama Kaori 5), Makoto Miura 1), Sakaeda Toshiyuki 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2012. |
---|
![]() |
About the use situation of the lipid microsphere judging from an inquiry sent to the P2-403 transfusion DI center Ryo Iwahara fine weather, Yu Takebayashi flower, Noriko Suganuma, Yoshioka small Satoko, Star spring, Sayuri Watanabe, 淺賀慎一, Mayumi Fukuda, Hironori Kawano, Taro Matsuno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2012. |
---|
![]() |
The future role that activity contents and a pharmacist of NST in the hospital attached to the P2-404 Saga University School of Medicine should achieve Akihiro Hayashi 1), Mayumi 2 between the fronts), Toshihiko Mizuta 3), Atsushi Miyoshi 4), Fujito Expo 1), Koji Miyazaki 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 445-445, 2012. |
---|
![]() |
Examination of the intervention results of the pharmacist of the P2-405 NST addition first year Absence Katsuyuki 1), Arata Nakamura 1), Naoki Soma 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2012. |
---|
![]() |
About the association of nutritional evaluation and the infection for infants with P2-406 intestinal tract deficiency (in Hirschsprung affinity disease) Kyoko Fujieda 1), Large stick male size 1), Sakiko Kurokawa 1), Takashi Uno 1), Nobuo Suzuki 1), Tomoko Takeda 2), Taichi Fukuzawa 3), Takafumi Endo 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2012. |
---|
![]() |
Relation of the present conditions, a problem and the pharmacist of the P2-407 NST activity Takako Chino Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2012. |
---|
![]() |
Change of the nutrition index with the Infliximab high dose (10 mg/kg) administration at the P2-408 Crohn's disease relapse exacerbation Yuji Ogawa, Atsushi Urano, 小野田稔久, Midori Ito, Kiyoshi Sakuma, Hideki Kobayashi, Masaka Wataru Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2012. |
---|
![]() |
Effect of the turnover rate to give it to elution behavior of the gliclazide which mixed with half solidification water to use for P2-409 enteral feeding therapy 巖西真, 名徳倫明, Akaho, Nagano, The Matsuyama up, 浦嶋庸子, 廣谷芳彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2012. |
---|
![]() |
Effect of the coefficient of viscosity to give it to elution behavior of the gliclazide which mixed with half solidification water to use for P2-410 enteral feeding therapy Akaho, Nagano, 名徳倫明, 巖西真, The Matsuyama up, 浦嶋庸子, 廣谷芳彦 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 446-446, 2012. |
---|
![]() |
Examination about selenium in the intravenous hyperalimentation patients for a long term at-home P2-411 烏望枝奈 1), 松尾和廣 1), Kozono Kouki 2) 3), 佐々木英久 1), Tomoko Watanabe 1), Etsuko Shinohara 1), Takayoshi Kosugi 2), Kenji Nishizawa 2), Eagle Takahiro Sawa 3), Takashi Yoshio 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2012. |
---|
![]() |
Examination of the nutritional management in the postprandial hyperglycemia patients after the P2-412 gastrectomy Yutaka Inoue 1), Risa Takahashi 1), Akihiro Uchida 2), Strong arrow Kazuko 3), Isamu Murata 1), Ikuo Kanemoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2012. |
---|
![]() |
The relation of the pharmacist in NST of the P2-413 this hospital and future problem Keisuke Ito, Junichi Otsuka, Hiroyuki Kageyama, Katsumata Harumi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2012. |
---|
![]() |
Examination about the safety in the P2-414 glutamine bolus dose 1, Kishi, Matsuzaki) 2), Shunya Ishii 2) 3), 澤藤園子 1) 2), Shinichiro Suzuki 1), Hidetomo Yasujima 1), Misako Mori 2) 4), Kawahata sub-K 2) 4), Shibata rises 2) 5), Aya Onoe 2) 5), Akio Saito 1), Hiroshi Nakano 2) 6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2012. |
---|
![]() |
The present conditions and problem of P2-415 acute phase hospital NST Tomoko Yamano, It is Sachiko in a camp, Eiko Fukunaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2012. |
---|
![]() |
Prescription suggestion of berizym combination granules in NST for patients with P2-416 intractable diarrhea Nobuyuki Wakii, Shunichi Utsumi, Mitsui Miyuki, Yuichi Yano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 447-447, 2012. |
---|
![]() |
Enforcement of the appropriate nutritional management for patients with chronic renal failure by the P2-417 NST intervention Shunichi Utsumi, Nobuyuki Wakii, Mitsui Miyuki, Yuichi Yano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2012. |
---|
![]() |
We found from a screening sheet of each medical care team in the P2-418 City Kawanishi Hospital; and about the association with the team Hosomi Kengo 1), 久井裕美子 1), Hiroki Sugita 1), Sachiko Komaki 1), Norio Masumoto 1), Takako Yuko 1), 大槻裕朗 1), Yoshihisa Takao 2), Shuichi Nozaki 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2012. |
---|
![]() |
Blood level prediction of vancomycin for the P2-419 CKD patients Yukari Haneda 1), Yuichi Kikuchi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2012. |
---|
![]() |
Support - to action - Aichi regional medicine reproduction research business of the pressure sore training workshop for P2-420 pharmacists Kotaro Iida 1) 2), Masako Mizuno 2), Yasuhiro Noda 2), Old Masaru Den trans2), Yoshihiro Kondo 2), Minoru Nagata 2), Yoshihiro Kawade 2), Taku Morikawa 2), Yoko Nohara 2), Akihiro Aoyama 2), Keiko Yamaguchi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2012. |
---|
![]() |
Examination of the alternate-day administration of the China Cal Seto hydrochloride for the P2-421 second-related hyperparathyroidism Height of island Ichiro 1), Hiroyuki Nagasawa 1), Taku Tokuda 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2012. |
---|
![]() |
Mention of the most recent renal function to a medicine notebook that we use P2-422 Microsoft Excel Tetsuya Ito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 448-448, 2012. |
---|
![]() |
Relation of the pharmacist for the P2-423 outpatient department patient on dialysis Lower stone Kazuki 1), Ueki Soichi Hara 2), Eiko Fukunaga 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2012. |
---|
![]() |
Change examination from P2-424 hyperkalemia improvement agent Ca-resin to Na-resin Shintaro Mochizuki 1), Satoshi Suda 1), Akari Tanikawa 1), Yukiko Kaieda 1), Ueda bare reason 1), Takeshi Murai 1), Yoshiko Onuki 1), Kaori Ashizawa 2), Koichi Uchida 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2012. |
---|
![]() |
Examination of the change of gender-related eGFR in the P2-425 ethical pharmacy Mitsuru Suzuki 1), Takahiro Maeda 1), Miho Wada 2), Shiro Araki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2012. |
---|
![]() |
Examination about P2-426 silver colloid and the new vulnerary covering material using the xyloglucan Kaori Hirose 1) 2), 笹津備尚 2), Nao Nakamura 3), 中南秀将 3), Yusuke Sekine 4), Yayoi Kawano 2) 5), 野口雅久 3), Kiyoshi Okuyama 1), Satoshi Onishi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2012. |
---|
![]() |
It is satisfaction investigation ... using ... customer satisfaction analysis (CS analysis) about an evaluation of the simple suspension method induction in the P2-427 this hospital Kenji Doi 1), Yuki Oogi 1), Hideyuki Yoshizaki 2), Kazumi Matsumoto 2), Kenji Araki 2), Sumie Uchino 2), Hitoshi Harada 1), Kazutaka Matsumoto 3), 松本純隆 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2012. |
---|
![]() |
Prescription examination of the preparation for severe wound treatment using the P2-428 xyloglucan Kenichi Tomikawa 1), 笹津備尚 1), Kaori Hirose 1) 2), Yayoi Kawano 1) 3), Yusuke Sekine 4), 林太祐 5), Yoshiaki Ogita 6), Shunji Horikawa 7), Satoshi Onishi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 449-449, 2012. |
---|
![]() |
Use situation investigation of the febuxostat for patients with P2-429 severeness impaired renal function 森山亜矢子, 羽生智弘, 仲島優一郎, 沖田健太郎, 尾形美絵, 田村和彦, 新関みどり, 近藤和宏 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2012. |
---|
![]() |
Relation of the pharmacist to P2-430 CKD-MBD 福井圭亮, Hiroya Masuda, 阪井田哲, Yuko Sakaguchi, We are constipated and congratulate three temples, Takashi Suzuka daylight Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2012. |
---|
![]() |
Comparison of the renal function rating system in P2-431 renal-transplant recipients Kentaro Ueda, Kazufumi Iwata, 合澤啓二, It is Sachiko in a camp, Eiko Fukunaga Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2012. |
---|
![]() |
Relation of the pharmacist in pressure sore treatment of the P2-432 this hospital Rie Shoji 1), Masumi Saito 2), Muneo Tanida 3), Long Akira Shima 1), Koji Ito 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2012. |
---|
![]() |
Blood pressure evaluation of patients with chronic kidney disease in P2-433 consulting room and the health insurance pharmacy Ono prospers 1), Hiroshi Izumi world 1 Kim), Yumiko Sakurai 1), Kayoko Yamamoto 1), Takahiko Ono 2), Islet spring period 3), Koshin Ishikawa 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2012. |
---|
![]() |
Action of the pharmacist to the medical supplies proper use that assumed P2-434 renal function an index Mina Ushiyama 1), Akie Shigenaga 1), Takashi Furuta 1), 下堂薗権洋 1), Ryuji Ikeda 1) 2), Yasuo Takeda 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 450-450, 2012. |
---|
![]() |
Importance of the prescription suggestion about the phosphate binder in the early stage of the hospitalization of the P2-435 patient on dialysis Takayuki Okada 1) 2), Buddhism Junko 1), Michiko Kamo 1), Yoshio Takagi 1), Aze well Koichi 1), Nakamoto celebration of longevity husband 2), Shinichi Harada 2), Tokuyama still I 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2012. |
---|
![]() |
Comparison of the microalbuminuria by the immunoassay in P2-436 patients who received renal transplant from living donors and the gel filtration chromatography Nobuhiro Fujiyama 1), Katsuya Sasaki 1), Shotaro Kato 1), 三浦昌朋 1), Shigeru Sato 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2012. |
---|
![]() |
About an intervention investigation of the serum Mg level in the long-term use patients of P2-437 magnesium oxide Takako Notomi, Seiko Shimada, Noriko Takeda, 濱邊秋芳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2012. |
---|
![]() |
Efficiency of pressure sore treatment by the visualization of P2-438 DESIGN-R Takashi Furuno will 1), 小林賢滋 1), Yagita Mikako 1), Spring Mayuko 1), Kaori Hayakawa 2), Yutaka Okino 2), Hiroshi Okuyama 3), Shinko Endo 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2012. |
---|
![]() |
Prescription suggestion enforcement situation investigation of the pharmacist in the P2-439 psychopathic ward 進健司, Yuichi Umeda, Side former Kazuaki, Tatsuro Otani, Mamoru Uchida next, Shinsuke Takemoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2012. |
---|
![]() |
Effect of the education for patients which gives it to the medication adherence in the ward for P2-440 psychiatry acute phase 福山雄卯介 1), Hirotaka Suzuta 1), Fujita good memory 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 451-451, 2012. |
---|
![]() |
About the effect that the informed consent using the P2-441 explanation document gives to satisfaction of the antipsychotics in bipolar patients and a medication manner Hideki Ito 1), Hiroyuki Kamei 1) 2), Ono sand lily 1), 半谷眞七子 1), Ippei Takeuchi 1) 3), Junji Uno 3), Masaya Masuda 4), Takahiro Hayashi 4), Shigeru Yamada tree 4), Iwata relation straight 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2012. |
---|
![]() |
Examination from the prescribed drug investigation of P2-442 depression and the depressive state patients Takayuki Kobayashi 1) 2), Masahiko Shida 2) 3), Yosuke Ohashi 2) 4), Katsusane Tsurutani 2) 5), Mitsuru Takahashi village 2) 6), Willow Tomoyuki 2) 7), Isurugi Ikuko 2) 8), Ryoji Matsubara 9) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2012. |
---|
![]() |
Use of P2-443 lamotrigine situation investigation Yukihiro Kaneko, Hiroyuki Isobe, Aya Kamegawa, History of best male Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2012. |
---|
![]() |
The effect that simultaneous smoking cessation by the smoking cessation in the P2-444 site gives to schizophrenia inpatients Yuko Abe 1), Kenzo Miyazaki 1), Koba Sani beauty 1), Asako Endo 1), Nobuko Hiraki 1), Shinya Kawauchi 2), 趙岳人 1), Koichi Oda 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2012. |
---|
![]() |
The prescription fact-finding of the antidepressants in the P2-445 newcomer patients and consecutive examination Masako Wada, Mamoru Tanaka, Akio Okai, Hiroshi Araki positive Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2012. |
---|
![]() |
Use investigation of a sleeping drug, the anxiolytics in P2-446 antidepressants Kazuhiko Gomi 1), Takako Takemura 1), 羽場昇 1), Masakazu Maezawa 1), Toigake Tadahiko 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 452-452, 2012. |
---|
![]() |
The management of the medicine for patients with P2-447 Alzheimer disease (AD) therapeutic drug remedy and an investigation and case introduction of the side effect expression situation Satoko Ogawa, Naoto Niwa, Asami Takasawa, Mari Miura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2012. |
---|
![]() |
Action of the pharmacist in the P2-448 delirium prophylaxis team Satoko Aizawa 1), Yoko Okada 1), Atsushi Adachi 1), Shinge Keiko 1), Kuridani Yoshitaka 1), Kazusane Okubo 2), Great Seiyu Yuko 3), Tokuyama window or 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2012. |
---|
![]() |
About the activity of the pharmacist in P2-449 stress care ward "ward program" Original well Junko, Okada view enthusiast, Toshifumi Kido Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2012. |
---|
![]() |
A comparison and examination before and after the P2-450 psychiatry clinical path enforcement Mitsuru Takahashi village 1), Tooru Mori 1), Yoshiko Ishizuka 1), Hidekazu Yahagi 2), Sect charges next 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2012. |
---|
![]() |
Mainly on the suit for investigation - sexual function about the side effect using the check sheet for the P2-451 ambulant follow period schizophrenia patient - Tomomi Seta 1), Junko Kishimoto 1), Koshu Yasuhiro 1), Nozomi Shinohara child 1), Yusuke Nakamura 1), 1, Asuka, Kaneko), Masayuki Osako 2), 大野基恵 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2012. |
---|
![]() |
Risk analysis of the patients associated with fall, the fall in the P2-452 psychopathic ward Kaori Nakai 1), Sae Sasaki beauty 1), Flat Hiromi 1), Hajime Nakai 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 453-453, 2012. |
---|
![]() |
Relation of the pharmacist in the P2-453 psychiatric day care Keiko Hara, Akira Ichikawa, Ikuo Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2012. |
---|
![]() |
P2-454 Medicinal properties of methylphenidate hydrochloride extended-release tablets to pervasive developmental disorder accompanied by AD / HD symptoms 浜田茂明1), 森本真仁1), 島川清司2), 橋本俊顕2), 波多江崇3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2012. |
---|
![]() |
As compared with the prescription investigation of prescription situation - clinical psychiatry pharmacy meeting for the study of the antipsychotics in the inpatient with P2-455 schizophrenia ... Go Kato, Makoto Suda, Masayuki Inaba Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2012. |
---|
![]() |
Intervention ... from the P2-456 psychiatry region to fall, the fall with medical safety management - benzodiazepine drugs by the ward pharmacist whom we looked after Shintaro Takahashi 1), 上島聖秀 1), 濱元孝 1), Yoshiyuki Komori 2), 久保雅寛 3), Ryo Kawai intellect 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2012. |
---|
![]() |
Phosphorus revision and whole body control in the re-supplementation therapy of patients with P2-457 anorexia nervosa 杉沢諭 1), Ishikawa mere beauty 2), Yagi Satoshi 1), 平藤彰 1), Ishiyama evening Kei 2), 東一成 3), Aoki hemp pear 3), Minoru Sakata 2), Isao Saito 1), Junichiro Murayama 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2012. |
---|
![]() |
An example (case report) that showed aggressiveness to antiwine by P2-458 material coexistence characteristics disorder therapy program Isao Saito 1), Toshiaki Tsuneoka 2), Tomohiro Ikeda 3), Rie Ishizaka 4), Noriko Takagi 4), Junko Inamoto 2), Nobumasa Kato 2), Junichiro Murayama 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 454-454, 2012. |
---|
![]() |
Successive prescription investigation actual situation - first report ... for the bipolar disorder in P2-459 Hiroshima Chie Bessho 1) 2), Masashi Shintaku 2) 3), Yumiko Ishii 4), Yoko Hashimoto 2) 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2012. |
---|
![]() |
Use of lamotrigine in the P2-460 bipolar disorder and fact-finding of the onset of skin reaction and the action West Yugo 1), 吉邨善孝 2), Hiroshi Sugano 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2012. |
---|
![]() |
Successive prescription investigation actual situation - tertiary report ... for the bipolar disorder in P2-461 Hiroshima Yumiko Ishii 1), Chie Bessho 2), Masashi Shintaku 3), Yoko Hashimoto 4) 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2012. |
---|
![]() |
The evaluation of P2-462 psychopathic ward pharmacist duties and future problem Long volost Chikako, Yoichi Shinozaki, Junichiro Kato, Masaki Kitamura, Takashi Kawakubo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2012. |
---|
![]() |
Inspection about efficacy and the side effect for the behavioral disorder of children and adolescents of the P2-463 aripiprazole Rikiya Sato 1), Natsuko Ishida 1), 多田淑央 2), Kazumasa Murakami 1), Ichiro Ono 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2012. |
---|
![]() |
Adequacy of the P2-464 antipsychotics Fujita good memory 1), Hirotaka Suzuta 2), 福山雄卯介 2), 三角紳博 1), Toshihiro Matsumoto 1), Takashi Nishino 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 455-455, 2012. |
---|
![]() |
Relation of the pharmacist to the psychology education for the P2-465 alcohol addict Junichi Miyaura 1), Okusa English sentence 2), Masahide Okuda 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2012. |
---|
![]() |
Attitude survey to other healthcare occupations about visit drug control instruction duties of the pharmacist in the P2-466 psychiatry regional medicine Hidenori Kuwahara, 水野眞俊 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2012. |
---|
![]() |
For the adherence improvement of relation - patients to team approach in medical care of the P2-467 psychiatric hospitals pharmacy - Arrow Eri, Kaori Nishida, Misaki gain charges Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2012. |
---|
![]() |
We investigate a medicine notebook after the discharge in the P2-468 psychiatry region Kozue Kurihara, Yusuke Taki, Kusaka Toyoshi, Aiko Koyanagi, Takahiro Goto, Hirokazu Yamashiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2012. |
---|
![]() |
Prescribed drug investigation for P2-469 outpatient department bipolar patients Kyoko Mori, Kazuko Yamada, Masami Takeda, Akiko Shimizu, Koto slope Sachihiro Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2012. |
---|
![]() |
One patient whom fibromyalgia was suspected in from chronic pain complicated with mental disease at patient compliance instruction in the P2-470 ethical pharmacy Yukiyo Yamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 456-456, 2012. |
---|
![]() |
It is ... for the efficiency of trial - duties of the drug control instruction using "a drug control instruction, side effect check sheet" in P2-471 psychiatric hospitals Tomohito Wada 1), Ikuko Kimura 1), Yuka Ito 1), Hasada Yoshihiro 1), Naomi Ito 1), Kohei Fujita 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2012. |
---|
![]() |
Successive prescription fact-finding - second report ... for the bipolar disorder in P2-472 Hiroshima Masashi Shintaku 1) 2), Chie Bessho 2) 3), Yumiko Ishii 2) 4), Yoko Hashimoto 2) 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2012. |
---|
![]() |
Association between immunosuppressive drug susceptibility and lipids abnormality of patients with P2-473 minimal change type nephrotic syndrome Kenichi Ikeya 1), Sachiko Tanaka 1), Kenji Onda 1), Kentaro Sugiyama 1), Sayuri Shirai 2), Satoshi Kosaka 3), Noriko Yoshikawa 4), Iwao Nakabayashi 4), Masaharu Yoshida 4), Toshihiko Hirano 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2012. |
---|
![]() |
Physical assessment ... in examination - heart failure acute phase case about injection choice and the drug properties for P2-474 ventricular arrhythmias Yasushi Takai 1), Tamami Yamamoto 1), Takeki Kajima 1), Masashi Kato 2), Akio Iwata 2), Hiroyuki Suzuki 2), Hideo Nishikawa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2012. |
---|
![]() |
A venous thromboembolism prophylaxis effect after the orthopedics surgery using the P2-475 edoxaban (re-comb hole (R) lock) and inspection of the side effect 三枝芳1), 松本浩1), 阿部宏志1), 八田重雄1), 坂下裕子1), 増原慶壮1)2), 植原健二3), 新井賢一郎3), 松下和彦3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2012. |
---|
![]() |
The effectiveness of the HbA1c level drop effect in patients with type 2 diabetes with the P2-476 low dose sitagliptin administration 高場亜貴1), 山村麻里1), 八田信朗2), 立石博信3), 牛島美香4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 457-457, 2012. |
---|
![]() |
P2-477 Study of the proper use by Dabigatran etexilate methanesulfonate prescription patient survey 大串篤史1), 越前宏俊2), 並木淳郎3), 石井嘉之1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2012. |
---|
![]() |
Effect of the benzodiazepine drug on patients with P2-478 blepharospasm Yakichi Kuniko, Junko Kikuchi, Tomoko Ogaki, Makiko Hamano, 荒佐夜香 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2012. |
---|
![]() |
The instillation observance and patients satisfaction at use of P2-479 glaucoma combination eye drops Makiko Hamano, Junko Kikuchi, Yakichi Kuniko, Tomoko Ogaki, 荒佐夜香 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2012. |
---|
![]() |
Evaluation about the safety of the use of terra pre-building case in the P2-480 this hospital Daisuke Maehara 1), Akiko Kuroda 1), Kumiko Honma 1), Yumiko Fukui 1), Noriko Terakawa 1), 1, Kotobuki, Fukushima 2), Yoshiaki Inui 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2012. |
---|
![]() |
A use situation investigation of the deep vein thrombosis preventive medicine in the P2-481 lower limbs orthopedic surgery and comparison of each drug Yukiko Takemori 1), 祖川倫太郎 1), Yutaka Yonekura 2), 井手衆哉 2), 中野行孝 1), Masaaki Mawatari 2), Fujito Expo 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2012. |
---|
![]() |
Pharmacist educational program for the OTC medicine triage ability development that utilized P2-482 simulation customer Yukari Yoshioka, 半谷眞七子, Mayu Sakurai, Hiroyuki Kamei, Yoko Hamada, Juri Maeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 458-458, 2012. |
---|
![]() |
The effectiveness of the P2-483 new oral anticoagulant drug edoxaban and safety 森崎崇文1), 星野輝彦2), 塩津和則1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2012. |
---|
![]() |
About the relations with the CD4-positive lymphocyte counts and nutrition index after the P2-484 antiHIV therapy Shigeki Takematsu 1), Tomishima Kosuke 1), Yoriyuki Kawato 1), Katsuaki Kobayashi 1), Kiyoko Fujii 2), Tokiko Saegusa 2), Mimura party 3), Mimori Yasuyuki 3), Tomoko Katsuta 3), Yoshiro Mochizuki 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2012. |
---|
![]() |
Investigation of the side effect of the peginterferon ribavirin terra pre-building triple-drug therapy for the P2-485 chronic hepatitis C Saito giant tree 1), Kokufu Island Nobuyuki 2), Hiroki Oishi 1), Yagawa Yuko 1), Naoko Ishikawa 1), 三角紳博 1), Takashi Nishino 1), Makoto Nakamuta 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2012. |
---|
![]() |
Comparison between anti-peptic ulcus agents, polaprezinc and effect that zinc chloride gives to thymocyte containing P2-486 zinc 岡野善郎1), 緒方郁子2), 瀬尾量2), 石田志朗1), 小山保夫3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2012. |
---|
![]() |
Examination about the initial terra pre-building reduction administration example in the triple-drug therapy for P2-487 chronic hepatitis C Tetsuya Hirose 1), Mihoko Sasaki 1), Shigeru Sato 1), Hatsumi Kikuta 1), Miki Katsuragawa 1), Ryu Kobayashi 1), Hideji Ohara 1), Muki Ryoji 1), Ozeki solstice 2), Yoshiyasu Kano 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2012. |
---|
![]() |
Action of the pharmacist outpatient department for the P2-488 terra pre-building remedy patients Shigeki Tachihara 1), Mikiko Yamada 1), Kazunori Aoyama 1), Atsumi Yanaka 1), Toyohiko Kurosawa 1), Masahiko Shimada 1), 荒木眞裕 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 459-459, 2012. |
---|
![]() |
P2-489 infliximab, tocilizumab, fact-finding about the Abatacept enforcement 河野友里, 松尾宏一, 和田依子, 吉田宣政, 福原佐知, 樋口美奈子, 佐々木好美, 岩坪沙奈恵, 西野弘章 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2012. |
---|
![]() |
P2-490 The blood pressure improvement effect by Micombi (R) Combination Tablets BP introduced 山岡和幸, 黒岩遥香 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2012. |
---|
![]() |
Participation of the use situation and the pharmacist of the tolvaptan for patients with P2-491 heart failure 田中泉1), 山室蕗子1), 吉田愛1), 末吉栄志1), 近藤元三1), 伊藤彰彦2), 森上靖洋2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2012. |
---|
![]() |
Research about the thromboembolism incidence under the low-dose warfarin control in the P2-492 valvular disease postoperative patient and the side effect Yuko Enomoto 1), Etsuko Shinohara 1), Tatsuo Chiba 2), Uekusa Shusuke 2), 佐々木英久 1), 松尾和廣 1), Akiko Watanabe 1), 加藤裕芳 2), Toru Asayama 2), Takashi Yoshio 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2012. |
---|
![]() |
Example that the phantom pain of the P2-493 patient on dialysis responded to pregabalin Daisuke Kito, Makoto Hayashi, Kenji Miyazawa, Akemasa Yamaya, Hiroshi Funaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2012. |
---|
![]() |
Examination about the risk factor of deep vein thrombosis embolism to occur after P2-494 total hip replacement, total knee replacement Satohiko Akamine 1), Yukihiro Hamada 1), Takeshi Hirayama 1) 2), Tadashi Kawamura 3), 高平尚伸 4), Masaichi Kuroyama 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 460-460, 2012. |
---|
![]() |
Example that pregabalin was effective for refractory itching with the P2-495 dialysis Shunsuke Kawabata 1), Sachiko Yasumoto 1), Fukuko Shimokawa 1), Shiho Okada 1), Naoko Omoto 1), Hilum pond Kaori 1), Kazunari Taniguchi 1), Takashi Yamanaka 2), Fuminori Matsubara 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2012. |
---|
![]() |
Use situation investigation of the terra pre-building in P2-496 chronic hepatitis C treatment 安澤雄生, Hiroshi Okamura, Hiroshi Goto kernel, Tadashi Wakasugi, 西川能治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2012. |
---|
![]() |
P2-497 Teriparatide (Forteo (TM)) evaluation and issues of foreign introduction path 荒木隆一1), 竹田美佳1), 大成一誓2), 朝田尚宏2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2012. |
---|
![]() |
Level of clarithromycin in P2-498 normal bronchiole epithelial cells and influence for the time Rocky mountain books for admonition, Junpei Kimura, Shota Horiuchi, Rope field Takahiro, Design of turbulent waves Ryosuke, Koichi Otaki, Yoshiko Tanbo, 早勢伸正 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2012. |
---|
![]() |
Examination of the drug evaluation about the medication at pregnancy in P2-499 Physicians' Desk Reference and the Drugs in Pregnancy and Lactation eighth edition (Gerald G. Briggs. et. al.) Hiroki Masuda 1), Ayaka Takeya 1), Mari Fukamachi picture 1), Satoshi Ohba 1), Eri Maeda 1), Yuko Okada 1), Saori Kimura 2), Seiichi Maruyama 3), Satoshi Toyama 3), Hiroshi Sato 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2012. |
---|
![]() |
Examination of the drug evaluation about the medication at P2-500 ethical drug attachment document (JAPAN-PI) and nursing in Drugsin Pregnancy and Lactation 8th ed.(Gerald G. Briggs. et al.) Eri Maeda 1), Tomonori Sekiguchi 1), Hideyuki Wakahara 1), Haruka Asami 1), Yuko Okada 1), Hiroki Masuda 1), Young book Taro 2), Seiichi Maruyama 2), Satoshi Toyama 2), Hiroshi Sato 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 461-461, 2012. |
---|
![]() |
Examination about the risk assessment to a pregnant woman in P2-501 ethical drug attachment document and the Drugsin Pregnancy and Lactation eighth edition Yuko Okada 1), Ayaka Takeya 1), Mari Fukamachi picture 1), Manure Aya Tano 1), Eri Maeda 1), Hiroki Masuda 1), Saori Kimura 2), Seiichi Maruyama 3), Satoshi Toyama 3), Hiroshi Sato 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2012. |
---|
![]() |
Examination of the drug evaluation about the medication at nursing in P2-502 Physicians' Desk Reference and the Drugsin Pregnancy and Lactation eighth edition (Gerald G. Briggs. et. al.) Hiroko Iino 1), Tomonori Sekiguchi 1), Hideyuki Wakahara 1), Eri Maeda 1), Yuko Okada 1), Young book Taro 2), Seiichi Maruyama 2), Satoshi Toyama 2), Hiroshi Sato 2), Hiroki Masuda 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2012. |
---|
![]() |
Evaluation of the milk transitivity of amlodipine in the nursing mother of the P2-503 pregnancy-induced hypertension syndrome Kubono Naoko 1), Takafumi Naito 1), Kimiyoshi Hirano 1), Shuhei Deguchi 2), Masahisa Sugihara 2), Toshiyuki Uchida 3), Hajime Suzuki existence 3), Hiroaki Ito 3), Kanayama Hiroshi Shou 3), Junichi Kawakami 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2012. |
---|
![]() |
Experience, an evaluation and the future problem that were given "a lecture about the pharmacotherapy to pregnant woman nursing mother" for P2-504 business training Chihiro Iwasa 1), Takashi Sato 2), Etsuko Oyamada 3), Jun Hamada 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2012. |
---|
![]() |
It is drug control in the lactation from P2-505 late pregnancy Aiko Imamoto 1), Motoko Funato 1), Keiko Nitta 1), Toshihiko Iura 2), Masaaki Mori 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2012. |
---|
![]() |
Examination of the action for a pregnant woman, the nursing mother pharmacotherapy support in the P2-506 Kurashiki adult disease center Mari Sugihara, Chie Takemoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 462-462, 2012. |
---|
![]() |
Examination about the effect that magnesium sulfate doses give to neonates on P2-507 mother Yumi Konishi 1) 2), Takako Yamauchi 3), Masanori Takeuchi 1), Masako Watanabe 1), Hiroki Mase 1), Tray Tadashi Nomoto 2), Naoya Inukai 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2012. |
---|
![]() |
Collagen diseases of lung high blood disease merger pregnant one case that was able to give birth by use of P2-508 epoprostenol safely Emi Otani 1), Keiko Fukunaga 1), Kuwata gain rare 1), Takuma honest 1), Katsuhiko Tada 2), 更科俊洋 3), Hiroshi Matsubara oneself 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2012. |
---|
![]() |
P2-509 1 case of valacyclovir treatment lactating women who avoid the termination of breast-feeding by the proposal of pharmacist : Consideration from pharmacokinetics prediction of acyclovir administration infant through breast milk 大久保正1), 田中真理子2), 大久保七枝3), 大久保節子4), 大久保美穂5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2012. |
---|
![]() |
An attitude survey for the pregnant woman nursing mother of the pharmacist in the P2-510 this hospital and future problem Bush clover Ayumi, Group bridge Yuki, Tomoko Suzue Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2012. |
---|
![]() |
Relation of the pharmacist to vascular pain in the use of the mug cent (R) note for the P2-511 early or threatened labour Masae Tsuji, Morihiro Okada, Yu Kanetani, Kimi Sakata, Hisae Miyata, Hiroaki Mizuno, Origin of Takeda, It is moisture in the west Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2012. |
---|
![]() |
About an effect of the ritodrine hydrochloride in the P2-512 early or threatened labour Eriko Nakano 1), Noboru Okamura 2), Kazumoto Nakamura 2), Keiko Teshima 1), 小川智孝 1), Iwaki Akifumi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 463-463, 2012. |
---|
![]() |
Use fact-finding of medical supplies in P2-513 pregnant woman and the nursing mother 平舩寛彦 1), Takeshi Chiba 2), Soichiro Kimura 3), Hideo Ueda 3), Yasunori Morimoto 3), Katsuo Takahashi 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2012. |
---|
![]() |
Pregnant woman in the P2-514 night emergency visit, prescription investigation of the nursing mother 小川智孝 1), Keiko Teshima 1), Eriko Nakano 1), Small wasabi 1), Yuko Soga 1), Iwaki Akifumi 1), Naoki Nishikawa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2012. |
---|
![]() |
Relation of the pharmacist for the P2-515 nursing mother Yuri Yoshino picture, Akira Hori charges, Suzuki sheath, Tanaka reason princess, Yoko Yonekawa, 酒井欣嗣 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2012. |
---|
![]() |
P2-516 Comparison of neo-percamin (R) S and Marcaine (R) 0.5% in caesarean section during spinal anesthesia 野村美枝1), 後藤拓也1), 中島誠1), 森理惠1), 相澤佑佳1), 熊谷隆浩1), 三島信行1), 高橋雄一郎2), 川鰭市郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2012. |
---|
![]() |
Search of the instruction method for the purpose of the uneasy reduction to the medication of the P2-517 pregnant woman 石田諭史 1), Noriko Tsuchiya 2), Haru Sato or 1), Naoyuki Yakura 2), Junko Matsuoka 2), Motomu Kobayashi 2), Masakazu Miyachi 2), Tetsuro Yumoto 1) 2), Shotaro Sakurai 1), Kenjiro Inaba 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2012. |
---|
![]() |
The present conditions of the folic acid supplement intake in the P2-518 pregnant woman Yuka Kobayashi 1), Taku Ohara 2) 3), Yuriko Murai 2) 4), Metoki Konin 3), Hiroshi Sato 1), Jun Imai 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 464-464, 2012. |
---|
![]() |
Case study about the effect on milk transitivity and infants of P2-519 lamotrigine Makiko Morita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2012. |
---|
![]() |
Discussion of questionary survey and the improvement policy for the medicine of P2-520 pregnancy, the nursing mother Fumiko Miyoshi, Nao Matsushige, Takafumi Izumo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2012. |
---|
![]() |
Making of the continuous care seat and individual guidance tool for the medicine remedy patients for diabetes in the P2-521 health insurance pharmacy Tomoko Miyazaki, Tanaka evening K, Miyoshi Kawakami, Tomoji Yoshiyama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2012. |
---|
![]() |
Hypoglycemic recognition investigation in patients with P2-522 diabetes Toshifumi Miyamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2012. |
---|
![]() |
Action to drug control instruction using P2-523 CGM results Taku Ito 1), Kazuhiro Yoshida 2), 今田愛也 1) 3), Yayoi Otani 1), Jun Ozawa 1), Mayuko Soma 1), Yoichi Sasaki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2012. |
---|
![]() |
P2-524 Clinical evaluation of the DPP-4 inhibitor vildagliptin : Study in switching patients from sitagliptin phosphate hydrate 長橋かよ子1), 田中裕子1), 杉本三千代2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 465-465, 2012. |
---|
![]() |
Action of the diabetes pharmacotherapy support by the pharmacist in the P2-525 convalescent rehabilitation ward Kato Toyonori, 高井希依, Ai Uno, Shinobu Tsukatani, Naoko Shinoda, Megumi Sakashita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2012. |
---|
![]() |
About effect of the oral hypoglycemics on P2-526 Alzheimer disease Satoshi Shimizu, Hiroyuki Horiguchi, Masayuki Tamura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2012. |
---|
![]() |
About the combination of P2-527 liraglutide and SU medicine situation 森祐美子1), 杉山喜久1), 山西香織1), 和田恭一1), 老田章1), 小原延章1), 桑原健1), 槙野久士2), 岸本一郎2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2012. |
---|
![]() |
Significance of HDL - cholesterol reduction by the lipid-lowering medication probucol for P2-528 patients with diabetic nephropathy Ishida early Sachimi 1), 佐々木英久 1), Kiyoshi Sakuma 2), Endo Valley 3), 松尾和廣 1), Tomoko Watanabe 1), Etsuko Shinohara 1), Masaka Wataru 2), Koji Shirai 3), Takashi Yoshio 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2012. |
---|
![]() |
Elucidation of hyperoxide-producing increase by terminal saccharification product (AGEs) in P2-529 diabetes and the depression effect mechanism with the pravastatin 永味千枝 1), Moat Hideo 2), Chigusa Kikuchi 3), Masayoshi Takeuchi 4), 松永民秀 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2012. |
---|
![]() |
Examination of the use situation and the usefulness of the P2-530 DPP-4 repressor alogliptin 山下真由美1), 吉岡大樹1), 藤田有紀子1), 藤田成裕2), 嵩下浩子1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 466-466, 2012. |
---|
![]() |
Action to a medication continuation plan at disaster development for patients with P2-531 diabetes Rina Suzuki 1), Hidenori Nakamichi 1), Kazumi Kawamura 1), Mitsuru Shiokawa 1), Genma Rieko 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2012. |
---|
![]() |
For qualitative improvement of ... diabetes medical treatment instruction to think about the efficacy of the P2-532 "DM theater" Keiko Imai 1) 2), Masako Morimoto 1) 3), Ueda Kosuke 1) 4), Yutaka Maruyama virtue 1) 5), Hiroshi Sasaki enthusiast 1) 6), Mayumi Kitajima 1) 7), Takahiro Shiga 1) 8), Motoki Miyashita 1) 9), Reiko Nakano 1) 10) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2012. |
---|
![]() |
Screening investigation about diabetes of patients who received P2-533 cancer chemotherapy 冨 ヶ Yuki Hara 1), Shuichi Nawata 1), Tokumaru falcon flat 1), Nobuko Wada 2), Yuki Iwasaki 2), Mieko Miyazaki 1), Tadashi Yamakawa 3), Shinya Hashimoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2012. |
---|
![]() |
Examination of the clinical response of sitagliptin and the glimepiride combination therapy in patients with P2-534 type 2 diabetes 大島聡子, 坂下舞, 難波由里子, 紙屋めぐみ, 笹山祐布子, 新井亘, 増田裕一 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2012. |
---|
![]() |
Contribution to the instruction by the pharmacist at the P2-535 GLP-1 analog induction and the effect of treatment improvement Noriko Ishida 1) 2), Tatsuya Ono 1) 2), Tokuyama still I 2), Hideyuki Nishida 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2012. |
---|
![]() |
Examination of the utility of the class for diabetics in P2-536 diabetes education inpatients Harumi Teramoto 1), Yuko Nakagawa 1), 城尾晃太 1), Shinichiro Matsuda 1), Sakie Senoo 1), Maze Hisanori 1), Yuki Ichihashi 2), Megumi Ito 2), Persimmon castle Yasuyuki 2), Maho Kikuta 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 467-467, 2012. |
---|
![]() |
Evaluation after the business training of the diabetes pharmacotherapy on-site training in the P2-537 prior learning Chigusa Kikuchi, 松永民秀, Tadashi Suzuki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2012. |
---|
![]() |
Evaluation about the diabetes management from the laboratory values of patients receiving DPP4 inhibitor by the P2-538 multicenter conjugation 竹内崇浩 1) 2), Ito Atsuo 1) 2), Sayaka Azuma 1) 2), Hirokuni Kataoka 1), 石下宏征 2) 3), Minoru Sakata 3), Toshiko Ogawa 2) 4), 1, Kotobuki, Sekine 2) 4), Yuki Nishimura 2) 5), 河野博充 2) 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2012. |
---|
![]() |
Examination about the index of the insulin secretional capacity in the P2-539 drug choice Kazutoshi Fukumori Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2012. |
---|
![]() |
The case that a glycemic control came to have poor by the self-administration to the P2-540 induration site Takao Koyama 1), 舩瀬芳子 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2012. |
---|
![]() |
P2-541 Research and discussion of changes in the HbA1c by prescription change from Sitagliptin to Alogliptin 廣瀬浩一1), 齋田正和1), 本由美1), 松井健一1), 岡本智枝1), 金本秀之2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2012. |
---|
![]() |
Attitude survey for hypoglycemia in the P2-542 this hospital Great Yumiko Tsuyama, Shuhei Suzuka, Fujita Aoi, The Aya Yamamoto beauty, Kazuya Hirata, Naoyuki Matsumoto, Kazuki Tago, Miki Nakamura, Person of moat Yumiko, Naoki before yellow Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 468-468, 2012. |
---|
![]() |
Examination about the efficacy of DPP-4 inhibitor building Doug re-Putin in patients with P2-543 type II diabetes mellitus Step Masaaki Hayashi, Rie Ueno, Anzai 1,000 folds child, Shogo Nakamura, 杉本更絵子, Yukihiro Hayakawa, Kazue Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2012. |
---|
![]() |
P2-544 EBM of TETOHUXTLE: Challenge from trace blood samples of multi-item clinical examination 富岡節子, 村田和子, 久保博昭 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2012. |
---|
![]() |
A questionnaire about the insulin proper use in the P2-545 Fujinomiya Municipal Hospital and the correspondence Mariko Ijiri, Osamu Kitamura, Kazuo Katsumata, Hiroshi Kawaguchi fruit, Yoshinori Kobayashi, Yutaka Kobayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2012. |
---|
![]() |
Induction of the simple suspension method in the P2-546 critical care center Rie Hirai 1), Kozono Kouki 1), One Makoto Hayashi 2), Oyamada Hanako 3), Hazuki Sakamoto 3), Eriko Suzuki 1), Washisawa Takahiro 4), Mitsuru Honda 2), Katsunori Yoshihara 2), Kenji Nishizawa 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2012. |
---|
![]() |
About the drug information offer in the P2-547 lifesaving ward Hiroshi Tanaka period 1) 2), Tadashi Nanba intellect 1), Your forest sect 1), Toshitaka Takenouchi 1), Isao Saito 2), Junichiro Murayama 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2012. |
---|
![]() |
Contribution and evaluation to team approach in medical care by the NICU permanent residence of the P2-548 pharmacist Akiko Tomota 1), Misako Suzuki 1), Ritsuko Miyajima 1), Hideya Kokubun 1), Rumiko Kondo 1), Hajime Matsubara 1), Kazuo Yago 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 469-469, 2012. |
---|
![]() |
Activities of the pharmacist in the team approach in medical care in the P2-549 this hospital ICU 赤羽理也 1), Eriko Tanimoto 1), Charcoal Masaki 1), Yasuyuki Tsujita 2), Yutaka Eguchi 2), 寺田智祐 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2012. |
---|
![]() |
Comparison of two kinds of urinary drug screening kits (try age DOA and Monitect-9) in the P2-550 acute poisoning Masayuki Chuman, Toru Imai, Takako Sakagami, Toru Kitano, Norikazu Kikuchi, Morio Kaburagi, Zenichi Yoshida Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2012. |
---|
![]() |
About the contribution of the pharmacist in the P2-551 intensive care unit Hiroshi Tsujimura, 橋冨 Yayoi, Jun Taniguchi, Atsushi Nakamura, Naomi Kuroki, 吉野裕統 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2012. |
---|
![]() |
Relation of the pharmacist in the P2-552 second emergency care organization Junichi Isogai 1), Shinji Ito 1), Hiroyuki Matsunaga 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2012. |
---|
![]() |
About the action of the pharmacist in the P2-553 ICU half day permanent residence Valley water Kumiko, Hiroyuki Yamane, Takeshi Shimada, 邑上達也, Masato Ishii, 萩原眞理, Yoshiaki Kita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2012. |
---|
![]() |
Participation of the pharmacist in rt-PA intravenous-injection treatment for the P2-554 ischemic cerebrovascular disease acute phase 1 related to Kiuchi), Yumiko Kikuchi 2), Mieko Kuroiwa 2), Toru Ooi 1), Takashi Higuchi 3), Akiko Goto 4), Shozo Goto 4), Kazuo Nakajima 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 470-470, 2012. |
---|
![]() |
Change ... of contribution - drug information offer number and the number to the patients security of the P2-555 ICU permanent residence pharmacist of pre-Abo id examples Yuka Ogi, 熊倉裕昌, Wataru Arai, Yuichi Masuda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2012. |
---|
![]() |
Contribution to the medical security by the P2-556 ICU charge pharmacist and a medical cost reduction effect 今浦将治 1), Kowata male solstice 1), Takashi Igarashi 1), Takeshi Yamaya 1), Hiroyuki Takahashi 2), Hiroshi Sugano 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2012. |
---|
![]() |
Action of the resident pharmacist for the incompatibility to occur in P2-557 ICU Shoichi Imanaka, Takeshi Yamamoto, 三浦幹剛, Hideyuki Shimizu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2012. |
---|
![]() |
Injection sterility preparation duties in the P2-558 NICU satellite pharmacy Ayumi Sanada 1), Keita Hirai 1), Emiko Senoo 2), Masako Yonekura 2), Tatsu Sakamoto Ichiro 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2012. |
---|
![]() |
Improvement of the drug-related duties of the operation region by the intervention of the P2-559 pharmacist Sato Shiori, Junko Arima, 下堂薗権洋, Yasuo Takeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2012. |
---|
![]() |
Drugstore duties improvement by the P2-560 joint medical treatment management (CDTM) induction 小川壮寛 1) 2), 中島利裕 1), Yoko Moriyasu 1), Akira Matsushita 3), Kenichi Shimada 2), Takashi Egawa 2), 五味田裕 2), Masashi Takahashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 471-471, 2012. |
---|
![]() |
About the TDM duties induction by the many types of job using P2-561 electronic chart system Tomoyuki Kato 1), Stone Kenji Hama 1), Tomoko Narishima 1), Furukawa first arrow incense 1), Mika Shiotsuka 2), Capital storehouse Hiroko 3), Minoru Doi 4), Takahiro Shimizu 4), 本郷偉元 5), 堀治 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2012. |
---|
![]() |
P2-562 Humira introduction by pharmacists and their effects : Questionnaire after the introduction results and analysis of consultation contents 益成宏1), 豊岡慶子1), 大森義朗1), 佐伯久美子1), 山本佐和子1), 野原寛章2), 斉藤満2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2012. |
---|
![]() |
Questionnaire findings about the way for the doubt inquiry of P2-563 physician and the pharmacist The Iioka cord beauty Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2012. |
---|
![]() |
Action of the perioperative glycemic control by the pharmacist for patients in P2-564 orthopedics department 古川静保 1), Nobushi Yamamura 1), Katsuya Nakano 1), Maki Nomoto 1), Yuka Tsutsui 1), Yukinobu Nishii 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2012. |
---|
![]() |
Active contribution and MBD treatment algorithm making of the pharmacist in the P2-565 outpatient department patient on dialysis Junko Onishi, Yuichiro Hayashi, Plum Miyoshi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2012. |
---|
![]() |
Prescription input - of action - pharmacist to the pain control in the P2-566 orthopedics region Takamitsu Fujioka 1), Masatoshi Saito 1), Yoshikazu Kobayashi 1), Takashi Ito kernel 1), Masayoshi Nishi beauty 1), Reiko Fujino 1), Shinya Abe 1), Koji Masubuchi 1), Takashi Inoue 1) 2), Atsuta Koichiro 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 472-472, 2012. |
---|
![]() |
Action ... of the new duties development Hitachi General Hospital Pharmaceutical Affairs Bureau of the pharmacist in the team approach in medical care-shaped in the P2-567 Pharmaceutical Care rounds - next generation Yoshifumi Aoyama 1), Sachiko Saito 1), 澤畠孝幸 1), Masayo Okawa 1), Slightly dried fish Yuka 1), Masashi Onozaki 1), Shusaku Ito 2), Tsuyoshi Ando 2), Hideyuki Mishima 2), Tsunehiko Maruyama 2), Yasushi Usami virtue 2), Toshiro Kamoshita 2), Kazumitsu Ueda 2), Yasunori Watanabe 2), Shinji Hirai 2), Okumura Minoru 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2012. |
---|
![]() |
Confirmation ... of the effect loss of the drug in one - declare of brain death associated with brain death lower organ donation as P2-568 pharmacist Yuichi Hanada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2012. |
---|
![]() |
About P2-569 Himeji medical center ward pharmacist resident duties (the third report) action - of in connection with - CRC with the ward charge pharmacist Yuka Takahara 1), Morishita Kumiko Hara 2), Yoko Nakata 2), Hiroshi Beppu kernel 3), Hisashi Yagi Yoshiko 1) 2), Katsuaki Kobayashi 1) 2), Yasuo Wada 2), Shinki Nishimura 4), Yoshiro Mochizuki 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2012. |
---|
![]() |
Safety of medicine evaluation - antitumor agents (hematologic cancer) - that we saw it from P2-570 clinic dose, an exposure level and a nothing toxic level, an exposure level Tsuneo Kodama 1), Nao Oguri 2), Okada auspicious sign 2), Kazuyuki Saito 3), Shunsuke Ono 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2012. |
---|
![]() |
Action to a trial in the P2-571 psychiatry Hirotaka Suzuta 1), 福山雄卯介 1), Fujita good memory 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2012. |
---|
![]() |
Utilization ... of system maintenance and the tool checked at action ... investigational new drug administration time of the pharmacist to conduct P2-572 injection anticancer drug trial safely Yoko Iguma 1), Old real name Tsu child 1), 1 related to Kamiyama), Bird mouth Naoko 2), Shiori Yoshida 2), 因藤伊織 2), Natsu Matsumoto period 2), Yoshiko Ishizuka 1), Toshiya Katsura 1), Kazuo Matsubara 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 473-473, 2012. |
---|
![]() |
The introduction of IT of P2-573 trial secretariat duties and application of database Akio Tanaka, Yukiko Ishizuka, 百合草憲勇, 栗原康彰, Isao Hasegawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2012. |
---|
![]() |
Consideration to P2-574 investigational new drug temperature management deviation correspondence Rieko Miyashita, Chiaki Tagawa, Katsuyuki Tanaka, Motoko Munemura, Naoya Saito Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2012. |
---|
![]() |
Examination of the CRC duties efficiency using P2-576 iPad Katsuya Yamashita, Junichiro Hayashi, Yukako Okuyama, City lower Yumi, Kaoru Yoshii, Miho Miyamoto, Masayo Atsuko Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2012. |
---|
![]() |
Action for the construction of the clinical studies enforcement support system in the hospital attached to P2-577 Nippon Medical School 1, Chinaga, Takase), Asuka Sekiguchi 1), Yukiko Sakamoto 1), Yuki Manda 1), Michiko Sakata 1), Kumi Yoshii 1), Naomi Takamura 1), Yoichi Sato 1), Shiro Katayama 1), 2), Masahiro Yasutake 1), 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2012. |
---|
![]() |
Regional medicine cooperation of Masuda-shi that did communication of the Rev. P2-578 three society thickly Nishizono Kenro 1), Takahiro Ohba 2), Hiroshi Takamura 2), Takashi Naito period 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 474-474, 2012. |
---|
![]() |
Development of medical care, the care information communalization software in the treatment at home by the P2-579 university-industry research collaboration Arai country three 1), Masako Hashimoto 1), Matsuzaki A 1), Kanako Hashimoto 1), 加茂川慶吾 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2012. |
---|
![]() |
It is ... through illness medicine cooperation - inhalation instruction check seat in the inhalational instruction of the P2-580 outpatient Hirata detailed child 1), Hanao Norihide 1), Yukari Omae 2), Yoshiko Washimi 3), Kuramoto clothes beauty 4), Masaru Yoshimura 4), West horse illumination 4), Onishi still 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2012. |
---|
![]() |
Examination about the way of the actual situation of the receipt of "the drug control summary" in the P2-581 health insurance pharmacy and the future illness medicine cooperation Kazuhiro Watanabe 1), 千島巳幸 2), Kazuhiro Aga 3), Tomoyuki Hamamoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2012. |
---|
![]() |
It is ... led by patients with action ... asthma bronchial of the illness medicine cooperation in the P2-582 this hospital Yayoi Kuroyanagi 1), Chie Yoshimura 2), Kazuko Nagasawa 3), Shinichi Sumimoto 4), Hirokazu Horikoshi 5), Harue Kinoshita 1), Mikiko Fujii 1), True 1 between the small), Takashi Doi still 1), Masahiro Ishizu 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2012. |
---|
![]() |
Action ... of compliance investigation - medicine medicine cooperation after the renal disease education hospitalization in the P2-583 this hospital Maiko Tanaka 1), Misaki Watanabe 2), Manabu Yokota 3), Friend waterfall Kazuto 1), Chie Suzuki 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2012. |
---|
![]() |
Future problem toward significance and the drugstore duties enhancement to perform meeting a demand of the prescription which P2-584 laboratory study information was attached to Yoshiaki Kimura, Mieko Itakura Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 475-475, 2012. |
---|
![]() |
Investigation about the utility of "the drug "management" reporting book" which we sent for high quality medical care without interruption by P2-585 security for local medical care and a welfare institution Akiko Sandai 1), Hiroki Ogata 2), Chika Kai 3), Ichihara length person 1), Okinoshima Yuki 1), 茂亨嘉 1), Satoshi Sato boatman 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2012. |
---|
![]() |
Action to P2-586 children treatment at home Yoshiyuki Akimoto 1), Bridge Eriko Oka 1), Noriko Tamai 2), Hideko Ozaki 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2012. |
---|
![]() |
Trial of the inhalational instruction medicine medicine cooperation for children with P2-587 children asthma bronchial Minako Mori 1), Harvest festival Hanae 1), Emiko Iguchi 1), Takahashi Hiromitsu 1), Jun Isozaki 2), Mitsumasa Yamagata 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2012. |
---|
![]() |
About the present conditions of the case that became the changing hospital using P2-588 stroke regional medicine cooperation pass Sukeyuki Tsuchiya 1), Hiroyuki Fujimura 1), 牛越聡 2), Koji Teratani 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2012. |
---|
![]() |
About medicine medicine cooperation about the proper use of patients receiving P2-589 terra pre-building Misa Takenaka, Tei Hara Expo, Takayuki Kinoshita, Hiroshi Hidaka, Toshihiko Ushio, Kojiro Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2012. |
---|
![]() |
P2-590 Osaka Prefectural respiratory apparatus, present conditions of the inhalational instruction in the allergic medical center neighborhood health insurance pharmacy Fumie Shimazu, Keiko Fujita, Saya Komiyama Kei, Gilt bronze Yoko, Kazuko Shimura, Nobuhisa Fukushima Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 476-476, 2012. |
---|
![]() |
It is ... for proper use of action ... dabigatran of the medicine medicine cooperation that we maintain the joint study session with the P2-591 local health insurance drugstore 瀧祐介, 松下久美, 日下豊史, 栗原梢, 小柳愛子, 後藤貴裕, 安藤奈津子, 山城博和 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2012. |
---|
![]() |
Relation of the pharmacist in the P2-592 smoking cessation outpatient department Momose Hazu child 1), Toshi Yokoyama period 1) 2), Jun Sasaki 1), Haneda enthusiast example 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2012. |
---|
![]() |
The making of a part of the medicine medicine cooperation in the P2-593 outpatient department chemotherapy and the information communalization tool which we did and use Seiko Fujii 1), Tatsuya Hayama 1), Onuma sprouting 1), Kentaro Uejima 1), Tomoko Nakata 1), Daisuke Tsutsumi 1), Ogre storehouse Kazuyo 2), Moe Otani 3), Masatoshi Hayasaka 1), Zenichi Yoshida 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2012. |
---|
![]() |
Than ... warfarin and a combination case thinking about importance of the medicine medicine cooperation from P2-594 drug interactions of the miconazole gel ... Kazumi Kimura, Hiroko Iwamura, Hiromi Nagai, Kanako Sakashita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2012. |
---|
![]() |
The medicine notebook bringing enlightenment motion of P2-595 Yodogawa Christianity hospital and investigation of the medicine notebook bringing rate 琢磨寛孝 1), Kyoji Terasawa 1), Tomoaki Katayama 1), Inoue sacred night child 1), Uchiyama eyes 1), Tomoko Yamashita 1), Kenichi Miyata 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2012. |
---|
![]() |
Making - of action (the first report) - brochure, the home medical care support drugstore map to home medical care support in P2-596 treatment at home promotion Committee Yu Aoki 1) 2), Makoto Iwashita 2) 3), Edge Hiroaki Sawa 2) 3), Yasushi Kuramoto 2) 3), Takeshi Omori 2) 3), Kazue Hayashi 2) 3), Miwa Tanaka 1) 2), Ryo Komatsu 2) 3), Mikiro Hanaoka 3), Kazumi Yoda 1) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 477-477, 2012. |
---|
![]() |
The example that we inquired of about a doubt in the patients whom renal function degeneracy was seen in by eGFR described in P2-597 out of the hospital prescription Miki Yamamoto, Masayuki Okada, Shiho Kato, Yamagata Natsumi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2012. |
---|
![]() |
Present conditions investigation of the inhalational instruction by the pharmacist under P2-598 Kagawa 篠永浩 1) 2) 3), Hiroki Kondo 1), Sakae Matsuoka virtue 4), Yasushi Nishiyama 5), Yohei Maruyama 2) 6), Yutaka Nimura 2) 3) 6), Seiji Nagaoka 7), Hiroyuki Nakamura 3) 8), 南木伸基 3) 9), Tadashi Kamei 3) 10) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2012. |
---|
![]() |
Result of the physician, pharmacist collaboration "periodical health consultation" for P2-599 mountains depopulated area inhabitants Tomishige Eri lawn 1), Akio Kochi 1), Masaharu Hori 2), Fuminori Ezaki 1), Mika Nakagawa 1), Capital Ryoichi 1), Keiko Narumi 1), Junichiro Sonoda 1), Kei Sato wound 3), Toshiro Motoya 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2012. |
---|
![]() |
The present conditions of the action to treatment at home in the P2-600 health insurance pharmacy and future problem 高橋恵美利 1), Misato Kurabayashi 1), Kaoru Kimura 2), Yuko Okada 1), Kayo Murata 1), Masayuki Sekizuka 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2012. |
---|
![]() |
Examine P2-601 disease; the examination about the way of the information on adverse drug reactions management for the medicine medicine cooperation Seiichi Kobayashi, Uchida Kei greens child, Hitomi Hakamada, Kurita A, Moeko Hara, Keiko Iwasa, 長嶋一泰, Takashi Adachi, Atsushi Yamashita, 西尾益治 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2012. |
---|
![]() |
Action of the medicine medicine cooperation in the P2-602 outpatient department cancer chemotherapy Koji Ichiki 1), Tomoyo Nakajima 1), Yorikazu Furuya 1), Moji Keiko 1), 井手飛香 2), Ishii Yuta 3), Fumihiro Morishige 3), Masaharu Takahashi 3), Kojiro Takahashi 2), Asahara Minoru straight 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 478-478, 2012. |
---|
![]() |
The present conditions and problem of infection measures at the at-home fluid therapy in the P2-603 this hospital Kazuko Takahashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2012. |
---|
![]() |
Present conditions of the action ... acute phase Hospital in P2-604 Kumamoto stroke cooperation pass, pharmacist section and new development ... Akira Tokunaga oneself 1), Takayuki Taniguchi 2), Etsuko Toyonaga 3), 楊祈恵 4), History of Kashima 4), Yuki Fujimoto 1), Harumi Tanoe 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2012. |
---|
![]() |
Action ... in inflection method - this hospital of the P2-605 medicine notebook Person of moat Yumiko, Tomoko Katsube, Fujita Aoi, Kazuya Hirata, Naoyuki Matsumoto, Kazuki Tago, Shuhei Suzuka, Great Yumiko Tsuyama, Miki Nakamura, Naoki before yellow Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2012. |
---|
![]() |
It is the activity in the triage area in the institution other than the early days in the P2-606 stricken area Koji Takizawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2012. |
---|
![]() |
The polypharmacy patients whom it became the change of prescription triggered by P2-607 earthquake disaster, and a side effect reduced Shinobu Sugiyama 1), Yasufumi Sawada 2), Doi reason Yuko 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2012. |
---|
![]() |
... which prevents future pharmacist image ... avoided death that it showed from P2-608 Great East Japan Earthquake hospital practice report and the reflection point 坂京彙子, Emiko Asakura, Tetsuya Ohashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 479-479, 2012. |
---|
![]() |
Action of the storage medical supplies use for a P2-609 size scale disaster Masaki Mizuguchi 1), Kan Yutaka Otaka 1), Motohiro Ishibashi 2), Takafumi Ichida 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2012. |
---|
![]() |
P2-610 ... [you work on Republic of Turkey size scale earthquake disaster medical care support in 2011 and report it] ... (make use of experience by the republic, Republic of Haiti dispatch in Myanmar) Haruhiko Sato 1) 2), 高力俊策 2) 3), Koichi Ikehara 2) 4), 渡慶次賀博 2) 4), 伊禮武 5), Katsuyo Uehara 1), 知花幸仙 5), 伊波潔 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2012. |
---|
![]() |
Relations with dust and the cough symptom after the tsunami in the P2-611 Great East Japan Earthquake Hiroyuki Nanba 1), 江谷勉 2), Hideshige Takada 3), Satoshi Suzuki 4), Kunihiro Fukushima 5), Mitsuhiro Okano 5), Norio Sahashi 6) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2012. |
---|
![]() |
About prescription correspondence in the early period of Great East Japan Earthquake in the P2-612 this hospital Takashi Sasaki 1), Yuta Suzuki 1), Sugano sum 1), Tetsushi Takeda 1), History of Yasushi Iwabuchi 2), Lacquer Tachi rare 3), 追木正人 1), Hiroyuki Abe 1), Jin Wagatsuma 4), Akihiko Furuta 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2012. |
---|
![]() |
Practical skill identification test (initial interview) for the P2-613 trainee 角岡 is elegant, Flatter; up size Jiro, Tomoko Okamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2012. |
---|
![]() |
An investigation and evaluation about the compounding of medicines error of the trainee in the P2-614 long-term business training Naomi Nishioka, Yu Ono will, Junko Usami, Katsumi Kitagawa, Shiho Ishida, Shinge Keiko, Kuridani Yoshitaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 480-480, 2012. |
---|
![]() |
The present conditions investigation for the P2-615 long-term business training end student and the evaluation Osamu Takeshita example, Makoto Shigematsu, Masako Ono, Satoko Katsuragi, Masahiro Moriyama, Hilum Muneo Hayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2012. |
---|
![]() |
Than the questionary survey to effect - trainee and the instruction pharmacist whom P2-616 business training brought ... Chika Okumura, Junko Totsuka, Yoshiyuki Shibayama Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2012. |
---|
![]() |
Fact-finding about the abstract in the P2-617 business training institution and the mixture measurement compounding of medicines method Kunihiko Fujiwara 1), Makoto Matsuura 2), Takeshi Chiba 1), Katsuo Takahashi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2012. |
---|
![]() |
Investigation about the achievement degree evaluation of a trainee and the instruction pharmacist in the P2-618 Hospital business training Shigekazu Watanabe, Eri Nakamura, Watanabe many Maki, Isao Murakami, The Saito hundreds of branches beauty, 土屋雅勇 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2012. |
---|
![]() |
The action of the resident teacher in the business training in the hospital attached to the P2-619 Nagoya University School of Medicine thinks about medical treatment from resuscitation / living body information monitor, auscultation training 椿井朋 1) 2), Yukihiro Noda 2), Teruhiro Mori 2), Sakiko Nishikawa 3), Yoko Hibi 4), Masaya Hasegawa 4), Kiyobumi Yamada 4), Makoto Nakao 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2012. |
---|
![]() |
Advance training due to the infection control part of the P2-620 six years system pharmacy student 野口雅久 1), Ippei Tanaka 1), 中南秀将 1), History of Sen Matsunaga 2), Yutaka Nasu 2), Yoko Yamada 2), Kanako Yamada 2), Naoto Koike 2), Kenta Utsumi 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 481-481, 2012. |
---|
![]() |
Utility of the information exchange society between a university, the hospital about the P2-621 Hospital business training Hideo Kurosawa 1), Yukiko Kasatani 2), 3, Toyofusa, Kobayashi), Yoshikatsu Shinoda 4), Hiroko Tai 5), Kyoji Terasawa 6), 長谷圭悟 7), 野村剛久 1), Hiroko Matsui 8), Eiichi Maruta 9), Tajima Shigetoshi 7) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2012. |
---|
![]() |
Action ... using evaluation ... automatic medication record bottle (MEMS bottle) of the antiHIV medicine simulated medication experience-based training in the P2-622 long-term business training Hiroshi Kimura 1), Well hilum Keiko 1), Mamoru Tanaka 1), 末丸克矢 2), Hiroshi Araki positive 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2012. |
---|
![]() |
Examination of the student questionnaire findings for the P2-623 clinic business training and future problem Manabu Abe, Toshinari Asakura, Naoko Iimura, Kazuyuki Ueno, Kenji Kawano, 齊藤幹央, 本澤忍, Noriaki Yokou, Hiroyuki Wakabayashi, Kenichi Watanabe Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2012. |
---|
![]() |
An action and evaluation of the pharmacy student business training in the P2-624 this hospital Yuki Itagaki, Hideko Maki, Akiko Ishiyama, Koji Wada Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2012. |
---|
![]() |
Result of the practice of pharmaceutical problems to be carried out by P2-625 individual work Michiru Watanabe 1), Naoko Takeda 1) 2), Tomoko Yoshii 1), Kazu Kojima child 1), 小清水治太 1), Junko Ogawa 1), Junichi Tajima 1), Kiyoshi Mihara 1), Oil field Masaki 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2012. |
---|
![]() |
Action of the business training in the cottage-hospital out of one of P2-626 equivalence corporation 川岸諭佳 1), Emi Watanabe 1), Sei Ikegami 1), Kengo Umehara 2), Keisuke Otsu 2), Miyamaru Akina 2), Yoshiko Wada 2), Young book Azusa 2), Shintaro Takayama 2), First mountain Tae 2), Masato Kazama 2), Hideki Sato 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 482-482, 2012. |
---|
![]() |
Development of the teaching materials tool for the mixture compounding of medicines acquisition using iPad for the P2-627 pharmacy school trainee Sada light, Kazuhiko Yamaji, Ida Hiromi, Shin Matsubara, Hiroki Ichikawa, Sendo Toshiaki Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2012. |
---|
![]() |
It is ... from the results of the attitude survey of ... pharmacist with the role of the pharmacist participating in P2-628 "business true taking lessons previous learning" Akiko Murata 1) 2), Yukiyo Nakao 1) 3), Yuko Matsuda 1), South Eriko 1) 4), Chika Yamanaka 1) 5), Takashi Hatae 1), Chikako Numata 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2012. |
---|
![]() |
Analysis using the structure equation modeling of the factor to influence student satisfaction in the P2-629 Hospital training Hideki Hayashi 1), Shinji Koshio 2), Tomoki Tsuji 1), Kazuyuki Inoue 1), Satoshi Uchino sincerity 1), Kazuhito Kosuge 1), 宮嵜靖則 1), Hiroshi Yamada 1), Kunihiko Ito 1), Yoshiyuki Kagawa 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2012. |
---|
![]() |
Of the antineoplastic preparation for the pharmacy school business trainee in the P2-630 this hospital, actually Upper ノ step Tomori 1), 権玲奈 1), Yoshida Matsumi 2), Maeda Yuka 1), Takahiro Kurokawa 1), Tamami Tomita 1), Koichi Nawata 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2012. |
---|
![]() |
Identification test (the last inspection) of the P2-631 business training Flatter; up size Jiro, 角岡 is elegant, Tomoko Okamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2012. |
---|
![]() |
Problems of the six years system business training by the P2-632 student questionnaire and future problem examination Hiroshi Ohara 1), Taku Ohara 2), Nobuyuki Midorikawa 1), Takashi Hatae 3), Keiji Kuramoto 1), 伊藤鍛 1), Akiko Sato 1), Hitoshi Tada 1), Toru Shoji 1), Masataka Hayasaka 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 483-483, 2012. |
---|
![]() |
Fact-finding of a hospital about the patients personal information protection in the P2-633 long-term business training and the medicine-based university Yasuyuki Saeki, 垰越崇範, Takashi Tomita, Kiyomi Shinohara, Furrow well Hiroko, Yasuhiro Kimura, Tree flat Kenji Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2012. |
---|
![]() |
Satisfaction and the understanding degree of program evaluation - learner of the business training in the P2-634 Hospital and the contribution factor Miho Utsumi 1), Hiroshi Onishi High School 2), Sachi Hirano 1), Yuki Fujii 1), Hiroshi Yamamoto 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2012. |
---|
![]() |
An action in the improvement of the ward duties training for the P2-635 pharmacy school life and the evaluation Yuka Kobayashi 1) 2), Kazushi Masuda 1) 3), 仲佐啓詳 1), Hiroshi Nakamura justice 1), Amount of Ariyoshi example 1), Koichi Kitada 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2012. |
---|
![]() |
Examination of the likelihood of the physical assessment application using the P2-636 attachment document information Fuminori Shibuya, Yoshiko Chiba, Miki Nakamura, Ayako Terada, 廣原正宜, Kyoji Taguchi, Jun Toda, Tomoyuki Hamamoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2012. |
---|
![]() |
Evaluation of the physical assessment education stratagem by the PBL type simulator practice in the P2-637 pharmacy school advanced subject Takashi Egawa 1), Kenichi Shimada 1), 小川壮寛 1) 2), Mitsuru Kishimoto Rina 1), Tomishige hemp Saki 1), Junko Tomita 1), Ono Hiroshige 1), Takashi Shibata 1), Masashi Takahashi 2), 五味田裕 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2012. |
---|
![]() |
Learning will investigation of the student by P2-638 vital signs training having changed the disease simulation treatment using the tall handloom ability patients simulator to "a practice type" from "a visit type" Takashi Hashimoto still 1), Nobuyuki Takahashi 2), Emiko Sato 2), Yuriko Murai 2), 平澤典保 2), Yoshihisa Tomioka 2), Tochikubo Katsuyuki 1), Hiroshi Sato 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 484-484, 2012. |
---|
![]() |
Attitude survey of the pharmacy student for the schizophrenia patient with the new curriculum induction of the P2-639 psychiatry region Saito hundreds of branches beauty 1), Machiko Watanabe 1), 土屋雅勇 1), Shinichi Niwa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2012. |
---|
![]() |
Examination of the interactive class style in the great lesson type lecture aiming at the class will improvement of the P2-640 pharmacy student Tadashi Taguchi cord 1), Ichitomo Miwa 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2012. |
---|
![]() |
Evaluation of the early on-site training that adopted the vital signs education in the P2-641 pharmacy school Masahiko Hayashi, Yoshihiro Nishimura, Satoshi Yokoyama, Fence Hidefumi Azuma, Kazuya Ooi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2012. |
---|
![]() |
Recognition investigation of the simple suspension method for the nurses of the P2-642 cancer chemotherapy nursing authorization nurse course Maho Miyazawa 1), Saori Miura 2), Yukihisa Imaizumi 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2012. |
---|
![]() |
P2-643 About the clinical practice in the community-acquired medical facilities of the Sojo University Pharmacy 6 annual student and the effect 瀬尾量1), 藤井績1), 吉岡優一2), 平井信孝3), 後藤慶次4), 緒方健一5), 杉野茂人6), 内田友二1), 松倉誠1), 小田切優樹1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2012. |
---|
![]() |
Follow-up three years after the P2-644 3 annual "medicine-based internship volunteer experience-based training" student attending a lecture Kurio Wasa child, Motomi Konishi, Satoshi Okuno, Yu Yamamoto fruit, Chie Nishikawa, Tomohisa Yasuhara, Kazuo Yanagida, Nakamura three kinds of filial duties, Satoru Sone way, Takeyuki Kawano Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 485-485, 2012. |
---|
![]() |
A workshop reports the action of the pharmacy education by the P2-645 medicine medicine cooperation "what is made as a pharmacist at a disaster?" Toru Imai 1), Isobe good luck 1), Yoko Ito 2), Norikazu Kikuchi 1), Seiichi Saito 3), Takashi Saji 4), Hiruma Kojiro 5), Yuko Yoshiki 6), 1, Sakae, Ishigaki 7), Zenichi Yoshida 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2012. |
---|
![]() |
It is ... more as a result of three years of continuation learning which aimed at the ... patients center medical care practitioner what kind of behavior modification the composite learning of P2-646 EBM X PBL brought a pharmacist Etsuko Tange 1), Masayo Takeuchi 2), Yuriko Matsue 1), Noriko Fujikawa 1), Yukiko Kasatani 1), Kazuyo Maeda 1), Old corner Yuka 1), Matsusaka Tomomi 1), Keiko Matsumoto 1), 高垣伸匡 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2012. |
---|
![]() |
Evaluation of the inconvenient on-site training in connection with P2-647-related welfare University Taiko Masao, Junji Iwashita, Katsumi Kido, Megumi Iimori Yoshiko, Shinichiro Ando, 前田共秀, Keiko Morita Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2012. |
---|
![]() |
The education effect of the student in the P2-648 physical assessment training and search (the first report) of the potential consciousness Masaaki Machida 1), Body marsh Masami 2), Kazumi Ishizuka 1), Yoshikazu Tanaka 1), Shunsuke Shiromizu 1), Haru Sato or 1), Masahiko Shimada 1), Tetsuro Yumoto 1), Shotaro Sakurai 1), Kiyoshi Sugiyama 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2012. |
---|
![]() |
It is result and a problem in the first year a P2-649 medical care system department, the drugstore pharmacist training training to contribute to team approach in medical care by the affiliated hospital cooperation Tadashi Suzuki 1), Satoshi Fujii 1), Keiko Akashi 2), Hirotaka Ohara 3), 木村和哲 1) 4), 金兌勝 5) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2012. |
---|
![]() |
Enforcement of the continuous set training aiming at improvement of the ability in the P2-650 JA Hokkaido public welfare ream for fur Matthew tical care plan making and the ability for discussion Hiroyasu Sato 1) 2), Ryu Kobayashi 1) 3), Hideji Ohara 1) 3), Yu Tanaka season 1) 4), Hiroaki Watanabe 1) 5), Descent from a mountain Koichi 1) 4) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 486-486, 2012. |
---|
![]() |
Examination of the pharmacist training program using the P2-651 TERUMO medical plastic neck Water pond love, 前田幹広, Minatogawa Hiroko, Upper mound Tomoko, Keiso Masuhara Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2012. |
---|
![]() |
Practice and evaluation of the measurement art of dispensing education for the P2-652 pharmacy school six years system postgraduate training life Masato Katsuura, Katsuhiro Fujimoto, Mitsunori Nishikawa, Miho Yamaguchi, 村地康, Yuko Kinugasa, Manabu Takegami, Masako Oishi, Yoshihiro Miwa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2012. |
---|
![]() |
P2-653 Re-evaluation of the knowledge and skills of Hospital long-term practical training [injection preparation] of pharmacy education 6-year one graduating class : That it seemed to accept the new positions who 石塚寛和, 花澤恵美, 永井淳子, 佐々木忠徳 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2012. |
---|
![]() |
The intervention to the initial physician clinical practice program by the P2-654 pharmacist and prospective effect 佐藤紀宏 1), Kumiko Kasashi 1), Takehiro Yamada 1), Yoshihiko Shibayama 1), Junko Yamada 1), Yasushi Miyata 2), Toshitaka Fukai 1), Takeshi Iseki 1) 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2012. |
---|
![]() |
For a pharmacist resident system as the P2-655 six years system postgraduate training Koji Washiyama, Makoto Otsuka, Kojiro Nikami Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2012. |
---|
![]() |
The anticancer drug handling situation (questionary survey for the training participation pharmacist) with the cancer medical institution of the P2-656 our country 牧野好倫 1) 2), Ryoko Udagawa 1), Toru Akagi 1), Reina Nishigaki 1), Small Ido Keiichi 1), Mitsue Hirano 1), 橋本浩伸 1), Haruhiko Sakamoto 1), Genei Shinya 3), Masato Yonemura 3), Reiko Matsui 3), Yasuhiko Ichida 3), Satoshi Izumi Shiro 3), Hiroshi Yamamoto 3), Masashi Kato 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 487-487, 2012. |
---|
![]() |
Accidental ingestion materials of the patients coming to the hospital in accidental ingestion for P2-657 emergency pediatric service are various Tsutomu Tsujimoto, Tetsuo Nishimoto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2012. |
---|
![]() |
Role ... of the medical information engineer of thing - pharmacist whom a pharmacist has for the P2-658 introduction of IT era Kazuyuki Ikeda, Rikio Tsuji, Yukiko Morita, North Keiji, Masayuki Uno Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2012. |
---|
![]() |
Study on inhabitants attitude survey about the P2-659 influenza vaccination and prophylactic intervention 1000, Yokota beauty 1), Yuji Otake 2), Tadashi Eguchi light 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2012. |
---|
![]() |
Effect of the DMSO which gives it to the expression of drug metabolizing enzyme of P2-660 human liver cancer cells 牧寛子, Tomomi Watanabe, Chiaki Fukagawa, Satoshi Muto Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2012. |
---|
![]() |
The thing which we see from patient related consultation and the other medical institutions consultation situation during P2-661 hospitalization Jun Wada, Chieko Yamanaka Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2012. |
---|
![]() |
Evaluation of the circadian rhythm of Parkinson's disease using the P2-662 symptom diary Naoto Nakagawa, Miki Yamamoto, Yuka Takebayashi Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 488-488, 2012. |
---|
![]() |
Characteristic of the patients hospitalized with P2-663 heart failure repeatedly Yukiko Uchiyama 1), Mariko Ooka 1), Akihiro Ihara 1), Mayumi Matsumoto 1), Takahashi sub-Mana 1), Riyusuke Rokusha 1), Tatsu Sada still 1), Keigo Ezaki 1), Tamami Teranishi 2), Takao Maruyama 3) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2012. |
---|
![]() |
Dissolution after the simple suspension of the P2-664 sustained release drug Adalat L lock 越野優希, 石田志朗, 椎野愛子, 神崎姫奈, 山下あずさ, 岡野善郎 Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2012. |
---|
![]() |
Inhibition of resorption of strontium with the P2-665 alginic acid and cesium and eliminant effect Hitomi Harada 1), Yoko Idota 1), Kaori Morimoto 1), Akiko Kobayashi 2), Kakinuma 1, Chihaya), Chihiro Miyajima 3), Kasahara sentence good 3), Taku Ogiwara man 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2012. |
---|
![]() |
Attitude survey of the student athlete about the P2-666 doping The Ikeda future, 初田泰敏, Kenji Ikeda, Sono Kawanishi charges, 西井諭司, Masashi Ogawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2012. |
---|
![]() |
Fact-finding of the P2-667 medical supplies Internet sale Hironari Mizuta, 初田泰敏, Kenji Ikeda, Sono Kawanishi charges, 西井諭司, Masashi Ogawa Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2012. |
---|
![]() |
Action of the health insurance pharmacy that affected the increase of P2-668 smoking cessation-treated patients Eiji Hotta 1), Takasaki lawn world 1), River Takashi 1 liking it), 向畠卓哉 1), Hisako Ito 1), Hideyuki Shinoda 2), Kojiro Takashima 1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 489-489, 2012. |
---|
![]() |
We used P2-669 medical appointment data and are built the prescription publication reservation system in the hospital visiting Kazuaki Hirao 1), Blue Tooru Mori 1) 2) 3), Masaki Abe 1), Keiko Iizuka 1), Tomonori Nakamura 1) 2), Yasushi Yamamoto Jiro 1) 2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 490-490, 2012. |
---|
![]() |
Trial of the new face education through the P2-670 new hiring medical supplies investigation Takawa Hiroshi, Yusuke Tanaka, Takashi Araki University, 金光祥臣, Akiko Ito, Hiroyasu Sasahara, Keiko Arakawa, Seiichi Maruyama, Satoshi Toyama, Hiroshi Sato Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 490-490, 2012. |
---|
![]() |
CJK-P-01 Appling Metabolomics to the Investigation on Anti-Sport Fatigue Effects of Korean Ginseng Given to Professional Athletes Bei Yan1)2), Jiye A1), Guangji Wang1), Ying Zhang1), Weibin Zha1), Linsheng Liu1), Hu xin2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2012. |
---|
![]() |
CJK-P-02 Cyclosporine therapeutic drug monitoring in nephrotic syndrome: which time point to use for a generic product? Du Xiaoli1), Wang Haiyun2), Fu Qiang1), Wang Ke2), Chen Limeng2)3), Li Xuemei2), Zhu Zhu1) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2012. |
---|
![]() |
CJK-P-03 EFFECT OF CO-ADMINISTRATION ATENOLOL ON THE RENAL EXCRETION OF ORAL EXCRETION OF ORAL HYPOGLYCEMIC AGENT METFORMIN HYDROCHLORIDE IN RATS J.X. Ren, Y. Zhou, Y.H Wei, X.A. Wu, G.Q. Zhang, J.P. Zhang Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 493-493, 2012. |
---|
![]() |
CJK-P-04 EFFECTS OF PYRIDOXINE ON THE INTESTINAL ABSORPTION AND PHARMACOKINETICS OF ISONIAZID IN RATS Y. Zhou, J.X. Ren, D. Wang, F. Zhang, Y.H. Wei, XA Wu, G.Q. Zhang, H.G. Duan, L.J. Wang Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 494-494, 2012. |
---|
![]() |
CJK-P-05 A Systematic Evaluation of Ginkgo Biloba Leaves Injection’s Effect on Coronary Heart Disease Yang Yiheng, Zhang Mengsen Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 494-494, 2012. |
---|
![]() |
CJK-P-06 Preliminary Study on Thetreatment Mechanism of Yin-Zhi-Huang Granules to Rat Cholestasis Inducedby Estrgen G.Q. Zhang, Y. Zhou, J.X. Ren, J.P. Zhang, F. Zhang, Y.H. Wei, XA Wu Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 494-494, 2012. |
---|
![]() |
CJK-P-07 Issues in Prescription Analysis and Recognition of Inappropriate Prescription Wang Hailian, Yan Suying Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 495-495, 2012. |
---|
![]() |
CJK-P-08 Effects of Pluronic(R) F68 and PEF400 on the biliary excretion and urine excretion of rifampicin J. Zhao, Y.H. Wei, G.Q. Zhang, X.A. Wu, J.X. Ren Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 495-495, 2012. |
---|
![]() |
CJK-P-09 THE PHARMACOKINETICS OF RIFAMPICIN, CARBAMAZEPINE AND METFORMIN HYDROCHLORIDE IN MICE WITH CHOLECYSTECTOMY Y.H. Wei, X.A. Wu, F. Zhang, Y. Zhou, D. Wang, G.Q. Zhang, J.P. Zhang Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 495-495, 2012. |
---|
![]() |
CJK-P-10 Improve Hypertension Patient Education Material’s Quality using illustration and animation:a randomized study. GONG Jue1)2), ZHAI Suodi1)2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 496-496, 2012. |
---|
![]() |
CJK-P-11 Assessment of drug induced liver injury and the relevant factors; Fluconazole and Voriconazole Ah Young Jeon, Go Wun Choi, Yoon Sook Cho, Hyang Sook Kim, Hye Suk Lee Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 496-496, 2012. |
---|
![]() |
CJK-P-12 Analysis of outpatient medication use in elderly patients and adequacy assessment Hyun-Hee Pako, Hui-Gyeong Woo, Eun-Jeong Shin, Jeong-Mi Lim, Hyang-Suk Kim, Hye-Suk Lee Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 496-496, 2012. |
---|
![]() |
CJK-P-13 Review of pharmacists’drug prescription double check method - Based on split / grinding prescription Joo Kyoung Kim, Yun Hee Jo, Sun Hoi Jung, Hye Sook Lee Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 497-497, 2012. |
---|
![]() |
CJK-P-14 The Analysis of Adverse events and The Assessment of Risk factor of Anti-Tumor Necrosis Factor (TNF) Jung Eun Kim, Sun Hyo Jeong, Hye Suk Lee Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 497-497, 2012. |
---|
![]() |
CJK-P-15 Modification of Warfarin Dosing in Korean Patients with Mechanical Heart Valves before Teeth Extraction Moon Jin Kim1), Kyung Ae Kim1), Jung Mi Lim1), Hyang Sook Kim1), Hye Suk Lee1), Kyung Hwan Kim2), Ki Bong Kim2), Hyuk Ahn2) Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 497-497, 2012. |
---|
![]() |
CJK-P-16 L-asparaginase hypersensitivity reactions in Korean pediatric acute lymphoblastic leukemia patients. Su Hyun Ryu, Jung Ran Lee, Kui Sook Kim, Yong Hwa Lee, Hye Suk Lee Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 498-498, 2012. |
---|
![]() |
CJK-P-17 Development of a Simple Suspension Method for New Drugs Yasuyuki Masaoka, Akane Takemoto, Atsushi Ogawa, Satoru Ezumi, Yoichi Kawasaki, Toshiaki Sendo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 498-498, 2012. |
---|
![]() |
CJK-P-18 Cytotoxicity of Three Polymerization Agents on Human Monocytes Yoichi Kawasaki, Chiaki Tsuboi, Miwa Morizane, Toshiaki Sendo Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 498-498, 2012. |
---|
![]() |
CJK-P-19 Outcome of nutrition support team intervention in patients with diarrhea Yukari Shibata, Tomohide Fukamizu, Yasuo Takeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 499-499, 2012. |
---|
![]() |
CJK-P-20 A survey on communication skills for the trainees pharmacy practice Yoshihiro Shimodozono, Keiko Yaji, Ryuji Ikeda, Yasuo Takeda Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 499-499, 2012. |
---|
![]() |
CJK-P-21 The effects of pharmacists’ active intervention in Therapeutic Drug Monitoring Hitomi Ariga, Nobue Yoshinari, Tetsuya Kudo, Ayaka Ohta, Masayo Tanaka, Takao Orii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 499-499, 2012. |
---|
![]() |
CJK-P-22 Practical use of a large-scale database for safety measures Takao Orii Abstracts of Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences (suppl.1): 500-500, 2012. |
---|